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Abstract 
The ENGAGE project (http://www.engage-europe.eu/) was a collaboration between eight institutions 
across Europe. The aim was to boost the scientific cooperation to use whole genome sequencing 
(WGS) analysis in food safety and public health protection. ENGAGE focused on Escherichia coli 
(commensal E. coli) and different Salmonella spp. serotypes. A total of 3,360 genomes, 778 and 
2,582 of E. coli and Salmonella, respectively, were produced. These genomes were stored and shared 
among partners in a temporary repository to be submitted to the European Nucleotide Archive by the 
end of the project. Generated genomes were used for benchmarking exercises to assess the 
possibility of replacing conventional typing with WGS for outbreak investigation. For the analysed 
strains, the benchmarking exercises showed that SPAdes assembly performed better than Velvet and 
that, by using different bioinformatics tools, WGS Salmonella serotyping and antimicrobial resistance 
genes detection, were largely in concordance with phenotypic data. Discrepancies were related to 
sequence quality and phenotype misclassification rather than to limitations of the bioinformatics tools. 
All partners were able to infer the expected phylogeny for the Salmonella and Campylobacter isolates 
in benchmarking exercises. Two WGS proficiency tests (assessing different genomic quality markers) 
were conducted among partners with satisfactory results. Guidelines including available bioinformatics 
tools and standard operating procedures (wet and dry lab) were prepared and posted online. 
Workshops, training courses and twinning programmes were conducted. The training focused on 
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online, Galaxy-based, and command line bioinformatics tools. To reach out beyond ENGAGE, an e-
learning course (17 videos) was developed and made available online. Several proof of concept 
projects were run and some outcomes published, e.g. the discovery of colistin resistance gene, mcr-5. 
Overall, the project showed that laboratories without previous WGS experience need a period of time 
to implement and perform WGS for foodborne pathogens routine analysis. All developed material will 
remain available on the ENGAGE website. 
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Summary 
The project entitled “Establishing Next Generation sequencing Ability for Genomic analysis in Europe” - 
ENGAGE (http://www.engage-europe.eu/) established a collaboration to boost scientific cooperation 
between eight public health, food and veterinary institutions across the European Union (EU), in order 
to build and enhance the use of whole genome sequencing (WGS) and analysis in food safety and 
public health protection. The project partners were the Technical University of Denmark - National 
Food Institute (DTU Food) from Denmark, Istituto Zooprofilattico Sperimentale del Lazio e della 
Toscana (IZSLT) from Italy, Federal Institute for Risk Assessment (BfR) from Germany, National 
Institute of Public Health – National Institute of Hygiene (NIPH-NIH) from Poland, National Veterinary 
Research Institute (NVRI) from Poland, Istituto Zooprofilattico Sperimentale delle Venezie (IZSVe) 
from Italy, Public Health England (PHE) from the United Kingdom (UK), and the Animal and Plant 
Health Agency (APHA) from the UK. 
The project implemented joint proof-of-concept WGS projects that focused on subtypes of Escherichia 
coli (E. coli) and Salmonella spp. All activities were framed around these projects with a number of 
specific tasks embedded in 11 work packages and steered via 5 phases.  
Seven affiliated institutions (who did not receive funding but collaborated on certain activities) also 
joined the project: verotoxin producing E. coli (VTEC) EURL (Italy), Salmonella EURL (the 
Netherlands), Listeria monocytogenes EURL (France), Institute of Food Safety, Animal Health and 
Environment “BIOR” (Latvia), Laboratorio Central Veterinario-Sanidad Animal (Spain), the Norwegian 
Veterinary Institute (Norway) and the United States of America Food and Drug Administration (US 
FDA). A Code of Conduct (CoC) was signed between the consortium and the affiliated partners where 
relevant to ensure the protection of shared genomic data. 
The ENGAGE consortium defined the criteria for the selection of strains and genomes to be included in 
the project: to include isolates from the nine most common Salmonella serotypes from both, human 
and food/animals infections, commensal E. coli as well as multidrug resistant (MDR)/extended 
spectrum beta-lactamase (ESBL) producing Salmonella and E. coli from the EU AMR monitoring 
programmes. It was also decided to keep the list flexible to target future emerging sub-types. 
Additional relevant and already available genomes were identified among the partners for both proof-
of-concept projects and benchmarking activities.  
DTU, IZSLT, BfR, NIPH-NIH, NVRI, and IZSVe participated in the initial twinning programmes. For 
these, partners brought their own strains to the hosting institute, DTU, for DNA extraction and 
purification, library preparation, WGS and analysis. In later twinning programmes, DTU and IZSVe 
visited PHE and APHA to learn how to use the PHE bioinformatics pipelines or to get acquainted with 
the IT infrastructure used.  
Most of the institutes including DTU initiated the process of outsourcing WGS at the beginning of the 
project due to an approximately 50% cost reduction compared to running WGS in house. As a result 
of being part of ENGAGE, BfR and IZSVe obtained WGS platforms at the end of 2016, and IZSLT and 
NVRI at the beginning of 2017. Towards the end of the project period, all but one institute (NIPH-NIH) 
acquired sequencing platforms and established the ability to sequence isolates as well as to conduct 
bioinformatics analysis in-house, thus ceased outsourcing of sequencing.  
A working space infrastructure was developed for the purpose of hosting produced genomes. The 
ENGAGE project facilitated the production of 3,360 genomes, of which 778 and 2,582 of E. coli and 
Salmonella, respectively. The 3,360 genomes were stored and shared among partners in a temporary 
repository (the working space) and were subsequently submitted to European Nucleotide Archive 
(ENA). 
A list of online available bioinformatics tools and software was prepared in order to: (1) identify 
potential tools that could be used for benchmarking exercises focusing on Salmonella serotyping, 
identifying antimicrobial resistance genes, and assessing phylogeny of Salmonella and Campylobacter, 
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(2) identify potential tools to be used by the partners initiating WGS and lacking bioinformaticians, and 
(3) create an online repository of guidelines and standard operating procedures (SOPs) for building 
whole genome sequencing typing (WGST) capacity in laboratories outside the ENGAGE consortium.  
A large amount of sequence data and a number of bioinformatics tools were tested within the six 
benchmarking exercises conducted during the project including: 1) De novo assembly tools (SPAdes 
3.9 vs. Velvet 1.2), 2) Genotypic Salmonella serotype prediction, 3) Genotypic Salmonella serotype 
prediction complying to the Draft International Standard ISO 16140-6,1 4) Genotypic detection of 
antimicrobial resistance (AMR) genes, 5) Salmonella Enteritidis phylogeny, and 6) Campylobacter coli 
phylogeny. 
Two proficiency tests (PTs) organised within the Global Microbial Identifier (GMI) were executed once 
per year to evaluate the performance of the partner laboratories. The aim of the PTs was to assess 
the WGS quality during the period of the project. Two isolates of the six bacterial genus/species 
targeted, L. monocytogenes, Klebsiella pneumoniae, and Campylobacter jejuni (trial 2016), as well as 
Salmonella enterica, E. coli, and Staphylococcus aureus (trial 2017), were selected for the PTs and 
reference material was produced. Seven out of the eight consortium partners participated in testing 
one to three of the bacterial genus/species per PT trial. NIPH-NIH was not able to participate as they 
did not yet have an in house WGS platform. Summary reports of the conducted PTs are available on 
the ENGAGE website (www.engage-europe.eu). 
The protocols and SOPs for DNA extraction, library preparation, and sequencing procedures and the 
list of available bioinformatics tools are publicly available on the ENGAGE website to maximise reach-
out in boosting the scientific collaboration outside the project.  
Two workshops and training courses were conducted. The first training course focused on basic 
bioinformatics analysis using the Center for Genomic Epidemiology (CGE) tools and basic Galaxy tools 
(platform used by PHE). This was held back-to-back with the annual workshop from the 10th to the 
14th of October 2016 at the consortium institute, NIPH-NIH in Warsaw. The second training course 
and workshop were organized by IZSLT and took place from 23 to 27 October 2017 in Rome. This 
course dealt with the utility of the most relevant and commonly used bioinformatic software and tools 
from CGE or other institutions, executed in an UNIX environment and by command line. 
Several joint proof-of-concept WGS projects that targeted various topics within ENGAGE were 
conducted, including:  
 mcr-1-harbouring plasmids in E. coli in Denmark and their phylogenetic relationship with mcr-1 
plasmids from other geographical regions (DTU Food) 
 Phylogeny of Salmonella Paratyphi B variant Java (ST-28) harbouring mcr-1 (BfR) 
 Identification of a novel transposon-associated phosphoethanolamine transferase gene, mcr-5, 
conferring colistin resistance in d-tartrate fermenting Salmonella enterica subsp. enterica serovar 
Paratyphi B (BfR) 
 VIM-1 producing Salmonella Infantis isolated from swine and minced pork meat in Germany (BfR) 
 Salmonella Infantis in Italy and EU: phylogeny and plasmid carrying virulence, fitness and 
antimicrobial resistance (AMR) genes (IZSLT) 
 Molecular epidemiology of mcr-encoded colistin resistance in Enterobacteriaceae in Italy (IZSLT) 
 Genomic diversity of Salmonella Derby in different European countries (IZSVe) 
 Whole genome characterization of Salmonella Napoli isolates spanning 2005-2015: a national 
issue of international interest (IZSVe) 
 Comparative genomic analysis provides novel insights into the ecological success of the 
monophasic Salmonella Serovar 4,[5],12:i:- (IZSVe) 
 WGS of rare and unrecognised Salmonella serovars (NVRI)  
 mcr-1 positive E. coli in Poland (NVRI)  
                                                          
1  ISO/DIS 16140-6:2017 Microbiology of the food chain — Method validation —Part 6: Protocol for the validation of alternative 
(proprietary) methods for microbiological confirmation and typing procedures. 
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As described in Section 3.10, various scientific contributions were published, presented at meetings, 
accepted or submitted to peer-reviewed scientific journals during the project period.  
To maximize the outreach for capacity building, ENGAGE also produced an E-learning component 
consisting of 17 videos of a total length of 2 hours and 58 minutes describing the whole topic from 
basic conventional molecular sub-typing and the characterization of foodborne pathogens to the use 
of bioinformatics tools and the ENA submission tool (batch-upload) developed by CGE. 
Six newsletters were issued on the ENGAGE website during the project period. These included 
information on management issues, the momentum of the project, the completed deliverables, results 
produced and related conclusions. In addition to the newsletters, information on the ENGAGE 
activities and the results of the serotyping benchmarking exercise were published as news on the GMI 
website (http://www.globalmicrobialidentifier.org/news-and-events/nyheder/Nyhed?id={3AD64758-
03A2-4ACD-92ED-1DEEE427BA63} and http://www.globalmicrobialidentifier.org/news-and-
events/nyheder/2016/09/providing-resources-and-guidance-for-next-generation-
sequencing?id=e341eaa2-bad2-4afb-8d52-d14bb0c1e95c 
All developed material will remain available on the ENGAGE website (http://www.engage-europe.eu/). 
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 Introduction  
 
 Background and Terms of Reference as Provided by the Requestor 
This grant was awarded by EFSA to: Technical University of Denmark, National Food Institute (DTU 
Food) 
Beneficiaries: Technical University of Denmark - National Food Institute; Istituto Zooprofilattico 
Sperimentale del Lazio e della Toscana; Federal Institute for Risk Assessment; National Institute of 
Public Health – National Institute of Hygiene; National Veterinary Research Institute; Public Health 
England; Animal and Plant Health Agency, and Istituto Zooprofilattico Sperimentale delle Venezie 
Grant title: ENGAGE - Establishing Next Generation sequencing Ability for Genomic analysis in Europe 
Grant number: GP/EFSA/AFSCO/2015/01 
 
Main objective of the call  
The main objective of this call is to facilitate a scientific cooperation framework, the development and 
implementation of joint projects and the exchange of expertise and best practices in the fields within 
the Authority’s mission. In particular, the action financed by the European Food Safety Authority 
(EFSA) grant to be awarded following the present call for proposals shall contribute to the objective of 
boosting scientific cooperation between scientists and research organisations with a competence in 
the development and validation of new approaches in the area of microbiological and chemical hazard 
assessment. It is of paramount importance to coordinate efforts between the food, veterinary and 
human health sectors in order to obtain maximum benefits from the use of WGS and read across 
methodologies for microbial and chemical food safety, respectively. 
 
Specific objectives of the call  
Making use of molecular approaches to identify and characterise microbial foodborne pathogens, 
specifically using WGS analysis, to enhance the understanding, the traceability and spread of the 
disease in humans that these bacteria populations may cause.  
The molecular approach to identify and characterise microbial foodborne pathogens, specifically using 
WGS analysis, provides a golden opportunity to (i) explore the bacterial genetic diversity within and 
between compartments in the food chain; (ii) to assess the epidemiological relationship of isolates 
from different compartments; and (iii) to identify the presence of putative markers conferring the 
potential to survive/multiply in the food chain and/or cause disease in humans (e.g. virulence and 
antimicrobial resistance). The methodology is very promising, and the technology is still evolving 
quickly. However it is still unclear when and how this technology will be ready to be applied to routine 
activities and proof-of-concept projects for application in a public health context are needed. 
 
 Interpretation of the Terms of Reference  
The specific objectives of this call focus at using WGS to identify and characterise foodborne 
pathogens as described in Section 1.1. The ENGAGE consortium opted also to focus on exchanging 
expertise, developing and providing training on WGS, providing consensus quality parameters on NGS 
outputs applied to WGS-based characterisation of bacterial pathogens, providing benchmarking 
exercises on bioinformatics tools, producing SOPs and training materials as described below. 
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1) To build a One Health, all sectors network to boost scientific cooperation 
a. To achieve the One Health approach, we included partners from the three sectors: public 
health, food, and the veterinary sectors. Thus, we contacted the EURL-AR network, the 
European Commission (EC), Food and Waterborne Disease (FWD) network of the European 
Centre for Disease Prevention and Control (ECDC), and partners within the “COllaborative 
Management Platform for detection and Analyses of (Re-)emerging and foodborne outbreaks 
in Europe” (COMPARE; http://www.compare-europe.eu/) consortium working with bacteria. 
 
2) To develop and implement joint proof-of-concept WGS projects on foodborne pathogens (FBP) 
to investigate genetic diversity, epidemiological links, successful clones, virulence and AMR of 
isolates from different compartments 
a. Launching projects that focused on E. coli as, globally, E. coli is one of the most frequent 
bacterial species both in human and animals. Some E. coli strains are important human 
bacterial pathogens that cause a variety of infections including poorly understood foodborne 
infections as well as large outbreaks. Most of these projects focused on commensal E. coli, as 
these bacteria are subjected to high antimicrobial pressure and are interesting from the AMR 
point of view. Additionally, very little is known about clones and serovars circulating as 
serotyping is rather rarely used. The other selected target organism was Salmonella spp. as 
this is still one of the top FBP in EU. For both organisms, infectious strains resistant to 
cephalosporins and carbapenems persisting or emerging in the food chain have been reported. 
b. Collecting strains to be whole genome sequenced and storing sequences temporarily in a 
central working space for comparative analysis. This also included genomes of strains that 
had already been sequenced by consortium partners.  
 
3)  To exchange expertise and best practices in WGS and bioinformatics analysis 
a. Organising workshops, training courses and twinning programmes for consortium partners 
(self-supported network participants) and E-learning for the entire network for bioinformatics 
analysis of WGS data in order to disseminate knowledge, share best practices, SOPs and WGS 
analysis results. 
 
4) To develop and appraise new bioinformatics tools used in microbial risk assessments of 
foodborne pathogens 
a. Storing the data collected in a temporary working space, thus allowing the partners to 
individually i) investigate clonal diversity and epidemiological links, ii) search for virulence and 
AMR markers in major clones and iii) assess successful clones. 
b. Establishing PT/QC guidelines to ensure reliable WGS data for reliable cross sector/cross 
country comparability. 
c. Performing benchmarking exercises to assess the performance of different bioinformatics 
tools. We aimed to provide the results of such exercises to a broader audience during joint 
workshops.  
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 Objectives 
The objective of ENGAGE (Establishing Next Generation sequencing Ability for Genomic analysis in 
Europe) was to establish collaboration between the public health, food and veterinary sectors across 
the EU and to build capacity for WGS and bioinformatics analysis to ensure better food safety and 
public health protection.  
The ENGAGE project boosted the scientific cooperation among leading food-, veterinary- and public 
health institutes across Europe by implementing joint proof-of-concept WGS projects to investigate: 
1) bacteria evolution and genetic diversity driven by genetic exchange, selection, and clonal expansion; 
2) epidemiological relationships between the target microorganisms; 3) identification of successful 
clones; and 4) microbial determinants of virulence, AMR, and other putative markers in various 
emerging ‘epidemic’ strains of commensal E. coli and Salmonella spp. that have the potential to have 
a strong impact in public health across Europe. 
The ENGAGE project pursued the following specific objectives I – V within the format of a two-year 
program. Together these five specific project objectives shaped the overall framework of ENGAGE. 
 
I. Joint proof-of-concept WGS projects targeting emerging commensal E. coli and Salmonella spp. 
Isolates were selected and collected by consortium partners within the first quarter of the project 
period.  
WGS data was generated for joint analyses by the consortium partners and used for a number of 
scientific publications. A total of 3,360 E. coli and Salmonella spp. were sequenced throughout the 
project period. The strains originated from the daily routine diagnostics and the national/EU 
monitoring programs. Affiliated partners were invited to participate in the workshops and training 
courses of ENGAGE.  
 
II. Creation of a temporary database for hosting genome data 
The genome data of emerging commensal E. coli and Salmonella spp. isolates were temporarily stored 
in a secure working space (genome database) developed in the first quarter of the project period. 
Subsequently, all data was released to the European Nucleotide Archive (ENA) and EFSA, by the end 
of the project period. The consortium partners had full access to the working space including raw 
reads and a minimum set of metadata consisting of isolation source, host, host status, pathogenic 
organism, strain, subtype, collection date and country. 
 
III. Benchmarking of bioinformatics analytic tools to assess the applicability and integration of WGS 
into public health 
Currently, there are no international standardized guidelines on how to analyse WGS data. Thus, it 
was important to validate the bioinformatics methods being used to ensure that whatever tool was 
applied, the same epidemiological links, successful clones, virulence factors and AMR markers would 
be detected in the same data set. To address this, various commercial and online open access 
bioinformatics analytic tools were used in a comparative benchmarking analysis to ensure comparable 
results despite differences in the tools being used.  
 
IV.  To establish and conduct WGS proficiency tests 
To ensure reliable WGS data from organizations generating WGS data, it was of paramount 
importance to establish and conduct WGS PTs regularly (e.g. at least once a year). In addition to the 
PTs, best practices guidelines, protocols and SOPs for quality assurance (QA) were developed, as well 
as reference materials which were made available. In the framework of GMI, the DTU and PHE were 
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already involved in setting up a PT scheme consisting of two components: 1a. DNA extraction, 
purification, library-preparation, and WGS from live cultures; 1b. WGS of pre-prepared DNA. ENGAGE 
decided to use the PT designed in the framework of the GMI PTs, using the reference material already 
available to avoid duplication of work and draw from the synergy between the two programmes. 
Overall, the PTs assessed the quality of the obtained genome sequences. The results of the PT trials 
were disseminated annually to ENGAGE partners through specific ENGAGE reports.  
 
V. To boost scientific collaboration between scientists, clinicians, and risk assessors to exchange 
expertise and knowledge and build capacity in WGS and bioinformatics analysis 
In the first year of the project, ENGAGE developed and organised training courses, twinning 
programmes and workshops for consortium and/or affiliated partners in order to promote knowledge 
transfer and expertise exchange and boost scientific collaboration in the area of WGS. In addition, E-
learning modules were developed to build WGS capacity. The consortium partners discussed regularly, 
with participation of EFSA, the latest results through conference calls. The European Centre for 
Disease Prevention and Control (ECDC) participated as an observer in important meetings and 
discussions. In cases of emergency, ad hoc meetings would be autonomously arranged to disseminate 
urgent information.  
 
 Data and Methodologies  
ENGAGE was planned as a two-year program divided into five phases that was carried out by 11 work 
packages (WP): 
 WP1 Project Cooperation Framework  
 WP2 Data Collection 
 WP3 Whole Genome Sequencing  
 WP4 Genome Database  
 WP5 Analysis/Benchmarking  
 WP6 Proficiency Testing  
 WP7 Output/Outcome  
 WP8 Training/E-Learning  
 WP9 Workshops  
 WP10 Dissemination 
 WP11 Project Management  
The first phase, the “Kick-off phase”, involved three WPs facilitating the start-up process of the project 
(WP1 Project Cooperation Framework, WP2 Data Collection; and WP4 Genome Database).  
The “Analytic phase” was one of the three operational phases and included WP3 Whole genome 
sequencing and WP5 Analysis/Benchmarking. 
The “Proficiency testing phase” was the second operational phase and was related to WP6 Proficiency 
testing. 
The “Boosting scientific collaboration phase” was the third operational phase and included WP7 
Output/outcome, WP8 Training/E-learning and WP9 Workshops. 
The “Administrative phase” included WP10 Dissemination and WP11 Project Management and 
continued throughout the project period. 
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 Programme Phases and Work Packages 
The Kick-off phase involved three work packages: WP1, WP2 and WP4. WP1, Project cooperation 
framework, provided a framework for the project with the aim of identifying and inviting affiliated 
partners including EURLs, EFSA, ECDC, relevant National Reference Laboratories (NRLs) and FWD 
network members. WP2 Data collection aimed to develop a sampling strategy and to identify 
additional relevant and already available genomes among the partners for both, proof-of-concept 
projects and benchmarking activities. WP4 Genome database was the third WP component of the 
Kick-off phase and the aim of this work package was to develop a working space at DTU to 
temporarily store collected genomes until submission to ENA.  
The Analytic phase included WP3 and WP5 in which WP3 Whole Genome Sequencing included 
identification of already available strains for WGS, as well as identification and sequencing of strains 
from strain collections. We anticipated generating approximately 3,000 genomes of the target 
organisms, namely selected E. coli and Salmonella spp. strains, during the project period. This task 
would feed directly into performing sequence analyses and subsequently into ongoing and real-time 
analysis (WP5) of the generated genomes as benchmarking analysis reports and proof-of-concept 
projects. This phase continued throughout the project ending with all genomes submitted to ENA and 
EFSA.  
The Proficiency Testing phase (WP6) explored the possibility for collaboration with already existing 
activities, e.g. GMI, to avoid duplications. Consequently, existing documents, protocols, etc. were re-
used and modified to meet the requirements of a PT for the ENGAGE project. Based on the PT results, 
a quality assurance guideline2 and a bioinformatic QC pipeline were developed. The QC pipeline was 
integrated into the CGE batch-upload tool3. In addition to the PT, WP6 also produced or provided 
relevant reference material of recent outbreak strains, strains harbouring emerging AMR genes, or 
other relevant strains of the target pathogens. 
The Boosting scientific collaboration phase included WP7 in which a range of protocols and SOPs were 
developed to assist scientists in DNA extraction, library preparation and the execution of WGS and 
bioinformatics analysis. Based on identified suitable bioinformatics tools and software, a best practice 
guideline was developed with the purpose of indicating how to get started when embarking on WGS. 
Based on the developed guidance materials and previous experiences, the curricula for two three-day 
training courses running back-to-back with two 2-day workshops were developed, followed by 
invitations to workshops and training events (WP8 and WP9). The two workshops were organized to 
boost the scientific collaboration, and for the consortium partners to steer the project, ensuring that 
milestones were reached and deliverables developed. These meetings also provided a forum to 
disseminate the state-of-the-art knowledge and scientific presentations. Moreover, as part of WP8, 
twinning participants were identified and twinning programmes established and conducted during the 
project period, with most programmes running at the beginning of the project period. To ensure a 
proper outreach and sustainability of the developed material, E-learning lectures were developed 
based on training course presentations and posted online with open access. Developing the E-learning 
modules added to the sustainability of the project results. 
The Administrative phase included administrative support to consortium partners, arranging 
conference calls, organizing kick-off-meeting, interim-meeting, and the final meeting with partners 
and EFSA, as well as reporting the progress and dissemination of news and results (WP10 and WP11). 
The administrative efforts also included maintaining the consortium information flow as a whole, 
coordinating activities with EFSA and INNUENDO4, collaboration with INNUENDO in relation to their 
                                                          
2  Available for download on the ENGAGE website; http://www.engage-europe.eu/resources/protocols-and-training 
3  https://cge.cbs.dtu.dk/services/cge/ 
4  A novel cross-sectorial platform for the integration of genomics in surveillance of foodborne pathogens 
(http://www.innuendoweb.org/). The INNUENDO project has received funding from European Food Safety Authority 
(EFSA), grant agreement GP/EFSA/AFSCO/2015/01/CT2 (New approaches in identifying and characterizing microbial and 
chemical hazards) and from the Government of the Basque Country. 
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participation in a number of activities such as the benchmarking of serotyping tools, workshops and 
training courses. 
 
 Results  
 Establishment of the ENGAGE Cooperation 
In January 2016, as part of WP1, Project cooperation framework, potential affiliated partners were 
identified and invited to participate in ENGAGE (not co-funded) by providing them with the 
opportunity to link with the project consortium and their activities, i.e. DTU Food reached out to 
relevant EURLs (EURLs of VTEC, Salmonella and L. monocytogenes (EURL-Lm)), the National 
Reference Laboratories (NRLs) of the EURL-AR network, ECDC, ECDC FWD network members, the US 
FDA, the US CDC, and WHO. WP1 also involved evaluating options to ensure compliance with the 
legal aspects of sharing data, strains and genomes including Non-disclosure agreements (NDAs), 
Memorandum of understanding (MoUs), Material transfer agreement (MTAs), or Codes of conduct 
(CoC). 
The Legal department at DTU did not find it necessary to create a NDA, MoU or MTA to allow sharing 
of potential political sensitive genomic data and protect the Intellectual Property (IP). In February 
2016, the legal department suggested to create a Code of Conduct (CoC) substituting the above 
documents.  
In total, seven affiliated partners, which included the EURL-VTEC (Istituto Superiore di Sanità, ISS, 
Italy), EURL-Salmonella (the Dutch National Institute for Public Health and the Environment, RIVM, 
the Netherlands) and EURL-Lm (French Agency for Food, Environmental and Occupational Health 
Safety, ANSES, France), in addition to the Institute of Food Safety, Animal Health and Environment 
(BIOR, Latvia), the Laboratorio Central Veterinario-Sanidad Animal (Spain), the Norwegian Veterinary 
Institute (Norway), and the US Food and Drug Administration (USA), joined the project. The main 
reason why some of the contacted laboratories were reluctant to join ENGAGE was that they did not 
have genomic data to share nor did they yet have the capacity for WGS.  
 
 Working Space Infrastructure 
Prior to the project launch, DTU as part of COMPARE had created a working space infrastructure 
which was further developed for the needs of ENGAGE for the purpose of hosting produced genomes. 
The working space allowed for upload/download of genomes either as singletons or in batches. 
Additionally, the working space allowed for submission of metadata via an excel sheet including key 
epidemiological markers such as date of isolation, origin (human, pig, etc.), source (stool, blood, etc.), 
geographical location of the sampling, as well as funding body, ownership, etc. This enabled the users 
to search for specific genomes for either benchmarking or other projects. The access to the working 
space was managed within WP4. 
The working space allowed for uploads and downloads in batches as well as sharing data among 
partners. Some partners, i.e. PHE, BfR, IZSVe and APHA, who submitted their own genomes directly 
to ENA, included the ENGAGE project identifier to enable ENGAGE partners to locate the sequence 
data at ENA. In contrast, DTU downloaded genomes from NVRI, IZSLT and NIPH-NIH via the working 
space and submitted these genomes to ENA via the working space. 
All the 3,360 isolates that have been sequenced during the project are available on the ENA website. 
The final dataset consists of 2,582 strains of S. enterica and 778 strains of E. coli. The Supplementary 
Table 1 (Annex A) references all the accession number for the sequences. 
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 Data Collection 
Early in the kick off phase and in a discussion with EFSA it was agreed that it would be preferable to 
expand the target to include commensal E. coli in general, and to have a strong focus on AMR for 
both target organisms, i.e. focusing on multidrug resistant (MDR)/extended spectrum beta-lactamase 
(ESBL) producing Salmonella and E. coli from the EU AMR monitoring programmes. In the selection 
criteria for strain and genome inclusion, efforts were made to avoid redundancies with the COMPARE 
(S. Typhimurium, monophasic S. Typhimurium, S. Enteritidis) and the INNUENDO (S. Enteritidis, VTEC) 
projects. However, as the scopes of COMPARE and INNUENDO differed from ENGAGE, it could be 
justified to include the above serovars in ENGAGE proof-of-concept and benchmarking projects.  
A consensus consortium agreement was to focus on the nine most common Salmonella serotypes 
from both human and food/animals infections. This included the following serovars: S. Infantis, S. 
Kentucky, S. Stanley, S. Enteritidis, S. Paratyphi B var. java, S. Typhimurium, S. 4,[5],12:i:‐/4,12,:i:‐ 
(monophasic S. Typhimurium) S. Newport, and S. Derby. Moreover, S. Napoli, a relatively uncommon 
Salmonella serovar in Europe, was taken into consideration as it is among the top serovars causing 
human infections in Italy, but the reservoir and transmission pathways are still unknown. 
Additional focus was to target commensal E. coli as well as MDR/extended spectrum beta-lactamase 
(ESBL) Salmonella and E. coli from EU AMR monitoring programmes. The specific antimicrobial classes 
and drugs targeted within ENGAGE were the following: fluoroquinolones (ciprofloxacin), 3rd 
generation cephalosporins and cephamycins (cefotaxime, ceftazidime, cefoxitin), carbapenems 
(meropenem, imipenem), azithromycin, temocillin, tigecycline, and colistin. The selection process was 
kept flexible to allow targeting potential emerging sub-types but also fully susceptible strains. One of 
the laboratories also included some VTEC for specific studies (NIPH-NIH). 
DTU, BfR, NVRI, and APHA provided strains of animal and food origin whereas PHE and NIPH-NIH 
provided human strains. IZSVe and IZSLT provided strains from all sectors. In summary, ENGAGE 
collected strains are representing the One Health approach. The provision of isolates was addressed in 
WP2 Data collection, which also contains a set of tasks. One of the consortium partners, DTU, is also 
the EURL for AMR, and as such supported the ENGAGE project with additional strains from other 
countries.  
The information on the strains to be included in the project was captured from all partners in order to 
identify the strains available for sequencing (Appendix A). ENGAGE produced 3,360 genomes, 778 and 
2,582 of E. coli and Salmonella, respectively. This included the following number of genomes per 
partner: DTU: 520, PHE: 500, APHA: 439, BfR: 382, NIPH-NIH: 320, NVRI: 368, IZSLT: 382, and 
IZSVe: 449. A summary of the 3,360 genomes, including ENA accession numbers, was provided in 
Supplementary Table 1 (Annex A).  
 
 Development of Protocols, Guidelines and SOPs for WGS and 
Analysis of WGS Data 
Most activities in WP7 were related to facilitating the capacity building of laboratories which are in the 
process of implementing WGS. The WP includes guidelines and documents that support how to get 
started on performing WGS analysis and using bioinformatics tools. This included the following 
documents: the best practise guideline, “How to get started” (Appendix B), SOPs and protocols 
describing the DNA extraction, library preparation, and sequencing procedures using MiSeq, available 
bioinformatics tools (Appendix C and D) and a description about sequencing quality.5 The WP also 
included writing all of the benchmarking reports allowing laboratories to identify the best tool for the 
analysis.  
                                                          
5  Available on http://www.engage-europe.eu/resources/protocols-and-training 
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All produced protocols, SOPs, and guidelines are also publicly available on the ENGAGE website 
(http://www.engage-europe.eu/).  
 
 Whole Genome Sequencing 
The consortium partners used a range of different sequencing technologies and platforms. This 
included Life Technology’s Ion Torrent PGM and Illumina’s Miseq, Nextseq and Hiseq platforms. DTU, 
BfR, IZSVe, NVRI and IZSLT have access to in-house Illumina Miseq. In addition, DTU had access to 
in-house Illumina Nextseq. PHE had access to in house Illumina Hiseq 2500 and APHA to two Illumina 
MiSeq/Roche 454/Mini-ION and Illumina NextSeq. Several partners - NIPH-NIH, NVRI, APHA, DTU, 
IZSLT - outsourced parts of the sequencing to subcontractors to save costs.  
At the time when the project was initiated, PHE, APHA, and DTU had already established WGS 
capacity. The three institutes immediately initiated the in-house sequencing. In the early phase of the 
project, the remaining institutes, IZSLT, BfR, NIPH-NIH, NVRI, and IZSVe did not have an established 
WGS capacity or trained staff, and thus training of participants from these institutions through 
twinning was done in an early phase of the project. During the twinning at DTU, the participants 
brought their own strains for DNA extraction, library preparation and WGS including IZSVe: 9 strains 
of S. Derby and 25 monophasic variant of Salmonella Typhimurium; NVRI: 2 strains of S. Infantis, 6 
strains of Salmonella enterica spp. diarizonae; BfR: 8 strains of S. Infantis; IZSLT: 7 strains of S. 
Infantis and 14 strains of E.coli; NIPH-NIH: 3 strains of Salmonella enterica subsp. enterica 
1,4,[5],12:b:-, 2 strains of Salmonella enterica subsp. enterica 1,4,[5],12:i:-, 1 strain of S. 
Senftenberg and 1 strain of S. Paratyphi B var. Java. Subsequently, the genomes produced were 
analysed using the online CGE bioinformatic tools developed by DTU.  
Later in 2016, most of the institutes, including DTU, initiated the process of outsourcing the WGS due 
to an approximate 50% cost reduction. This change was accepted by the financial unit at EFSA and 
the sequencing centres were included in the ENGAGE project as sub-contractors. In mid-2016, BfR 
and IZSVe developed in house capacity to perform WGS and bioinformatics analysis. Towards the end 
of 2016, IZSLT and NVRI also developed this capacity as a direct outcome of being part of ENGAGE. 
At the end of the project (January 2018) the only institute that was part of the ENGAGE consortium 
that had not established WGS capacity was NIPH-NIH and even this institute, as a direct consequence 
of their ENGAGE experience, is exploring (planning and cost calculation) the possibility of setting up its 
own Food and Waterborne Diseases WGS laboratory. 
The appropriate and available bioinformatics pipelines and software for the WGS analysis and 
benchmarking were identified via Github, websites, and from the scientific literature. All partners used, 
and had access to, a number of available bioinformatics tools, either in house or online, for cluster 
analysis and detection of different epidemiological markers such as AMR genes. 
 
 Benchmarking Exercises 
A list of bioinformatics tools and software for the analysis and benchmarking was generated and 
added to a list as the project progressed (Appendix D). The list presents an overview of bioinformatics 
tools available to analyse WGS data for different purposes and was intended to be used as a starting 
point to select and try out software available at the time of the study. As bioinformatics tools and 
software evolves with new techniques, it is advised to check for newly released software updates 
regularly. The list served three purposes: 1) listing the bioinformatics tools that could potentially be 
used for benchmarking exercises, 2) providing information for the partners initiating WGS and lacking 
bioinformatics capacities, and 3) summarizing in the ENGAGE website, the bioinformatics tools for the 
online repository of guidelines and SOPs for building WGS capacity (WP7) in laboratories outside the 
consortium.  
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Six benchmarking exercises were conducted and the reports summarised below present the details of 
the analyses. The benchmarking reports are available as appendices to this report and they have been 
posted on the ENGAGE website at http://www.engage-europe.eu/resources/benchmarking. 
1. Benchmarking of de novo assembly tools: SPAdes 3.9 vs Velvet 1.2 (Appendix E): This 
benchmarking exercise was designed to compare two different assembly tools, SPAdes and Velvet. 
For the set of sequences analysed, the benchmarking showed that SPAdes generates longer 
contigs than Velvet. Furthermore, the accuracy of predicting the correct MLST in the sequenced 
Salmonella genomes was higher using SPAdes (100%) in comparison to using Velvet (94%). 
2. Benchmarking of genotypic Salmonella serotype prediction (general) (Appendix F): General 
genotypic Salmonella serotype prediction of 786 different isolates (all strains from DTU were not 
part of ENGAGE project) covering 196 different serotypes using the MOST tool, 
SalmonellaTypeFinder, and the SeqSero stand-alone tool. During the project, this serotyping 
exercise was repeated with the inclusion of the SISTR tool developed by Public Health Agency 
Canada. The report presents the benchmarking of all four tools. Genotypic Salmonella serotype 
prediction of 786 different isolates covering 196 different serotypes using MOST, 
SalmonellaTypeFinder 1.4, the SeqSero 1.2 stand-alone tool and SISTR v1.0.1, clearly 
demonstrated that serotyping of Salmonella spp. using NGS data is a very feasible option. The 
result of the exercise, for the set of sequences analysed, showed that the best bioinformatics tool, 
SISTR, achieved 88% (694 isolates out of 786) correlation with the conventional serotyping, 
followed by MOST and SalmonellaTypeFinder with 85% (669 and 668 isolates respectively), 
whereas SeqSero had 65% correlation with the conventional serotyping, which is a conservative 
number considering that none of the isolates have been re-tested to ensure correct serotyping; 
moreover, different assembly tools were used by the participants which may also have an effect on 
the results. The ‘no correlation’ rate (miscorrelation, no prediction and ambiguous) was 12% for 
SISTR, 15% for MOST and SalmonellaTypeFinder and 35% for SeqSero. The miscorrelation rates 
or cases  where the tools  predicted a different serotype than the expected were in the range of 
3-4% for MOST, SeqSero and SalmonellaTypeFinder and 8% for SISTR in this study. At least half 
of these miscorrelations are potentially due to mistakes in the conventional serotyping excluding 
the effect of using different assembly tools prior to benchmarking. Such a low miscorrelation rate 
would probably be hard to achieve for most laboratories performing conventional serotyping. It is 
recommended to perform classical serotyping of the isolates where the predictions from the tools 
disagree with the expected serotype. This is especially important for the isolates where all tools 
have identical miscorrelations. A higher miscorrelation rate was expected for the tested dataset as 
of the 786 tested isolates 500 were routine isolates provided by PHE, 208 diverse isolates provided 
by DTU (not sequenced as part of the ENGAGE project) and 78 rare isolates provided by APHA (i.e. 
antigenic formulas observed occasionally in routine laboratory diagnostics). The correlation of the 
serotype prediction with the conventional serotyping was > 90% with all tested tools (92-100%) 
for the 4 Salmonella serovars S. Typhimurium, S. Enteritidis, S. Kedougou and S. Kentucky. The 
results of this benchmarking exercise (Genotypic Salmonella serotype prediction) will be published 
in a peer-reviewed scientific journal. 
3. Benchmarking of genotypic Salmonella serotype prediction complying to the Draft International 
Standard ISO 16140-6 (ISO/DIS 16140-6:2017 Microbiology of the food chain — Method validation 
—Part 6: Protocol for the validation of alternative (proprietary) methods for microbiological 
confirmation and typing procedures) (Appendix G): The main purpose of this benchmarking 
exercise was to perform an inter-laboratory study in order to evaluate a number of available 
bioinformatics tools for the in silico prediction of Salmonella serovars from raw WGS data. The 
setup of the study complied with the Draft International Standard ISO 16140-6 (ISO/DIS 16140-
6:2017 Microbiology of the food chain — Method validation —Part 6: Protocol for the validation of 
alternative (proprietary) methods for microbiological confirmation and typing procedures). In this 
study, a total of 27 genomes (not part of ENGAGE project) were tested including 18 isolates of 6 
Salmonella serovars: Enteritidis (n=3), Hadar (n=3), Infantis (n=3), monophasic Typhimurium 
(n=3), Typhimurium (n=3), Virchow (n=3); 5 non-target Salmonella serovars: Derby, Dublin, 
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Kentucky, Mbandaka, Stanley; 4 non-target genus, but of the same family (Enterobacteriaceae): 
Citrobacter freundii, E. coli, Klebsiella pneumoniae, Shigella flexneri. According to the current 
legislation (Reg. (EC) No 2160/2003 and subsequent implementing acts) on the control of 
Salmonella in poultry populations, a list of different serovars are considered relevant (called target 
serovars) and to control such serovars specific corrective measures must be implemented. All the 
other serovars are considered non-target and their control are based on different approaches. The 
results of this benchmarking study demonstrated that serotyping using WGS data is a promising 
option. The tools predicting the Salmonella serovars most optimally, in the current study, were 
SISTR, SeqSero, SalmonellaTypeFinder followed by MOST, resulting in a 96.3% correlation (SISTR 
(v1.0.1 and v0.3.6), SeqSero 1.0 (command line version), SalmonellaTypeFinder 1.3 
(https://cge.cbs.dtu.dk/services/SalmonellaTypeFinder/) and MOST) with the conventional 
serotyping for the set of sequences analysed. When analysing the data in accordance with ISO/DIS 
16140-6:2017, the evaluation of results at species level showed to be within the acceptability limits 
for inclusivity and exclusivity as indicated in ISO/DIS 16140-6, but at serovar level they exceeded 
these limits. This latter was mainly caused by the fact that for 7 target strains, 3 tools could not 
identify the Salmonella serovar. Testing non-target strains additionally to target strains in such a 
study showed to be important as in three datasets Citrobacter was incorrectly identified as 
Salmonella. The choice of assembly tools and/or different options/parameter settings still needs 
some attention when using WGS for serotyping Salmonella. It is recommended to repeat 
conventional serotyping of the isolates where the predictions from the tools disagree with the 
expected serovar.  
4. Benchmarking of genotypic detection of antimicrobial resistance (AMR) genes (Appendix H): The 
results obtained when detecting AMR genes in 164 E. coli and 125 Salmonella genomes (two of the 
125 Salmonella genomes included in this study were not sequenced as part of ENGAGE project) 
using bioinformatics tools showed that predicting antimicrobial resistance using WGS is a feasible 
and realistic alternative to phenotypic susceptibility testing. Of the 4 tested tools (ResFinder 1.2, 
KmerResistance 2.1, SRST2 v0.1.7, PHE GeneFinder (no version available; tests performed on 
01.02.2017)), the ResFinder 1.2 and the PHE GeneFinder tools provided the highest degrees of 
specificity, sensitivity, Matthew’s Correlation Coefficient (MCC) and accuracy in the Salmonella 
dataset. ResFinder also provided the highest accuracy and MCC in predicting resistance in the E. 
coli genomes for the set of sequences analysed. However, in comparison to Salmonella, all 4 tested 
tools performed with a lower accuracy when testing E. coli; especially low accuracy was achieved 
in profiling β-lactam. This could be due to the inclusion of the E. coli containing upregulated 
chromosomal ampC mutation (mediating β-lactam resistance) in the dataset which none of the 
tools tested at the time could predict. As a result, the detection of ampC and chromosomal point 
mutations were included in the new, updated version of ResFinder 1.3. The results of this 
benchmarking exercise will be published in a peer-reviewed scientific journal. 
5. Benchmarking for Salmonella Enteriditis phylogeny (Appendix I): The main purpose of this 
benchmarking exercise was to evaluate a number of available bioinformatics tools (online or 
command line), both to detect variants and to build a phylogeny based on the variants alignment 
detected for S. Enteritidis isolates. With the use of WGS, phylogeny is used as a method to 
investigate outbreaks and to perform surveillance among isolates that are genetically related. The 
results were compared using two main approaches: (1) Alignment and distance matrix comparison 
and (2) Topology of the tree: global topology, Robinson-Fould symmetric difference and 
percentage of edge similarity (number of branches in one tree that are present in another). The 
main conclusions of the study, for the set of sequences analysed, were that the SNP alignments 
generated by different methods showed similar results except in 3 cases when Snippy v3.0, 
CSIPhylogeny v1.4 method without heterozygote removal and with alignments produced by one 
customized pipeline (Centre 10) were used. The SNP alignments in these 3 cases showed a 
discrepancy between distantly related isolates The scores based on the topology demonstrate that 
most of the methods tested are able to retrieve the topology derived from the gold standard 
except for the method used by Centre 10 [VCF-kit v0.1.2 pheno tree nj]. During this benchmarking 
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we have identified that a key point in building a phylogeny based on the SNP-differences between 
isolates is the detection and filtering of the SNPs. Different tools/parameters can lead to the same 
topology but with a variable number of SNP- differences. This point is really important as new WGS 
investigation for outbreak based their case definition on a clustering approach (SNP-differences 
between isolates). Based on this benchmarking we recommend a minimum depth coverage for the 
SNPs detection > 10, a minimum mapping read quality of 30, and 90% consensus for the reads 
mapped at a position that differs from the reference. The best tools to build a tree from an 
alignment are maximum likelihood methods. Topology obtained using these methods produced 
trees with the best correlation between gold standard and the obtained phylogeny. 
6. Benchmarking for Campylobacter coli phylogeny (Appendix J): The main purpose of this 
benchmarking exercise was to evaluate a number of available bioinformatics tools to detect 
variants and to build a phylogeny based on the variants alignment detected as a method to 
characterize outbreaks and perform surveillance of genetically related isolates. In this specific 
exercise, the participants were asked to take into account the possibility of recombination between 
isolates. The main conclusions from the study, for the set of sequences analysed, are that the 
methods used to generate the SNP alignment in the 11 different test sets showed similar results 
except for two centres where the comparisons of the distance matrix showed discrepancies 
between those isolates that are closely related. During this benchmarking we have identified that a 
key point in building a phylogeny where a recombination can occur is to link distance matrices and 
the phylogeny. The subtle topology of a closely related cluster is highly correlated to the presence 
of a recombination. We can also confirm with this benchmarking that, if the organism is likely to 
contain recombinations and discrepancies occur between phylogeny and epidemiology information, 
it is recommended to carry out a detection of recombination. This benchmarking shows that 
partners have used “gold standard” methods both for SNP detection and tree building. Filtering of 
SNPs has been properly carried out and most of the participants have used a maximum likelihood 
method to generate the phylogeny. It also demonstrated that, despite knowing the good practice 
to derive a phylogeny from WGS, phylogeny needs to be used with caution and can be only fully 
explained given support from other epidemiological data. 
Overall, the benchmarking exercises showed that the tested bioinformatics tools were all performing 
as anticipated in serotyping Salmonella, identifying AMR genes and inferring phylogeny to Salmonella 
and Campylobacter. At this stage, it is not recommended to select only one single bioinformatics tool 
for the bioinformatics analysis since all tools are regularly updated and improved and all perform 
satisfactorily. All benchmarking exercises included the limitation that different assembly tools were 
used prior to testing the bioinformatics tools in question, potentially affecting the results. 
 
 Proof-of-Concept Projects  
The ENGAGE project has been highly valuable for all ENGAGE consortium partners which also is 
reflected in the proof-of-concept projects executed as part of the ENGAGE project. The outcome of 
the ENGAGE project, including the selection of strains made by each ENGAGE consortium partner 
(covering the target organisms defined for WP3) and a summary of the proof-of-concept projects are 
presented below. Collaboration between several partners was facilitated and has led to valuable 
outcomes and in some cases to publications. Full descriptions of these projects are presented in 
Appendix K.  
 
Feedback from DTU (Denmark) 
The Technical University of Denmark, National Food Institute (DTU Food) was the coordinator of the 
ENGAGE consortium and had already, before the launch of the project, implemented whole genome 
sequencing (WGS) for routine analysis. At the point of the launch of the project, DTU Food already 
had access to the MiSeq (Illumina, San Diego, USA) and Ion Torrent (Life Technologies, Thermo 
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Fisher Scientific, Waltham, USA) platforms. In addition, DTU Food has developed a wide range of 
bioinformatics tools with open online access, i.e. the Center for Genomic Epidemiology tool-box (CGE). 
Even though DTU Food had already implemented WGS technology, the ENGAGE project contributed to 
and added value to several activities. Already prior to the initiation of the ENGAGE project, DTU Food 
was organizing and facilitating a proficiency test (PT) in the framework of GMI/WHO/COMPARE 
project. ENGAGE, however, ensured the momentum and keeping of deadlines of the PT during the 
project period. A working space, i.e. a sharing site for sequence data, was one of the tasks in the 
ENGAGE project in order to facilitate the sharing of genomes in a protected area. The working space 
was already scheduled and funded by COMPARE, but was not created until there was an immediate 
need for this in relation to ENGAGE. Similarly, E-learning had been discussed at DTU Food for some 
time but E-learning in relation to WGS had not been developed until the delivery of the videos for 
ENGAGE, the funding body of this activity. Basically, ENGAGE was the driver for these activities to be 
developed but none of the activities received double funding. 
ENGAGE also provided the scene for a more targeted exercise to have bioinformatics tools 
benchmarked, which for DTU Food was valuable in the sense of providing knowledge about how CGE 
tools performed in comparison to competing tools.  
Proof-of-concept project headed by DTU: mcr-1-harbouring plasmids in Escherichia coli in Denmark 
and their phylogenetic relationship with mcr-1 plasmids from other geographical regions (Appendix 
K.1) 
This proof-of-concept project was the result of collaboration between EURL-AR, DTU-Food and NRL-
AR Italy. The aim of the project was to characterize mcr-1 harbouring plasmids in E. coli in Denmark, 
also comparing them by phylogenetic analysis with those circulating in other countries.  
For this purpose, the following isolates were selected by the NRL-AR for WGS: 115 E. coli isolates 
from food or animal origin from the Danish Integrated Antimicrobial Resistance Monitoring and 
Research Programme (DANMAP), out of which 50 were resistant to colistin (MIC ≥ 4 mg/L) and 65 
were susceptible with an MIC of 2 mg/L. After screening for the presence of colistin resistance genes, 
60 isolates were selected and whole genome sequenced (only 41 isolates were sequenced under the 
ENGAGE project). 
Main results of this study are: 
- 10 phenotypically susceptible isolates (MIC = 2 mg/L) harbor mcr-1 (15% of the 65 colistin-
susceptible isolates tested) 
- 41 phenotypically resistant isolates (MIC > 2 mg/L) harbor mcr-1 (82% of the 50 colistin-
resistant isolates tested) 
- mcr-1 is integrated in IncX4 plasmids in 19 isolates (37% of the 41 mcr-1-positive isolates) 
- One colistin-resistant isolate harbors no mcr genes but displays a point mutation in 
pmrA/pmrB two component system (pmrB V161G) 
- Eight colistin-resistant isolates have no currently known mechanism of colistin resistance 
 
Feedback from BfR (Germany)  
Experts agree that next-generation sequencing is changing microbial genomics. Once implemented in 
food, veterinary and clinical laboratories, this technique allows continuous molecular surveillance of 
food-borne pathogens and improves consumer protection and food safety. However, implementing a 
new method is time-, cost- and labour-intensive.  
The German Federal Institute for Risk Assessment (BfR) acquired the first Illumina sequencer at the 
end of 2014. Nevertheless, generation and evaluation of WGS data in a regular and routine manner 
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was considerably improved after training of staff in twinning courses within the ENGAGE project early 
2016.  
Through vibrant exchange of experiences between consortium partners, including the twinning at DTU 
(May 2016), as well as workshops in Warsaw (October 2016) and Rome (November 2017), the 
scientists at the BfR learned which protocols are most appropriate for library generation, sequencing 
and quality control and how simple bioinformatics analysis can be performed. Benchmarking exercises 
further improved the knowledge on availability and suitability of bioinformatics tools for sequencing 
data evaluation. The regular participation in proficiency tests ensured a consistently high quality of 
obtained data and results. In conclusion, participation in the ENGAGE project was the first step 
towards the future of real-time pathogen surveillance and outbreak investigation at the BfR. 
In the two years of the ENGAGE project, the BfR sequenced more than 382 Salmonella enterica and E. 
coli isolates from animal, food and environmental sources using the in-house MiSeq and NextSeq 
(Illumina) sequencers. Salmonella isolates of the most common serovars as well as E. coli isolates 
were selected based on conspicuous phenotypic antimicrobial resistance profiles.  
The BfR performed altogether three proof-of-concept projects to demonstrate the advantages of NGS 
use in microbial genomics.   
In the first proof-of-concept project (see Appendix K.2) multidrug-resistant d-tartrate fermenting 
(dTa+) Salmonella enterica subsp. enterica Paratyphi B (also known as variant Java) isolates from 
chicken with decreased colistin susceptibility were of particular interest. Initially, the focus was to 
provide new insights into the evolution and spread of the plasmid-mediated colistin resistance gene 
mcr-1. However, sequencing of mcr-1 negative but colistin-resistant isolates finally led to the 
discovery of the novel transposon-associated and plasmid-encoded colistin-resistance gene mcr-5, 
which lead to another proof-of-concept project (see Appendix K.3).   
In a third proof-of-concept project (see Appendix K.4), two recently identified carbapenem resistant 
isolates from the strain collection of the NRL for Salmonella at the BfR were analysed by WGS 
methods to get a deeper insight in the spread of carbapenemase encoding plasmids. In summary, 
findings obtained during the ENGAGE project were presented to the scientific community in several 
posters and presentations and resulted in four publications in scientific journals (references listed in 
project descriptions). An additional manuscript is in progress.  
Proof-of-concept project headed by BfR: Phylogeny of Salmonella Paratyphi B variant Java (ST-28) 
harbouring mcr-1 (Appendix K.2)  
In 2015, plasmid-mediated colistin resistance was reported to be caused by a mobilized 
phosphoethanolamine transferase gene (mcr-1) in Enterobacteriaceae. Originally identified in E. coli, 
the gene was later reported in other Enterobacteriaceae including Klebsiella and Salmonella. 
Approximately 400 S. Paratyphi B dTa+ isolates originating from food producing animals and food 
products received from 2006 to 2016 in the German NRL for Salmonella were selected for PCR 
screening for the presence of the mcr-1 gene. Altogether 63 mcr-1 positive S. Paratyphi B dTa+ ST28 
isolates were subjected to WGS. Results showed that the mcr-1 gene was located on plasmids 
belonging to the IncHI2 or IncX4 replicon group. Strains isolated from 2008 to 2011 tend to carry the 
mcr-1 gene on large multidrug-resistant IncHI2 plasmids and cluster in the phylogenetic tree, whereas 
strains isolated after 2011 mainly carry mcr-1 on IncX4 plasmids and show a higher phylogenetic 
diversity. 
Evaluation of data is still in progress. The complete genome sequence of the earliest S. Paratyphi B 
dTa+ isolate harbouring mcr-1 from the collection of the German NRL for Salmonella was published as 
an article in the journal Genome Announcement: 
Borowiak et al. 2017: Complete genome sequence of Salmonella enterica subsp. enterica serovar 
Paratyphi B sequence type ST28 harboring mcr-1. Genome Announc 5:e00991-17 
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Proof-of-concept project headed by BfR: Identification of a novel transposon-associated 
phosphoethanolamine transferase gene, mcr-5, conferring colistin resistance in d-tartrate fermenting 
Salmonella enterica subsp. enterica serovar Paratyphi B (Appendix K.3) 
Plasmid-mediated colistin resistance is known to be caused by phosphoethanolamine transferases. At 
the beginning of the study, two mobilized colistin resistance genes termed mcr-1 and mcr-2 were 
known. In the study, a novel phosphoethanolamine transferase-like protein in 14 avian colistin-
resistant, but mcr-1 and mcr-2 negative Salmonella Paratyphi B variant Java isolates was identified. 
The respective gene (1644 bp), further termed as mcr-5, is part of a 7,337 bp transposon of the Tn3-
family usually located on multi-copy ColE-type plasmids. In one isolate an additional variant was 
detected which carries the mcr-5 transposon in the bacterial chromosome. The incidence of mcr-5 
carrying colistin-resistant S. Paratyphi B dTa+ isolates in the collection of the NRL Salmonella in 
Germany is low and restricted to 14 strains isolated between 2011 and 2013. Nevertheless, these 
findings suggest that mobilized colistin resistance genes might be more common than expected and 
raise concern on their real variety, their prevalence and distribution in Europe and other continents as 
well as their relevance in public health.  
 
Results of the study were published:  
Borowiak et al.: Identification of a novel transposon-associated phosphoethanolamine transferase 
gene, mcr-5, conferring colistin resistance in d-tartrate fermenting Salmonella enterica subsp. enterica 
serovar Paratyphi B. J Antimicrob Chemother. 2017; 72: 3317–3324 
 
Proof-of-concept project headed by BfR: VIM-1 producing Salmonella Infantis isolated from swine and 
minced pork meat in Germany (Appendix K.4) 
Carbapenems are considered last-line clinical antibiotics for treating severe human infections caused 
by multidrug-resistant Gram-negative bacteria. In 2011, VIM-1 carbapenemase-producing Salmonella 
enterica subspec. enterica serovar Infantis (S. Infantis) and E. coli were isolated for the first time from 
livestock farms in Germany. Within this study, the first detection of a blaVIM-harbouring S. Infantis 
recovered from food (minced pork meat) in 2015 was described. Mapping of NGS data to already 
published resistance plasmid sequences revealed that the plasmid harboured by the food isolate is 
100% similar to the previously published plasmid sequence of isolate R27 from swine in 2011. This 
finding hints towards a link between the isolates and to a transmission of this plasmid or these 
Salmonella isolates from the primary production into the food chain. The occurrence of 
carbapenemase-producing Enterobacteria (CPE) in food and food-producing animals might bear a risk 
of getting colonized with CPEs and raises major public health concerns.  
Results of the project were published:  
Borowiak et al.: VIM-1-producing Salmonella Infantis isolated from swine and minced pork meat in 
Germany. J Antimicrob Chemother 2017; 72(7):2131-2133  
Borowiak et al. 2018. Complete genome sequence of a VIM-1-producing Salmonella enterica subsp. 
enterica serovar Infantis isolate derived from minced pork meat. Genome Announc 6:e00327-18 
 
Feedback from IZSLT (Italy) 
The participation of the General Diagnostic Department, Italian National Reference Laboratory for 
Antimicrobial Resistance (NRL-AR), Istituto Zooprofilattico Sperimentale del Lazio e della Toscana 
(IZSLT), as member of the ENGAGE consortium has given to the department the opportunity to 
improve their knowledge on applications of Next Generation Sequencing (NGS) technologies in the 
field of molecular epidemiology of foodborne diseases and related antimicrobial resistance, and to 
implement Whole Genome Sequencing (WGS) data analysis in the Department and in the NRL-AR 
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Italy, IZSLT laboratories. The ENGAGE project also represented for the NRL-AR IZSLT one of the main 
means to bring WGS to the attention of decision makers at the IZSLT and to proceed to the purchase 
of a MiSeq sequencer (Illumina).  
The evaluation of the different NGS technologies on the market performed by NRL-AR IZSLT, based 
on principles and parameters of the Health Technology Assessment and used for the choice of the 
technology and the machine to be proposed for purchase, was shared within the ENGAGE consortium 
and the network of the NRLs at the 2017 EURL-AR Training Course. The training course was held at 
DTU Food Kgs. Lyngby on 26-28 September 2017 and the presentation was entitled “Advocacy - how 
to bring WGS to the attention of decision makers at the institute”. 
IZSLT participated in twinning programmes in 2016 hosted at DTU Food which provided the possibility 
to develop and improve the capacities on performing all the steps of WGS analysis: from the wet-lab 
component (DNA purification, library preparation, normalization and sequencing using a MiSeq 
machine, Illumina) to the bioinformatics analysis by using different web-based freeware tools (dry-lab 
component). Participation in these twinning opportunities and also in the two annual training courses 
held in Warsaw (October 2016) and in the one organised by the NRL-AR IZSLT itself in Rome (October 
2017) has allowed to update and improve the capacities at IZSLT on performing the analysis of the 
raw reads directly retrieved from the sequencer, also using some tools (Trimmomatic, SPAdes, CGE 
Docker tools) from command line in a Linux environment and the analysis of the genomes assembled 
with the bioinformatic tools (e.g. Velvet, SPAdes). This training activity also helped to identify the pros 
and cons of using different tools and thus improving the attitudes for an informed decision on which 
tool to employ in different situations. In this regard, IZSLT has implemented routine protocols also for 
the identification and characterization of resistance genes and other genetic markers (e.g. virulence 
markers, fitness markers, housekeeping genes for population structure, etc.).  
The acquisition of these new competences on WGS analysis represents a crucial turning point for the 
NRL-AR IZSLT in the area of surveillance of pathogens and related antimicrobial resistance (AMR) and 
on monitoring programmes and activities. In this regard, the laboratory is implementing an internal 
routine WGS protocol in the context of National and European AMR monitoring programmes for a 
basic evaluation of the quality of the raw reads, the assembly quality of the reads and the quality of 
the contigs. The main application of this protocol will be the detection of the many different molecular 
markers used for further characterization of pathogens and their accessory genome (e.g. 
housekeeping genes for Multilocus Sequence Typing, Plasmid Typing based on Replicons, 
PlasmidMLST, Integrons), virulence markers and molecular mechanisms leading to AMR (point 
mutations, acquired resistance genes), since WGS may potentially replace within a single laboratory 
procedure and analysis conducted by the use of ad hoc bioinformatic pipelines, a multitude of assays 
that so far had to be run separately by most of laboratories all over the world. This approach leads to 
a relevant improvement of the overall efficiency and helps in the optimisation of human and material 
resources.  
Moreover, the participation of the NRL-AR IZSLT in the Proficiency tests organized within the two-
years of the ENGAGE project has provided a robust and practical way to test the performance of the 
newly acquired capacities in WGS analysis and to identify those critical points in the process that 
would need further attention and monitoring. Comparing the results from IZSLT with those obtained 
by the other participants was also very useful, and seen as a challenge to learn and improve the 
application of new bioinformatics tools in order to reach a high degree of accuracy and a harmonised 
choice of quality parameters.  
Proof-of-concept project headed by IZSLT: Salmonella Infantis in Italy and EU: phylogeny and plasmid 
carrying virulence, fitness and antimicrobial resistance (AMR) genes (Appendix K.5) 
This project focused on S. Infantis, since this serotype is emerging worldwide, and it is one of the top 
five serovars involved in human infections in Europe. MDR-S. Infantis has increasingly been reported 
in Italy in the last years from food-animals and humans, and is also highly prevalent in several 
European countries in the broiler meat industry. The purpose of the project was to provide molecular 
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data based on WGS analysis in order to investigate similarities and differences within Salmonella 
enterica subsp. enterica serovar Infantis across Europe and across animal and food sources.  
A total of N=229 S. Infantis isolated from humans (N=64), animal (N=115), and food/environment 
(N=50) sources in the frame of National Control Programmes and monitoring activities were analysed. 
Regarding the country of origin, 150 were isolated in Italy and 79 in other EU countries, including 20 
from Ireland, 18 from Luxembourg, 26 from the Netherlands and 15 from Poland. In addition, a total 
of 153 sequenced genomes were added, including 34 provided by APHA (UK), 38 by BfR (Germany) 
and 80 by EURL-AR DTU-Food (Denmark).  
To date, the IZSLT, in collaboration with the DTU, are doing further analyses on accessory genome 
(especially pESI-like plasmids) harboured by the isolates in the collection. Remarkably, specific 
markers of pESI-like megaplasmids, such as pESI backbone, fim and K88 genes have been found in 
isolates from all the countries participating in the study. Further in silico analysis to confirm the 
presence of S. Infantis isolates harbouring the pESI-like megaplasmid are still ongoing.  
SNPs-based phylogenetic and phylogeographic analysis by using the CSI phylogeny is still ongoing.  
To date, a manuscript that includes part of the results of this proof-of-concept and with a working title 
of “Salmonella Infantis in Italy and EU: phylogeny and plasmid carrying virulence, fitness and AMR 
genes” will be ready to be submitted in a peer-reviewed scientific journal by the end of summer 2018. 
 
Proof-of-concept project headed by IZSLT: Molecular epidemiology of mcr-encoded colistin resistance 
in Enterobacteriaceae in Italy (Appendix K.6) 
This project focused on the epidemiology of transferable colistin resistance mediated by mcr genes in 
food producing animals in Italy, since it is rapidly evolving across Europe and timely information on 
prevalence, trends and variants of mcr-positive isolates is needed to enhance surveillance and 
implement prevention and control measures. The purpose of the project was to investigate the 
molecular epidemiology of mcr genes and their genetic environment in commensal E. coli, Extended 
Spectrum Beta-Lactamase (ESBL)/AmpC-producing E. coli, and Salmonella spp. in different primary 
productions and foodstuffs of animal origin in Italy, collected over the last three-years (2014-2016) by 
the Italian NRL-AR in the frame of National Control Programmes and monitoring activities. 
A total of 55 E. coli and 14 Salmonella of different serotypes phenotypically resistant to colistin and 
mcr positive by PCR, with the majority of them being also MDR including Extended-Spectrum 
Cephalosporin-resistant (ESC-R), were selected for WGS, along with 6 fully susceptible E. coli isolates 
included as negative control. All isolates had been collected from different primary productions 
(fattening turkey, broiler chicken, fattening pigs and calves). Additionally, three multidrug resistant 
(MDR) S. Infantis collected in 2016-2017, displaying a colistin MIC value ≥ 4 mg/L and mcr-1 positive 
by PCR with two of them being also ESC-R, were sequenced after the end of the ENGAGE project 
(December 2017) and then included in this project. 
For a better interpretation of the results, the isolates were divided into two sub-groups according to 
the species, the serotype and the source, and deeply investigated: 
1) 31 isolates collected from turkeys (28 E. coli and 3 Salmonella enterica isolates), 5 E. coli from pig 
samples and 6 E. coli from bovine samples. 
2) 4 multidrug resistant (MDR) S. Infantis from broilers (N=3) and broiler meat samples (N=1), with 
two of them being also ESC-R. 
To date, the main findings derived from this study were: 
- The E. coli population harbouring colistin resistance mediated by mcr was highly heterogeneous.  
- The mcr gene was detected in different Salmonella serovars (S. Typhimurium, S. Newport, S. 
Blockley and S. Infantis) circulating in Italy. 
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- The 4 MDR S. Infantis contained both pESI-like megaplasmids and IncX4 plasmids harbouring mcr-
1.1.  
Part of this study has been included in a scientific paper: 
Alba P, Leekitcharoenphon P, Franco A, Feltrin F, Ianzano A, Caprioli A, Stravino F, Hendriksen R, 
Bortolaia V, Battisti A. Molecular epidemiology of mcr-encoded colistin resistance in 
Enterobacteriaceae from food-producing animals in Italy revealed through the EU harmonised 
antimicrobial resistance monitoring. Accepted for publication in the peer-reviewed scientific journal 
Frontiers in Microbiology (May 2018). doi: 10.3389/fmicb.2018.01217 
To date, the IZSLT in collaboration with the DTU are preparing a manuscript that includes part of the 
results of this proof of concept, entitled “Colistin resistance mediated by mcr-1 in ESBL-producing, 
multidrug-resistant Salmonella Infantis in broiler chicken industry, Italy (2016-2017)” to be submitted 
in a peer-reviewed scientific journal. 
 
Feedback from IZSVe (Italy) 
The participation of the Italian Istituto Zooprofilattico Sperimentale delle Venezie (IZSVe) to the 
ENGAGE project has been a fruitful opportunity for building and enhancing the use of Whole Genome 
Sequencing and analysis of Salmonella to better address genotypic characterization in the everyday 
work of the Italian National Reference Laboratory (NRL) for Salmonellosis.  
Before participating in ENGAGE, the Italian-NRL for Salmonella had no experience either in WGS data 
production or in WGS data analysis. At the end of the ENGAGE project, IZSVe has acquired autonomy 
in using the MiSeq instrument and has successfully sequenced, shared and uploaded to ENA 449 
genomes of Salmonella strains.  
Moreover, the participation in ENGAGE has allowed the IT-NRL for Salmonellosis to strengthen its 
networking capabilities and to facilitate transnational collaboration with international high-profile 
researchers and institutions across the EU. The expertise exchange with project partners and the 
opportunities of trainings and twinning conducted have been rewarding chances to harmonize 
procedures and pipelines and acquire best practices. 
Indeed, the IT-NRL for Salmonellosis is now leading a number of scientific projects based on the use 
of WGS for Salmonella characterization and outbreaks analysis, thus increasing research excellence 
and enhancing national and international competitiveness. 
Proof-of-concept project headed by IZSVe: Genomic diversity of Salmonella Derby in different 
European countries (Appendix K.7) 
S. Derby is a serovar generally associated to pig chain; however, with a lower frequency, it is isolated 
also from other sources, such as turkeys, at least in specific geographical areas. Previous studies have 
demonstrated that different lineages are associated with different sources (Hayward et al., doi: 
10.1186/s12866-016-0628-4). This project was aimed at characterising S. Derby isolates from 
different sources and different lineages, as well as to identify specific genetic features that could 
explain host adaptation and persistence along the food chain in relation to specific sources. Also, 
human isolates were included in the investigation in order to infer the main sources of human 
infection associated to this serovar. Partners were asked to contribute to the project with 60-80 
isolates from pigs, turkeys, humans and other species. Both isolates from animals and foodstuffs were 
considered, moreover, participants were asked to contribute also with human isolates. A total of 342 
sequences of S. Derby were retrieved from 7 partners (IZSVe, BfR, DTU, NVRI, APHA, PHE and NIPH-
NIH) whilst additional 87 strains were internally provided from PHE, for a grand total of 429 strains. A 
preliminary analysis of the sequences was carried out in the context of the twinning between IZSVe 
and PHE that took place in summer 2017. A subset of about 200 isolates was analysed according to 
the standard PHE internal pipeline, including: quality metrics checking, species identification, MLST 
based on the 7 housekeeping genes, MLST-guided serotyping prediction/serotyping from raw 
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sequencing reads, AMR in-silico characterization, eBURST Group (eBG) assignation and single 
nucleotide polymorphism (SNP) address assignation. The analysed isolates belonged to 9 different ST 
(39, 40, 71, 682, 683, 1326, 3135, 3857 and 3871), corresponding to three eBGs (57, 244 and 264). 
Isolates belonging to different eBGS were further investigated by multiple alignment in order to 
ascertain their level of similarity in relation to sources, geographical area of origin and other distinctive 
features. A selection of isolates was subject to in-silico Salmonella pathogenicity island (SPI) detection, 
confirming the massive presence of a panel of different SPIs. Further investigation will be conducted 
to ascertain the presence of SPI23 to test the hypothesis of its role in characterizing host adaptability.  
This project has been a great opportunity of collaboration among ENGAGE partners in terms of 
sequences sharing as well as an opportunity for the proposing partner (IZSVe) to be trained by the 
PHE on the analytical approaches used on their routine. Data analysis for this project is, however, still 
ongoing. 
Proof-of-concept project headed by IZSVe: Whole genome characterization of Salmonella Napoli 
isolates spanning 2005-2015: a national issue of international interest (Appendix K.8) 
S. Napoli is among the top serovars causing human infections in Italy and the number of isolates 
belonging to this serovar has been rising since 2000. It is relatively uncommon in other European 
countries. Several outbreaks related to this serovar and associated to the consumption of Italian food 
products have been documented during the last years. S. Napoli is generally isolated from humans 
and environment, whereas strains from animals and food are quite rare. Several studies, using 
different approaches, tried to infer the sources of infection for this serovar, however, the reservoirs 
and transmission pathways are still partly unknown. Moreover, the interest toward this serovar is 
triggered also by epidemiological, clinical and molecular evidences revealing important similarities 
between S. Napoli and typhoidal serovars. In order to investigate this serovar and clarify its 
epidemiology, 157 S. Napoli isolates from three partners (IZSVe, BfR and DTU) were collected. At the 
time of the project start, no other partners had reported S. Napoli isolates. Isolates were sequenced 
and their metadata collected. Sequences obtained will be analysed to identify differences/overlaps 
among isolates from different sources as well as among isolates from humans and from other sources, 
to deepen insight into the potential virulence of this serovar as well as to identify the isolates closer to 
the human ones in order to infer probable sources of this emergent serovar.  
This project has been a great opportunity to investigate S. Napoli, which is a peculiar serovar since, 
although limited in its geographical spread, it has a relevant epidemiological role. Data analysis for 
this project is however still ongoing. 
Proof-of-concept project headed by IZSVe: A Comparative Genomic Analysis Provides Novel Insights 
Into the Ecological Success of the Monophasic Salmonella Serovar 4,[5],12:i:- (Appendix K.9) 
Over the past decades monophasic variant of Salmonella Typhimurium, S. 4,[5],12:i:- has been 
recognized as an emergent serovar for its rapid spread especially along the swine food chain. 
Although many studies have documented the ecological success of this serovar, few investigations 
have been conducted to explain this phenomenon from a genetic perspective.  
In Italy, since 2011 S. Typhimurium 4,[5],12:i:- has ranked as the first serovar both from human and 
veterinary sources and there has been an increasing interest toward the identification of the putative 
markers, which could explain its epidemiological success and address the identification of effective 
control measures. Because of the relevance of this emergent serovar at national level, it was one of 
the main fields of research for IZSVe during the last years and when ENGAGE started IZSVe had 
collected a panel of S. Typhimurium 4,[5],12:i:- strains to investigate through WGS. 
A comparative whole-genome analysis of 50 epidemiologically unrelated S. 4,[5],12:i:- isolates was 
performed. The isolates selected for the investigation were obtained from different sources over the 
last years. The main genetic trait shared by the investigated strains was represented by heavy metals 
tolerance gene cassettes. Functional studies were also performed to assess S. 4,[5],12:i:- capability to 
tolerate copper in the environment suggested, in order to ascertain that the acquisition of heavy metal 
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tolerance genes is useful for preventing the toxic effects of metals, thereby highlighting that this is a 
potential factor contributing to the success of this Salmonella serovar in farming environments. 
Moreover, phylogenetic analyses indicated a distinction among the investigated isolates based on the 
above described genetic traits, suggesting the involvement of different polymorphisms that give rise 
to multiple independent clones of S. 4,5,12:i:-.  
Results of the project were published in Frontiers in Microbiology, section Food Microbiology: 
Mastrorilli E et al. (2018) A Comparative Genomic Analysis Provides Novel Insights Into the Ecological 
Success of the Monophasic Salmonella Serovar 4,[5],12:i:-. Front. Microbiol. 9:715. doi: 
10.3389/fmicb.2018.00715 
This project was entirely conducted by IZSVe and ENGAGE provided an important technical and 
financial support to finalize this research.  
 
Feedback from NIPH-NIH (Poland) 
Despite the fact that WGS techniques are now widely available and were implemented in many 
European national laboratories, WGS has not been yet implemented at the Polish National Institute of 
Public Health – National Institute of Hygiene (NIPH NIH). Within the ENGAGE project the institute had 
the opportunity to apply WGS technology and this kind of advanced analysis on a large group of 
bacterial strains. During the project the first strains were sequenced in the whole genome scale. In 
total, 320 Salmonella strains from the public health sector in Poland were sequenced by outsourcing 
(7 strains sequenced at DTU during twinning, 167 strains sequenced in cooperation with PHE and 146 
strains sequenced in cooperation with BioBank Lab, University of Lodz). All sequences were then 
submitted to the ENA database. Thanks to twinning, training courses, guidelines and E-learning 
lectures conducted during the project, knowledge was acquired on the sequencing process and, even 
more importantly, on sequence data analysis. Analysis of sequences enabled introduction to practical 
data analysis at NIPH-NIH particularly important for future epidemiological molecular investigations. 
As a result, during the project, NIPH-NIH performed WGS analysis of e.g. monophasic Salmonella 
Typhimurium strains, Salmonella Enteritidis strains with decreased susceptibility to quinolones isolated 
in a hospital in Warsaw, as well as VTEC strains. Based on these experiences NIPH-NIH was able to 
conduct similar WSG analysis for Salmonella Enteritidis strains collected in a “point in time analysis” to 
investigate the epidemiological situation in Poland due to the outbreak connected with Polish eggs. 
During this study additional 93 Salmonella Enteritidis strains (79 from clinical samples and 14 from 
food samples) were sequenced and analysed using, among others, SNP address to assign the 
outbreak strains. As a result 9 strains (11.4%) isolated from the clinical samples were assigned as 
outbreak strains (6 from cluster 175 and 3 from cluster 360). From food samples, 4 strains were 
assigned as outbreak strains (all from cluster 175). These results indicated that the outbreak strains 
are prevalent in Poland. Further, more detailed analysis using WGS will be performed to investigate 
the outbreak deeply. 
The intention was, based on the gained knowledge, to conduct similar future studies in the context of 
collaborative epidemiological outbreak investigations with other European laboratories. Additionally, 
based on the experiences obtained within both wet and dry lab, plans were made for implementation 
of WGS technology, initially as a project-based approach and ultimately for routine use. 
 
Feedback from NVRI (Poland) 
The ENGAGE project was crucial for implementing WGS technology at the Polish National Veterinary 
Research Institute (NVRI). NVRI has joined the consortium with neither experience nor WGS 
laboratory capacities. As partner in the project, this supported the successful application for 
governmental funding for setting up laboratory capacities, including designation of laboratory areas, 
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purchasing of Illumina MiSeq along with peripheral equipment and hiring the necessary personnel. By 
the end of the project NVRI was running a fully operational WGS laboratory. 
The ENGAGE project, via trainings, workshops, and collaboration, provided opportunity for gaining 
skills, practical knowledge and experience in WGS and bioinformatic analyses of the results which 
have been verified by participation in intensive, multi-level proficiency testing. The benchmarking 
activities raised the awareness of multiple available tools and their performance in bioinformatics 
analyses. 
The ENGAGE project has been highly useful to solve current diagnostic problems. Firstly, WGS was 
used in a real-life outbreak scenario. In autumn 2016, following the identification of a multi-country 
outbreak of Salmonella Enteritidis related to Polish eggs, thirteen strains originating from egg-
producing farms identified in the epidemiological infection were sequenced (HiSeq, outsourcing). 
Following the acquisition of sequences, they were shared with EURL Salmonella (RIVM, NL). In return, 
several reference sequences (strains from outbreak confirmed human cases) were obtained for in-
house comparison. The performed phylogenetic SNP tree analyses led to the following conclusion: 
1) similarity to the reference sequences definitely confirmed Polish eggs as a source of the outbreak; 
2) diversity of the tested strains indicate on possible multi-source infections of the flocks. Those 
conclusions were refereed by the General Veterinary Office (March 2017) that decided to increase the 
number of the strains to be sequenced. The sequencing performed later in 2017 (MiSeq, in-house) 
was conducted within reference activities on NRL Salmonella (outside ENGAGE project). The initial 
conclusions were confirmed and led to the concept of transport cages as a possible vector of multiple 
Salmonella strains introduction into numerous flocks located in 19 farms. All S. Enteritidis sequences 
were openly deposited in ENA. 
Secondly, by identification of rare, exotic and highly similar Salmonella serovars, it helped to solve one 
of the burning diagnostic problems at NRL for Salmonella. S. Newport (6,8,20:e,h:1,2) and S. Bardo 
(8:e,h:1,2) as well as S. Senftenberg (1,3,19:g,[s],t:-) and S. Dessau (1,3,15,19:g,s,t:-) show 
similarities of antigenic formulas, thus producing difficulties in serotyping. WGS results provided 
evidence that isolates serotyped as S. Bardo and S. Dessau in fact belong to Newport and Senftenberg, 
respectively. Based on the genome comparison serovars Bardo and Dessau do not exist and they 
should be erased from Kauffman-White-Le Minor scheme. Furthermore, SeqSero failed to predict 
serovar based on gene identification, therefore current performance of bioinformatics tools should be 
taken with caution and improved accordingly. The findings will be presented to the scientific 
community during the International Symposium on Salmonella and Salmonellosis (submitted, 
September 2018) and are described in the proof-of-concept project headed by NVRI (Appendix K.10). 
WGS of other strains of incomplete antigen formula indicated that in fact they belong to well-known 
and epidemiologically relevant serovars (i.e. 9:-:- identified as S. Enteritidis). A number of strains 
representing inter alia other than enterica subspecies of Salmonella enterica were not perfectly 
identified with current bioinformatics tools. 
Thirdly, the participation in ENGAGE research projects (i.e. on S. Derby, mcr-positive E. coli) gave the 
opportunity to improve quality of the research run at NVRI. S. Derby sequences (n = 56) were 
provided for the proof-of-concept project headed by IZSVe (Appendix K.7) whereas 80 mcr-1 positive 
E. coli were used to analyze the epidemiological situation in Poland as an own proof-of-concept 
project (Appendix K.11). 
Invaluable advantage of the project results from networking with the ENGAGE partners. The 
collaboration provided an opportunity for comparison of strains isolated across Europe. The 
conclusions drawn from WGS results are therefore more valuable and generalized. This cooperation 
will hopefully continue beyond the life of the project, for both research projects and for any future 
incidents and international outbreaks. 
For the above reasons, NVRI already has and definitely will benefit from having been an active partner 
in the ENGAGE project. 
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Proof-of-concept project headed by NVRI: WGS of rare and unrecognised Salmonella serovars 
(Appendix K.10) 
The aim of this project was to characterise Salmonella isolates causing difficulties in serotyping 
(incomplete or ambiguous antigenic structure and rare serovars from uncommon isolation sources) 
and to set up a database of reference sequences. For this purpose, the NVRI institute analysed 113 
strains. The outcome of the project includes:  
1/ confirmation that Salmonella Bardo should be actually included into Salmonella Newport; the 
isolates occurring occasionally in food chain in Poland are considerably diverse (SNP tree) and 
represent several sequence types (ST 31, ST 118, ST 166). Similar conclusions were drawn for 
Salmonella Dessau that should be included into S. Senftenberg (ST14, ST 210). Twenty-six strains 
complied with the selection criteria. Results of this study will be presented as a poster during 
International Symposium Salmonella and Salmonellosis (I3S) in September 2018. 
2/ relevant gene identification confirmed serovar identification of several isolates of strange or 
uncommon origin i.e. European grass snake (Salmonella IIIb 28:z10:z, unknown ST; IIIb 38:r:z:[z57], 
ST 645; Salmonella Sunnycove, unknown ST), pet geko (Salmonella II 16:m,t:[z42], unknown ST), 
sheep (Salmonella IIIb 61:k:1,5, ST 432). Fifty strains complied with the criterion. Based on WGS they 
were classified into 33 Salmonella serovars. 
3/ WGS of 37 strains with incomplete antigenic structure make it possible to classify them to the most 
common and Salmonella control programme relevant serovars i.e. Salmonella 1,4,5:-:- recognised as 
Salmonella Typhimurium, Salmonella 9:-:- (S. Enteritidis), Salmonella 6,7:-:1,5, (S. Choleraesuis, S. 
Thompson), Salmonella 6,7:z10:- (S. Mbandaka), Salmonella 35:-:- (S. Monschaui). Sequence types of 
the strains allowed their allocation in the common clones i.e. S. Enteritidis ST 11, and S. Mbandaka ST 
413 occurring in food chain in Poland.  
 
Proof-of-concept project headed by NVRI: mcr-1 positive E. coli in Poland (Appendix K.11) 
This project dealt with the characterisation of colistin-resistant (mcr-1 positive) E. coli isolated from 
animals in Poland. The outcome of the project is the deep characterisation of mcr-1 positive E. coli 
along the food chain in Poland. Importantly, mcr-1 genes were found mostly (62%) in colistin 
susceptible strains (MIC = 2 mg/L) and mostly in turkey isolates. The gene was present in a quite 
diverse group of isolates (n = 80) belonging to numerous STs partly related to isolation source. Beta-
lactam and quinolone resistance co-occurred, as well as chromosomally encoded polymyxins 
resistance mechanisms. Multiple plasmid replicons were identified, but the vast majority of strains 
carried IncX4 plasmid, suspected to be a mcr-1 carrier. Final results are presented in a manuscript on 
prevalence and characterization of mcr-1 positive E. coli isolated from food-producing animals in 
Poland that is planned to be submitted in June 2018. 
Preliminary results of the project were reported (oral presentation) during the 2nd International 
Caparica Conference in Antibiotic Resistance, Caparica, Portugal, 12–15 June 2017. 
Zając et al. 2017. Whole genome sequencing characterisation of mcr-1 positive Escherichia coli 
isolated from turkeys and chickens, Proceedings of 2nd International Caparica Conference in Antibiotic 
Resistance, p 188. 
 
Feedback from APHA (United Kingdom) 
Molecular typing of pathogens is a priority, core Defra development that will incorporate sequencing 
and genomic analytical framework at the APHA (UK) for replacement of traditional typing methods 
with more powerful WGS based methods. Currently, this is being developed for three high priority 
statutory animal diseases – bovine TB, avian influenza and Salmonella. The results of the Salmonella 
molecular typing based on WGS will be used for operation of the Salmonella National Control 
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Programme and to compare Salmonella isolates with human isolates for human Salmonella Outbreak 
Control. Public Health England (PHE) has already moved to Salmonella WGS and the switch to WGS at 
APHA will allow harmonisation with PHE, which will increase efficiency and facilitate future outbreak 
detection and investigations nationally and also internationally. Within APHA, a Salmonella serotyping 
pipeline was established which benefits from several publicly available bioinformatics typing tools that 
were combined and tested in order to increase the reliability of the results. The pipeline outputs were 
tailored to fulfil the EU requirements for use of the White-Kauffmann-Le Minor (WKLM) serotyping 
scheme for veterinary Salmonella typing and also the APHA reference laboratory service requirements. 
The serotype is predicted by three different tools, MOST, SeqSero and SISTR that were part of the 
inter-laboratory benchmarking exercise carried out within ENGAGE (Appendix F) for which APHA 
sequenced 78 rare isolates (i.e. antigenic formulas observed occasionally in routine laboratory 
diagnostics). In addition, we have developed and tested a novel WGS-based method to differentiate S. 
Enteritidis, S. Typhimurium, S. Gallinarum and S. Pullorum live vaccine from field isolates. The results 
of the Salmonella serotyping benchmarking exercise and the performance of the APHA Salmonella 
pipeline will be published in peer reviewed journals.  
The inter-laboratory benchmarking exercises and proficiency testing carried out within ENGAGE 
project enabled further evaluation of the performance of a number of bioinformatics tools. APHA 
sequenced further 124 Salmonella spp. genomes with different AMR determinants for inclusion in the 
benchmarking exercise ‘Salmonella Serotyping according to ISO’ (Appendix H), contributed 10 
genomes for the benchmarking exercise ‘Salmonella Serotyping general’ (Appendix G) and took part in 
the exercises ‘S. Enteritidis phylogeny’ (Appendix I) and ‘C. coli phylogeny’ (Appendix J). As part of 
the ENGAGE project, APHA was responsible for WP2, data collection, and for developing 
protocols/SOPs for DNA extraction, library preparation and sequencing. The ENGAGE project has been 
highly valuable to APHA in terms of providing opportunities to share WGS methods and practices with 
the scientists from other member states and in terms of developing long lasting collaborations. 
 
Feedback from PHE (United Kingdom) 
Public Health England (PHE) has been using WGS for routine surveillance and outbreak investigation 
of Salmonella since 2014 and has progressively introduced WGS methods for other gastrointestinal 
bacterial pathogens such as E. coli, Shigella, Campylobacter and L. monocytogenes. Since 2016, all of 
these pathogens have been routinely sequenced at PHE. The Gastrointestinal Reference Bacterial Unit 
(GBRU) works in conjunction with PHE’s Genomic Services and Development Unit to sequence around 
400 isolates per week with all isolates analysed with bioinformatics pipelines developed by the core 
bioinformatics group. The WGS analysis pipeline from PHE includes common components for all the 
gastro pathogens sequenced. This pipeline includes several components: quality and trimming 
analysis, species identification based on k-mer identification (KmerID https://github.com/phe-
bioinformatics/kmerid), followed by MLST typing made by using MOST (Tewolde et al., 2016 - 
https://github.com/phe-bioinformatics/MOST) when public databases are available. Several specific 
components have been developed by the core bioinformatics group for serotyping (MOST and an 
altered version of SeqSero), stx subtyping for E.coli toxins (GeneFinder – in-house software, not 
publicly available), serotype prediction for L. monocytgenes. An AMR pipeline running with different 
databases for Salmonella, E. coli and Campylobacter spp. has been developed using a reads mapping 
approach. Finally, SNP typing is performed using a combination of software developed by the core 
bioinformatics unit and the Gastro Intestinal Reference Unit. SNP typing is performed by using the 
PHEnix SNP detection pipeline (http://phenix.readthedocs.io/en/latest/) and SnapperDB (Dallman et 
al., 2018 - https://github.com/phe-bioinformatics/snapperdb). Most of our in-house bioinformatics 
software is publicly available (https://github.com/phe-bioinformatics). 
As part of the ENGAGE project, PHE was responsible, along with other consortium partners, for the 
bioinformatics benchmarking activities including AMR and phylogeny benchmarking. PHE contributed a 
total of 500 strains to the final ENGAGE collection and has provided further 39 isolates (only shared 
internally with partners) for the specific phylogeny benchmarking based on our outbreak detection (9 
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Campylobacter and 30 Salmonella). PHE also supplied isolates for specific projects like S. Derby. This 
experience was highly profitable as it enabled the PHE-developed AMR pipeline to be compared with 
other AMR pipelines using the same dataset and this has contributed to the validation of the PHE 
pipeline. A manuscript on the AMR benchmarking is in preparation in collaboration with DTU. 
Comparing PHE pipelines with other tools or gold standard methods through such benchmarking 
activities helps to validate that PHE software are performing well. 
The ENGAGE project has also been highly useful in terms of collaborating with other partners. It 
provided the opportunity to work with other scientists from other member states and share WGS 
experiences and practice. The relationships developed will continue to give value beyond the life of 
the project. Together with other partners, PHE worked on the benchmarking activities to design, 
launch and write reports. PHE has also been extensively involved in the training session both with 
online tools and command line tools. This experience has been invaluable as the developed training 
material can be reused for training purpose within PHE. It has also provided a great opportunity for 
scientists to gain experience of designing and running such activities. Hosting two of the partners for 
twinning has also been a rewarding experience for both sides.  
In terms of public health, the ENGAGE project has promoted the use of WGS across member states, 
enabling the comparison of strains between consortium partners which will enhance the investigation 
of any future incidents or outbreaks. Benchmarking tools by ENGAGE provides information on tools 
and helps ensure tools are comparable. Maximum benefit from WGS will be gained by the universal 
uptake of WGS and the sharing of results. Assisting other member states to do this has advantages 
for everyone involved, which is why PHE has and will benefit from being an active partner in the 
ENGAGE project.  
 
 Results of the Proficiency Testing 
PT is a rather expensive activity due to the need for providing of the reference material such as closed 
genomes and DNA/cultures to the participants. Due to these circumstances, the original idea for 
including PT into the ENGAGE project was based on the synergy with the GMI PT testing and the 
opportunity to share the reference material and evaluation pipeline. This conflicted with the GMI 
selected target organisms for 2016 – L. monocytogenes, K. pneumoniae and C. jejuni. This, however, 
was not seen as an issue as the quality control is not dependent on the species but the ability to 
sequence. In 2017, the GMI aligned the target organisms ENGAGE to include S. enterica, E. coli, and 
S. aureus. Two isolates of the three genus/species per trial were selected and sent to the US company 
Microbiologics for lyophilisation. Subsequently, the produced reference material was sent to US FDA 
for closing the genomes to serve as reference genomes.  
Seven out of the eight partners in ENGAGE participated in either the entire PT components or only 
targeted one of the species. NIPH-NIH was not able to participate as they did not yet have the in 
house WGS capacity. Overall, the PTs were useful exercises as they allowed ENGAGE consortium 
partners to assess the quality of their own data as well as to identify critical points for improvement. 
In general, all data analysed in the PT reports were satisfactory showing WGS proficiency among the 
seven partners (Appendices L and M). 
 
 Twinning Programmes, Training Courses and E-Learning 
To ensure the early implementation of abilities to perform WGS and conduct bioinformatics analysis 
among the consortium partners, twinning opportunities were established in spring 2016. Twinning 
programmes aimed at providing exchange of expertise and best practices among the consortium 
members and also building capacity on WGS data production and analysis were conducted. The 
twinning programmes were provided by the experienced partners in the consortium: DTU, PHE and 
APHA. Twinning participants were identified on the basis of the declared needs of knowledge on WGS 
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data production or/and analysis of consortium partners. The first twinning programme was provided 
by DTU and consisted of a two weeks training in wet lab (DNA purification, library preparation, DNA 
sequencing on Illumina platform) and dry lab (WGS data analysis via CGE tools). A total of nine 
participants from six partner institutions were invited to DTU for one week (Table 1). The twinning 
was directed at less experienced in WGS participants. All participants brought their own bacterial 
strains for the sequencing (see Section 3.5). Details on participants are reported in Table 1. 
 
Table 1:  Participants of the first twinning programme provided by DTU 
Consortium Partner Participant Type of twinning Date 
IZSVe Sara Petrin Wet lab/Dry lab 25/04/2016-04/05/2016 
Alessandra Longo Wet lab/Dry lab 22/05/2016-01/06/2016 
IZSLT Patricia Alba Wet lab/Dry lab 01/02/2016-13/02/2016 
Alessia Franco Wet lab/Dry lab 13/06/2016-22/06/2016 
Fabiola Feltrin Wet lab/Dry lab 13/06/2016-22/06/2016 
BfR Maria Borowiak Wet lab/Dry lab 22/05/2016-01/06/2016 
NVRI Magdalena Zając Wet lab/Dry lab 22/05/2016-01/06/2016 
Katarzyna Półtorak Wet lab/Dry lab 13/06/2016-22/06/2016 
NIPH-NIH Tomasz Wołkowicz  Wet lab/Dry lab 13/06/2016-22/06/2016 
EFSA Beatriz Guerra Román Dry lab 29/05/2017-31/05/2017 
 
The second twinning programme was provided by PHE and APHA and consisted of a deep training in 
dry lab (data analysis and IT infrastructure management).  
Two partners joined the programme, DTU and IZSVe, and the visiting researchers were Rolf Sommer 
Kaas and Eleonora Mastrorilli, respectively. One participant from DTU was invited to PHE and APHA for 
one week visit to discuss the UK implementation of IT infrastructure and workflows for conducting 
routine surveillance. One participant from IZSVe (Table 2) was invited to PHE for two weeks in the 
summer of 2017 to learn about UK bioinformatics tools used for surveillance and to boost 
collaboration on one of the proof-of-concept project (S. Derby). Details of this second twinning 
programme are reported in Table 2.  
 
Table 2:  Participants of the second twinning programme provided by PHE and APHA 
Consortium Partner Participant Type of twinning Date 
DTU Rolf Sommer Kaas  Dry lab 13/06/2016-17/06/2016 
IZSVe Eleonora Mastrorilli Dry lab 17/07/2017-28/07/2017 
 
The set objectives of the twinning programmes to address the needs of knowledge transfer in order to 
enable the institutions to enhance their networking and scientific capabilities were fully completed. 
Partner organizations with no prior experience have been provided with an opportunity to acquire 
expertise in WGS; procedures and bioinformatics pipelines have been harmonized. 
Moreover, the consortium partners have strengthened their research excellence and increased 
scientific reputation and attractiveness. This enabled enhancement of collaborations amongst the 
twinning institutions that led to joint publications in peer reviewed journals and grant applications.  
To also target outside users as well as the consortium partners, a training course focused on basic 
bioinformatics analysis using the CGE tools and to some degree Galaxy implemented tools 
(https://usegalaxy.org/), was conducted in October 2016. The training course was held back to back 
with the annual workshop from 12 to 14 October 2016 at the consortium institute NIPH-NIH, in 
Warsaw. A total of 18 participants from partner institutions and 8 participants from non-partner 
institutions participated in the course. In line with the collaboration with the INNUENDO project, the 
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coordinator of this project was invited to participate in the Workshop to present the project. Highlights 
from the two workshops held and the two training courses are available for download from the 
website.6  
As a continuation of the first ENGAGE training course held in 2016 in Poland, a training course on 
“NGS analysis based on command line tools”, organized by the Istituto Zooprofilattico Sperimentale 
del Lazio e della Toscana “M. Aleandri” (IZSLT, Italy), was held from 25 to 27 October 2017 at 
LAZIOCREA (Lazio Region), Rome, Italy. The aim of this course was to provide to the participants a 
basic knowledge of the tools used for the analysis independently of the web tools. At this regard, an 
overview of the LINUX systems and the use of tools based on command line for the NGS data analysis 
were proposed. This course was designed for users who had a basic knowledge in analysing NGS data 
using online tools and wished to acquire competence in more efficient NGS data analyses using 
command line tools. The event was attended by internal (ENGAGE Consortium) as well as external 
(non-ENGAGE Consortium) participants. A total of 19 participants with different background and level 
of experience in NGS data analysis took part in this course.7 They represented a variety of institutions 
from different European countries (including the UK, Poland, Germany, Italy and The Netherlands).  
To maximize the outreach for the capacity building, ENGAGE has produced an E-learning component 
consisting of 17 videos of a total length of 2 hours 58 minutes describing the topic from basic 
conventional molecular sub-typing to the use of CGE tools and batch upload. The video presentations 
available at http://podcast.llab.dtu.dk/index.php?id=292 were launched on 30 September 2017 and 
updated on 10 December 2017, and include:  
1. General Principles in typing of Bacteria 
2. Surveillance of Antimicrobial Resistance Using Whole Genome Sequencing 
3. Application of Genomic Tools One Technology Take´s It All 
4. Introduction to NextGeneration Sequencing (NGS) 
5. De Novo Assembly, from Raw Reads to Contigs: Assembler Tool  
6. Sequence quality of whole genome sequencing of bacteria 
7. Species identification: KmerFinder tool description and applications 
8. MLST Typing: MLST tool description and applications 
9. cgMLSTFinder: core genome multilocus sequence typing tool 
10. Resistance Gene Detection: ResFinder Tool description and applications 
11. Salmonella Serotype Identification: SeqSero Tool Description and Application 
12. Salmonella serotype identification: SalmonellaTypeFinder tool description and application 
13. E.coli Serotype Identification: SerotypeFinder Tool Description and Application 
14. Plasmid replicon identification and plasmid typing 
15. Bacterial Analysis Pipeline Batch Upload 
16. Phylogenetic Relatedness: CSIPhylogeny Tool Description and Application 
17. Multipurpose detection of genetic markers MyDbFinder tool description and application 
A Massive Open Online Course (MOOC) “Whole genome sequencing of bacterial genomes – tools and 
applications” at COURSERA was setup including the E-learning videos number 1-5, 7-8, 10-11 and 13-
17. With just a few mouse clicks, students around the world can access this free online course and be 
introduced to whole genome sequencing techniques, which have revolutionized the way diseases are 
detected and outbreaks are investigated. The videos 6, 9 and 12 were filmed after the MOOC was 
launched and are therefore not included in the MOOC. 
                                                          
6 http://www.engage-europe.eu/resources 
7 Complete list of participants is reported in the workshop highlights, see http://www.engage-europe.eu/resources  
ENGAGE 
 
 
 
www.efsa.europa.eu/publications 32 EFSA Supporting publication 2018:EN-1431 
The present document has been produced and adopted by the bodies identified above as author(s). In accordance with Article 36 of Regulation (EC) No 
178/2002, this task has been carried out exclusively by the author(s) in the context of a grant agreement between the European Food Safety Authority and 
the author(s). The present document is published complying with the transparency principle to which the Authority is subject. It cannot be considered as an 
output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the 
conclusions reached in the present document, without prejudice to the rights of the author(s). 
 
Students will learn the theory behind the methods and receive training in how to use various free 
online tools to analyse whole genome sequencing data in order to type bacteria and map the 
occurrence of resistance in the bacteria. There is continuous enrolment on the five-week course, 
which is taught in English. The course is aimed at people with an interest in the field – e.g. 
undergraduate or graduate students, laboratory technicians, researchers and people working in the 
food, health or veterinary sectors. Teaching takes place via an interactive textbook, which contains 
videos, quizzes and assignments. During the course students have the opportunity to meet in an 
online study group. Students should expect to spend one to two hours a week on their studies. People 
who complete the course are able to receive a course certificate for a fee of 50 USD. The course is 
offered through Coursera, which is an international provider of free E-learning courses. The full course 
description is available on Coursera’s website at https://www.coursera.org/learn/wgs-bacteria. The 
course was launched on Coursera in September 2017 and by January 2018 more than 2000 learners 
were active.  
Conducted Annual Workshops: 
The first ENGAGE workshop was held at NIPH-NIH in Warsaw from 10 to 11 October 2016. The 
purpose of the workshop was to follow up on all activities with a focus on the benchmarking exercises 
and proof-of-concept projects as described above. A total of 22 participants attended the meeting, of 
which 15 were from partner institutions. The complete list of participants as well as the workshop 
minutes have been posted on the ENGAGE website.
8
 A number of joint proof-of-concept WGS projects 
were planned during the meeting to target various target organisms selected within the WP 2. Further 
details of the proof-of-concept projects are described in Appendix K.  
The second ENGAGE Workshop was held from 23 to 24 October 2017 at LAZIOCREA (Lazio Region), 
Rome, Italy, organized by the IZSLT, D. O. Diagnostica Generale, NRL-AR, Italy. The objectives of the 
workshop were to review the project progress, to communicate updates on project deliverables and to 
identify any potential emerging issues associated with the activities proposed in the Workshop held in 
Warsaw in 2016. A total of 24 participants attended the workshop, including the participants of the 
ENGAGE projects, representatives of EFSA and three non-ENGAGE participants, representatives of: 
EURL-VTEC (ISS, Italy), EURL-Salmonella (RIVM, The Netherlands), and INNUENDO consortium (EFSA 
co-funded project, coordinated by University of Helsinki, Finland; http://www.innuendoweb.org). The 
complete list of participants as well as the workshop minutes have been posted on the ENGAGE 
website.8 
 
 Dissemination of Project Progress to Consortium Partners and 
Project Results to the GMI Network 
Project dissemination includes several components such as the general dissemination of information 
on the project activities during meetings, conferences, etc., but also via newsletters and GMI. The 
general dissemination activity of the project was an ongoing activity. As an example ENGAGE was 
mentioned several times during the WHO/PAHO Meeting on the Application of WHO Whole Genome 
Sequencing as a Tool to Strengthen FBD Surveillance and Response in Developing Countries, 
Washington DC, USA, 10-13 January 2017.  
Six newsletters were issued on the ENGAGE website (http://www.engage-europe.eu) from May 2016 
to October 2017, describing management issues, the momentum of the project and the information 
on the completed deliverables. In addition to the newsletters, information on the ENGAGE activities 
and the results of the serotyping benchmarking exercise were published on the GMI web site at 
http://www.globalmicrobialidentifier.org/news-and-events/nyheder/Nyhed?id={3AD64758-03A2-4A
CD-92ED-1DEEE427BA63} and http://www.globalmicrobialidentifier.org/news-and-events/
                                                          
8 http://www.engage-europe.eu/resources  
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nyheder/2016/09/providing-resources-and-guidance-for-next-generation-sequencing?id=e341eaa2-
bad2-4afb-8d52-d14bb0c1e95c).  
The project management has encouraged the partners to timely submit produced genomes to the 
ENA repository. All acquired and generated genomes within ENGAGE were submitted and are already 
publicly available at ENA. All the sequences were also downloaded from ENA to the current WGS EFSA 
repository (Amazon S3 bucket).  
Currently, five scientific papers containing results obtained during the ENGAGE project have been 
published in peer-reviewed journals. In addition, a number of draft publications are in progress and 
also posters and presentations containing ENGAGE results have been presented to the scientific 
community.  
 
Journal articles 
 
Alba P, Leekitcharoenphon P, Franco A, Feltrin F, Ianzano A, Caprioli A, Stravino F, Hendriksen R, 
Bortolaia V, Battisti A. Molecular epidemiology of mcr-encoded colistin resistance in 
Enterobacteriaceae from food-producing animals in Italy revealed through the EU harmonised 
antimicrobial resistance monitoring. Accepted for publication in the peer-reviewed scientific journal 
Frontiers in Microbiology (May 2018). doi: 10.3389/fmicb.2018.01217 
Borowiak M, Hammerl JA, Fischer J, Szabo I, Malorny B. 2017. Complete genome sequence of 
Salmonella enterica subsp. enterica serovar Paratyphi B sequence type 28 harboring mcr-1. Genome 
Announc 5:e00991-17 
Borowiak M, Szabo I, Baumann B, Junker E, Hammerl JA, Kaesbohrer A, Malorny B, Fischer J: VIM-1-
producing Salmonella Infantis isolated from swine and minced pork meat in Germany. J Antimicrob 
Chemother. 2017 Jul 1;72(7):2131-2133 
Borowiak M, Fischer J, Hammerl JA, Hendriksen RS, Szabo I, Malorny B: Identification of a novel 
transposon-associated phosphoethanolamine transferase gene, mcr-5, conferring colistin resistance in 
d-tartrate fermenting Salmonella enterica subsp. enterica serovar Paratyphi B. J Antimicrob 
Chemother. 2017 72(12):3317-3324 
Borowiak M, Fischer J, Baumann B, Hammerl JA, Szabo I, Malorny B. 2018. Complete genome 
sequence of a VIM-1-producing Salmonella enterica subsp. enterica serovar Infantis isolate derived 
from minced pork meat. Genome Announc 6:e00327-18 
Mastrorilli E, Pietrucci D, Barco L, Ammendola S, Petrin S, Longo A, Mantovani C, Battistoni A, Ricci A, 
Desideri A and Losasso C (2018) A Comparative Genomic Analysis Provides Novel Insights Into the 
Ecological Success of the Monophasic Salmonella Serovar 4,[5],12:i:-. Front. Microbiol. 9:715. doi: 
10.3389/fmicb.2018.00715 
Piekarska K, Wołkowicz T, Wolaniuk N, Zacharczuk K, Rzeczkowska M, Gierczyński R. Analysis of draft 
genome of three clinical strains of Salmonella enterica serotype Enteritidis ST11 with decreased 
susceptibility to ciprofloxacin. Med Dosw Mikrobiol. 2018; 70: 26-36. 
Furthermore, the BfR is currently preparing a manuscript on the phylogeny of mcr-1 harbouring S. 
Paratyphi B ST-28. The manuscript is planned to be submitted in 2018, and to date, the IZSLT, in 
collaboration with the DTU, are doing further analysis on accessory genome (especially pESI plasmids) 
harboured by S. Infantis isolates collected in the frame of the S. Infantis proof-of-concept project 
headed by IZSLT. Most likely, a manuscript that includes part of the results of this proof-of-concept 
and with a working title of “Salmonella Infantis in Italy and EU: phylogeny and plasmid carrying 
virulence, fitness and AMR genes” will be ready to be submitted in a peer-reviewed scientific journal 
by the end of summer 2018. 
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Moreover, the IZSLT in collaboration with the DTU are currently preparing a manuscript entitled 
“Colistin resistance mediated by mcr-1 in ESBL-producing, multidrug-resistant Salmonella Infantis in 
broiler chicken industry, Italy (2016-2017)” to be submitted in a peer-reviewed scientific journal, that 
includes part of the results of the proof-of-concept project “Molecular epidemiology of mcr-encoded 
colistin resistance in Enterobacteriaceae in Italy” (Appendix K.6). 
A publication based on the AMR benchmarking report (Appendix H) is in preparation with the tentative 
title: Benchmarking Antimicrobial Resistance tools using bacterial whole genome data. 
 
Conference communications 
Oral presentations: 
Borowiak M. 2017: Phylogeny of Salmonella Paratyphi B variant Java harbouring mcr-1. ECCMID 2017, 
Vienna 
Zając M, Sztromwasser P, Wasyl D, Hoszowski A. 2017. Whole genome sequencing characterisation of 
mcr-1 positive Escherichia coli isolated from turkeys and chickens, Proceedings of 2nd International 
Caparica Conference in Antibiotic Resistance, p 188 
Posters: 
Fischer J, Borowiak M, Baumann B, Szabo I, Malorny B. 2017: Whole genome sequencing analysis of 
multidrug-resistant Salmonella Infantis isolates circulating in the German food-production chain. 
ECCMID, 2017, Vienna. 
Borowiak M. 2017: Transposon-associated phosphoethanolamine transferase gene (mcr-5) is 
responsible for mobilized colistin resistance in Salmonella Paratyphi B variant Java (application for the 
poster competition for PhD students as part of the EFSA EU-FORA Fellowship programme). 
Alba P, Feltrin F, Iurescia M, Amoruso R, Donati V, Caprioli A, Leekitcharoenphon P, Hendriksen RS, 
Battisti A, Franco A. Transferable colistin resistance mediated by the mcr- 1 gene is widespread 
among Escherichia coli and is emerging in Salmonella in the Italian fattening turkey industry. 26th 
European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2016). 9-12 April, 
Amsterdam, the Netherlands. 
Alba P., Feltrin F., Iurescia M., Amoruso R., Donati V., Caprioli A., Leekitcharoenphon P., Hendriksen 
R., Franco A., Battisti A. Transferable colistin resistance mediated by the mcr-1 gene is widespread 
among Escherichia coli and is emerging in Salmonella in the Italian fattening turkey industry. 2018. 
18th International Symposium of the World Association of Veterinary Laboratory Diagnosticians. 
Sorrento (Italy). 
 
 Conclusions 
The project entitled “Establishing Next Generation sequencing Ability for Genomic analysis in Europe” 
(ENGAGE, http://www.engage-europe.eu/) progressed as planned and has created much capacity and 
boosted the scientific cooperation to build and enhance the use of WGS and bioinformatics analysis in 
food safety and public health protection among the consortium partners, which are eight public health, 
food and veterinary institutions across the EU. Seven additional affiliated institutions (not co-funded 
by the project) which included the EURLs, EU NRLs and other major international organizations also 
joined and benefitted from the project. The project implemented benchmarking activities and joint 
proof-of-concept WGS projects that focused on subtypes of E. coli and Salmonella spp. All consortium 
activities were framed around these benchmarking activities and projects with a number of specific 
tasks embedded in the work packages.  
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The ENGAGE consortium selected isolates from partner institutions focusing on the nine most common 
Salmonella spp. serotypes including both human and food/animals infections, as well as on 
commensal E. coli and on MDR/ESBL-producing Salmonella spp. and E. coli from EU AMR monitoring 
programmes. Most of the institutes initiated the process of outsourcing the WGS due to an 
approximately 50% cost reduction compared to running WGS in house. Four consortium partners 
acquired WGS platforms during the project period, of which two as a direct result of being part of 
ENGAGE. In addition, all consortium partners established the ability to sequence isolates and conduct 
bioinformatics analysis. 
A total of 3,360 genomes were produced, 778 and 2,582 of E. coli and Salmonella spp., respectively. 
All sequenced genomes were shared among consortium partners in the created ENGAGE working 
space and subsequently submitted to ENA. From there, they were downloaded to the current EFSA 
WGS repository. 
Several of the sequenced genomes were included in six benchmarking exercises to assess the utility 
and performance of a number of bioinformatics tools, and for the proof-of-concept projects. The 
following six benchmarking exercises were conducted during the project: 1) De novo assembly tools: 
SPAdes 3.9 vs Velvet 1.2; 2) Genotypic Salmonella serotype prediction; 3) Genotypic Salmonella 
serotype prediction complying to the Draft International Standard 16140-6; 4) Genotypic detection of 
AMR genes; 5) Salmonella Enteritidis phylogeny, and 6) Campylobacter coli phylogeny. Overall, the 
benchmarking exercises showed that all tested bioinformatics tools performed in accordance with the 
expected phenotypic results in relation to serotyping of Salmonella and identification of AMR genes, as 
well as in relation to inferring phylogeny for Salmonella and Campylobacter. The benchmarking 
exercises were performed with the limitation that different assembly tools had been used prior to 
testing the bioinformatics tools in question. Differences in the quality of the sequences included in the 
data set analysed and assembly tool employed may have had an effect on the results of the 
bioinformatics tools tested. Additionally, although the overall performance of the tools used for 
genotypic Salmonella serotyping prediction may have been underestimated by some choices made in 
the study design, they were deemed as very good. Indeed, the inclusion of uncommon serovars, and 
possible mistakes/inconsistencies of the original conventional serotyping results in the set of 
Salmonella spp. used for the “genomic serotyping”, may have been a source of discordant results 
between the in silico serotype prediction and the conventional serotyping method. 
To maximise reach-out in terms of boosting the scientific collaboration outside of the project, a series 
of guidelines or protocols have been developed for DNA extraction, library preparation, and 
sequencing procedures as well as a list of available bioinformatics tools. In addition, series of videos 
were produced as an E-learning component with open access and were posted alongside the 
guidelines and protocols on the created website. The guidelines and on-line course represent a good 
overview of the initial steps for applying WGS technology in laboratories performing surveillance and 
research. 
Six partners participated in a twinning programme that facilitated sequencing and analysis of ‘own’ 
strains. Furthermore, two workshops and two training courses were held enabling a more in-depth 
and comprehensive training on the use of bioinformatics tools. The presence of participants from 
different institutions with different backgrounds and experience in the field of NGS, optimised 
knowledge exchange between all partners. Subsequently, the quality of sequencing by seven partners 
was evaluated via participation in developed PT trials where all performed satisfactorily. The PT 
highlighted the importance of good practices at every step of the end to end WGS process. Moreover, 
as the results of the benchmarking exercises indicate, the choice of protocols and tools, even at 
genome assembly level, represents a crucial aspect of the reliability of the output of WGS analysis. 
A number of joint proof-of-concept WGS projects targeting various topics within ENGAGE were 
conducted. These were based on data from strains sequenced during the ENGAGE project, focusing 
on the Salmonella serovars Infantis, Derby, Napoli, and monophasic variant of Typhimurium, rare and 
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monophasic Salmonella spp., AMR genes mcr-1, mcr-5, and blaVIM-1, and phylogeny of Salmonella 
Paratyphi B var. Java. At the conclusion of the ENGAGE project (January 2018), the proof-of-concept 
scientific contributions were either published, or accepted or submitted to peer-reviewed scientific 
journals. 
The deliverables and output generated within ENGAGE and hosted on the website provide sufficient 
guidance on implementation of WGS, should other European institutes, national authorities, official 
and reference laboratories choose to do this. Knowledge has been exchanged between the partner 
institutions and affiliated partners. Furthermore, consortium partners could act as facilitators and as 
disseminators of knowledge in their respective countries for laboratories intending to start working on 
WGS. Knowledge gained through this project has provided the ability to input into EFSA initiatives on 
assessment of the implementation of WGS in molecular surveillance of food borne pathogens. As part 
of the project period, ENGAGE has facilitated the introduction of fast-response, high throughput WGS 
and analysis methodology into EU institutions without previous experience in WGS. Such rapid 
implementation supports the feasibility of an EU-wide implementation of WGS that will facilitate future 
outbreak detection and investigation, identification of emerging strains with enhanced epidemic 
potential and epidemiological analyses. While maintaining the EU Salmonella control and hygiene 
regulations requirements for use of the conventional serotyping scheme for veterinary Salmonella 
typing, the close agreement between phenotypic and WGS-based serotyping of Salmonella spp. 
demonstrated that WGS-based serotyping to this standard is feasible and that the most relevant 
serovars were correctly identified, including the six major, regulated serovars.  
Furthermore, the results of the benchmarking of AMR bioinformatics tools suggest that if 
chromosomal point mutations were to be included in the WGS-based AMR predictive bioinformatics 
tools for identification of AMR genes, phenotypic surveillance could in the future be supported by or 
replaced with the application of these tools. 
Currently, more than 2000 specific AMR genes and multiple gene variants of AMR genes encoding the 
same resistance phenotype or efflux pump mechanisms that may be associated with increased risk, 
and the genetic elements associated with transferable resistance, can be identified by the tested 
bioinformatics tools.  
Benchmarking of bioinformatics tools to detect sequence variants and to build a phylogeny based on 
variants alignment for Salmonella and Campylobacter further supported the use of WGS as a method 
to characterize outbreak strains and perform surveillance among isolates that are genetically related. 
However, as in standard methods, there is a potential inter-laboratory variability intrinsic in WGS 
methods, and as such differences may be associated with operational or data errors rather than 
reflecting true biological differences and characteristics it is essential for robust investigations that all 
apparently discrepant data are rigorously checked. At this stage, ENGAGE cannot recommend one 
single bioinformatics tool since all tools appear to perform satisfactorily and are being regularly 
updated and improved. Observed lower performance of some tools was often due to phenotypic 
misclassifications or limitations in quality of the sequences and different assembly tools being used 
prior to testing the bioinformatics tools in question and potentially affecting the results.  
In the project period, ENGAGE has shown that it is possible to implement WGS and the use of 
bioinformatics tools in laboratories without any prior knowledge of WGS, and that other countries can 
be supported to do this through partnerships. In addition, ENGAGE has showed that some current 
phenotypic methodologies, e.g. Salmonella serotyping, could in the future be replaced by WGS and 
the use of bioinformatics tools. The ENGAGE project was successful on many levels both in terms of 
boosting WGS and analysis capacity and capability across Europe but also in demonstrating 
advantages of having genome data sets from different sources and different countries for validation 
and benchmarking exercises as well as investigative analyses. To date there has been little 
benchmarking of bioinformatics tools for microbial genome analysis and this project has contributed 
significantly to this which is beneficial to all who use such tools. A limitation to move the WGS 
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technology forward in zoonoses surveillance and food safety is likely due to lack of funding at 
institutions. Consequently, there is a risk of not being able to meet the future requirements in 
diagnostics and surveillance. We recommend, either at national or EU level, to provide more funding 
initiatives for the implementation of WGS for food safety in laboratories without current capacity. 
 
 Additional Supporting Information  
Annex A - Excel file: Supplementary Table 1 - Sequences produced and used in the ENGAGE project. 
This table includes ENA submission numbers, isolates IDs and their use.  
Annex A can be found in the online version of this output (‘Supporting information’ section): 
https://efsa.onlinelibrary.wiley.com/doi/10.2903/sp.efsa.2018.EN-1431. 
 
Annex B - Excel file: Supplementary Table 2 - Phenotypic antimicrobial resistance (AMR) genes and 
resistance genes detected using SPAdes 3.9 vs Velvet 1.2 de novo assembly tools. This table includes 
the antimicrobial susceptibility results and AMR genes from 50 Salmonella isolates. 
Annex B can be found in the online version of this output (‘Supporting information’ section: 
https://efsa.onlinelibrary.wiley.com/doi/10.2903/sp.efsa.2018.EN-1431. 
 
Annex C - Excel file: Supplementary Table 3 - Detailed results for the ENGAGE benchmarking of 
genotypic Salmonella serotype prediction (general). This table includes list of serotypes, correlation, 
miscorrelation, no prediction, ambiguous results and summary graph.  
Annex C can be found in the online version of this output (‘Supporting information’ section: 
https://efsa.onlinelibrary.wiley.com/doi/10.2903/sp.efsa.2018.EN-1431. 
 
Annex D - Excel file: Supplementary Table 4: - Sequencing quality and detailed results for the 
ENGAGE benchmarking of genotypic Salmonella serotype prediction complying to the Draft 
International Standard ISO 16140-6. This table includes sequencing quality, species, species-
correlation, species-miscorrelation, species-no prediction, summary-species, serotype, serotype-
correlation, serotype-miscorrelation, serotype-ambiguous, serotype-no prediction and summary 
serotype.  
Annex D can be found in the online version of this output (‘Supporting information’ section: 
https://efsa.onlinelibrary.wiley.com/doi/10.2903/sp.efsa.2018.EN-1431. 
 
Annex E - Excel file: Supplementary Table 5: - Sequence list and detailed results for the ENGAGE 
benchmarking of genotypic detection of antimicrobial (AMR) genes. This table includes sequence list 
from APHA, sequence list from DTU, comparison of AMR tools for Salmonella and E. coli dataset.  
Annex E can be found in the online version of this output (‘Supporting information’ section: 
https://efsa.onlinelibrary.wiley.com/doi/10.2903/sp.efsa.2018.EN-1431. 
 
Annex F - Excel file: Supplementary Table 6: - Sequence list and detailed results for the ENGAGE 
benchmarking of Salmonella Enteritidis phylogeny and Campylobacter coli phylogeny. This table 
includes 30 Salmonella isolates and 9 Campylobacter isolates. 
Annex F can be found in the online version of this output (‘Supporting information’ section 
https://efsa.onlinelibrary.wiley.com/doi/10.2903/sp.efsa.2018.EN-1431. 
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APHA Animal Plant Health Agency 
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CDC Centers for Disease Control and Prevention 
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CoC Code of Conduct  
DNA Deoxyribonucleic acid  
DTU Technical University of Denmark, National Food Institute  
eBG e-Burst Groups 
E. coli Escherichia coli  
ECDC European Centre for Disease Prevention and Control  
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EU European Union 
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EURL-AR European Union Reference Laboratory for Antimicrobial Resistance 
FBP Foodborne pathogens  
FDA Food and Drug Administration  
FWD Food and Waterborne Disease  
GMI Global Microbial Identifier 
IP Intellectual Property 
IZSLT Istituto Zooprofilattico Sperimentale del Lazio e della Toscana M. Aleandri 
IZSVE Istituto Zooprofilattico Sperimentale delle Venezie 
MCC  Matthew’s Correlation Coefficient 
MDR Multidrug resistant 
MoU Memorandum of understanding 
MTA Material transfer agreement  
NDA Non-disclosure agreements 
NGS Next Generation Sequencing 
NIPH-NIH National Institute of Public Health – National Institute of Hygiene 
NRL National Reference Laboratory 
NRL-AR National Reference Laboratory for Antimicrobial Resistance 
NVRI National Veterinary Research Institute 
PAHO Pan American Health Organization  
PHE Public Health England 
PT Proficiency Testing  
QC Quality control  
RIVM The Netherlands National Institute for Public Health and the Environment 
SNP Single Nucleotide Polymorphism 
SOP Standard operating procedures  
SPI  Salmonella pathogenicity Island 
ST  Sequence Type 
US United States of America  
USDA US Department of Agriculture  
VTEC Verotoxin producing E. coli 
WGS Whole genome sequencing  
WGST  Whole genome sequencing typing  
WHO World Health Organization  
WP Work Packages   
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Appendix A – Data collection 
 
Based on the recorded phenotypic information combined with the existing epidemiological data and 
traditional molecular typing methods such as AMR and plasmid profiling, multi-locus variable-number 
tandem repeat analysis (MLVA), PFGE and multi locus sequence typing (MLST) based on 7 house-
keeping genes, the consortium partners selected Salmonella spp. and E. coli strains for WGS. The 
overall aim was to retrospectively sequence a large number of strains in a comprehensive background 
strain collection to provide datasets for the benchmarking exercises, including strains for the specific 
pilot studies to provide high resolution information on the phylogenetic relationships amongst isolates 
from different EU countries and provide insight on pathogen evolution and acquisition and spread and 
AMR. The suggested criteria for strain selection were:  
Salmonella spp.: Salmonella isolates with a specified AMR profile (e.g. ACSSuT, ASSuT, Cip/Nal, Cip 
without Nal, 3GCs, gentamicin) including isolates of human, food and animal origin isolated in the 
previous 10 years. To monitor the evolution, a few representative isolates of a specific serovar or AMR 
pattern older than 10 years were included in the selection. For animal isolates the selection was made 
on the basis of serovar per host/year base, to allow for proportional sampling of the number of 
isolates from specific animal host to the number of total isolates in that year and avoid 
overrepresentation, unless isolates are outbreak related. Strain selection for the Salmonella serotyping 
benchmarking exercise was based on inclusion of a collection of wide variation of serovars including 
commonly isolated serovars and rare serovars, seldom found.  
E. coli: commensal E. coli and a few VTEC were included. The selections was done based on serotype 
and/or pulsotype, where available; E. coli isolates with a specific AMR profile including isolates of 
human, food and animal origin isolated in the previous 10 years were included in the selection. In 
addition, E. coli isolates from the 2015 EU surveillance in Germany, Denmark and the UK were 
sequenced.  
All sequenced isolates (Table A.2) with the corresponding ENA submission numbers and project 
submission numbers are listed in the Supplementary Table 1 (Annex A). All sequences are thus 
publically available and also, most sequences have been included in ENGAGE proof-of-concept 
projects or ENGAGE benchmarking exercises as indicated in Annex A. Some sequences have not been 
included in ENGAGE projects but have been sequenced with the purpose of populating the ENA with 
sequences of relevant, interesting phenotypes.  
 
DTU = 520 
During the ENGAGE project period, DTU Food WGS typed a total of 520 genomes (212 Salmonella and 
308 E.coli) isolated between 2008 and 2017. The sequenced Salmonella spp. isolates included 
serovars for inclusion in the proof of concept studies, i.e. 64 S. Derby strains covering the last five 
years and 5 S. Napoli sequences were included in the proof-of-concept studies conducted by IZSVe. 
Similarly, 81 S. Infantis strains were whole genome sequenced for the proof of concept study 
conducted by IZSLT. Due to all Danish S. Paratyphi B var. Java resistant to colistin being of German 
origin, we set up a proof of concept study with BfR to include the Danish genomes (17 Salmonella spp. 
sequences) in the project led by BfR. Forty-five of the sequenced Salmonella strains have not been 
included in ENGAGE projects but have been sequenced with the purpose of populating the ENA with 
sequences of relevant, interesting phenotypes. Of the 308 E. coli whole genome sequenced by DTU 
Food, 41 E. coli strains resistant to colistin were included in a DTU Food led project to characterize the 
strains and plasmids, 164 E. coli in the benchmarking exercise for genotypic detection of antimicrobial 
resistance (AMR) genes, 97 EBSL producing E. coli from the national AMR monitoring of animal 
species not included in the EU monitoring in the respective years (not included in an ENGAGE project 
but sequenced with the purpose of populating the ENA with sequences of relevant, interesting 
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phenotypes), and six E. coli ST-131 (not included in an ENGAGE project but sequenced with the 
purpose of populating the ENA with sequences of relevant, interesting phenotypes).  
ENA Study ID: PRJEB23891, PRJEB23082, PRJEB18587, PRJEB14641, PRJEB18619, PRJEB22091, 
PRJEB14086 
 
PHE = 500 
As PHE routinely sequenced Salmonella since 2014, we selected 500 genomes of different Salmonella 
serovars to include in the serotyping benchmarking exercise to give a broad and deep overview of the 
Salmonella diversity seen between 2014 and 2015. To cover maximum diversity, we selected 5 strains 
for each serovar isolated during the period 2014-2015. All the 500 genomes selected were used in the 
serotyping benchmarking. As Salmonella Enteriditis and Salmonella Typhimurium are the most 
common serovars, more than 5 strains were selected from these two serovars to also capture the 
sequence type diversity. The final contribution included more than 100 different Salmonella serovars. 
The strain accession numbers are available on the SRA project PRJNA248792 (PHE global repository 
for Salmonella isolates). Table A.1 below summarizes the strain selection: 
 
Table A.1:  PHE strain selection 
Serovars: each serovar mentioned contains # strains (see number in the column 
to the right) 
Number of 
isolates per 
serovar 
Typhimurium 16 
Enteritidis 13 
Paratyphi 8 
Abony, Adelaide, Agama, Agbeni, Ago, Agona, Ajiobo, Alachua, Albany, Anatum, Bareilly, 
Blockley, Bovis-morbificans, Braenderup, Brandenburg, Bredeney, Cerro, Chester, Coeln, 
Colindale, Corvallis, Derby, Dublin, Durham, Eastbourne, Emek, Gaminara, Give, Gold-coast, 
Hadar, Haifa, Havana, Heidelberg, Hvittingfoss, Ibadan, Indiana, Infantis, Jangwani, Java, 
Javiana, Kedougou, Kentucky, Kenya, Kingston, Kottbus, Litchfield, Livingstone, London, 
Mbandaka, Mikawasima, Minnesota, Mississippi, Monschaui, Montevideo, Muenchen, Napoli, 
Newport, Nima, Ohio, Oranienburg, Oslo, Panama, Poona, Potsdam, Richmond, Rissen, 
Saint-paul, San-diego, Schwarzengrund, Senftenberg, Stanley, Stanleyville, Takoradi, Tel-el-
kebir, Tennessee, Thompson, Typhi, Umbilo, Virchow, Wassenaar, Weltevreden 
5 of each 
serovar 
Aberdeen, Bispebjerg, Fluntern, Meleagridis, Muenster, Rubislaw, Vitkin 4 
Altona, Bonn, Concord, Ealing, Khami, Kisangani, Manchester, Nottingham 3 
Amager, Apapa, Glostrup 2 
 
APHA = 439 
APHA sequenced a total of 439 bacterial genomes including 339 Salmonella and 100 E. coli for 
inclusion in different ENGAGE studies. The selected isolates were: 94 ”rare” Salmonella spp. isolates of 
different serovars isolated between 1988 and 1997, for inclusion in the Salmonella serotyping 
benchmarking exercise (Benchmarking exercise #2). The strains were selected from the APHA strain 
collection used for production of O and H anti-sera for the traditional Salmonella serotyping. Sixteen of 
the 94 “rare” Salmonella were not included in ENGAGE projects but were sequenced with the purpose 
of populating the ENA with sequences of relevant, interesting phenotypes. Further 123 Salmonella spp. 
isolates collected between 2006 and 2016 were selected for the AMR benchmarking exercise 
(Benchmarking exercise #4). In addition, 59 S. Dublin isolates collected from 2006-2016 were 
selected for inclusion in an EU-wide study lead by RIVM (external subproject lead by this affiliated 
partner, data not included in this report) 29 S. Derby isolates from 2006-2016 for inclusion in the 
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study lead by IZSVe and 34 S. Infantis strains from 2006-2016 for inclusion in the study lead by IZLST. 
S. Dublin, S. Derby, S. Infantis and isolates for the AMR benchmarking exercise were collected as part 
of the UK National Control Program (NCP) or as part of the passive surveillance conducted through the 
submission of isolates from clinical diagnostic samples. The 100 ESBL producing E. coli strains were 
part of the 2015 EU AMR monitoring programme for E. coli (not included in an ENGAGE project but 
sequenced with the purpose of populating the ENA with sequences of relevant, interesting 
phenotypes).  
ENA study ID: PRJEB24311 (123 Salmonella spp isolates included in the AMR benchmarking study), 
PRJEB24308 (92 Salmonella spp. isolates included in the serotyping benchmarking), PRJEB23868 (2 
Salmonella spp. isolates included in the serotyping benchmarking), PRJEB24107 (34 S. Infantis 
isolates included in the pilot study), PRJEB24103 (59 S. Dublin isolates included in the pilot study), 
PRJEB24097 (25 S. Derby isolates include in the pilot study), PRJEB24583 (4 S. Derby isolates 
included in the pilot study), and PRJEB21131 (100 E. coli isolates) (Supplementary Table 1 Annex A). 
BfR = 382 
In the two years of the ENGAGE project, BfR sequenced 382 S. enterica (290) and E. coli (92) isolates 
from animal, food and environmental sources using the in-house Illumina MiSeq and NextSeq 
sequencers. Salmonella isolates of the most common serovars as well as Escherichia coli isolates were 
selected based on conspicuous phenotypic antimicrobial resistance profiles. Altogether 16 S. Enteritidis, 
49 S. Infantis, 35 S. Derby, 72 S. Typhimurium (monophasic and biphasic variants), 99 S. Paratyphi B 
variant Java, 1 S. Heidelberg, 1 Salmonella rough colony, 3 S. Newport, 3 S. Saintpaul, 11 S. Napoli 
and 92 E. coli were sequenced. The strains were uploaded to the ENA studies PRJEB23094 
(Salmonella, 290 isolates) and PRJEB23572 (Escherichia coli, 92 isolates).  
NIPH-NIH = 320 
A total of 320 strains were sequenced from the National Institute of Public Health – NIH collection. 
The strain list included 31 Escherichia coli VTEC isolates collected between 2003 and 2017, 
representing most of the VTEC strains isolated in Poland in this time period. Of these, 24 were of the 
most prevalent serotype O157, 4 were O26 and 3 were not typed using classical phenotypic method 
(further performed analysis of WGS data showed that one of these strains was O157:H34, one 
O26:H11 and one H4 with no O type genes found). 
Additionally 289 Salmonella enterica strains isolated between 2013 and 2017 were sequenced. Among 
them the most numerous group was monophasic S. Typhimurium (105 strains). Of other sequences 
Salmonella enterica 43 were S. Enteritidis, 18 S. Typhimurium, 16 S. Infantis, 4 S. Derby, 2 S. 
Paratyphi B and 1 S. Napoli (all included in the proof of concept partners projects). Additionally WGS 
was performed for 10 strains from other common serovars (S. Hadar, S. Virchow and S. Mbandaka) 
and 58 strains from rare serovars S. Schwarzengrund, S. Schleissheim, S. Oranienburg, S. Senftenberg, 
S. Bredeney, S. Poitiers and S. Vitkin. To check and point out the opportunities offered by WGS 
technology, 32 S. enterica strains, non-fully typed using classical phenotypic tests were sequenced. All 
sequences and metadata were uploaded on ENGAGE working space with no restrictions on their public 
availability. 
ENA Study ID: PRJEB23743, PRJEB26541, PRJEB26514, PRJEB26516, PRJEB26511, PRJEB26513, 
PRJEB26517, PRJEB26518, PRJEB26520, PRJEB26519, PRJEB26504, PRJEB26523, PRJEB26528, 
PRJEB26529, PRJEB26506, PRJEB26530, PRJEB26527, PRJEB26510, PRJEB26503, PRJEB26515, 
PRJEB26521, PRJEB26507, PRJEB26505, PRJEB26539, PRJEB26522, PRJEB26524, PRJEB26525, 
PRJEB26526. 
NVRI = 368 
National Veterinary Research Institute has performed analyses of 368 bacterial isolates fulfilling 
predefined strain selection criteria. They were isolated between 2010 and 2017, but mostly (66%) in 
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2014-2016, when official AMR monitoring was launched. These included 182 Salmonella isolated along 
the food chain and 186 E. coli isolated from food (N = 52; from chicken, cattle and pig meat) and 
animal faeces (N = 134; isolates mostly from official AMR monitoring). At the very beginning of the 
project, the sequencing was outsourced (N = 202; Illumina MiSeq and HiSeq platform) whilst the rest 
of the strains were sequenced with Illumina MiSeq platform implemented at NVRI laboratories in 2017. 
All sequences and metadata were uploaded on ENGAGE working space with no restrictions on their 
public availability. The sequences are available for miniprojects run at NVRI and other partners within 
ENGAGE project. Specifically, NVRI projects focused on: 
 identification of rare and atypical Salmonella serovars (N = 102) 
 ad hoc project on WGS of S. Enteritidis related to egg-related outbreak (N = 13; confirmation 
of infection source) 
 characterisation of colistin-resistant (mcr-1 positive) E. coli isolated from animals in Poland (N 
= 80) 
ENA study ID: PRJEB23993. 
IZSLT = 382 
IZSLT sequenced a total of 382 isolates of which 321 were S. enterica and 61 E. coli: 
-Sequenced E. coli isolates, phenotypically colistin-resistant (N=55) or susceptible (N=6), were all 
included in the proof-of-concept project entitled “Molecular epidemiology of mcr-encoded colistin 
resistance in Enterobacteriaceae in Italy, headed by IZSLT in collaboration with DTU.  
-Sequenced Salmonella isolates consisted of 229 S. Infantis included in the proof-of-concept project 
entitled “Salmonella Infantis in Italy and EU: phylogeny and plasmid carrying virulence, 
fitness and antimicrobial resistance (AMR) genes”, headed by IZSLT in collaboration with DTU 
and 14 Salmonella of different serotypes included in the proof-of-concept project entitled “Molecular 
epidemiology of mcr-encoded colistin resistance in Enterobacteriaceae in Italy, headed by IZSLT in 
collaboration with DTU. Seventy-eight S. Typhimurium isolates were also analysed for comparison 
purposes of detecting similarities and differences between colistin-resistant and colistin-susceptible 
isolates in these animal productions. All the S. Typhimurium isolates were collected in the context of 
Italian passive surveillance activities and active voluntary monitoring programmes conducted in meat-
producing animals (2014-2015-2016), according to the sampling frame of the Dec. 2013/652/2015.  
All sequenced data was uploaded to the ENGAGE working space and to ENA under the project 
accession numbers: PRJEB23778 and PRJEB23728 
IZSVe = 449  
IZSVe sequenced 449 Salmonella genomes, spanning years from 2005-2016 (older isolates for S. 
Napoli only, due to its low frequency of isolation), for different ENGAGE studies. The selected isolates 
were: 141 S. Napoli, 150 S. Derby, 88 monophasic S. Typhimurium, 30 S. Enteritidis and 40 other 
serovars (1 S. Abony, 1 S. Infantis, 2 S. Bredeney, 2 S. NA, 21 S. Stanleyville, 4 S. enterica subsp. 
Houtenae, 9 S. Kentucky, part of which were shared for the “rare serovar” project led by NVRI). All 
sequenced data were uploaded to ENA under project numbers PRJEB21283, PRJEB22761 (monophasic 
variant of S. Typhimurium), PRJEB23440 (S. Derby), PRJEB23407 (S. Napoli), PRJEB23485 (other 
serovars). The sequences were used for the projects run at IZSVE (S. Napoli, S. Derby, monophasic S. 
Typhimurium) and shared with other partners for their own projects. 
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Table A.2:  Number of isolates sequenced 
Institute Number of strains in ENA*  
DTU 520 
PHE 500 
APHA 439 
BfR 382 
NIPH-NIH 320 
NVRI 368 
IZLST 382 
IZSVe 449 
TOTAL 3,360 
* Supplementary Table 1 (Annex A). 
Abbreviations 
A = Ampicillin  
C= Chloramphenicol  
S= Streptomycin  
Su = Sulphonamide compounds  
T = Tetracycline  
Nal = Nalidixic acid 
Cip = Ciprofloxacin 
3GCs: 3rd generation cephalosporins 
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Appendix B – Guideline on how to get started 
 
Considerations when designing a whole genome sequencing (WGS) service: From Sample 
to Result 
Nucleic Acid Extraction 
 Bacteria will require DNA extraction from isolates. Development of a robust protocol for 
nucleic acid extraction is critical but already available from many sources, e.g. ENGAGE (see 
Appendix C in this report). A key component to this is the extraction method. Many manual 
kits (e.g. Promega Wizard genomic DNA purification and Qiagen/Stratec genomic DNA 
purification spin columns) are suitable but it is critical to check that the resulting DNA is of 
sufficient quantity (Illumina recommendation 8-100 ng/µl, Illumina Nextera recommendation 
1ng/µl then diluted to 0.2ng/µl). If more than a few tens of samples are expected to be 
processed per week a high throughput DNA purification system such as Qiasymphony, EZ1, 
SP/AS, Qiacube HT (Qiagen company) is recommended. 
 Viruses present a greater problem for extraction and either an amplicon strategy (quick et al., 
2016) or bait-based enrichment protocol (Depledge et al., 2011) is required. 
 In both of these cases, work to assess yields from these protocols is essential so that a 
standard operating procedure (SOP) can be produced which, if followed, results in a high 
probability of the amount and quality of DNA being sufficient for subsequent library 
preparation. 
 
Quantification 
 Although it is possible that following a SOP generated from the previous step results in a 
consistent amount of DNA that does not require quantification, it is recommended that prior 
to library preparation, quantification is performed. 
 Recommended instruments for quantification include the GloMax (high throughput) from 
Promega and Qubit (single tube) from ThermoFisher. The NanoDrop (ThermoFisher) is not 
recommended, due to lack of sufficient accuracy and consistency of the readings for the 
purposes of library preparation. 
 
Library Preparation 
 There are two main alternatives for library preparation: 
o Nextera – a kit from Illumina that makes the number of hands on steps minimal but 
has the disadvantages of giving slightly less uniform coverage compared to physical 
sheering methods (see below) and having a higher per sample cost. In addition, it is 
susceptible to being less efficient for genomes with a %GC content significantly 
different from 50%. Furthermore, Nextera is recommended for bacterial genomes but 
is probably not suitable for smaller viral genomes. 
o Physical sheering of DNA (e.g. from Covaris) and adaptor ligation. This is more 
technically challenging and the upfront cost is greater. However, the per sample cost 
is less and the uniformity of sequence coverage is better and less susceptible to 
variations in %GC. 
 After preparing libraries for each sample including the addition of unique indices per sample, 
normalization of the quantity of DNA added per sample into the pooled tube (PAL) that will be 
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sequenced is essential in order to ensure each sample has adequate coverage. There are 
again at least two possible methods: 
o Using the Nextera XT kit Guide 150319425031942 following the protocol revision C 
(http://support.illumina.com/downloads/nextera_xt_sample_preparation_guide_15031
942.html) where a bead-based method ensures simple normalization of sample 
quantities that are added. Other bead based normalisation kits are available. 
o Measurement of the concentration of each sample. 
 Ideally the fragment size of the libraries should also be measured before addition to the PAL 
tube in order to ensure the correct range for efficient sequencing (250 - 1000 bp). This can be 
achieved by fragment analysers such as LabChip from Perkin Elmer or BioAnalyser from 
Agilent. 
 During library preparation a positive control comprising DNA from a known isolate (to check 
the effectiveness of library preparation and the absence of sample transposition) and ideally a 
negative control (to check for lack of contamination) should be included. 
 
Sequencing 
There are several short read sequencing technologies that are currently on the market, including 
Illumina and Ion Torrent™ Personal Genome Machine™ (from Thermo Fisher Scientific company) both 
of which have ‘desktop’ machines, the MiSeq and Ion Torrent™ Personal Genome Machine™ (PGM), 
respectively. These technologies also have larger capacity high throughput machines. When deciding 
which technology to use it is important to consider capacity and speed. Is turnaround time crucial and, 
if so, how much of a sequencing plate is required to be filled before it is sufficiently cost effective? 
Whatever the technology used one critical step that should always be carried out and audited is the 
on-machine quality metrics calculation. It implies that the quality of the data as assessed by the 
machine is recorded as well as the quality of the final output fastq files. On the Illumina platform this 
will include metrics such as cluster density and percentage of clusters that pass/fail. 
 
Post-sequencing data processing 
 Demultiplexing 
When processing samples through the desktop machines, e.g. MiSeq, the processing of raw 
reads into per sample fastq files can occur on board the machine itself. However, for the 
higher throughput machines a server/computing infrastructure will likely be required. 
 Quality Control 
Once the sequencing data has been demultiplexed it is critical that quality assessment is 
carried out (fastQC, see Appendix D, is recommended) and that, if necessary, poor quality 
data is removed using software such as Trimmomatic (Appendix D). At the very least adapter 
removal should be performed. 
 Analytical processes 
Before embarking on the process of analysing samples to obtain results it is critical to think 
what the end point is and what result needs to be reported. Then a literature search can be 
carried out to assess how this can be best achieved. The list of software provided as part of 
the ENGAGE project (Appendix D) or the tools listed here (https://omictools.com/whole-
genome-resequencing-category) will be a good place to start. A key consideration will be 
throughput. For any more than a few samples per week, a web based solution will probably 
not be suitable since it will be too person-hour expensive and difficult to audit and record. 
Alternatives for running analytic pipelines include: 
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o Web services 
A good example of this are the services at the Centre for Genomic Epidemiology 
(https://cge.cbs.dtu.dk/services/all.php). These allow sample by sample processing 
and in some cases batch processing. However, tracking the result outcomes and 
version of software is challenging. 
o Galaxy 
A wide range of tools as listed in this report (Appendix D) are available via the Galaxy 
website (https://usegalaxy.org/) and these can be chained together into pipelines. 
This offers a lot of flexibility although it is likely that downstream processing of the 
outputs will be required in order to make them ready for interpretation. 
o Infrastructure 
If processing any more than a few samples a dedicated server running best practice 
software is desirable. However, this will require ongoing dedicated IT support and 
programmatic bioinformatics skills.  
Whichever solution is chosen from the options listed above, the location for the long term storage of 
the data should be considered. Although data can be uploaded to the public nucleotide archives (e.g. 
EMBL-EBI (https://www.ebi.ac.uk/ena/submit/sra/#home) or NCBI https://www.ncbi.nlm.nih.gov/sra/
docs/submitportal/), it is likely that local storage of the files will be necessary. The amount of storage 
space required will be in the order of several terabytes. A resilient storage system recommended by 
local IT should be purchased unless they can give assurance of being able to store data of this 
magnitude. 
 
Reporting 
It is critical to think about the format and content of the final report that contains results derived from 
WGS. At an early stage consultation with the end-users (microbiologists, clinicians and epidemiologists) 
should be carried out in order to discuss what should be reported. The process by which the final 
outputs from the analytical pathways can be converted into a report should be planned at an early 
stage, to enable automatization. 
 
Sample tracking and auditing 
Throughout all these processes good record keeping and tracking of sample progress should be 
employed in order to allow construction of a full audit trail. A NGS sample LIMS (Laboratory 
Information and Management Systems) would be recommended such as the one listed here 
(https://omictools.com/lims-category). 
 
References 
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Companies’ main websites 
o QIAGEN: https://www.qiagen.com/gb/ 
o STRATEC: https://www.molecular.stratec.com/home 
o THERMO FISHER: https://www.thermofisher.com  
o PROMEGA: https://www.promega.co.uk/ 
o COVARIS: http://covaris.com/ 
o ILLUMINA: https://www.illumina.com/ 
o PERKIN ELMER: http://www.perkinelmer.com 
o AGILENT: https://www.agilent.com/  
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Appendix C – SOPs for DNA extraction and library preparation when 
using the Illumina sequencing platform 
 
Introduction 
With rapid development of whole genome sequencing (WGS) analysis, many bacterial DNA extraction 
procedures have been tested. Here, we review three methods commonly used to extract bacterial 
DNA and library preparation methods for WGS. 
 
DNA extraction methods 
APHA uses an automated MagNA pure system (Roche Life Science) for routine DNA extraction. MagNA 
Pure LC 2.0 Instrument performs a majority of the extraction steps, including binding of DNA to 
magnetic glass particles, washing steps and elution of pure DNA. The purified DNA was analysed with 
respect to DNA integrity, recovery, purity and ability to amplify target sequence with LightCycler® 480 
and LightCycler® (Roche Life Science) Carousel-Based Instruments. The product has since been 
withdrawn. Related products can be found the Roche website 
(https://lifescience.roche.com/en_gb/products/magna-pure-24-instrument.html). 
In addition, APHA tested boilate method for bacterial DNA extraction for WGS. The boilate method 
developed for PCR templates (Queipo-Ortuno et al., 2008; Wimalarathna et al., 2013) has proven to 
be suitable for the preparation of libraries for WGS of Mycobacterium bovis at the APHA sequencing 
unit, however, testing by comparison to sequencing extracted DNA using MagNA Pure extraction 
method showed the boilates method not to be suitable for sequencing Salmonella spp. and E. coli 
genomes. The advantages of the boilate method include no requirements for special equipment or 
reagents, rapid preparation and a safe way to transport pathogenic isolates for sequencing and thus 
further method development outside this project will be carried out for potential use in Salmonella 
sequencing.  
Since the start of the project, the MagNA Pure extraction system has been discontinued from 
production by Roche Life Sciences and therefore APHA adopted a similar magnetic separation protocol 
using KingFisher™ Duo Prime Magnetic Particle Processor (Thermofisher) 
(https://assets.thermofisher.com/TFS-Assets/LSG/manuals/KingFisher_Duo_Prime_User_Manual_
5400110.pdf).  
At DTU, genomic DNA extraction is carried out using Easy-DNA™ Kit (Invitrogen, Thermofisher). The 
extraction method yields high-quality DNA with an average size between 100 kb and 200 kb, which is 
suitable for PCR, DNA hybridization, genomic DNA library construction, and other applications. The 
extraction procedure contains only 4 steps with no special equipment required. 
(https://tools.thermofisher.com/content/sfs/brochures/713_021456_easydnapr_bro.pdf) 
At PHE, genomic DNA extraction is carried out using an automated method to extract DNA from 
bacterial cells. The QIAsymphony DNA Investigator Kit (Qiagen) enables automated purification of 
genomic DNA from up to 96 samples from a wide range of starting material such as swabs, filters, 
casework, crime-scene samples and blood. Purification is fast and efficient, and purified DNA performs 
well in downstream analyses. This method requires QIAsymphony SP/AS instrument. 
(https://www.qiagen.com/gb/resources/resourcedetail?id=b0c38b97-2200-4102-a2d5-ba99648fc9d5
&lang=en) 
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Sequencing library preparation  
DTU, APHA and PHE follow the Illumina NexteraXT library preparation manual (Illumina) 
(https://support.illumina.com/content/dam/illumina-
support/documents/documentation/chemistry_documentation/samplepreps_nextera/nexteradna/nexte
ra-dna-library-prep-reference-guide-15027987-01.pdf). 
Sequencing method 
DTU, APHA and PHE use Illumina sequencing platforms including MiSeq, HiSeq and NextSeq. 
 
Reference 
Queipo-Ortuno MI, De Dios Colmenero J, Macias M, Bravo MJ and Morata P, 2008. Preparation of 
bacterial DNA template by boiling and effect of immunoglobulin G as an inhibitor in real-time PCR 
for serum samples from patients with brucellosis. Clinical and Vaccine Iimmunology: CVI, 
15(2):293-296. 
Wimalarathna HM, Richardson JF, Lawson AJ, Elson R, Meldrum R, Little CL, Maiden MC, McCarthy ND 
and Sheppard SK, 2013. Widespread acquisition of antimicrobial resistance among Campylobacter 
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Microbiology, 13:160. 
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APPENDIX C.1  STANDARD OPERATING PROCEDURE – DNA extraction (bacteria), DTU 
Food 
Easy-DNA™ Kit (Invitrogen) 
 
Prepared by: Rolf Sommer Kaas  
Contact: rkmo@food.dtu.dk 
Institution: DTU Food, Denmark 
SOP-version: 1 
 
 
Introduction 
This protocol describes a bacterial DNA extraction method to extract DNA. Easy-DNA™ (Invitrogen) 
extraction method yields high-quality DNA with an average size between 100 kb and 200 kb, which is 
suitable for PCR, DNA hybridization, genomic DNA library construction, and other applications. In this 
method, protein and lipids are precipitated and extracted by the addition of solution B and chloroform. 
The solution is then centrifuged to separate it into two phases with a solid interface in between the 
phases. The DNA is in the upper. The extraction procedure contains only four steps with no special 
equipment required. 
 
Sample Material 
Bacterial culture  
 
Equipment 
- Heating block capable of maintaining 65°C 
- Microcentrifuge  
- Vortex Mixer 
 
Reagents 
- Easy-DNA™ Kit, cat.no. K1800-01 (Invitrogen) 
 
Literature 
Order info: https://www.fishersci.com/shop/products/kit-easy-dna/k180001  
Procedure, DNA extraction (bacteria), DTU Food (Easy-DNA™ Kit (Invitrogen)) 
1. Resuspend a 10 µl loopful of bacterial cells streaked on blood agar in 200 µl PBS. 
2. Add 350 µl of Solution A and incubate at 65°C for 10 min.  
3. Add 350 µl of Solution B and vortex vigorously. 
4. Add 500 µl of chloroform and vortex. 
5. Spin at 20,000 g for 10 min at 4°C. 
6. Transfer 300-500 µl of the upper phase into 1 ml of cooled ethanol. 
7. Incubate on ice for 30 min. 
8. Centrifuge at 20,000 g for 10-15 min at 4°C. 
9. Wash with 500 µl of cooled 80% ethanol. 
10. Centrifuge at maximum speed for 3-5 min at 4°C to remove ethanol. 
11. Resuspend pellets in 100 µl of Tris-RNase (40 µg/ml) and incubate for 1 h at 37°C. 
12. Store DNA samples at -20°C until required.  
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APPENDIX C.2  STANDARD OPERATING PROCEDURE – DNA extraction (bacteria), PHE 
 
QiaSymphony DNA (Qiagen) extraction 
 
Prepared by: Satheesh Nair, Craig Swift 
Contact: Satheesh.Nair@phe.gov.uk; Craig.Swift@phe.gov.uk 
Institution: PHE, UK 
SOP-version: 1 
 
 
Introduction 
This protocol describes an automated method to extract DNA from bacterial cells. The QIAsymphony 
DNA Investigator Kit (Qiagen) enables automated purification of genomic DNA from 1–96 samples 
from a wide range of starting material, such as swabs, filters, casework or crime-scene samples, and 
blood on the QIAsymphony SP. Purification is fast and efficient, and purified DNA performs well in 
downstream analyses. 
 
Sample Material 
Bacterial culture  
 
Equipment 
- Heating block capable of maintaining 95°C 
- Microcentrifuge tubes 
- Vortex Mixer 
- QIAsymphony SP/AS instrument 
 
Reagents 
- QIAsymphony DNA Investigator Kit 
 
Literature 
Application note:  
https://www.qiagen.com/gb/resources/resourcedetail?id=b0c38b97-2200-4102-a2d5-ba99648fc9d5&lang=en  
 
Procedure, DNA extraction (bacteria), PHE (QiaSymphony DNA extraction) 
1. Transfer 700 µl of overnight culture into a Fortitude 96 well plate. 
2. Spin at 3500 rpm for 20 min to collect bacterial cells.  
3. Lyse cells with ATL buffer and Proteinase K. 
4. Add 4 µl of RNase. 
5. Heat inactivate for 95°C for 10 mins. 
6. Transfer plate onto the QiaSymphony extractor. 
7. Perform automated DNA extraction. 
8. Store DNA samples at -20°C until required.  
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APPENDIX C.3  STANDARD OPERATING PROCEDURE – DNA extraction (bacteria), APHA 
 
Bacterial DNA extraction with the MagNA Pure LC (Roche Life Science) system 
 
Prepared by: Yue Tang 
Contact: yue.tang@apha.gsi.gov.uk 
Institution: APHA, UK 
SOP-version: 1 
 
 
Introduction 
This protocol describes an automated method to extract DNA from bacterial cells. The isolation 
procedure is based on magnetic-bead technology. The samples are lysed by incubation with a special 
buffer containing chaotropic salts and Proteinase K. Magnetic Glass Particles are added and the DNA is 
bound to their surfaces. Unbound substances are removed by several washing steps, then the purified 
DNA is eluted. The MagNA Pure LC automatically performs all isolation and purification steps such as 
addition of Lysis/Binding buffer and magnetic glass particles (MGPs), binding of DNA to the MGPs, 
washing steps, elution of the pure DNA, and transfer to a cooled storage cartridge. 
 
Sample Material 
Bacterial culture  
 
Equipment 
- Heating block capable of maintaining 65°C 
- Microcentrifuge tubes 
- Vortex Mixer 
- MagNA Pure LC 2.0 Instrument for 8-32 samples per run 
 
Reagents 
- MagNA Pure LC DNA Isolation Kit III (Bacteria, Fungi) 
 
Literature 
Application note:  
MagNA Pure LC 2.0 Instrument has since been withdrawn. Related products can be found the Roche 
website (https://lifescience.roche.com/en_gb/products/magna-pure-24-instrument.html).  
 
Procedure, DNA extraction (bacteria), APHA (bacterial DNA extraction with the MagNA Pure LC system) 
1. Prepare 1.5 ml overnight cultures in LB broth from a single colony. 
2. Spin to collect bacterial cells. 
3. Wash cells with 500 μl of TE buffer. 
4. Re-suspend cells in 100 μl of TE buffer.  
5. Add 130 μl of Bacterial Lysis Buffer and 20 μl of Proteinase K. 
6. Incubate at 65°C for 10 minutes. 
7. Place 100 μl of sample mix in a sample cartridge. 
8. Perform automated DNA extraction. 
9. Store DNA samples at -20°C until required. 
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APPENDIX C.4  STANDARD OPERATING PROCEDURE – DNA extraction (bacteria), APHA 
 
Preparation of cell boilates to extract DNA suitable for sequencing library preparation 
 
Prepared by: Richard Ellis 
Contact: richard.ellis@apha.gsi.gov.uk 
Institution: APHA, UK 
SOP-version: 1 
 
 
Introduction 
This protocol describes a rapid and inexpensive method to extract DNA from bacterial cells. This crude 
extract has proven to be suitable for the preparation of libraries for WGS of some bacteria such as 
Mycobacterium bovis. 
 
Sample Material 
Bacterial culture (single colony or pellet following centrifugation of broth culture) 
 
Equipment 
- Heating block capable of maintaining 95°C 
- Microcentrifuge tubes 
- Vortex Mixer 
 
Reagents 
- Molecular Biology Grade Water 
 
General remarks 
All bacterial cultures and boilates should be handled at the appropriate containment level. Once the 
inactivation of the bacteria by the heating process has been properly assessed and validated, boilates 
can be transferred to a lower containment level. 
 
Literature 
None 
 
Procedure, DNA extraction (bacteria), APHA (preparation of cell boilates to extract DNA suitable for 
sequencing library preparation) 
1. Dispense 100 µl of Molecular Biology Grade Water into Microcentrifuge tube. 
2. Resuspend a single colony of bacteria (~3 mm2) in the water. 
3. Vortex for 15 s. 
4. Briefly spin down to collect the liquid in the bottom of the tube. 
5. Heat tube at 95°C for 10 minutes. 
6. Spin down at 3500 rpm for 2 minutes to pellet cell debris. 
7. Transfer supernatant to a fresh centrifuge tube (or well of a 96 well plate). 
8. Store at -20°C until required. 
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APPENDIX C.5  STANDARD OPERATING PROCEDURE – Sequencing library preparation, 
APHA 
 
Prepared by: Richard Ellis 
Contact: Richard.Ellis@apha.gsi.gov.uk 
Institution: APHA, UK 
SOP-version: 1 
 
 
Introduction 
This protocol describes Nextera XT DNA Library Preparation (Illumina) with genomic DNA samples. 
The principle is that genomic DNA is randomly broken into small fragments (typically less than 1000 
bp), before ligating sequencing primers to each end. Each of these ligated fragments are immobilized 
and clonally amplified, before denaturing. As complimentary bases are sequentially added to the 
single stranded template the sequence of nucleotides for each template is determined. 
 
Sample Material 
Genomic DNA samples 
 
Equipment 
- Heating block capable of maintaining 65°C 
- 96-well microtiter plates 
- Plate sealing film 
- Centrifuge (capable of spinning 96-well plates between 100 x g and 1100 x g, room  
 temperature) 
- Thermocycler for 96-well plates 
- Vortex mixer 
 
Reagents 
- Nextera XT library kit  
 
Literature 
Application note 
http://emea.support.illumina.com/sequencing/sequencing_kits/nextera_xt_dna_kit/documentation.html 
 
Procedure, Sequencing library preparation, APHA 
1. Fragment DNA and then tags the DNA with adapter sequences in a single step. 
2. Normalize gDNA. 
3. Amplify libraries with 12 cycles of PCR. 
4. Clean up libraries with AMPure XP beads. 
5. Run 1 μl of undiluted library on an Agilent Technology 2100 Bioanalyzer to check libraries. 
6. Normalize libraries to ensure equal representation. 
7. Combine equal volumes of normalized libraries in a single tube for pooling libraries. 
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APPENDIX C.6  STANDARD OPERATING PROCEDURE – DNA sequencing using the MiSeq 
Instrument, APHA 
 
Prepared by: Richard Ellis  
Contact: Richard.Ellis@apha.gsi.gov.uk 
Institution: APHA, UK 
SOP-version: 1 
 
 
Introduction 
This procedure describes the steps required for the preparation of pooled Nextera® XT libraries for 
loading onto an Illumina® MiSeq Sequencing Platform. The Illumina MiSeq® system combines proven 
sequencing by synthesis (SBS) technology with a revolutionary workflow that enables you to go from 
DNA to analyzed data in as little as 8 hours. The MiSeq integrates cluster generation, sequencing, and 
data analysis on a single instrument.  
 
Sample Material 
Pooled libraries 
 
Equipment 
- The Illumina MiSeq desktop sequencer 
- The Illumina Sequence Analysis Viewer software  
- Vortex mixer 
 
Reagents 
- MiSeq Sequencing Kit v2 300 cycles (Illumina) 
 
Literature 
User guide:  
http://support.illumina.com/content/dam/illumina-
support/documents/documentation/system_documentation/miseq/miseq-system-guide-15027617-01.pdf  
 
Procedure, DNA sequencing using the MiSeq Instrument, APHA 
1. Mix 2.5 µl of diluted NaOH and 7.5 µl of a library pool for 5 min at RT. 
2. Add 940 µl of hybridisation buffer to the denatured library and 50 µl PhiX Control. 
3. Load 600 µl of the library mix onto the reagent cartridge. 
4. Run the MiSeq system. 
5. Wash the instrument with PR2 buffer. 
6. Inspect cluster density for the data output quality.  
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Appendix D – List of online bioinformatics tools and software used for 
capacity building (status January 2018) 
 
This document describes the most commonly used software and algorithms for processing whole 
genome sequencing. It is divided into categories, which describe the key processes for analysing short 
read data. Tools of particular interest will be tag with a specific character (historical†, commonly 
used*, easy to run#, etc). We are aware that the list is not complete, and that we present the status 
as of January 2018. It should be also taken into account that the area is continuously under 
development and new tools, not included here, will be released. 
Most of the presented tools are command line based. In order to use them, you will need to install 
them on your infrastructure. We highly recommend that you ensure to have proper settings for your 
infrastructure (i.e. storage capacity and memory to run tools/software) as some of them require a lot 
of resources. In case you want to try these softwares and do not have infrastructure, we can 
recommend you to run Bio-Linux using a Virtual Box.9 
 
Quality Assessment and Trimming 
This is the process by which the quality of fastq files is determined and subsequent optional trimming 
of the data to trim or remove poor quality reads is carried out. 
o Trimmomatic* 
 http://www.usadellab.org/cms/index.php?page=trimmomatic  
 Trimmomatic: A flexible trimmer for Illumina Sequence Data.  
Bolger, A. M., Lohse, M., & Usadel, B. (2014). Bioinformatics, btu170. 
 Windows, Mac OS X and Linux 
 A flexible read trimming tool that will remove Illumina adapters, reads below a certain 
length and low quality ends of the read 
 Comments: Trimming occurs in the order, which the steps are specified on the command 
line. It is recommended in most cases that adapter clipping, if required, is done as early 
as possible. Options will strongly depend on the data you used i.e. single end, paired end.  
o FastQC*# 
 http://www.bioinformatics.babraham.ac.uk/projects/fastqc/ 
 Windows, Mac OS X and Linux 
 A quality control tool for assessing the quality of NGS data 
 Comments: tool available both online/command line. If running more than few samples 
using the command line is recommended. Interpretation of the results is linked to the 
sequencing method used. The online documentation details all the warnings and how to 
interpret them. 
o Seqtk 
 https://github.com/lh3/seqtk 
 Windows, Mac OS X and Linux 
 Tool for processing sequences in the FASTA or FASTQ format that can be used for 
adapter removal and trimming of low-quality bases 
o FastX 
 http://hannonlab.cshl.edu/fastx_toolkit/  
                                                          
9 Installation of Virtual Box tutorial is included at the end of this Appendix. 
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 Windows, Mac OS X and Linux 
 Toolkit for FASTQ and FASTA pre-processing that can be used for trimming, clipping, 
barcode splitting, formatting and quality trimming. 
 
Assembly 
This is the process of joining short/long reads into longer contigs (contiguous lengths of DNA) without 
the need for a reference sequence.  
o VelvetK 
 http://www.vicbioinformatics.com/software.velvetk.shtml 
 Windows, Mac OS X and Linux 
 Perl script to estimate best k-mer size to use for your Velvet de novo assembly. 
o VelvetOptimiser 
 http://www.vicbioinformatics.com/software.velvetk.shtml 
 Mac OS X and Linux 
 Perl script to assist with optimising the assembly. 
 Comments: optimisation can be made using different metrics (e.g. with best N50, best 
coverage…) 
o KmerGenie 
 http://kmergenie.bx.psu.edu/ 
 Informed and Automated k-Mer Size Selection for Genome Assembly. Chikhi R., Medvedev 
P. HiTSeq 2013. 
 Windows, Mac OS X and Linux 
 Best k-mer length estimator for single-k genome assemblers like velvet. 
o Khmer 
 http://khmer.readthedocs.io/en/v2.0/ 
 The khmer software package: enabling efficient nucleotide sequence analysis. Crusoe et 
al., 2015. F1000 http://dx.doi.org/10.12688/f1000research.6924.1 
 Linux and Mac OS X 
 Set of command-line tools for dealing with large and noisy datasets to normalise and 
scale the data for more efficient genome assembly. 
o Minia 
 http://minia.genouest.org/ 
 Space-efficient and exact de Bruijn graph representation based on a Bloom filter. Chikhi, 
Rayan and Rizk, Guillaume. Algorithms for Molecular Biology, BioMed Central, 2013, 8 (1), 
pp.22.  
 Windows, Mac OS X and Linux 
 Short-read assembler based on a de Bruijn graph for low-memory assembly. 
o SPAdes*# 
 http://cab.spbu.ru/software/spades/ 
 SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell 
Sequencing, Anton Bankevich, Sergey Nurk, Dmitry Anipov, Alexey A. Gurevich, Mikhail 
Dvorkin, Alexander S. Kulikov, Valery M. Lesin, Sergey I. Nikolenko, Son Pham, Andrey D. 
Prjibelski, Alexey V. Pyshkin, Alexander V. Sirotkin, Nikolay Vyahhi, Glenn Tesler, Max A. 
Alekseyev, and Pavel A. Pevzner. Journal of Computational Biology 19(5) (2012), 455-477. 
doi:10.1089/cmb.2012.0021 
 Mac OS X and Linux 
 Short and hybrid-long read assembler based on a de Bruijn graph that also performs error 
correction and is a multi-k genome assembler. 
 Comments: Illumina Paired reads (2*150 and 2*250) need to be assemble with the 
specific option --careful (see application note for full details) to get the best assembly 
possible 
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o Velvet†* 
 https://www.ebi.ac.uk/~zerbino/velvet/ 
 Velvet: Algorithms for de novo short read assembly using de Bruijn graphs. Daniel R. 
Zerbino and Ewan Birney. Genome Res. May 2008 18: 821-829; Published in Advance 
March 18, 2008, doi:10.1101/gr.074492.107 
 Linux 
 De novo short read genome assembler with error correction to produce high quality 
unique contigs. 
 Comments: parameters can be difficult to select, some scripts have been developed and 
are working well to help choose the best parameters. Optimisation of the option should be 
used: VelvetOptimiser or VelvetK 
o Canu 
 http://canu.readthedocs.io/en/stable/index.html 
 Canu: scalable and accurate long-read assembly via adaptive k-mer weighting and repeat 
separation. Sergey Koren, Brian P. Walenz, Konstantin Berlin, Jason R. Miller, Adam M. 
Phillippy doi: http://dx.doi.org/10.1101/071282 
 Windows, Mac OS X and Linux 
 Long-read assembler designed for high-noise data such as that generated by PacBio or 
Oxford Nanopore MinION. Canu also performs error correction. 
 Comments: specifically designed to work with long read 
o Unicycler 
 https://github.com/rrwick/Unicycler 
 Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. 
Ryan R. Wick, Louise M. Judd, Claire L. Gorrie, Kathryn E. Holt , Published in PLoS 
Comput Biol (2017) https://doi.org/10.1371/journal.pcbi.1005595  
 Mac OS X and Linux 
 Unicycler is an assembly pipeline for bacterial genomes. It can assemble Illumina-only 
read sets where it functions as a SPAdes-optimiser. It can also assemble long-read-only 
sets (PacBio or Nanopore) where it runs a miniasm+Racon pipeline. For the best possible 
assemblies, give it both Illumina reads and long reads, and it will conduct a hybrid 
assembly. 
 Comments: use mainly as hybrid assembly for long read associated with Illumina read. 
Well documented with a Wiki-tutorial https://github.com/rrwick/Unicycler/wiki/Tips-for-
finishing-genomes 
o Bandage# 
 http://rrwick.github.io/Bandage/ 
 Bandage: interactive visualization of de novo genome assemblies. Ryan R. Wick, Mark B. 
Schultz, Justin Zobel, and Kathryn E. Holt. Bioinformatics (2015) 31 (20): 3350-3352 first 
published online June 22, 2015 doi:10.1093/bioinformatics/btv383 
 Linux and Mac 
 Program for visualising de novo assembly graphs by displaying connection which are not 
present in the contigs file for assembly assessment. 
 Comments: possibility to use blast inside the software to annotate regions of interest. Can 
help determine relations between contigs. 
 
Annotation 
The process which takes the raw sequence of contigs resulting from assembly and marks it with 
features such as gene names and putative functions. 
o Prokka*# 
 http://www.vicbioinformatics.com/software.prokka.shtml 
 Prokka: rapid prokaryotic genome annotation. Seemann T. Bioinformatics. 2014 Jul 
15;30(14):2068-9. PMID:24642063 
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 Windows, Mac OS X and Linux 
 Software tool for the rapid annotation of prokaryotic genomes. 
o RAST 
 http://rast.nmpdr.org/ 
 The RAST Server: Rapid Annotations using Subsystems Technology. Aziz RK et al.. BMC 
Genomics, 2008 
 Online tool 
 Fully-automated service for annotating complete or nearly complete bacterial and 
archaeal genomes. 
o Genix 
 http://labbioinfo.ufpel.edu.br/cgi-bin/genix_index.py 
 Online tool 
 Fully automated pipeline for bacterial genome annotation. 
o Prodigal 
 https://github.com/hyattpd/Prodigal/wiki/Introduction 
 Hyatt, Doug et al. “Prodigal: Prokaryotic Gene Recognition and Translation Initiation Site 
Identification.” BMC Bioinformatics 11 (2010): 119. PMC. Web. 25 Apr. 2018. 
 Windows, Mac OS X, GenericUnix (Linux) 
 Prodigal is a software is a protein-coding gene prediction software tool for bacterial and 
archaeal genomes 
o NCBI Prokaryotic Genome Annotation Pipeline (PGAP) 
 https://www.ncbi.nlm.nih.gov/genome/annotation_prok/ 
 Online tool – available for GenBank submitters only 
 PGAP is a pipeline for prediction of protein-coding genes, as well as other functional 
genome units such as structural RNAs, tRNAs, small RNAs, pseudogenes, control regions, 
direct and inverted repeats, insertion sequences, transposons and other mobile elements 
 
Alignment or sequence searching 
Tools to align a sequence to other sequences locally or against publically available nucleotide or 
protein archives.  
o BLAST†#* 
 http://blast.ncbi.nlm.nih.gov/Blast.cgi   
 Basic local alignment search tool. Stephen F. Altschul,Warren Gish,Webb Miller,Eugene W. 
Myers,David J. Lipman. Journal of Molecular Biology, Volume 215, Issue 3, 5 October 
1990, Pages 403-410 
 Windows, Mac OS X and Linux 
 Search tool to find regions of similarity between biological sequences through alignment 
and calculating statistical significance. 
 Comments: classic methods to search for specific sequence. Different version can be used 
such as blastn or megablast depending on the similarity between biological sequences. 
Possibility to create local specific database with makeblastdb. 
o MUMmer 
 http://mummer.sourceforge.net/ 
 Versatile and open software for comparing large genomes. A.L. Delcher, A. Phillippy, J. 
Carlton, and S.L. Salzberg, Nucleic Acids Research (2002), Vol. 30, No. 11 2478-2483. 
 Windows, Mac OS X and Linux 
 A system for rapidly aligning entire genomes and finding matches in DNA sequences. 
o Clustal suite – ClustalO and ClustalW 
 http://www.clustal.org 
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 Thompson JD, Higgins DG, Gibson TJ. (1994). CLUSTAL W: improving the sensitivity of 
progressive multiple sequence alignment through sequence weighting, position-specific 
gap penalties and weight matrix choice. Nucleic Acids Res., 22, 4673-4680. 
 Sievers et al. (2011) Fast, Scalable Generation of High‐quality Protein Multiple Sequence 
Alignments Using Clustal Omega. Molecular Systems Biology, 10.1038/msb.2011.75 
 Windows, Mac OS X and Linux and online (webservers) 
 Software that preforms sequences alignments. Mostly based on sequence weighting, 
position-specific gap penalties and weight matrix choice. 
 Comments: ClustalO is usually present as performing better (faster and more accurate) 
than the original version of ClustalW.  
o MUSCLE*#† 
 https://www.drive5.com/muscle/ 
 Edgar, R.C. (2004) MUSCLE: a multiple sequence alignment method with reduced time 
and space complexity. BMC Bioinformatics, (5) 113  
 Windows, Mac OS X and Linux and online (webservers) 
 Software for multiple alignment of protein sequences. 
 
Mapping 
Alignment of short reads against a reference sequence so that amount of coverage or variations 
compared to the reference can be assessed. 
o BWA*# 
 http://bio-bwa.sourceforge.net/ 
 Fast and accurate short read alignment with Burrows-Wheeler Transform. Li H. and 
Durbin R. (2009) Bioinformatics, 25:1754-60. [PMID: 19451168] 
 Windows, Mac OS X and Linux 
 Software package for mapping low-divergent sequences against a large reference genome 
using the Burrows-Wheeler transform algorithm.  
o Bowtie 2*# 
 http://bowtie-bio.sourceforge.net/bowtie2/index.shtml 
 Fast gapped-read alignment with Bowtie 2. Langmead B, Salzberg S. Nature Methods. 
2012, 9:357-359. 
 Windows, Mac OS X and Linux 
 Tool for aligning sequencing reads to long reference genomes also based on the Burrows-
Wheeler transform algorithm. 
o Tablet 
 https://ics.hutton.ac.uk/tablet/ 
 Using Tablet for visual exploration of second-generation sequencing data. Milne I, 
Stephen G, Bayer M, Cock PJA, Pritchard L, Cardle L, Shaw PD and Marshall D. 2013. 
Briefings in Bioinformatics 14(2), 193-202. 
 Windows, Mac OS X and Linux 
 Comments: Lighweight, high-performance graphical viewer for next generation sequence 
assemblies and alignments that can be used to view mapping. 
 
Assembly refinement 
Process of curating assembly by re-using reads and re-mapping steps  
o Pilon 
 https://github.com/broadinstitute/pilon/wiki 
 Bruce J. Walker, Thomas Abeel, Terrance Shea, Margaret Priest, Amr Abouelliel, Sharadha 
Sakthikumar, Christina A. Cuomo, Qiandong Zeng, Jennifer Wortman, Sarah K. Young, 
Ashlee M. Earl (2014) Pilon: An Integrated Tool for Comprehensive Microbial Variant 
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Detection and Genome Assembly Improvement. PLoS ONE 9(11): e112963. 
doi:10.1371/journal.pone.0112963 
 Windows, Mac OS X, Linux 
 Java based software that automatically improve draft assemblies. Find variation among 
strains, including large event detection. 
 Comments: assembly need to be performs prior to use the software. 
o FGAP 
 https://github.com/pirovc/fgap 
 Piro, Vitor C et al. “FGAP: An Automated Gap Closing Tool.” BMC Research Notes 7 (2014): 
371. PMC 
 Online servers or Linux and Mac OS X 
 FGAP is a tool for closing gaps of draft genome. It uses BLAST to align multiple contigs 
against a draft genome assembly aiming to find sequences that overlap gaps. The 
algorithm selects the best sequence to fill and eliminate the gaps. 
 
 
Assembly statistics and quality assessment  
o Quast*#  
 http://quast.sourceforge.net/ 
 Alexey Gurevich, Vladislav Saveliev, Nikolay Vyahhi and Glenn Tesler,  
QUAST: quality assessment tool for genome assemblies,  
Bioinformatics (2013) 29 (8): 1072-1075. doi: 10.1093/bioinformatics/btt086 
First published online: February 19, 2013  
 Linux, MAC OS X and online servers 
 QUAST is a tool design to evaluate assembly. Calculates metrics such as N50, number of 
contigs, length of assemblies, GC content. 
 Comments: this tool accepts multiple assemblies and is suitable for comparing assemblies. 
 
 
Variant Calling 
Variant calling is the process by which variants (differences) are identify from sequence data. It 
usually follows the step of mapping reads against a reference. 
o SAMtools* 
 http://samtools.sourceforge.net/ 
 The Sequence alignment/map (SAM) format and SAMtools. Li H.*, Handsaker B.*, 
Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R. and 1000 
Genome Project Data Processing Subgroup (2009) Bioinformatics, 25, 2078-9. [PMID: 
19505943] 
 Windows, Mac OS X and Linux 
 Toolkit that provides various utilities for manipulating alignments in the SAM format and 
also can be used  for generating consensus sequences and variant calling 
o GATK* 
 https://software.broadinstitute.org/gatk/ 
 The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation 
DNA sequencing data. Aaron McKenna, Matthew Hanna, Eric Banks, Andrey Sivachenko, 
Kristian Cibulskis, Andrew Kernytsky, Kiran Garimella, David Altshuler, Stacey Gabriel, 
Mark Daly, and Mark A. DePristo. Genome Res. September 2010 20: 1297-1303; 
Published in Advance July 19, 2010, doi:10.1101/gr.107524.110 
 Windows, Mac OS X and Linux 
 Toolkit with a primary focus on variant discovery and genotyping. 
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o Picard 
 http://broadinstitute.github.io/picard/ 
 Windows, Mac OS X and Linux 
 A set of command line tools (in Java) for manipulating high-throughput sequencing data 
and formats. 
 Comments: command line only, but helpful to convert/sort and use different output bam, 
sam… 
o Varscan (version 2) 
 http://dkoboldt.github.io/varscan/ 
 VarScan 2: Koboldt, D., Zhang, Q., Larson, D., Shen, D., McLellan, M., Lin, L., Miller, C., 
Mardis, E., Ding, L., & Wilson, R. (2012). VarScan 2: Somatic mutation and copy number 
alteration discovery in cancer by exome sequencing Genome Research DOI: 
10.1101/gr.129684.111 
 Windows, Linux and Mac OS X 
 A set of command line tools running with Java that detects different kind of variants such 
as  Germline variants (SNPs an dindels), Multi-sample variants (shared or private) in 
multi-sample datasets (with mpileup), Somatic mutations, Somatic copy number 
alterations (CNAs). 
 
Phylogenetic analysis 
Assessment of the evolutionary relationship between strains using either distance-based or Bayesian 
methodologies 
o RaxML* 
 http://sco.h-its.org/exelixis/web/software/raxml/index.html 
 RAxML Version 8: A tool for Phylogenetic Analysis and Post-Analysis of Large Phylogenies. 
A. Stamatakis. Bioinformatics (2014) 30 (9): 1312-1313. 
 Windows, Mac OS X and Linux 
 Randomized Axelerated Maximum Likelihood program for sequential and parallel 
Maximum Likelihood based inference of large phylogenetic trees. 
 Comments: maximum-likelihood methods give more resolution/accuracy than FastTree 
but take longer to run. Substitution models can be use as parameters.  
o FastTree*# 
 http://www.microbesonline.org/fasttree/ 
 FastTree: Computing Large Minimum-Evolution Trees with Profiles instead of a Distance 
Matrix. Price, M.N., Dehal, P.S., and Arkin, A.P. (2009). Molecular Biology and Evolution 
26:1641-1650, doi:10.1093/molbev/msp077. 
 Windows, Mac OS X and Linux 
 Comments: Faster tool for speedy inference of approximately-maximum-likelihood 
phylogenetic trees from alignments of nucleotide or protein sequences. Particularly useful 
to quickly generate trees. 
o CSI Phylogeny*# 
 https://cge.cbs.dtu.dk/services/CSIPhylogeny/ 
 Solving the Problem of Comparing Whole Bacterial Genomes across Different Sequencing 
Platforms. Rolf S. Kaas , Pimlapas Leekitcharoenphon, Frank M. Aarestrup, Ole Lund. PLoS 
ONE 2014; 9(8): e104984. 
 Comments: Online tool, easy to use and configure. Tool to call SNPs, filter the SNPs and 
to do site validation and inference of phylogeny through a graphical user interface. 
o Harvest 
 https://www.cbcb.umd.edu/software/harvest 
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 The Harvest suite for rapid core-genome alignment and visualization of thousands of 
intraspecific microbial genomes. Treangen TJ, Ondov BD, Koren S, Phillippy AM. Genome 
Biology, 15 (11), 1-15 
 Windows, Mac OS X and Linux 
 Suite of core-genome alignment and visualization tools for quickly analysing thousands of 
intraspecific microbial genomes, including variant calls, recombination detection, and 
phylogenetic trees. 
 Comments: parsnp from this tool can compute trees based on very large number of 
assembled genomes.  
o Gubbins 
 http://sanger-pathogens.github.io/gubbins/ 
 Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome 
sequences using Gubbins. Croucher N. J., Page A. J., Connor T. R., Delaney A. J., Keane J. 
A., Bentley S. D., Parkhill J., Harris S.R. doi:10.1093/nar/gku1196, Nucleic Acids Research, 
2014. 
 Windows, Mac OS X and Linux 
 Gubbins (Genealogies Unbiased By recomBinations In Nucleotide Sequences) is an 
algorithm that iteratively identifies loci containing elevated densities of base substitutions 
while concurrently constructing a phylogeny based on the putative point mutations 
outside of these regions. 
 Comments: detection of recombination and generation of phylogeny. Depending on the 
number of genomes to analyse, this tool can be really long to run. 
o BEAST 
 http://beast.bio.ed.ac.uk/ 
 Bayesian phylogenetics with BEAUti and the BEAST 1.7. Drummond AJ, Suchard MA, Xie 
D & Rambaut A (2012) Molecular Biology And Evolution 29: 1969-1973. 
 Windows, Mac OS X and Linux 
 Cross-platform program for Bayesian analysis of molecular sequences using MCMC. 
 Comments: can be use to generate phylogeny based on prior information like time. Useful 
if you expect some time-relation in your phylogeny but really long to run. 
o FigTree*# 
 http://tree.bio.ed.ac.uk/software/figtree/ 
 Windows, Mac OS X and Linux 
 A graphical viewer of phylogenetic trees and program for producing publication-ready 
figures of trees. 
 Comments: easy tools to visualise/manipulate trees 
o I-TOL*# 
 https://itol.embl.de/ 
 Letunic I and Bork P (2016) Nucleic Acids Res doi: 10.1093/nar/gkw290 Interactive Tree 
Of Life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other 
trees 
 Online server 
 I-TOL Interactive Tree Of Life is an online tool for the display, annotation and 
management of phylogenetic trees. 
 Comments: This is only visualisation. Registration  to have a workspace to 
save/manipulate tree. Really powerful to view large/complex tree. An extensive range of 
annotation available. 
o Mega† 
 http://www.megasoftware.net/ 
 MEGA7: Molecular Evolutionary Genetics Analysis version 7.0 for bigger datasets. Kumar S, 
Stecher G, and Tamura K (2016) Molecular Biology and Evolution 33:1870-1874 
 Windows, Mac OS X and Linux 
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 Comments: Sophisticated and user-friendly software suite for analysing DNA and protein 
sequence data from species and populations. Contains building tree algorithms. 
 
Virulence and antimicrobial resistance gene prediction 
Inference of potential for a virulent phenotype or resistance to an antimicrobial based on nucleotide 
sequences. 
 
Virulence prediction 
o PathogenFinder 
 https://cge.cbs.dtu.dk/services/PathogenFinder/ 
 PathogenFinder - Distinguishing Friend from Foe Using Bacterial Whole Genome Sequence 
Data. Cosentino S, Voldby Larsen M, Møller Aarestrup F, Lund O. (2013) PLoS ONE 8(10): 
e77302. 
 Online tool 
 Web-server for the prediction of bacterial pathogenicity by analysing the input proteome, 
genome, or raw reads provided by the user. 
Antimicrobial resistance prediction 
o Resfinder 
 https://cge.cbs.dtu.dk//services/ResFinder/ 
 Identification of acquired antimicrobial resistance genes. Zankari E, Hasman H, Cosentino 
S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. J Antimicrob 
Chemother. 2012 Jul 10 
 Online tool 
 Web-server that identifies acquired antimicrobial resistance genes in total or partial 
sequenced isolates of bacteria. 
o ARIBA 
 https://github.com/sanger-pathogens/ariba 
 ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads. Martin 
Hunt, Alison E Mather, Leonor Sánchez-Busó, Andrew J Page, Julian Parkhill, Jacqueline A 
Keane, Simon R Harris. doi: https://doi.org/10.1099/mgen.0.000131 
 ARIBA (Antimicrobial Resistance Identification By Assembly), identifies AMR-associated 
genes and single nucleotide polymorphisms directly from short reads 
 Comments: can also be used for MLST calling, you need to provide your reference set. 
o KmerResistance 
 https://cge.cbs.dtu.dk/services/KmerResistance-2.2/ 
 Benchmarking of methods for identification of antimicrobial resistance genes in bacterial 
whole genome data 
Philip T.L.C. Clausen, Ea Zankari, Frank M. Aarestrup, Ole Lund  
Journal of Antimicrobial Chemotherapy. 2016 
 KmerResistance is a tool on a web-server that identifies antimicrobial resistance genes 
based on read mapping. It examines the co-occurrence of k-mers between the WGS data 
and a database of resistance genes. 
 Comments: reads mapping based detection of AMR genes is a great alternative to 
assembly based methods. 
o SRST2 
 https://github.com/katholt/srst2 
 SRST2: Rapid genomic surveillance for public health and hospital microbiology labs. 
Inouye et al. Genome Medicine. 2014 
 Linux, Mac OS X 
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 Short Read Sequence Typing for Bacterial Pathogens (SRST2) is designed to take Illumina 
sequence data, a MLST database and/or a database of gene sequences (e.g. resistance 
genes, virulence genes, etc) and report the presence of STs and/or reference genes. 
o GeneFinder 
 In-house tool developed by Public Health England (PHE, UK) 
 Genefinder software is a tool to determine presence and absence of genes and retrieve 
specific sequence variations from NGS paired-end fastq files, using a set of reference 
sequences in FASTA format 
o CARD: The Comprehensive Antibiotic Resistance Database (not a tool) 
 https://card.mcmaster.ca/home 
 CARD 2017: expansion and model-centric curation of the comprehensive antibiotic 
resistance database. Jia et al. Nucleic Acids Res. 2017. DOI:10.1093/nar/gkw1004 
 Contain an online pipeline RGI (Resistance Gene Identifier) to identify/query the CARD 
database for your genomes. 
 Database of resistance genes, their products and associated phenotypes. 
 Comments: useful resource for AMR. RGI need assemblies to run. 
 
Species and serovar identification 
Tools and software that uses various algorithms methods to identify a species by using reads or 
assembly and predict serovar. These software relies on databases to predict species or serovar. 
o Kraken 
 https://ccb.jhu.edu/software/kraken/ 
 Kraken: ultrafast metagenomic sequence classification using exact alignments. Wood DE, 
Salzberg SL. Genome Biology 2014, 15:R46. 
 Linux 
 System for assigning taxonomic labels to short DNA sequences, usually obtained through 
metagenomics studies. 
o MetaPhlan2 
 https://bitbucket.org/biobakery/metaphlan2 
 MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Duy Tin Truong, Eric A 
Franzosa, Timothy L Tickle, Matthias Scholz, George Weingart, Edoardo Pasolli, Adrian 
Tett, Curtis Huttenhower & Nicola Segata. Nature Methods 12, 902-903 (2015) 
 Linux – command line 
 MetaPhlAn 2: Metagenomic Phylogenetic Analysis - profiling the composition of microbial 
communities (Bacteria, Archaea, Eukaryotes and Viruses) from metagenomic shotgun 
sequencing data with species-level. The StrainPhlAn module allows to perform accurate 
strain-level microbial profiling. 
o Kmerfinder 
 https://cge.cbs.dtu.dk/services/KmerFinder/ 
 Rapid whole-genome sequencing for detection and characterization of microorganisms 
directly from clinical samples. Hasman H, Saputra D, Sicheritz-Pontén T, Lund O, 
Svendsen CA, Frimodt-Møller N, Aarestrup FM. J Clin Microbiol. 2014 Jan;52(1):139-46. 
 Online tools and standalone Linux version 
 Tool to identify species from an assembly or reads based on k-mer detection, searching k-
mer from a pre-build database (bacterial, fungi viruses…).  
 Comments: the online tool can be used with different database 
o SISTR# 
 https://lfz.corefacility.ca/sistr-app/ 
 The Salmonella In Silico Typing Resource (SISTR): an open web-accessible tool for rapidly 
typing and subtyping draft Salmonella genome assemblies. Catherine Yoshida, Peter 
Kruczkiewicz, Chad R. Laing, Erika J. Lingohr, Victor P.J. Gannon, John H.E. Nash, 
Eduardo N. Taboada. PLoS ONE 11(1): e0147101. doi: 10.1371/journal.pone.0147101 
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 Web based application or standalone version on Linux and Mac OS X 
 SISTR is a prediction software that predict serovar predictions from whole-genome 
sequence assemblies by determination of antigen gene. It also includes MLST, rMLST and 
cgMLST gene alleles prediction. 
 
o SeqSero 
 http://www.denglab.info/SeqSero 
 Zhang S, Yin Y, Jones MB, Zhang Z, Deatherage Kaiser BL, Dinsmore BA, Fitzgerald C, 
Fields PI, Deng X. Salmonella serotype determination utilizing high-throughput genome 
sequencing data. J Clin Microbiol. 2015 May;53(5):1685-92.PMID:25762776 
 Online webserver and command line (Unix based) 
 SeqSero is a pipeline for Salmonella serotype determination from raw sequencing reads or 
genome assemblies 
o MOST 
 https://github.com/phe-bioinformatics/MOST 
 Tewolde, Rediat et al. “MOST: A Modified MLST Typing Tool Based on Short Read 
Sequencing.” Ed. Nicholas Loman. PeerJ 4 (2016): e2308. PMC. Web. 25 Apr. 2018. 
 Command line (Unix based) 
 MOST is a software derived from SISTR that assign MLST profile and infer Salmonella 
serotyping from bacterial genomic short read sequence data 
 Comments: require MLST database, detects novel allele if not present in the database, 
quality of the results assess by different metrics. Can be run in a Galaxy environment. 
o Serotypefinder  
 https://cge.cbs.dtu.dk/services/SerotypeFinder/ 
 Joensen, K. G., A. M. Tetzschner, A. Iguchi, F. M. Aarestrup, and F. Scheutz. 2015. Rapid 
and easy in silico serotyping of Escherichia coli using whole genome sequencing (WGS) 
data. J.Clin.Microbiol. 53(8):2410-2426. doi:JCM.00008-15 [pii];10.1128/JCM.00008-15 
 Online tool 
 SerotypeFinder identifies the serotype in total or partial sequenced isolates of E. coli. 
 
 
Comparative genomic tools 
Comparison of multiple genomes to determine regions of similarity or difference either on a gene-by 
gene basis or across the whole genome. 
o BEDTools 
 http://bedtools.readthedocs.io/en/latest/index.html 
 BEDTools: a flexible suite of utilities for comparing genomic features. Aaron R. Quinlan 
and Ira M. Hall. Bioinformatics (2010) 26 (6): 841-842 first published online January 28, 
2010 doi:10.1093/bioinformatics/btq033 
 Mac OS X and Linux 
 Toolkit for the manipulation of genome data for genomic analysis tasks on genomic 
intervals from multiple files. 
o Roary 
 https://sanger-pathogens.github.io/Roary/ 
 Roary: Rapid large-scale prokaryote pan genome analysis. Andrew J. Page, Carla A. 
Cummins, Martin Hunt, Vanessa K. Wong, Sandra Reuter, Matthew T. G. Holden, Maria 
Fookes, Daniel Falush, Jacqueline A. Keane, Julian Parkhill. Bioinformatics, 
2015;31(22):3691-3693 doi:10.1093/bioinformatics/btv421. 
 Windows, Mac OS X and Linux 
 High speed stand-alone pan genome pipeline, which takes annotated assemblies in GFF3 
format and calculates the pan genome. 
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o Mauve 
 http://darlinglab.org/mauve/mauve.html 
 Mauve: Multiple Alignment of Conserved Genomic Sequence With Rearrangements. Aaron 
C.E. Darling, Bob Mau, Frederick R. Blattner, and Nicole T. Perna. Genome Res. July 2004 
14: 1394-1403; doi:10.1101/gr.2289704 
 Windows, Mac OS X and Linux 
 Interactive genome alignment software that allows for easy browsing of multiple genomes 
to look for similarities and differences. 
o ACT 
 http://www.sanger.ac.uk/science/tools/artemis-comparison-tool-act 
 ACT: the Artemis Comparison Tool. Carver TJ, Rutherford KM, Berriman M, Rajandream 
MA, Barrell BG and Parkhill. Bioinformatics (Oxford, England) 2005;21;16;3422-3. 
PUBMED: 15976072; DOI: 10.1093/bioinformatics/bti553  
 UNIX, MacOS and Windows 
 Java application for displaying pairwise comparisons between two or more DNA 
sequences and allowing browsing of detailed annotation 
o BRIG 
 http://brig.sourceforge.net/ 
 BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. NF Alikhan, 
NK Petty, NL Ben Zakour, SA Beatson (2011). BMC Genomics, 12:402. PMID: 21824423 
 UNIX, MacOS and Windows 
 Image generating software that displays circular blast comparisons between a large 
number of genomes or DNA sequences 
 
o EasyFig 
 http://mjsull.github.io/Easyfig/ 
 Easyfig: a genome comparison visualiser. Sullivan MJ, Petty NK, Beatson SA. (2011) 
Bioinformatics; 27 (7): 1009-1010.PMID: 21278367 
 UNIX, MacOS and Windows 
 Python application for creating linear comparison figures of multiple genomic loci with an 
easy-to-use graphical user interface (GUI) 
o SeqFindR 
 https://github.com/mscook/SeqFindR 
 UNIX and MacOS 
 Tool to easily create informative genomic feature plots by detecting the presence or 
absence of genomic features from a database in a set of genomes 
 
Cloud Services 
If infrastructure is not available the cloud based services are worth considering 
 Genomics-Specific 
o MRC CLIMB 
 http://www.climb.ac.uk/ 
 Microbial bioinformatics cyber-infrastructure. 
o Genomics Virtual Laboratory 
 https://www.gvl.org.au/ 
 A genomics-specific version of Galaxy 
o Galaxy 
 https://usegalaxy.org/ 
 an open source, web-based platform for data intensive biomedical research. 
 
 Non-Genomics Specific 
o Amazon Web Services 
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 https://aws.amazon.com 
 Pay per usage cloud computing managed by amazon.com for temporary computing of big 
data 
o Azure (Microsoft) 
 https://azure.microsoft.com/en-us/  
 Multiple services divided into the following categories: AI + Machine Learning, Analytics, 
Compute, Containers, Databases, Developer Tools, DevOps, Identity, Integration, Internet 
of Things, Management Tools, Media, Migration, Mobile, Networking, Security, Storage, 
Web 
 
Commercial software 
o Bionumerics Seven 
 http://www.applied-maths.com/applications 
 Offers a range of tools to analyse sequence data including MLST, wgMLST, AMR profiling, 
wgSNPs. 
o Ridom SeqSpehere + 
 http://www.ridom.de/seqsphere/index.shtml 
 Software design to analyse NGS data by using MLST/cgMLST  
 
Blogs and Twitter 
A lot of useful information in the rapidly evolving field of bioinformatics can be gained by following 
bioinformaticians on twitter or reading their blogs. 
o Blogs 
 Bits and bugs https://bitsandbugs.org/  
 Loman Labs http://lab.loman.net/page3/ 
 Opinionomics http://www.opiniomics.org/  
 The genome factory http://thegenomefactory.blogspot.co.uk/  
 Simpson Lab Blog http://simpsonlab.github.io/2016/08/23/R9/  
 Jonathon Eisen’s Lab https://phylogenomics.wordpress.com/ 
 Living in an Ivory Basement http://ivory.idyll.org/blog/  
 Holt Lab https://holtlab.net/ 
 Heng Li’s blog https://lh3.github.io/  
 The Darling lab http://darlinglab.org/blog/  
 The Quinlan Lab http://quinlanlab.org/ 
 
o Help pages 
 https://www.biostars.org 
 http://stackoverflow.com/  
 
o Bioinformaticians to follow on Twitter 
 @pathogenomenick @BioMickWatson @flashton2003 @WvSchaik @mattloose 
@torstenseemann @tomrconnor @MikeyJ @jaredtsimpson @aphillipy @BillHanage 
@happy_khan @daanensen @jennifergardy @genomiss @Becctococcus @phylogenomics 
@ctitusbrown @DrKatHolt @ZaminIqbal @TimDallman @bioinformant @LaurenCowley4 
@gkapatai @keithajolley @froggleston @lexnederbragt @jacarrico @biocomputerist 
@mjpallen @Bio_mscook @bawee @lh3lh3 @andrewjpage @aaronquinlan @koadman 
@Maxi_Zu 
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Installation of Virtual Box tutorial 
 
Getting started: how to run Bio-Linux as a VM 
 
Here is a brief guide on how to set up a Virtual Machine on your PC to simulate a Linux environment 
with several bioinformatics tools.    
Downloading VirtualBox 
VirtualBox is a free and powerful cross-platform VM manager found at https://www.virtualbox.org/. 
1. Ensure you have at least 40GB of free disk space. 
2. Download and install the appropriate version of VirtualBox using the link above. 
3. Follow the installation instructions. 
4. Wait before starting any new VM. 
 
VirtualBox 5.0 for Windows. Within VirtualBox Ubuntu 14.04 is running. 
For further info on how to setup a VM on/with whichever OS you like, please refer to the manual (also 
enclosed to this email).  
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Downloadin Bio-Linux 8 as an OVA file 
In order to minimize the number of tools we need to manually set up for our training, we choose to 
work with Bio-Linux 8, a free bioinformatics workstation platform that can be installed on anything 
from a laptop to a large server, or run as a virtual machine. Bio-Linux 8 adds more than 250 
bioinformatics packages to an Ubuntu Linux 14.04 LTS base, providing around 50 graphical 
applications and several hundred command line tools. You can find more information on it here
10
.  
⚠ Bio-Linux is a 64-bit operating system. Virtually all modern PC processors support 64-bits, even if 
you have 32-bit Windows installed. As a rule of thumb, if you have more than 1 processor core you 
will have 64-bit support. See: https://www.virtualbox.org/manual/ch03.html#intro-64bitguests. 
For our purposes, you should download the Bio-Linux 8 OVA file from 
http://nebc.nerc.ac.uk/downloads/bio-linux-8-latest.ova. The OVA file is designed for use with VirtualBox 
but should also work with similar systems like VMWare and Parallels.  
Setting up your VM instance 
To setup Bio-Linux 8 for VirtualBox: 
1. Start VirtualBox 
2. Select Import Appliance from the File menu and import the .ova file (don’t worry that it says 
you need an OVF file) [NOTE: this step may take several minutes to perform…] 
a. When importing the appliance, select the option to reinitialize the MAC addresses of 
network cards. 
3. Start the VM  
4. If you see a log-in screen, log in as user manager with password manager. 
 
Once this is working, you can delete the .ova file to save space. See the VirtualBox docs for more 
details including how to share folders (also detailed in the next paragraph) and hardware. You will 
also want to adjust hardware settings such as CPU, RAM and video acceleration settings to suit your 
hardware, by tuning the parameters of the “System” tab of your VM (when it is not running). 
 
 
For example, on a Windows 8.1 machine with 
 Intel i5-5200U CPU @ 2.20GHz 2.20GHz processor 
 8.00 GB RAM memory 
 64bit operating system, x64 processor 
                                                          
10  Note, however, that this project is no more funded/developed and therefore there might be a better long-term choice to 
setup a Linux/Ubuntu based machine where you can install all the tools you need. 
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we suggest the following settings: 
 Memory: 4096 MB 
 2 CPUs 
 10 MB video memory 
or, more generally, we suggest to set both memory and CPUs values at half the value of your 
actual system and never below 2GB of memory. 
 
Now you’re ready to start your Biolinux VM! 
For a list of all the tools included in this release of Bio-Linux, see this page. 
 
NOTE: You should treat the VM as a real machine for security purposes and apply all system security 
updates in a timely manner. The default manager password is, clearly, not secure.  This might not be 
a problem because by default nobody can access the Linux VM unless they have direct access to your 
computer, but if you open up the network settings (eg. by adding port forwarding rules) then you 
must secure the account with a strong password or else take other steps to limit remote access. 
Ideally enforce key-only access via SSH. 
 
 
A screenshot of my Bio-Linux VM instance 
 
Setting up a shared folder between your real machine and the VM 
It is sometimes very useful to have the chance of sharing files between your real machine and the VM. 
With the “shared folders” feature of VirtualBox, you can access files of your host system from within 
the guest system. This is similar how you would use network shares in Windows networks – except 
that shared folders do not need require networking, only the Guest Additions. Shared Folders are 
supported with Windows (2000 or newer), Linux and Solaris guests. Shared folders must physically 
reside on the host and are then shared with the guest, which uses a special file system driver in the 
Guest Addition to talk to the host. For Windows guests, shared folders are implemented as a pseudo-
network redirector; for Linux and Solaris guests, the Guest Additions provide a virtual file system. To 
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share a host folder with a virtual machine in VirtualBox, you must specify the path of that folder and 
choose for it a “share name” that the guest can use to access it. Hence, first create the shared 
folder on the host (e.g. we will refer to a folder called VM_share that I have in the Documents 
folder on my Win machine); then, within the guest, connect to it. In order to set an existing folder (on 
the host) as shared (with the VM) 
 Start your VM 
 Go to Devices > Shared Folders > Shared Folders Settings… 
 
 Use  to add a shared folder 
 Navigate to the folder path 
 Tick the options “Auto-mount” and “Make Permanent”  
 Restart your virtual machine to see the changes. 
ENGAGE 
 
 
 
www.efsa.europa.eu/publications 75 EFSA Supporting publication 2018:EN-1431 
The present document has been produced and adopted by the bodies identified above as author(s). In accordance with Article 36 of Regulation (EC) No 
178/2002, this task has been carried out exclusively by the author(s) in the context of a grant agreement between the European Food Safety Authority and 
the author(s). The present document is published complying with the transparency principle to which the Authority is subject. It cannot be considered as an 
output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the 
conclusions reached in the present document, without prejudice to the rights of the author(s). 
 
 
 This will link your VM_share folder between the real and virtual machine, by putting it into the 
/media folder on Bio-Linux. Note that all shared folders will have “sf_” as a prefix. 
 Now you can move to that directory (either from command line or from file explorer GUI) and 
copy files from it to have them locally on the VM. 
 
Installing some tools from command line 
Now all is set up to start working on your VM. If you want, you can try installing these two tools 
(which are not included in the Bio-Linux 8 release and that we will be using a lot during the training) 
directly from the command line. Please make sure you have internet connection available and open a 
terminal window to follow the instructions below 
Trimmomatic 
Trimmomatic is a flexible read trimming tool for Illumina NGS data. It is a Java-based tool, so first of 
all check if you have it installed on your VM by typing 
which java 
(default output should be /usr/bin/java). Then get trimmomatic by typing 
sudo apt-get install trimmomatic 
and insert the password “manager”. Once the installation is completed, you should be able to find 
it by typing 
which TrimmomaticPE 
To get usage information, just type  
man TrimmomaticPE 
on the command line. 
To use Trimmomatic, you need to retrieve the ADAPTERS files (fasta format). 
Run 
#### GET THE ADAPATERS FOR TRIMMOMATIC 
cd /usr/local/bioinf 
sudo wget \ http://www.usadellab.org/cms/uploads/supplementary/Trimmomatic/Trimmomatic-
0.36.zip 
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(note that the last three lines is actually one command only). 
Then type  
  sudo unzip Trimmomatic-0.36.zip 
to extract the files. A usage example for Trimmomatic would be 
#### RUN TRIMMOMATIC ON ONE SAMPLE 
 
/!\ you should de locate one folder above the sample! 
training_set 
| 
| _ _ sample1 
| _ _ sample2 
| _ _ sample3 
| _ _ sample4 
| _ _ ... 
| _ _ sample9 
 
TrimmomaticPE -phred33 sample1/sample1.raw.R1.fastq.gz \ sample1/sample1.raw.R2.fastq.gz 
sample1/sample1.raw.process.R1.fastq.gz\ sample1/sample1.raw.orphans.R1.fastq.gz 
\ sample1/sample1.raw.process.R2.fastq.gz \ sample1/sample1.raw.orphans.R2.fastq.gz 
\ ILLUMINACLIP:/usr/local/bioinf/Trimmomatic-0.36/adapters/NexteraPE-PE.fa:2:30:10:8:true 
LEADING:30 TRAILING:30 SLIDINGWINDOW:10:20 \ MINLEN:50 
NOTE: Remember that your output files should always be in the format: 
sample1_R1_processed  sample1_R1_orphans 
sample2_R2_processed  sample2_R2_orphans 
 
You can retrieve more information (all the explanation for options meaning and why/how to set them) 
from Anais’s presentation. 
SPAdes 
SPAdes – St. Petersburg genome assembler – is an assembly toolkit containing various assembly 
pipelines. 
To get it, open the terminal and type 
wget http://cab.spbu.ru/files/release3.11.0/SPAdes-3.11.0-Linux.tar.gz 
 
Move it to the bin folder 
 
sudo cp SPAdes-3.11.0-Linux.tar.gz /usr/local/bin 
if password is required, type “manager”. Move to the selected folder and uncompress the file 
 
  cd /usr/local/bin 
sudo tar –xzf SPAdes-3.11.0-Linux.tar.gz 
[Optional] Create a soft link to the folder, so you don’t have to change much if you install a newer 
version later on: 
sudo ln –s SPAdes-3.11.0-Linux/ spades 
Add the folder to the path by modifying the .zshrc file (if your command line interpreter is zsh) or your 
/etc/profile file (if your command line interpreter is bash)
11
 
 
                                                          
11 In order to test which interpreter you are using, write echo $0 on the command line. If your result is zsh and you wish to 
change it to bash, just type “chsh -s /bin/bash” on the command line and restart the VM. 
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sudo nano ~/.zshrc 
add the line in the header of the file (see next screenshot). 
PATH="$PATH:/usr/local/bin/spades/bin" 
Save (Ctrl^O+Enter) and exit (Ctrl^X+Enter).  
 
Screenshot of the .zshrc file. Please insert the PATH command right after the comments 
(lines starting with #) and ignore the rest of the file content. 
In order to see the changes to the path without restarting the VM, re-type in the command line 
export PATH="$PATH:/usr/local/bin/spades/bin" 
For testing purposes, SPAdes comes with a toy data set (reads that align to first 1000 bp of E. coli). 
To try SPAdes on this data set, run from command line:  
   spades.py --test  
If the installation is successful, you will find the following information at the end of the log:  
===== Assembling finished. Used k-mer sizes: 21, 33, 55 
 * Corrected reads are in spades_test/corrected/ 
 * Assembled contigs are in spades_test/contigs.fasta 
 * Assembled scaffolds are in spades_test/scaffolds.fasta 
 * Assembly graph is in spades_test/assembly_graph.fastg 
 * Assembly graph in GFA format is in spades_test/assembly_graph.gfa 
 * Paths in the assembly graph corresponding to the contigs are in spades_test/contigs.paths 
 * Paths in the assembly graph corresponding to the scaffolds are in spades_test/scaffolds.paths 
======= SPAdes pipeline finished. 
========= TEST PASSED CORRECTLY. 
SPAdes log can be found here: spades_test/spades.log 
Thank you for using SPAdes! 
Quast 
Quast is a quality assessment tool for measuring the quality of your genome assembly. It is 
particularly useful because it can generate a table comparing different metrics of your genome 
assemblies. 
To download the tool, run: 
wget https://downloads.sourceforge.net/project/quast/quast-4.5.tar.gz  
sudo cp quast-4.5.tar.gz /usr/local/bin 
cd /usr/local/bin 
sudo tar -xzf quast-4.5.tar.gz 
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echo “PATH=\"$PATH:/usr/local/bin/quast-4.5\”” >> ~/.zshrc 
export PATH=\"$PATH:/usr/local/bin/quast-4.5\” 
Let’s analyze what these lines are doing: 
1. get the compressed installation file from internet 
2. copy the compressed file into the /usr/local/bin folder; you have to use sudo to have the 
administrator permissions to copy into this folder 
3. change directory to /usr/local/bin 
4. uncompress your compressed file 
5. update your config file so to add the quast folder to your PATH variable 
6. update your PATH on the fly to avoid rebooting your machine. 
Now that you have quast at hand, you can use it with a list of contig files to compare their qualities.  
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Appendix E – Benchmarking of de novo assembly tools: SPAdes 3.9 vs 
Velvet 1.2 
 
Report number  #1 
Responsible  Pimlapas Leekitcharoenphon (DTU) and Maria 
Borowiak (BfR) 
Other partners/institutions involved  - 
Benchmarking launched (date)  May 2016 
Deliverable due (date)  Due: May 2016    Delivered: August 2016 
 
Purpose of the benchmarking exercise 
The purpose of this benchmarking exercise was to evaluate and compare the performance of the 
mostly used de novo assembly tool, i.e. Velvet, and the newer introduced de novo assembly tool, 
SPAdes. 
Tools included in the benchmarking exercise 
De novo assembly tools; Velvet 1.2 with default parameters (Assembler-1.2 implemented in the tool 
Bacterial Analysis Pipeline - Batch Upload (https://cge.cbs.dtu.dk/services/cge/)) and SPAdes 3.9 
(http://cab.spbu.ru/software/spades/) with default parameters in careful mode. Both tools were run 
using different k-mer sizes and the assembled genome was set to pick up from the best k-mer size. 
 
Species and/or genomes included 
50 Salmonella enterica subsp. enterica serovar Paratyphi B dTa+ (S. Java) isolates were tested. DNA 
from bacterial cells was isolated from liquid cultures using the PureLink® Genomic DNA Mini Kit 
(Invitrogen, Carlsbad, CA, USA). Sequencing libraries were prepared with the Nextera XT DNA Sample 
Preparation Kit (Illumina, San Diego, CA, USA) according to the manufacturer’s protocol. Paired-end 
sequencing was performed in 2 × 300 cycles on the Illumina MiSeq benchtop using the MiSeq Reagent 
v3 600-cycle Kit (Illumina). Further details related to the included genomes can be found at the end of 
this report in Table E.2 and in Supplementary Table 2 (Annex B). 
 
Results 
Overall assembly quality 
Sequencing raw data without trimming was assembled using either Velvet or SPAdes assembly tools.  
Analysis of contigs using ContigAnalyzer-1.0, implemented in the Bacterial Analysis Pipeline - Batch 
Upload (https://cge.cbs.dtu.dk/services/cge/), revealed that the mean number of contigs is lower and 
the mean N50 value (median contig size of a genomic assembly) is higher in the genomes assembled 
using SPAdes (see Table E.1 and Figure E.1). The observed mean genome size however is similar for 
both assembly types. 
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Table E.1:  Assembly quality analysed using ContigAnalyzer-1.0 
  Spades Velvet 
Contig number mean 100 249 
min 51 144 
max 181 376 
sd 30 55 
 N50 mean 176,144 57,148 
min 53,662 26,926 
max 393,606 146,576 
sd 93,110 23,786 
Assembled genome size mean 4,924,464 4,872,591 
min 4,663,179 4,505,678 
max 5,076,872 5,027,353 
sd 101,043 121,670 
 
To further assess the quality of the assemblies, the Multi Locus Sequence Type (MLST) and antibiotic 
resistance genes were analysed. 
Results regarding MLST identification 
Analysis of the obtained assemblies regarding the Multi Locus Sequence Type (MLST) was performed 
using the tool MLST 1.6 (https://cge.cbs.dtu.dk/services/cge/). MLST types (based on the Enterobase 
scheme, https://enterobase.warwick.ac.uk) could be predicted in 100% of the SPAdes assembled and 
in 94% of the Velvet assembled genomes.   
Results regarding the identification of resistance genes 
Antimicrobial resistance patterns derived from MIC values (obtained by broth microdilution method 
following CLSI guidelines, and using the EUCAST epidemiological ECOFFs; testing conditions applied to 
the individual samples depend on the year the isolate was collected and are listed in Supplementary 
Table 2 (Annex B)) were compared with the ResFinder2.1 (https://cge.cbs.dtu.dk/services/cge/) 
output (AMR genes detected) for de novo assembled sequence data (see Supplementary Table 2 
(Annex B)). 
Concordance between genotypic and phenotypic resistance data (for detailed results see also 
Supplementary Table 2 (Annex B)): 
 In 35/50 cases the phenotypic resistance profile could be explained with genes found using 
Velvet as assembler. 
 In 38/50 cases the phenotypic resistance profile could be explained with genes found using 
SPAdes as assembler. 
 In 12/50 cases the phenotypic resistance profile could not be explained with genes found 
using either SPAdes or Velvet for assembly, one or more genotypic resistance determinants 
were missing. 
 In 5/50 cases resistance genes conferring resistance to aminoglycosides which were not 
expected based on phenotypic resistance data were found in both genome assemblies. 
 In 7/50 cases additional resistance genes which were not expected based on the phenotypic 
resistance profiles were found in the genomes assembled using SPAdes. This involves aac(3)-
VIa-like genes (6 cases) and erm(B) (1 case). 
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Conclusions 
All in all, SPAdes assembled genomes showed longer contigs and therefore higher N50 values. This 
seems to lead to an improved detection of MLST genes. Moreover, “missing” resistance genes, i.e. 
those absent from genomes assembled using Velvet, could be identified when using SPAdes for 
genome assembly. Nevertheless, there is a huge number of cases where not all expected genetic 
resistance determinants were identified. This can be caused by loss of resistance plasmid during 
storage and culturing or emergence of unknown resistance mechanisms and chromosomal point 
mutations which could not be identified using the ResFinder2.1 tool. Additional identification of 
streptomycin resistance determinants, which were not expected based on phenotypic data, are likely 
to be caused by incorrectly determined MIC values or changes regarding break points and test panels. 
For better comparison of the data, isolates with contradicting phenotypical and genotypical results 
should be subjected to MIC retesting. In case of the aac(3)-VIa-like genes and the erm(B) that were 
detected in 7 SPAdes assembled genomes, further analysis of the respective contigs revealed that all 
of them showed a low coverage. These contigs might have been derived from the assembly of low 
level read contaminations from other samples which might have led to the false positive detection of 
genotypic resistance determinants. Including low coverage contigs caused by read contamination in 
the assembled genomes might be a disadvantage of SPAdes. Additional filters should be applied to 
remove low coverage contigs.  
 
 
 
 
 
 
 
 
 
 
 
Graphical representation of overall assembly quality parameters including contig numbers, N50 values and genome sizes of 
genomes assembled with either SPAdes or Velvet. 
 
Figure E.1: Overall assembly quality 
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Table E.2: List of Strains (see also Supplementary Table 2 in Annex B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
sample_name genome_size contigs n50 genome_size contigs n50
03-02917 4674923 150 70852 4505678 360 26926
06-02242 4762839 157 88213 4633625 335 30290
07-01597 4663179 64 225719 4577464 213 51461
08-00436 4896492 118 119248 4797832 314 35933
08-00436 4967144 79 247068 4940435 222 85291
08-00844 4970846 91 213767 4941452 230 58722
08-00955 4965087 100 155361 4876611 278 43853
08-03422 4955841 120 137558 4876128 293 44300
09-02362 4871450 88 174043 4804866 227 53647
09-02946 5034312 91 225719 5027353 200 85169
09-02986 4954613 146 103875 4844786 337 30225
09-03610 4926660 97 164864 4918582 205 74734
09-04431 4962053 88 187927 4919965 239 51201
10-03145 4915801 181 53662 4754476 354 31818
10-03460 4818113 63 368622 4788341 346 34646
10-04072 4913494 122 82860 4833220 270 46531
10-04072 4909537 81 165445 4883184 192 76987
10-05043 4991716 172 68232 4888669 376 30963
11-01176 4782703 113 124638 4720850 271 44563
11-01525 4972448 92 184458 4962843 183 103705
11-02165 4966007 86 166565 4907581 242 44379
11-03654 5012273 83 173228 4986940 224 54113
11-03655 5011129 72 393606 4969447 222 56233
11-03656 5013701 86 206171 4995442 189 96509
11-04054 4897942 140 77220 4859167 290 40921
11-04056 4912808 90 165788 4873888 238 62293
11-04559 5014967 69 368674 5007664 144 146576
12-00555 5007211 115 94646 4855916 287 41914
12-01208 5016473 93 157181 4958028 248 48398
12-02541 4707937 128 93229 4634546 285 37900
12-02857 4774719 124 96314 4678889 302 35324
13-SA02194 4970145 75 385587 4943543 167 90284
13-SA02281 5008432 120 96736 4968954 303 38101
13-SA02283 4983075 68 253523 4968764 199 74230
13-SA02300 4986840 98 147698 4964091 248 46308
13-SA02435 4982663 104 121634 4949929 236 53586
13-SA02656 5076872 124 100656 5021983 285 45019
13-SA02788 4967735 80 192581 4948003 216 56954
14-SA00333 5010528 62 231654 4995680 210 83814
14-SA00775 4813906 109 103703 4772262 248 38773
14-SA00777 4987252 95 134015 4950980 259 51549
14-SA00918 4964052 96 121174 4914842 252 44954
14-SA01149 5013356 60 368866 4999641 185 93083
14-SA02536 5014878 69 275055 4998872 200 79253
14-SA02741 5009213 122 128575 4941385 287 47436
14-SA02860 4993807 116 131105 4961677 234 52422
15-SA00146 4776301 136 62450 4722696 267 35590
15-SA01434 4807642 67 172824 4795487 174 79619
15-SA01523 4805362 51 392833 4797115 175 82555
15-SA02829 4806710 64 231776 4789754 213 58324
VelvetSpades
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Appendix F – Benchmarking of genotypic Salmonella serotype 
prediction (general) 
 
Report number  #2 
Responsible  Anthony Underwood (PHE) 
Other partners/institutions involved  Lauren Cowley (PHE), Rolf Sommer Kaas (DTU), 
Pimlapas Leekitcharoenphon (DTU), Rob Davies 
(APHA), Mirko Rossi (University of Helsinki/ 
INNUENDO), Kathie Grant (PHE), Liljana Petrovska 
(APHA), Rene S. Hendriksen (DTU), Susanne 
Karlsmose Pedersen (DTU) 
Launch date  Nov 2016 
Deliverable date  Dec 2016 
 
Purpose of the benchmarking exercise  
The main purpose of this benchmarking exercise was to evaluate a number of available bioinformatics 
tools for predicting the Salmonella serotype. Some EC regulations require the use of conventional 
serotyping methods. This could influence the need and velocity in the implementation of NGS for 
animal and food surveillance.  
 
Tools benchmarked 
Benchmarking by determining serotype genotypical using the following tools with default parameters: 
1) MOST (PHE tool) run by DTU 
2) SalmonellaTypeFinder 1.4 run by PHE 
3) SeqSERO 1.2 stand-alone tool run by APHA and by PHE (as part of SalmonellaTypeFinder) 
4) SISTR v1.0.1 run by INNUENDO (https://lfz.corefacility.ca/sistr-app/) 
 
Species/genomes included 
Three datasets have been collected for this study (See below Table F.4 of “Tested serotypes”, Annex 
A, Annex C). Strain selection was based on inclusion of a wide variation of serovars including 
commonly isolated serovars and rare serovars, seldom found (Table F.1). 
The Animal and Plant Health Agency (APHA) collected 78 serotyped Salmonella isolates. The dataset 
included 78 serotypes of which all were rare serovars. Bacterial DNA was extracted using the MagNA 
Pure LC DNA Isolation Kit III (Roche) according to manufacturer’s instructions and sequencing 
libraries were prepared using the NexteraXT sample preparation method for sequenced on the 
Illumina HiSeq platform with paired-end 2x125bp reads (http://www.illumina.com). 
The National Food Institute at DTU collected 208 serotyped Salmonella isolates (these dataset were 
not sequenced under ENGAGE project). The dataset included 208 isolates from 87 serotypes, received 
from the project ‘100K Salmonella project’ (external subproject lead by this affiliated partner, data not 
included in this report). Genomic DNA was using an Invitrogen Easy-DNATM Kit (Invitrogen, Carlsbad, 
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CA, USA) and DNA concentrations were determined using the Qubit dsDNA BR assay kit (Invitrogen). 
The genomic DNA was prepared for Illumina pair-end sequencing using the Illumina (Illumina, Inc., 
San Diego, CA) NexteraXT® Guide 150319425031942 following the protocol revision C 
(http://support.illumina.com/downloads/nextera_xt_sample_preparation_guide_15031942.html). A sample 
of the pooled NexteraXT Libraries was loaded onto a Illumina HiSeq reagent cartridge using HiSeq 
Reagent Kit v2. The libraries were sequenced using an Illumina Hiseq platform. 
Public Health England (PHE) collected 500 serotyped Salmonella isolates. The dataset was selected to 
represent the serotypes that PHE receives routinely as a public health agency in the UK. It included 
500 isolates from the PHE collection and representing 104 serotypes included in the PHE collection. 
DNA extraction of Salmonella isolates begins with a manual lysis using ATL buffer, Proteinase K and 
RNAase A (Qiagen, Hilden, Germany) (220µl, 20µl and 4µl respectively) before loading onto a Qiagen 
Qiasymphony SP for purification. 
DNA quantification was performed using the Promega GloMax with the Invitrogen Quant-iT dsDNA 
Assay Kit (Broad range) (ThermoFisher Scientific, Waltham, Massachusetts, United States) according 
to the manufacturer’s instructions. Genomic DNA was then processed using the NexteraXT® sample 
preparation method and sequenced with a standard 2x101 base protocol on a HiSeq 2500 Instrument 
in fast mode (Illumina, San Diego, CA, USA). 
All selected isolates were serotyped phenotypically according to the WKLM scheme. 
Table F.1: Strain providers, number of isolates and serotypes 
DATASET ISOLATES SEROTYPES 
APHA SERIES  78 78 
DTU SERIES 208 87 
PHE SERIES 500 104 
TOTAL 786 196* 
*The number of serotypes is unique serotypes across the total dataset and therefore not a sum of the serotypes within each 
dataset. 
 
All datasets were sequenced on an Illumina HiSeq. 
Method 
Four tools have been benchmarked in this study: Metric-Oriented Sequence Typer (MOST), SeqSero 
(Zhang et al., 2015), SalmonellaTypeFinder, The Salmonella In Silico Typing Resource (SISTR). 
Availability of tools: 
MOST: https://github.com/phe-bioinformatics/MOST 
SeqSero: https://github.com/denglab/SeqSero 
SeqSero web tool: http://www.denglab.info/SeqSero 
SalmonellaTypeFinder: https://cge.cbs.dtu.dk/services/SalmonellaTypeFinder/ 
SISTR: https://lfz.corefacility.ca/sistr-app/. 
 
Briefly, about the three tools: 
MOST is based on the first version of the tool “Short Read Sequence Typing” (SRST) (Inouye et al., 
2012). MOST maps read data to MLST genes and infers an MLST type. The MLST type is subsequently 
looked up in a local MOST database that contains information on which serotypes that have been 
registered for the MLST type in question. The local database has been divided into two parts, one 
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database containing only information from PHE and another with information collected from 
EnteroBase (http://enterobase.warwick.ac.uk/) 
SeqSero is doing in silico molecular serotyping. In the sense that it maps read data to a local database 
of the genes that causes the phenotype of the specific serotypes. SeqSero thereby infers the phases 
and translates the phase profile into a serotype. 
SalmonellaTypeFinder is an attempt to merge the methods from the above tools. 
SalmonellaTypeFinder runs SeqSero and infers an MLST type using SRST2 (Inouye et al., 2014). The 
MLST type is subsequently looked up in a local database created from information in EnteroBase (this 
includes information from PHE) to determine which serotypes that have been registered for the 
particular MLST type. A serotype is then inferred from the MLST type based on the criteria that at 
least 3 registered isolates of the same serotype has been found with the MLST type in question, and 
at least 75% of the serotypes registered to the MLST type is identical. The final serotype is then found 
by comparing the serotype inferred by SeqSero and the serotype inferred by MLST. The serotype from 
SeqSero always takes precedence over the serotype inferred by MLST. If SeqSero reports several 
serotypes, the serotype (if any) agreeing with the MLST serotype is chosen. 
SISTR is a bioinformatics platform for rapidly performing simultaneous in silico analyses for several 
leading subtyping methods on draft Salmonella genome assemblies. The serovar prediction module in 
the SISTR server utilizes O (somatic) and H (flagellar) antigen and/or serogroup-specific probes 
previously designed for our Salmonella Genoserotyping Array (SGSA), which provides serovar 
identification for 90% (n = 2,190) of serovars. 
All isolates were trimmed using bbduk2 (part of the suit bbtools version 36.49) and de novo 
assembled using SPAdes. All isolates were analysed using all four tools. PHE ran the tools 
SalmonellaTypeFinder and SeqSero. SeqSero was run as a part of SalmonellaTypeFinder. DTU ran the 
tool MOST. The output from most is an array of all the serotypes registered to a specific MLST type, 
along with information on which were registered by PHE and which were not in EnteroBase. The 
authors of MOST (PHE) decided to predict a serotype by selecting the most commonly registered, by 
PHE, serotype for an MLST type. INNUENDO coordinator (University of Helsinki) ran SISTR. 
 
Overall results 
The results were divided into the serotype predictions that correlate with the expected serotype 
(Table F.2, Figure F.1) and those that do not correlate. The results that does not correlate has been 
further divided in to the predictions that give a different serotype than the expected (miscorrelation, 
Figure F.2), the predictions that yields no result (no prediction, Figure F.3), and the predictions that 
yield several possible serotypes, were the expected serotype is found among those (ambiguous, 
Figure F.4). For more detail of all the results, see Supplementary Table 3 in Annex C.  
 
Table F.2: Serotype prediction results 
 MOST SeqSero SalmonellaTypeFinder SISTR 
Correlation 668 (85%) 508 (65%) 669 (85%) 694 (88%) 
No Correlation 118 (15%) 278 (35%) 117 (15%) 92 (12%) 
- Miscorrelation 33 (4%) 22 (3%) 26 (3%) 65 (8%) 
- No prediction 85 (11%) 34 (4%) 34 (4%) 8 (1%) 
- Ambiguous 0 (0%) 222 (28%) 57 (7%) 19 (2%) 
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7 miscorrelations (0.9% of all isolates) were identical across all four tools, meaning that all the tools 
agreed upon the predicted serotype. The relatively low correlation for APHA dataset was due to the 
fact that APHA dataset consist of rare serotypes (Table F.3). 
Presented below is the correlation to each of the three datasets. 
Table F.3. Correlation result for different series of data: 
 MOST SeqSero SalmonellaTypeFinder SISTR 
APHA 17 (22%) 44 (56%) 46 (59%) 35 (45%) 
DTU 169 (81%) 155 (75%) 191 (92%) 192 (92%) 
PHE 482 (97%) 309 (62%) 432 (86%) 467 (93%) 
 
 
Conclusion 
The results of this benchmarking study clearly demonstrate that serotyping using NGS data is a very 
feasible option. The tool with highest correlation, SISTR, gets 88% correlation with the conventional 
serotyping (Figure F.5), and this is a conservative number, considered none of the isolates have be 
retested, to ensure correct serotyping. 
The miscorrelation rate, cases were the tools predicted a different serotype than the expected, were 
3-8% in this study. Additionally, at least half of these miscorrelations are heavily suspected to be 
mistakes in the conventional serotyping. Interestingly, the tool with highest correlation also seems to 
have the highest miscorrelation. It is not possible from this study to conclude why these 
miscorrelations happened, but the tools are under constant development and the errors made by the 
tools are decreasing with each new release.  
Such a low miscorrelation rate would probably be hard to achieve for most labs that does conventional 
serotyping.  
Three of the four tools archive similar scores with a correlation rate between 85-88% and “no 
correlation” rates between 12-15%. It is important to note that the lowest scoring tool “SeqSero” is an 
essential part of the higher scoring tool “SalmonellaTypeFinder”. 
 
 
Additional notes 
It is recommended to serotype the isolates were the predictions from the tools disagree with the 
expected serotype. This is especially important for the isolates where all tools have identical 
miscorrelations. Additionally, the different sequence quality and sequencing processing may have an 
effect on the results.  
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Table F.4: Tested serotypes 
Serotype count Serotype count Serotype count 
35:z10:- 1 Butantan 1 Hadar 7 
38:k:- 1 Canastel 1 Haifa 8 
4,12:d:- 1 Cerro 8 Havana 10 
9,46:z45:- 1 Chandans 1 Heidelberg 7 
Aberdeen 4 Chester 6 Hiduddify 1 
Abony 5 Chicago 1 Hvittingfoss 5 
Adelaide 5 Claibornei 1 Ibadan 5 
Agama 5 Coeln 6 II 1,4,12:z29:e,n,x 1 
Agbeni 5 Coleypark 1 II 16:m,t:[z42] 1 
Ago 5 Colindale 7 II 21:z10:z6 1 
Agona 6 Concord 8 II 55:k,z39:1 1 
Agoueve 1 Corvallis 9 II 58:d:z6 1 
Ajiobo 5 Derby 10 IIIa 41:z4,z23:- 1 
Alachua 5 Dublin 8 IIIa 47:z4,z23:- 1 
Albany 7 Dugbe 1 IIIa 51:g,z51:- 1 
Altona 4 Durham 6 IIIa 56:z4,z23:z32 1 
Amager 5 Ealing 3 IIIb 61:1,5,7:- 1 
Amsterdam 2 Eastbourne 5 IIIb 65:z10:e,n,x,z15 1 
Anatum 8 Elisabethville 1 Indiana 6 
Anfo 1 Emek 6 Infantis 10 
Ank 2 Enteritidis 24 Isangi 2 
Apapa 2 Falkensee 1 Istanbul 1 
Augustenborg 1 Fischerkietz 1 Itami 1 
Bardo 1 Florida 1 Ituri 1 
Bareilly 8 Fluntern 4 IV 48:g,z51:- 1 
Bergen 1 Freetown 1 IV 50:g,z51:- 5 
Bispebjerg 4 Fresno 1 Jangwani 5 
Blockley 6 Friedenau 1 Javiana 7 
Bonariensis 1 Gaminara 5 Jukestown 1 
Bonn 3 Georgia 1 Kambole 1 
Bovismorbificans 7 Give 8 Karachi 1 
Braenderup 7 Glostrup 2 Kedougou 12 
Brandenburg 7 Godesberg 1 Kentucky 12 
Bredeney 7 Goldcoast 5 Kenya 5 
Khami 3 Mpouto 1 Singapore 2 
Kibi 1 Muenchen 8 Solt 1 
Kimuenza 1 Muenster 6 Stanley 10 
Kingston 5 Nagoya 1 Stanleyville 5 
Kisangani 3 Napoli 5 Stockholm 1 
Kisarawe 1 Newport 11 Takoradi 6 
Kokomlemle 1 Nima 5 Tees 1 
Kottbus 6 Nottingham 3 Telelkebir 6 
Kuessel 1 Offa 1 Teltow 1 
Landwasser 1 Ohio 5 Tennessee 5 
Lexington 1 Omifisan 1 Thompson 7 
Lille 1 Onireke 0 Toricada 1 
Litchfield 7 Oranienburg 7 Typhi 5 
Liverpool 1 Oritamerin 1 Typhimurium 28 
Livingstone 6 Oslo 5 Uganda 3 
London 7 Panama 8 Umbilo 5 
Madjorio 1 Paratyphi A 5 Vejle 1 
Malstatt 1 Paratyphi B 4 Vinohrady 1 
Manchester 3 Paratyphi B var Java 7 Virchow 12 
Manhattan 2 Pomona 1 Virginia 1 
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Serotype count Serotype count Serotype count 
Matopeni 1 Poona 7 Vitkin 4 
Mbandaka 11 Potsdam 8 Vogan 1 
Meleagridis 5 Putten 1 Wangata 1 
Mgulani 1 Reading 2 Waycross 1 
Mikawasima 5 Richmond 5 Weltevreden 8 
Minnesota 6 Rissen 9 Westhampton 1 
Mishmarhaemek 1 Rubislaw 5 Widemarsh 1 
Mississippi 5 Saintpaul 8 Wilhelmsburg 1 
Moero 1 Sandiego 6 Wippra 1 
Monschaui 7 Schwarzengrund 8 Worthington 2 
Montevideo 8 Senftenberg 8   
Morningside 1 Shipley 1   
Note: Information on the isolates included in this benchmarking analysis is available in Annex C. 
 
 
 
 
Y-axis represents number of isolates that serotype predictions correlate with the expected serotype. 
 
 Figure F.1: Correlations 
 
0 
100 
200 
300 
400 
500 
600 
700 
800 
MOST SeqSero SalmonellaTypeFinder SISTR 
ENGAGE 
 
 
 
www.efsa.europa.eu/publications 89 EFSA Supporting publication 2018:EN-1431 
The present document has been produced and adopted by the bodies identified above as author(s). In accordance with Article 36 of Regulation (EC) No 
178/2002, this task has been carried out exclusively by the author(s) in the context of a grant agreement between the European Food Safety Authority and 
the author(s). The present document is published complying with the transparency principle to which the Authority is subject. It cannot be considered as an 
output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the 
conclusions reached in the present document, without prejudice to the rights of the author(s). 
 
 
Y-axis represents number of isolates that serotype predictions give a different serotype than the expected. 
 
Figure F.2: Miscorrelation 
  
 
Y-axis represents number of isolates that serotype predictions yield no result. 
 
Figure F.3: No prediction 
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Y-axis represents number of isolates that serotype predictions yield several possible serotypes, and the expected serotype is 
found among those. 
 
Figure F.4: Ambiguous 
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X-axis represents percentage. 
 
Figure F.5: Summary of correlation, miscorrelation, no prediction and ambiguous 
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Appendix G – Benchmarking of genotypic Salmonella serotype 
prediction complying to the Draft International Standard 
ISO 16140-6 (ISO/DIS 16140-6:2017 Microbiology of 
the food chain – Method validation – Part 6: Protocol for 
the validation of alternative (proprietary) methods for 
microbiological confirmation and typing procedures) 
 
Report number  #3 
Responsible  Eelco Franz (RIVM) and Pimlapas Leekitcharoenphon 
(DTU) 
Other partners/institutions involved  Pimlapas Leekitcharoenphon (DTU), Liljana Petrovska 
(APHA), Kirsten Mooijman (RIVM), Eelco Franz 
(RIVM), Susanne Karlsmose Pedersen (DTU), Rene S. 
Hendriksen (DTU), Angela van Hoek (RIVM), Indra 
Bergval (RIVM), Rolf Sommer Kaas (DTU) 
Benchmarking launched (date)  April 2017 
Deliverable due (date)  June 2017 
 
Purpose 
 
The main purpose of this benchmarking exercise was to evaluate a number of available bioinformatics 
tools for the in silico prediction of Salmonella serovars from raw whole genome sequencing data. The 
set-up of the interlaboratory (benchmarking) study complied with the Draft International Standard ISO 
16140-6 (ISO/DIS 16140-6:2017 Microbiology of the food chain – Method validation – Part 6: Protocol 
for the validation of alternative (proprietary) methods for microbiological confirmation and typing 
procedures).  
  
Participants 
Participants in this benchmarking exercise were institutions from the ENGAGE network, including also 
participation from EFSA representatives, and from RIVM.  
Thirteen sets of results were submitted from the following institutions:  
APHA (United Kingdom), BfR (Germany), DTU (Denmark), EFSA (2 sets of results), IZSLT (Italy), 
IZSVe (Italy), NIPH-NIH (Poland), NVRI (Poland), PHE (United Kingdom), RIVM (the Netherlands) (3 
sets of results). 
Participating institutes are identified by codes (1-13, see below) and each code is known only by the 
corresponding laboratory. The full list of laboratory codes is known only by the organizers (DTU).  
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Tools benchmarked 
Benchmarking exercise component to determine species using the following tools and setup (each 
number refers to the corresponding participant and the (combination of) tools they used): 
1. KmerFinder 2.1 (through Batch upload https://cge.cbs.dtu.dk/services/cge/index.php) 
2. KmerFinder 2.0 (unix command line version, integrated in RIVM pipeline) 
3. kmerid (PHE tool) tag version 2-1 
4. CGE Tools (SPAdes 3.9, Assembler 1.2; SpeciesFinder 1.2; KmerFinder 2.0) 
(https://cge.cbs.dtu.dk/services/) 
5. CGE KmerFinder 2.0. Scored method: winner takes it all. CGE SPADES 3.9 assembled sequences 
6. SISTR (https://lfz.corefacility.ca/sistr-app/) 1.0.1; CGE KmerFinder 2.0 scored method: winner 
takes it all 
7. CLC Genomics Workbench 9 & Species Finder 1.2 (https://cge.cbs.dtu.dk/services/SpeciesFinder/) 
8. CLC Genomics Workbench 9 and SISTR app 
9. CGE, blastn 
10. Kraken version 0.10.5-beta, with MiniKraken DB. Options used: --fastq-input --gzip-compressed --
quick --preload --paired 
11. Blastn 2.3.0 -evalue 0.001 -outfmt "6 qseqid qlen sseqid sacc slen qstart qend sstart send evalue 
bitscore length pident mismatch gaps staxid sscinames" -perc_identity 95 -max_target_seqs 2 -
qcov_hsp_perc 80 -db NT; for species confirmation: KmerFinder 2.0 (default options) 
12. KmerFinder 2.0, scoring: Winner takes all, db: bacteria 
13. KmerFinder 2.1 (BatchUpload of assembled data) 
 
Benchmarking determining the Salmonella serovar genotypically using the following tools and setup: 
1. SeqSero 1.0 (http://www.denglab.info/SeqSero) Reads paired-end 
2. SISTR_cmd 0.3.6 (unix command line tool based on SISTR, integrated in our pipeline) 
3. MOST (PHE tool) tag version 2-8, SeqSero (for antigenic formula) [-m 2 -b mem] 
4. CGE Tools (SeqSero 1.2) 
5. CGE SeqSero 1.2. We submitted raw sequences 
6. SISTR (https://lfz.corefacility.ca/sistr-app/) v1.0.1 
7. Seqsero 1.0 Genome Assembly and Species Finder 1.2  
8. SISTR app  
9. CGE (SeqSero, mlst) 
10. SeqSero 1.0. Options used: -m2 (for pair-end reads), -b sam (for bwa samse/sampe) 
11. SeqSero 1.0 -m2; for serotype confirmation: SISTR v0.3.4, --qc --no-cgmlst -f tab -o sistr-
output.tab 
12. SalmonellaTypeFinder 1.3 
13. SeqSero 1.2 (paired end reads) 
For further information on the serotyping tools, please see Appendix F – Benchmarking of genotypic 
Salmonella serotype prediction (general).  
 
Genomes of bacterial species and Salmonella serovars  
According to ISO/DIS 16140-6, the following number and type of strains have to be tested, per 
laboratory, in an interlaboratory study (ILS) when validating an alternative serotyping method 
(ISO/DIS 16140-6 includes protocols for validation of alternative confirmation and typing procedures 
i.e. including also serotyping) for Salmonella: 16 different strains from target serovars, 4 strains from 
non-target serovars within target subspecies and 4 strains from non-target genus. In this ILS, 27 
genomes without any pre-assembly or trimming of the following strains were tested (the strains in this 
study were not part of ENGAGE project): 
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 18 isolates of 6 target Salmonella serovars:  
o Enteritidis (n=3), Hadar (n=3), Infantis (n=3), monophasic Typhimurium (n=3), Typhimurium 
(n=3), Virchow (n=3). 
 5 non-target Salmonella serovars:  
o Derby, Dublin, Kentucky, Mbandaka, Stanley. 
 4 strains from the same family (Enterobacteriaceae) but non-target genus: 
o Citrobacter freundii, Escherichia coli, Klebsiella pneumoniae, Shigella flexneri. 
 
The genomic quality based on number of reads, N50, number of contigs and total base pairs of each 
strain was assessed (Table G.6 – List of selected genomes) and they all were of good quality 
(genomic quality data can be found in the Supplementary Table 4 (Annex D)).  
The National Institute for Public Health and the Environment (RIVM, the Netherlands), Centre for 
Zoonoses and Environmental Microbiology provided the genomes of six Salmonella genomes, 
serotyped by conventional methods, and one E. coli genome.  
The Animal and Plant Health Agency (APHA, United Kingdom) provided seven Salmonella genomes, 
serotyped by conventional methods, one Citrobacter freundii genome and one Klebsiella pneumoniae 
genome, respectively.  
The National Food Institute (DTU Food, Denmark) provided the 10 serotyped Salmonella genomes, 
serotyped by conventional methods and one Shigella flexneri genome.  
All genomes were sequenced on either an Illumina MiSeq or Illumina HiSeq. 
Overall results 
The results were divided into the species and serovar predictions and correlated with the expected 
species and serovar (Tables G.1 and G.2 and Figures G.1 and G.2). The results that did not correlate 
with the expected result were further divided into predictions that give a different species and serovar 
than the expected (miscorrelation, Figures 1 and 2), predictions that yield no result (no prediction, 
Figures G.1 and G.2), and predictions that yield several possible serovars (ambiguous, Figures G.1 and 
G.2). Results are described into more detail in the Supplementary Table 4 in Annex D.  
 
Table G.1: Correlation of in silico species prediction with conventional methods  
 1 2 3 4 5 6 7 8 9 10 11 12 13 
Correlation 25 25 26 24 24 25 25 26 26 25 26 25 25 
No Correlation              
   - Miscorrelation 2 2 1 2 1 1 2 1 1 2 1 1 2 
   - No prediction 0 0 0 1 2 1 0 0 0 0 0 1 0 
   - Ambiguous 0 0 0 0 0 0 0 0 0 0 0 0 0 
Numbers represent the number of isolates. Total number of isolates is 27. Numbers in the header of the columns correspond to 
the listed participants for species prediction. 
 
Table G.2: Correlation of in silico serovar prediction with conventional serotyping methods  
 1 2 3 4 5 6 7 8 9 10 11 12 13 
Correlation 20 22 22 17 19 22 16 22 20 20 22 22 20 
No Correlation              
   - Miscorrelation 1 1 1 0 1 1 1 1 1 1 1 1 1 
   - No prediction 0 0 0 4 1 0 6 0 0 0 0 0 0 
   - Ambiguous 2 0 0 2 2 0 0 0 2 2 0 0 2 
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Numbers represent the number of isolates. Total number of Salmonella isolates is 23. Numbers in the header of the columns 
correspond to the listed participants for serovar prediction. 
 
Correlation for species prediction of all participants was more than 88%. Most of the tools failed to 
predict Shigella flexneri but identified Shigella sonnei instead. Almost all the tools predicted all 
Salmonella enterica correctly. The exception was ENGAGE-BM-16 which participants 4 and 5 did not 
predict correctly. Correlation of serovar prediction was between 74% and 96% The tools that resulted 
in a 96% correlation were SISTR (v1.0.1 and v0.3.6), SeqSero 1.0 (command line version), 
SalmonellaTypeFinder 1.3 and MOST. Most tools predicted S. Hadar (ENGAGE-BM-14) as S. Eko, 
meaning that these tools agreed upon the predicted serovar. Either conventional serotyping 
misclassified this isolate or the incorrect fastq files were added to the test panel. Many tools predicted 
S. Hadar (ENGAGE-BM-11 and ENGAGE-BM-13) ambiguously as S. Hadar/S. Istanbul. Colony form 
variation (the variable expression of minor antigens by different single-colony picks from the same 
strain) may occur with the expression of the O:61 antigen by some serogroup C2 serovars (Hendriksen 
et al., 2009; Popoff, 2001). SeqSero was the most used tool, however the correlation between the 
different versions (web-based or command line)/modes of input data (raw reads or assembled 
genomes) varied from 74.1% to 96.3%. This variation might be due to the choice of assembly tools, 
different options/parameters in web-based and command line version and to the operator. The second 
most used tool was SISTR that resulted in a 96.3% correlation.  
Additionally, the results were evaluated following the data analysis and interpretation described in 
ISO/DIS 16140-6:2017. For this evaluation, the reference and alternative methods were compared for 
the target strains as well as for the non-target strains (inclusivity and exclusivity study, see Table G.3).  
 
Table G.3: Comparison and interpretation of results between the reference and alternative methods 
for the inclusivity study (target strains) and for the exclusivity study (non-target strains) 
Result of the (reference or alternative) method per 
strain 
Interpretation 
Reference confirmation 
procedure 
Alternative 
confirmation method 
Alternative confirmation method 
compared to reference confirmation 
procedure 
+ + PA 
+ - ND 
- + PD 
- - NA 
PA: Positive agreement; ND: Negative deviation; PD: Positive deviation; NA: Negative agreement. 
 
The results of the inclusivity and exclusivity analysis were compared to the acceptability limits (AL) 
indicated in ISO/DIS 16140-6:2017 (these acceptability limits are based on expert opinions), and are 
summarized in Table G.4 (species level) and Table G.5 (serovar level). For the evaluation at species 
level it was noticed that with two tools one Salmonella strain (BM-16) could not be identified and with 
three tools Citrobacter freundii (BM-06) was wrongly identified as Salmonella (Table G.4). For the 
evaluation at serovar level, the outcome ‘S. Hadar/S. Istanbul’, instead of ‘S. Hadar’ was still 
considered correct for reasons as described above. Additionally S. Hadar (ENGAGE-BM-14) was 
excluded from further analysis, because of inconsistent results between conventional and WGS 
serotyping. It was noticed that with three tools some Salmonella serovars could not be identified. 
These concerned 7 strains and in total 9 incidences (Table G.5). 
 
  
ENGAGE 
 
 
 
www.efsa.europa.eu/publications 96 EFSA Supporting publication 2018:EN-1431 
The present document has been produced and adopted by the bodies identified above as author(s). In accordance with Article 36 of Regulation (EC) No 
178/2002, this task has been carried out exclusively by the author(s) in the context of a grant agreement between the European Food Safety Authority and 
the author(s). The present document is published complying with the transparency principle to which the Authority is subject. It cannot be considered as an 
output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the 
conclusions reached in the present document, without prejudice to the rights of the author(s). 
 
Table G.4: Outcome inclusivity/exclusivity analysis at species level 
 N PA ND NA PD ND-PD AL ND+PD AL 
Inclusivity 299 297 2 0 0 2 3 2 5 
Exclusivity 52 0 0 49 3 Not Applicable Not Applicable 3 3 
PA: Positive agreement; ND: Negative deviation; PD: Positive deviation; NA: Negative agreement; AL: Acceptability limits (in the 
ISO WG working on ISO 16140-6 it was agreed for the Exclusivity not to set targets for ND-PD). 
 
Table G.5: Outcome inclusivity/exclusivity analysis at serovar level 
 N PA ND NA PD ND-PD AL ND+PD AL 
Inclusivity 221 212 9 0 0 9 3 9 5 
Exclusivity 117 0 0 114 3 Not Applicable Not Applicable 3 3 
PA: Positive agreement; ND: Negative deviation; PD: Positive deviation; NA: Negative agreement; AL: Acceptability limits 
 
Conclusions 
The results of this benchmarking study demonstrate that serotyping using WGS data is a promising 
option. The tools predicting the Salmonella serovars in the most optimal way, in the current study, 
were, SISTR, SeqSero, SalmonellaTypeFinder followed by MOST, resulting in a 96.3% correlation with 
the conventional serotyping. This value was observed for MOST (only 1 participant used it), SISTR (3 
participants used it), SeqSero (2 participants out of 8 who used this tool), and SalmonellaTypeFinder 
(only 1 participant used). The most optimal tool in this study based on unequal numbers of 
participants that used the tools. This was a limitation to evaluate the best tool in this study.  
When analysing the data in accordance with ISO/DIS 16140-6:2017, the evaluation of results at 
species level showed to be within the acceptability limits, but at serovar level they exceeded these 
limits. This latter was mainly caused by the fact that in 9 incidences the Salmonella serovar of the 
target strains could not be identified. Testing non-target strains additional to target strains in such a 
study showed to be important as with 3 tools Citrobacter was incorrectly identified as Salmonella. The 
quality of the sequences and the choice of assembly tools and/or different options/parameter settings 
still need some attention when using WGS for serotyping Salmonella as participants who used 
different settings or assembly tools (also same tool using different online platforms), they got different 
serotyping results. 
 
Additional notes 
It is recommended to re-serotype, using the conventional serotyping, the isolates where the 
predictions from the tools disagree with the expected serovar.  
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X-axis represents percentage of correlation, ambiguous, miscorrelation and no prediction of species prediction.  
Y-axis corresponds to the list of benchmark tools and participants for species prediction. 
 
Figure G.1: Species prediction 
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X-axis represents percentage of correlation, ambiguous, miscorrelation and no prediction of Salmonella serotype prediction.  
Y-axis corresponds to the list of benchmark tools and participants for species prediction. 
 
Figure G.2: Serovar prediction  
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Table G.6: List of selected genomes  
Target strains RIVM APHA DTU 
Typhimurium ENGAGE-BM-20 ENGAGE-BM-03 ENGAGE-BM-01 
monophasic Typhimurium ENGAGE-BM-04 ENGAGE-BM-10 ENGAGE-BM-19 
Enteritidis ENGAGE-BM-21 ENGAGE-BM-25 ENGAGE-BM-09 
Hadar ENGAGE-BM-11   ENGAGE-BM-13,  
ENGAGE-BM-14 
Infantis ENGAGE-BM-15 ENGAGE-BM-22 ENGAGE-BM-16 
Virchow ENGAGE-BM-18 ENGAGE-BM-24 ENGAGE-BM-07 
Non-target Salmonella serovars 
Dublin   ENGAGE-BM-26   
Stanley   ENGAGE-BM-27   
Derby     ENGAGE-BM-05 
Kentucky     ENGAGE-BM-23 
Mbandaka     ENGAGE-BM-08 
Same family, but non-target genus 
Citrobacter freundii   ENGAGE-BM-06   
Escherichia coli ENGAGE-BM-17     
Klebsiella pneumoniae   ENGAGE-BM-12   
Shigella flexneri     ENGAGE-BM-02 
Selected (sequence data of) strains for interlaboratory study WGS serotyping Salmonella. Indicated are the strains selected per 
institute. 
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Appendix H – Benchmarking of genotypic detection of antimicrobial 
resistance (AMR) genes 
 
 
Report number  
 
#4 
Responsible  Anthony Underwood (PHE) 
Other partners/institutions involved  Pimlapas Leekitcharoenphon (DTU), Yue Tang 
(APHA), James Pettengill (FDA), Rolf Sommer Kaas 
(DTU), Kathie Grant (PHE), Liljana Petrovska (APHA), 
Rene S. Hendriksen (DTU), Susanne Karlsmose 
Pedersen (DTU) 
Launch date   
Deliverable date  March 2017 
 
Antimicrobial resistance (AMR) of foodborne pathogens is important for guiding treatment and 
surveillance of the antimicrobial resistance prevalence. Phenotypic susceptibility testing such as disk 
diffusion and Minimal Inhibitory Concentration (MIC) determination is a time-consuming and laborious 
process. Whole genome sequencing (WGS) offers an alternative to the phenotypic testing for 
determining the susceptibility to a range of antibiotics in a single test.  
Purpose of the benchmarking exercise 
The purpose of this study was to benchmark several of the currently available bioinformatics software 
tools for identification of AMR genes. A well-characterized set of food pathogen isolates (Salmonella 
and E. coli) that have been phenotypically tested for their susceptibility to several antimicrobials were 
compared to the genotypic profiles based on whole genome sequence data. 
 
Benchmarked tools  
The following tools with default parameters were assessed in the benchmarking exercise: 
1) ResFinder 1.2 from DTU (available as command line and online tool) 
    - BLAST-based detection of horizontally acquired genes and chromosomal point mutations 
(command line version) 
2) KmerResistance 2.1 from DTU (available as command line and online tool) 
    - Kmer-based detection of horizontally acquired genes (command line version used) 
3) SRST2 v0.1.7 from http://katholt.github.io/srst2/ (available as command line only) 
    - Mapping based detection of resistance genes 
4) PHE Genefinder from PHE (available as command line only) 
    - Mapping based detection of horizontally acquired genes and point mutations 
 
Species/genomes included 
Two datasets were collected for the purpose of this study.  
The Animal and Plant Health Agency (APHA) collected 125 Salmonella isolates. Bacterial DNA was 
extracted using the MagNA Pure LC DNA Isolation Kit III (Roche) according to manufacturer’s 
instructions and sequencing libraries were prepared using the NexteraXT sample preparation method 
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for sequencing on the Illumina HiSeq platform with paired-end 2x125bp reads 
(http://www.illumina.com). 
The National Food Institute at DTU collected 164 E.coli isolates. Genomic DNA was extracted using an 
Invitrogen Easy-DNATM Kit (Invitrogen, Carlsbad, CA, USA) and DNA concentrations were determined 
using the Qubit dsDNA BR assay kit (Invitrogen). The genomic DNA was prepared for Illumina pair-
end sequencing using the Illumina (Illumina, Inc., San Diego, CA) NexteraXT® Guide 
150319425031942 following the protocol revision C 
(http://support.illumina.com/downloads/nextera_xt_sample_preparation_guide_15031942.html). A 
sample of the pooled NexteraXT Libraries was loaded onto a Illumina HiSeq reagent cartridge using 
HiSeq Reagent Kit v2. The libraries were sequenced using an Illumina Hiseq platform. 
The final datasets consisted of 289 isolates. Raw reads were trimmed using bbduk2 (part of the suit 
bbtools version 36.49) with the following cut-off; 1) length of read >= 50 bp, 2) Phred score per base 
>= 20. De novo assembly was performed using SPAdes with minimum Kmer coverage at 2 and 
minimum contig size at 500 bp.  
For dataset from APHA, the antimicrobial susceptibility testing of the 125 Salmonella isolates was 
performed and interpreted using the Kirby-Bauer disk diffusion method, on Isosensitest Agar (Oxoid) 
as described by the British Society for Antimicrobial Chemotherapy (BSAC). The following 
antimicrobials were included in the testing with the listed disc concentrations (µg per ml): nalidixic 
acid (30); tetracycline (10); neomycin (10); ampicillin (10); furazolidone (15); ceftazidime (30); 
sulphamethoxazole/trimethoprim (25); chloramphenicol (30); amikacin (30);  amoxicillin/clavulanic 
acid (30); gentamicin (10); streptomycin (10); sulphonamide compounds (300); cefotaxime (30); 
apramycin (15); ciprofloxacin (1).  
Minimum inhibitory concentration (MIC) determination was performed at DTU on the 164 E.coli 
isolates using commercially prepared dehydrated panels, EUVSEC and EUVSEC2 (Sensititre; TREK 
Diagnostic Systems Ltd., East Grinstead, England). EUCAST epidemiological cut-off values were used 
as interpretative criteria to determine the phenotypic resistance (http://www.eucast.org). Quality 
control was performed by using reference strain E. coli ATCC 25922 according to CLSI guidelines. 
 
Method 
Four tools were benchmarked in this study: ResFinder (Zankari et al., 2012), KmerResistance (Clausen 
et al., 2016), SRST2 (Inouye et al., 2014), PHE Genefinder. 
Availability of tools: 
ResFinder: https://cge.cbs.dtu.dk/services/ResFinder/  
KmerResistance: https://cge.cbs.dtu.dk/services/KmerResistance/  
SRST2: https://katholt.github.io/srst2/  
PHE Genefinder (in-house software, not publicly available) 
The genotypic testing was performed independently by the different collaborating partners and results 
were afterwards compared. Thus, DTU tested the ResFinder tool, PHE tested the KmerResistance tool 
and the Genefinder, and APHA tested the SRST2 tool. The phenotypic susceptibility data were used as 
proxy for the true result. The genotypic results were compared to the phenotypic susceptibility data 
and the performance of the tools was assessed by calculating the specificity, sensitivity, accuracy and 
the Matthew’s Correlation Coefficient (MCC). Additional statistical tests of agreement were also applied 
based on learning from the serotype benchmarking exercise. Given that resistance to different classes 
of antibiotics is conferred by different genes, it was decided to break down the results by antibiotics 
since some of the software tools perform better at calling a profile for different classes.  
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Overall results 
 
The results for specificity, sensitivity, accuracy and MCC for all antibiotic classes are presented in 
Table H.1 and Table H.2 and the accuracy in predicting different classes of antibiotic in Figure H.1, 
Figure H.2 and Supplementary Table 5 (Annex E). 
All tools tested provided an approximate accuracy of around 90% when testing the Salmonella 
genomes (Table H.1). All tested tools achieved an overall lower accuracy, between 80-82%, when 
testing the E. coli dataset (Table H.2). The accuracy in predicting resistance in E. coli for ß-lactams 
and fluoroquinolones using all tools was low, ranging between 55% - 58% and 82% - 84%, 
respectively (Figure H.2 and Supplementary Table 5 in Annex E).  
 
Table H.1: Results from Salmonella dataset for all antibiotic classes 
Software Specificity Sensitivity Accuracy MCC 
KmerResistance 0.95 0.74 0.86 0.72 
ResFinder 0.95 0.83 0.90 0.79 
SRST2 0.93 0.80 0.87 0.74 
PHE GeneFinder 0.97 0.83 0.90 0.81 
 
 
Table H.2: Results from E. coli dataset for all antibiotic classes 
Software Specificity Sensitivity Accuracy MCC 
KmerResistance 0.91 0.46 0.80 0.41 
ResFinder 0.89 0.60 0.82 0.51 
SRST2 0.89 0.57 0.81 0.48 
PHE GeneFinder 0.90 0.53 0.81 0.47 
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Y-axis represents accuracy ratio expressed as a fraction of 1. 
 
Figure H.1: Accuracy obtained by the benchmarked tools for three antimicrobial classes for the 
tested Salmonella dataset 
 
Y-axis represents accuracy ratio expressed as a fraction of 1. 
 
Figure H.2: Accuracy obtained by the benchmarked tools for three antimicrobial classes for the 
tested E.coli dataset 
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Conclusion 
 
The tools providing the highest degrees of specificity, sensitivity, MCC and accuracy in Salmonella data 
were the ResFinder 1.2 and PHE GeneFinder tools (no version available; tests performed on 
01.02.2017). ResFinder also provided the highest accuracy and MCC in predicting resistance in the E. 
coli genomes, while GeneFinder provided the highest MCC in predicting resistance in the Salmonella 
genomes.  
All tools revealed an approximate 90% correlation with the phenotypic susceptibility testing for 
Salmonella. Only the PHE Genefinder predicted resistance to fluoroquinolones based on chromosomal 
point mutation and hereby performed with a higher accuracy than other tools for fluoroquinolone 
resistance (Figure H.1). 
All tools performed with a lower accuracy when testing E. coli. A very low accuracy was achieved in 
profiling β-lactam (Figure H.2). This could be due to the possible bias in the dataset that included a 
number of E. coli containing upregulated chromosomal ampC mutations (mediating β-lactam 
resistance) which none of the tools could predict. By including the methods to detect ampC mutations 
and other chromosomal point mutations, the concordance for β-lactam and fluoroquinolone resistance 
can be increased. Therefore, ampC mutations and other chromosomal point mutations will soon be 
included in a new version of ResFinder. 
The results of this benchmarking study showed that predicting antimicrobial resistance using WGS is a 
feasible and realistic alternative to phenotypic susceptibility testing. In addition, for the Salmonella 
and the E.coli datasets, different criteria were applied for the definition of phenotypic resistance, as 
this can also influence the results. The comparability of the phenotypic results should be taken into 
account because phenotypic criteria for defining resistance and susceptible were different. This might 
affect the results on the correlations between phenotypes and genotypes.  
The miscorrelation rate (cases where the tools predicted a different antimicrobial profile than the 
expected) were 10-14% in the Salmonella dataset. These miscorrelations are suspected to be caused 
by mistakes in the phenotypic susceptibility testing.  
 
Additional notes 
It is recommended to retest the phenotypic susceptibility for the isolates showing discordant results 
with the genotypic prediction tools and the expected genotypic resistance profile derived from 
phenotypic susceptibility testing. This is especially important for the isolates where all tools showed 
identical miscorrelations. Additionally, the sequencing quality also influences the performance of the 
tools.  
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Appendix I – Benchmarking for Salmonella Enteritidis phylogeny  
 
Report number  #5 
Responsible  Anaïs Painset (PHE) and Anthony Underwood (PHE) 
Other partners/institutions involved  APHA (United Kingdom), BfR (Germany), EFSA 
(Italy), DTU (Denmark), IZSLT (Italy), IZSVe (Italy), 
NIPH-NIH (Poland), NVRI (Poland) 
Benchmarking launched (date)  September 2017 
Deliverable due (date)  October 2017 
 
Purpose of the benchmarking exercise 
The main purpose of this benchmarking exercise was to evaluate a number of available bioinformatics 
tools both to detect variants and to build a phylogeny based on the variants alignment detected for 
Salmonella Enteritidis isolates. With the use of Whole Genome Sequencing, phylogeny is used as a 
method to characterize microorganisms in outbreak investigations and for surveillance of isolates that 
are genetically related. 
 
Participants 
Participants in this benchmarking were institutions from the ENGAGE network. 
Twelve sets of results (phylogenies) were submitted from the following institutions:  
APHA (United Kingdom), BfR (Germany), DTU (Denmark), EFSA (Italy), IZSLT (Italy), IZSVe (Italy) (3 
phylogenies), NIPH-NIH (Poland), NVRI (Poland) (2 phylogenies), PHE (United Kingdom). 
Results from participating institutes are identified by codes (1-12 see below) and each code is known 
only by the corresponding laboratory. The full list of laboratory codes is known only by the organizers 
(PHE).  
 
Tools benchmarked 
Benchmarking by variants calling and generating SNPs alignment using the following tools and setup: 
1. Snippy v3.0 [default setting: min depth 10, 90% difference from ref] 
2. BioNumerics 7.6 (- Mapping /SNP Filtering (relative coverage: total: 5, forward: 1, reverse: 1, 
unreliable bases, ambiguous bases, gaps, non-informative SNPs)) 
3. CGE Tools (command line version) – CSIPhylogeny v1.4 
4. CGE Tools – CSIPhylogeny v1.4 online version default parameters (BWA v. 0.7.2 + BEDTools 
v. 2.16.2 + SAMTools v. 0.1.18) 
5. CGE Tools CSIPhylogeny v1.4 online version default parameters (BWA v. 0.7.2 + BEDTools v. 
2.16.2 + SAMTools v. 0.1.18) 
6. CGE Tools – CSIPhylogeny v1.4 online version default parameters (BWA v. 0.7.2 + BEDTools 
v. 2.16.2 + SAMTools v. 0.1.18) 
7. CGE Tools – CSIPhylogeny v1.4 online version default parameters and reference include in the 
final phylogeny (BWA v. 0.7.2 + BEDTools v. 2.16.2 + SAMTools v. 0.1.18) 
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8. CGE Tools – CSIPhylogeny v1.4 online version default parameters and reference include in the 
final phylogeny (BWA v. 0.7.2 + BEDTools v. 2.16.2 + SAMTools v. 0.1.18) 
9. CGE Tools – CSIPhylogeny v1.4 online version, reference include in the final phylogeny (BWA 
v. 0.7.2 + BEDTools v. 2.16.2 + SAMTools v. 0.1.18) 
10. Custom pipeline  
• Trimmomatic v.0.36 and Nextera-PE adapters to trim the reads. Following parameters were 
set: 
ILLUMINACLIP:Nextera-PE.fa:2:30:10 LEADING:3 TRAILING:3 SLIDINGWINDOW:4:15 
MINLEN:36 
• BWA MEM v.0.7.13 with default settings for mapping paired and unpaired reads (after 
trimming)  
• Freebayes v.1.1.0 (d784cf8) with “--ploidy 1” for joint variant calling on all samples 
• R package VariantAnnotation v1.22.3 to filter variants: variant calls with genotype-likelihood 
(GL) > -30 (likelihood > 10e-3) were set to unknown genotype. 
• VCF-kit v.0.1.2 “pheno fasta” and “pheno tree nj” to generate alignment and newick tree 
11. PHEnix 1.2 (BWA mapping + GATK variant calling) + SnapperDB 0.2.4 (get the snps A:80) 
12. CGE Tools – CSIPhylogeny v1.4 online version default parameters (BWA v. 0.7.2 + BEDTools 
v. 2.16.2 + SAMTools v. 0.1.18) 
 
 
Benchmarking by building trees using the following tools and setup: 
14. RAxML v.8.2.9 
15. Bionumerics v.7.6: Neighbor joining tree 
16. CGE Tools – CSIPhylogeny 1.4 command line (FastTree built-in) 
17. CGE Tools – CSIPhylogeny 1.4 online version (FastTree built-in) 
18. MEGA-CC 7 Minimum Evolution Methods 
19. MEGA-CC 7 Maximum Parsimony 
20. CGE Tools – CSIPhylogeny 1.4 online version (FastTree built-in) 
21. CGE Tools – CSIPhylogeny 1.4 online version (FastTree built-in) 
22. CGE Tools – CSIPhylogeny 1.4 online version (FastTree built-in) 
23. VCF-kit v0.1.2 with pheno tree nj   
24. RAxML v8.2.8-multithread (-N autoMRE -f a -p 12345 -x 12345 -m GTRCAT) 
25. CGE Tools – CSIPhylogeny 1.4 online version (FastTree built-in) 
 
Species/genomes included 
Public Heath England selected and provided genomes from Salmonella enterica serotype Enteriditis 
and part of the same eburst group EGB4. The genomes have been selected because they were part of 
an outbreak investigated by PHE. This outbreak has been well-studied (Dallman et al., 2016) and 
epidemiological information support the phylogeny associated with the selection. 
Thirty genomes represented by sets of fastq (paired) were included in the data set (Annex F). All 
genomes originated from sequencing using an Illumina HiSeq. Fastq were trimmed using Trimmomatic 
0.32 with the following options: ILLUMINACLIP:NexteraPE-PE.fa:2:30:10:8:true LEADING:30 
TRAILING:30 SLIDINGWINDOW:10:20 MINLEN:50, then the quality of the sequencing was assessed 
by running FastQC 0.11.3. The trimmed and quality assessed reads were used for the analysis 
(Supplementary Table 6 in Annex F). 
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The gold standard phylogeny use to perform comparisons was constructed following the methods 
employed by Centre 11. Tools used to build the gold standard phylogenies are PHEnix 1.2 for variants 
calling and filtering, follow by SnapperDB 0.2.4 to extract relevant SNPs and RAxML 8.2.8 to build the 
phylogeny. In this benchmarking, gold standard will be the phylogeny build following Centre 11 
tools/methods. 
 
Overall results 
The results were compared using two main approaches: 
1. Alignment and distance matrix comparison 
2. Topology of the tree: global topology, Robinson-Fould symmetric difference and percentage of 
edge similarity (number of branches in one tree that are present in another) 
 
Alignment and distance matrix 
All the participants were required to provide a fasta alignment of the SNPs detected by the method 
they employed to generate the phylogeny. To ensure consistent comparison of the alignments, we 
generated the distance matrices from the alignment using an in-house script and build the graphic 
with an in-house R script. 
Eight out of the twelve set of results provided by the partners were generated by using the CGE CSI 
Phylogeny tools. We decided to regroup results in Table I.1 where the parameters were the same. 
 
Table I.1: Alignment and statistic metrics 
Results 1 2 3/4/5/6/12 7/8 9 10 11 
Alignment length 779 698 633 644 636 1465 786 
Min distance matrix 0 0 0 0 0 0 0 
Max distance matrix 558 489 428 428 422 713 527 
Reference + - - + + - + 
Columns numbers correspond to the results submit by the partners. The list of benchmarking tools and participants for variants 
calling. 
 
The longest the alignment is the more SNPs have been detected in the dataset. Min and max distance 
matrix represent the number of SNP different between strains in the dataset. Strains supposedly part 
of an outbreak or closely related are expected to have a low number of SNP difference. The minimum 
distance captures the minimum number of SNPs between two strains in the dataset i.e. the two 
closest strains in the dataset. The maximum distance reflects the maximum number of SNPs between 
two strains in the dataset i.e. the more distant strain in the dataset. 
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Method use by centre 11 was used as the gold standard and is not represented on the comparisons. 
* Phylogenies 4/5/6 were based on the same alignment, therefore only one graph can be produce. 
Centre numbers correspond to the list of benchmarking tools and participants for variants calling. 
 
Figure I.1. Comparisons of distances generated from centre with gold standard.  
 
Topology of the tree 
All the phylogenies are presented in the Figures I.4 - I.16. They are labelled according to row number 
on the following table. The phylogenetic distance metrics were generated by using the ete toolktit 
(http://etetoolkit.org/) ete3 v.3.0.0 with his module compare and the additional phangorn R package 
v2.0.0.  
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Table I.2: Phylogenetic distance metrics 
 1 2 3 4 5 6 7 8 9 10 11 12 
E.size 31 30 30 30 30 30 31 31 31 30 31 30 
Ref + - - - - - + + + - + - 
nRF 0.46 0.32 0.2 0.2 0.37 0.37 0.19 0.19 0.19 0.78 0 0.2 
RF 26 13 10 10 20 20 10 10 10 42 0 10 
maxRF 56 41 50 50 54 54 52 52 52 54 56 50 
src-br+ 0.78 1 0.94 0.94 0.82 0.82 0.94 0.94 0.94 0.62 1 0.94 
ref-br+ 0.78 0.77 0.88 0.88 0.82 0.82 0.88 0.88 0.88 0.62 1 0.88 
KF.dist 0.198 356.692 0.073 0.073 313.742 - 0.151 0.151 0.166 0.395 0 0.073 
Columns numbers correspond to the list of benchmarking tools and participants for the tree building. 
Additional notes: meaning of the metrics (ete-compare): 
E.SIZE: effective size of the dataset used to calculate metrics 
nRF: Normalized Robinson-Foulds distance (RF/maxRF)  
RF: Robinson-Foulds symmetric distance  
maxRF maximum Robinson-Foulds value for this comparison  
%src_br (percent source branch): frequency of edges in target tree found in the reference (1.00 = 100% of branches are 
found)  
%ref_br (percent reference branch): frequency of edges in the reference tree found in target (1.00 = 100% of branches are 
found) 
KF.dist (Kuhner-Felsenstein distance): branch score distance (Kuhner & Felsenstein 1994) [compute with Phargorn]. 
 
The closer the normalized Robinson-Foulds (nRF) value is to 0, the better the match of the topology 
to the ’gold standard’ phylogeny. As we can see most of the trees are close to the reference one. One 
tree (Centre 10) is significantly different in terms of topology compared to the gold standard. 
The KF distance (KF.dist) measures the difference in term of branch length. As we can see most of 
the trees have really similar branch length. Tree of centre 2 and tree of centre 5 are not using the 
SNPs for the alignment as a branch length and this would explain why the difference in term of 
branch length is really high. 
The tree of centre 6 does not provide branch length in the newick file and therefore was exclude from 
this metric (Table I.2). 
 
Table I.3: Clade retrieval from gold standard compared to others methods  
 1 2 3 4 5 6 7 8 9 10 11 12 
Reference + - - - - - + + + - + - 
Outliers 
n=5 
N Y Y Y Y Y Y Y Y N Y Y 
Clade I 
n=3 
N Y Y Y Y Y Y Y Y N Y Y 
Clade II 
n=8 
Y Y Y Y Y Y Y Y Y N Y Y 
Clade III 
n=14 
Y Y Y Y Y Y Y Y Y N Y Y 
Columns numbers correspond to the list of benchmarking tools and participants for the tree building. 
n = number of isolates per clade, N if all isolates from the gold standard clade are not retrieved on the same clade in the 
phylogeny, Y if all isolates from the gold standard clade are retrieve on the same clade. +/- indicated presence/absence of the 
reference in the phylogeny. 
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This is a topological assumption: isolates from a clade are considered correct if they are on the same 
monophyletic branch. The three clades should be separated from the outliers by a long branch. The 
assumption is that isolates group in clades accordingly to the gold standard (Table I.3). 
The following tanglegrams illustrate the difference/similarity between the gold standard and the 
phylogeny where we found clade discrepancies. The lines in the middle reflect inversions in the 
position of isolates between the two phylogenies; it is used to illustrate the most different trees in 
terms of clade retrieval compare to the gold standard. 
 
Figure I.2. Tanglegram of the gold standard (left) versus the most different topology produce by 
Centre 10 
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Figure I.3. Tanglegram of the gold standard (left) versus the topology produce by Centre 1 
 
Conclusion 
The methods used to generate the SNP alignment by the different partners showed similar results 
except for three Centres, Centre 1 (Snippy), Centre 7 (CSI without heterozygote removal) and Centre 
10 (Custom pipeline) where the comparisons of the distance matrix show discrepancies between those 
isolates that are distantly related. Also, the topology produced shows great similarity, the number of 
SNPs difference between isolates can vary based on the tools and parameters.  
The scores based on the topology demonstrate that most of the methods tested are able to retrieve 
the topology derived from the gold standard. Only one method seems to give a markedly different 
topology (Centre 10, custom pipeline). 
During this benchmarking we have identified that a key point in building a phylogeny based on the 
SNP differences between isolates is the detection and filtering of the SNPs. Based on this 
benchmarking we can recommend a minimum depth coverage for the SNPs detection > 10, a 
minimum mapping read quality of 30, and 90% consensus for the reads mapped at a position that 
differs from the reference. 
The best tools to build tree from an alignment are maximum likelihood methods. Topology obtained 
using these methods produce trees with the best correlation between gold standard and the obtained 
phylogeny. 
 
Reference 
Dallman T, Inns T, Jombart T, Ashton P, Loman N, Chatt C, Messelhaeusser U, Rabsch W, Simon S, 
Nikisins S, Bernard H, le Hello S, Jourdan da-Silva N, Kornschober C, Mossong J, Hawkey P, de 
Pinna E, Grant K and Cleary P, 2016. Phylogenetic structure of European Salmonella Enteritidis 
outbreak correlates with national and international egg distribution network. Microbial Genomics, 
2(8):e000070. doi: 10.1099/mgen.0.000070 
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Additional Figures 
 
 
Scale represents the branch length stipulated into the newick file. 
 
Figure I.4: Gold standard phylogeny with reference 
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Scale represents the branch length stipulated into the newick file. 
 
Figure I.5: Phylogeny Centre 1 obtained with Snippy tool and RAxML  
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Scale represents the branch length stipulated into the newick file. 
 
Figure I.6: Phylogeny Centre 2 obtained with BioNumerics and a Neighbor joining tree reconstruction  
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Scale represents the branch length stipulated into the newick file. 
 
Figure I.7: Phylogeny Centre 3 obtained with CSI Phylogeny (CGE tools, command line version)   
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Scale represents the branch length stipulated into the newick file. 
 
Figure I.8: Phylogeny Centre 4 obtained with CSI Phylogeny (CGE tools, online version)  
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Scale represents the branch length stipulated into the newick file. 
 
Figure I.9: Phylogeny Centre 5 obtained with CSI tools alignment (command line version) and a 
minimum evolutionary model for tree reconstruction 
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Due to some missing branch lengths in the newick format all the branches appear with the same length. Scale represents the 
branch length stipulated into the newick file. 
 
Figure I.10: Phylogeny Centre 6 obtained with CSI Phylogeny (CGE tools, command line version) and 
a maximum parsimony tree reconstruction  
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Scale represents the branch length stipulated into the newick file. 
 
Figure I.11: Phylogeny Centre 7 obtained with CSI Phylogeny (CGE tools, online version) 
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Scale represents the branch length stipulated into the newick file. 
 
Figure I.12: Phylogeny Centre 8 obtained with CSI Phylogeny (CGE tools, online version) with 
heterozygous SNPs ignored  
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Scale represents the branch length stipulated into the newick file. 
 
Figure I.13. Phylogeny Centre 9 obtained with CSI Phylogeny (CGE tools, online version)  
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Scale represents the branch length stipulated into the newick file. 
 
Figure I.14: Phylogeny Centre 10 obtained with BWA-Mem mapping, Freebayes, VariantAnnotation 
for detection/filter of SNPs and VCF-kit to generate the final alignment and the Neighbor Joining Tree  
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Scale represents the branch length stipulated into the newick file. 
 
Figure I.15: Phylogeny Centre 11 obtained with PHEnix/SnapperDB and for variants detection and 
RAxML for tree building  
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Scale represents the branch length stipulated into the newick file. 
 
Figure I.16: Partner Centre 12 phylogeny obtained with CSI Phylogeny (CGE tool, online version)  
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Appendix J – Benchmarking for Campylobacter coli phylogeny 
 
Report number  #6 
Responsible  Anaïs Painset (PHE) and Timothy Dallman (PHE) 
Other partners/institutions involved  APHA (United Kingdom), BfR (Germany), DTU 
(Denmark), IZSLT (Italy), IZSVe (Italy), NIPH-NIH 
(Poland), NVRI (Poland) 
Benchmarking launched (date)  December 2017 
Deliverable due (date)  January 2018 
 
 
Purpose of the benchmarking exercise 
The main purpose of this benchmarking exercise was to evaluate a number of available bioinformatics 
tools both to detect genomic variants and to build a phylogeny based on the variants detected for 
Campylobacter coli isolates. In this specific exercise, we ask participants to take into account the 
possibility of recombination between isolates. With the use of Whole Genome Sequencing, 
phylogenetic is used as a method to characterise microorganisms in outbreak investigations and for 
surveillance of isolates that are may be genetically related. 
 
Participants 
 
Participants in this benchmarking were institutions from the ENGAGE network. 
Eleven sets of results were submitted from the following institutions:  
APHA (United Kingdom), BfR (Germany), DTU (Denmark), IZSLT (Italy), IZSVe (3 phylogenies) (Italy), 
NIPH-NIH (Poland), NVRI (Poland), PHE (2 phylogenies) (United Kingdom). 
 
Results from participating institutes are identified by codes (1-11, see below Table J.1) and each code 
is known only by the corresponding laboratory. The full list of laboratory codes is known only by the 
organizers (PHE). Table J.1 (below) describes the methods/tools used to produce each phylogeny. 
Final phylogenies will be referred as Centre XX later in the document where XX correspond to the row 
number of Table J.1. 
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Table J.1. List of tools/software used to produce each phylogeny submitted 
Cen
tre 
SNP alignments tools (version) 
[parameters] 
Tree building (version) 
[parameters] 
Recombination 
detection 
(version) 
[parameters] 
1 Snippy 3.0  
[default] 
Gubbins 2.1.0  
[default] 
Gubbins 2.1.0  
[default] 
→ post SNP 
detection 
2 Snippy 3.2  
[mapqual 60, basequal 20, mincov 10,minfrac 
0.9] 
vcftools 0.1.15  
[thin 100,recode] 
FastTree 2.1.7  
[-nt, Nucleotide distances: 
Jukes-Cantor, Joins: balanced, 
Support: SH-like 1000] 
- 
3 
 
 
CSIPhylogeny 1.4 command line  
[default] 
CSIPhylogeny 1.4 command line 
[default] 
- 
4 BWA Mem 0.7.12 
[-p and default for other parameters] 
samtools 1.5  
• view [-sb] 
• sort [default] 
• mpileup [-6 (Illumina +1.3), -C 50 (min 
quality 50), -v, -u] 
bcftools 1.5  
• call [-O v, --ploidy 1, -v, -m] 
vcf_fa_extractor 
(https://github.com/moskalenko/vcf_fa_extra
ctor) 
[default] 
clustalW built-in MEGA7 
[default] 
MEGA 7 
[Statistical Method: Maximum 
likelihood, Model/Method: Jukes 
and Cantor, Rates among Sites: 
Uniforms, ML Heuristic method: 
NNI (Nearest-Neighbor-
Interchange) 
- 
5 FastQC 0.11.2 
[default] 
Kraken 0.10.6  
[default] 
Trimmomatic0.32 
[ILLUMINACLIP:Nextera-PE.fa:2:30:10 
LEADING:20 TRAILING:20 
SLIDINGWINDOW:4:20 MINLEN:100] 
 
PHEnix 1.3 – bwa/GATKbuilt-in 
[sample_ploidy: 1, 
genotype_likelihoods_model: SNP, rf: 
BadCigar, out_mode: EMIT_ALL_SITES, nt: 1, 
ad_ratio: 0.9, min_depth: 15, qual_score: 30, 
mq_score: 30] 
RAxML 7.2.8 
[-f a -x 12345 -p 12345 -# 
autoMRE -m GTRGAMMA] 
- 
6 FastQC 0.11.2 
[default] 
Kraken 0.10.6  
[default] 
Trimmomatic0.32 
[ILLUMINACLIP:Nextera-PE.fa:2:30:10 
LEADING:20 TRAILING:20 
SLIDINGWINDOW:4:20 MINLEN:100] 
Snippy 3.2 
RAxML 7.2.8 
[-f a -x 12345 -p 12345 -# 
autoMRE -m GTRGAMMA] 
- 
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Cen
tre 
SNP alignments tools (version) 
[parameters] 
Tree building (version) 
[parameters] 
Recombination 
detection 
(version) 
[parameters] 
[mincov 15, minqual 30, types snp] 
7 FastQC 0.11.2 
[default] 
Kraken 0.10.6  
[default] 
Trimmomatic0.32 
[ILLUMINACLIP:Nextera-PE.fa:2:30:10 
LEADING:20 TRAILING:20 
SLIDINGWINDOW:4:20 MINLEN:100] 
bwa-mem 0.7.12  
[default] 
samtools 0.1.19-44428cd 
• mpileup [-I,-u] 
bcftools (part of samtools 0.1.19-44428cd) 
• view [-vcgI] 
vcfutils.pl varFilter  
[Q 25, d 30, w 10, W 15 ] 
Internal script for format conversion (vcf -> 
fasta) 
RAxML 7.2.8 
[-f a -x 12345 -p 12345 -# 
autoMRE -m GTRGAMMA] 
- 
8 CGE CSI phylogeny online tools 1.4 
[default] 
CGE CSI phylogeny online tools 
1.4 
[default] 
- 
9 BWA mem 0.7.13  
[default]  
Freebayes 1.1.0  
[ploidy 1] 
VariantAnnotation 1.22.3 
[remove monomorpic (AC > 0 & AC<8), set 
calls below 10x DP to no-call, remove variants 
with missing GT for >2 samples and no alts, 
remove variants with MQM < 50] 
VCF-kit 0.1.2 
• pheno fasta 
VCF-kit 0.1.2 
• pheno tree nj  
 
- 
10 PHEnix 1.2 – bwa/GATK built-in 
[ad_ratio: 0.9, min_depth: 10, qual_score: 
30, mq_score: 30]  
SnapperDB 0.2.4 
[a: A80, r: Y, ng: gubbins gff] 
RAxML 8.2.8 
[-N autoMRE 
-f a -p 12345 -x 12345 -m 
GTRCAT] 
Gubbins 2.0.0  
[c 16, u] 
recombination 
detected on WGS 
SNP alignment 
11 PHEnix 1.2 – bwa/GATK built-in 
[ad_ratio: 0.9, min_depth: 10, qual_score: 
30, mq_score: 30]  
SnapperDB 0.2.4 
[a: A80, r: N, ng: gubbins gff] 
RAxML 8.2.8 
[-N autoMRE 
-f a -p 12345 -x 12345 -m 
GTRCAT] 
Gubbins 2.0.0  
[c 16, u] 
recombination 
detected on WGS 
SNP alignment 
Each row will be referred to as Centre XX. 
 
 
Species/genomes included 
Public Health England selected and provided genomes from Campylobacter coli and part of the same 
sequence type complex ST-828 complex. This ST-complex is very diverse as it is one of the most 
common ST-complex found amongst Campylobacter isolates. The genomes were selected because 
they were part of a suspected outbreak investigated by PHE. The outbreak occurred in 2008 in the 
North of England where a teacher and students from a primary school were having gastrointestinal 
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symptoms. A suspected tap water isolate was also collected. The isolates were sent for testing, all 
came back as Campylobacter coli and the same phage type PT44 as found. Retrospective WGS 
analysis shows that all the isolates were part of the same ST-complex: ST-828.  
Nine genomes represented by sets of fastq (paired) were included the data set (Table J.6 with the list 
of selected genomes). All genomes were generated using an Illumina HiSeq and fastq provided to the 
partners were trimmed and assessed for quality before sharing. Fastq were trimmed using 
Trimmomatic 0.32 with the following options: ILLUMINACLIP:NexteraPE-PE.fa:2:30:10:8:true 
LEADING:30 TRAILING:30 SLIDINGWINDOW:10:20 MINLEN:50. Quality of the sequencing was 
assessed by running FastQC 0.11.3. The trimmed and quality assessed reads were used for the 
analysis (see Table J.6 under ‘Additional notes’, and Supplementary Table 6 in Annex F). 
In this outbreak, a recombination was suspected to occur; investigation confirmed the existing 
recombination that changes the topology and the branch length of the tree. 
Two reference phylogenies were used; these were constructed by removing recombination region 
according to the gold standard methods. In the following report, gold standard methods used to 
generate the reference phylogenies consist of high quality SNPs filter, recombination detected, 
exclusion of the SNPs included into a recombination region and final phylogeny build with a maximum-
likelihood method. 
Tools used to build the reference phylogenies are PHEnix 1.2 for variants calling and filtering, Gubbins 
2.0.0 for recombination detection, SnapperDB 0.2.4 to extract relevant SNPs and RAxML 8.2.8 to build 
the phylogeny. In this case reference phylogenies will be the phylogenies build following Centre 10 
and Centre 11 tools/methods. One included the reference genome, the other did not. This choice was 
made to balance the bias related to the high diversity on the ST-complex. 
 
Overall results 
The results were compared using two main approaches: 
1. Alignment and distance matrix comparison 
2. Topology of the tree: global topology, Robinson-Fould symmetric difference and percentage of 
edge similarity (number of branches in one tree that are present in another) 
 
Each result was compared to their closest reference phylogeny i.e. with or without the reference 
genome. 
Alignment and distance matrix 
All the participants were required to provide a fasta alignment of the SNPs detected by the method 
they employed to generate the phylogeny. To ensure consistent comparison of the alignments, we 
generated the distance matrices from the alignment using an in-house python script. Distances from 
the reference phylogenies were calculate and the graphic generated using an R script. 
 
Table J.2: Alignment and statistic metrics. Columns numbers correspond to Centre (ref. Table J.1) 
 1 2 3 4 5 6 7 8 9 10 11 
Min distance 
matrix 
11 5 0 21 0 5 2 0 2 0 0 
Max distance 
matrix 
9367 157 177 212 9276 8804 6293 3121 230 1976 30 
Reference + - - + + + + + - + - 
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* indicate no reference in the alignment 
 
Figure J.1:  Size of the SNPs alignments for each result 
 
For this benchmarking, we advised partners about potential recombination in the dataset. Results 
from Centre 10 and Centre 11 are taking into account recombination at the alignments step.  
Results including the reference genome have significant longer alignments due to the number of SNPs 
present between samples from the dataset and the reference genome. Campylobacter is known for 
having huge diversity inside the same ST-complex. As we can see results that did not include the 
reference are including only SNPs detected between isolates of the dataset.  
The selected isolates were part of a suspected outbreak and therefore the minimal SNP distance in the 
matrices should reflect the link between isolates. For eight out of eleven results the minimum SNPs 
distance is < 10 SNPs. This proves that all the methods are able to identify a strong link between 
some isolates of the dataset. The maximum distance found is highly related to the inclusion of the 
reference inside the alignment. 
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Centre numbers correspond to the list of benchmarking tools and participants for variants calling. 
 
Figure J.2:  Comparisons of distances generated from centre with gold standard without reference 
genome 
 
The method used by Centre 2 and Centre 9 to generate the SNP alignment seems to show 
discrepancies for the closest isolates. This can be related to a recombination between closely related 
isolates. 
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Centre numbers correspond to the list of benchmarking tools and participants for variants calling. 
 
Figure J.3:  Comparisons of distances generated from centre with gold standard with reference 
genome 
 
The methods used to generate the SNP alignment by the different partner show similar results except 
for Centre 4 where the comparisons of the distance matrix show discrepancies. There were also slight 
differences inside the closest isolates for all the methods used by the partners. 
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Topology of the tree 
All the phylogenies are presented on the additional figures J.4 to J.16. They are labelled according to 
row number on the following table. The phylogenetic distance metrics were generated by using the 
ete toolktit (http://etetoolkit.org/) ete3 v.3.0.0 with his module compare and the additional phangorn 
R package v2.0.0.  
 
Table J.3: Phylogenetic distance metrics 
 ref* E.size nRF RF maxRF %src-br+ %ref-br+ KF dist 
1 + 10 0.86 12.00 14.00 0.62 0.62 25976.63 
2 - 9 1.00 12.00 12.00 0.57 0.57 5.979280 
3 - 9 0.78 7.00 9.00 0.82 0.64 5.037388 
4 + 10 1.00 14.00 14.00 0.56 0.56 3.808749 
5 + 10 1.00 14.00 14.00 0.56 0.56 1.428548 
6 + 10 1.00 14.00 14.00 0.56 0.56 1.373172 
7 + 10 1.00 14.00 14.00 0.56 0.56 1.174685 
8 + 10 0.82 9.00 11.00 0.77 0.62 0.984009 
9 - 9 1.00 12.00 12.00 0.57 0.57 9.104187 
10 + 10 0.00 0.00 14.00 1.00 1.00 0 
11 - 9 0.00 0.00 12.00 1.00 1.00 0 
Row numbers correspond to Centre (ref. Table J.1) 
* +/- indicated presence/absence of the reference in the final phylogeny  
Additional notes: meaning of the metrics (ete-compare): 
E.SIZE: effective size of the dataset used to calculate metrics 
nRF: Normalized Robinson-Foulds distance (RF/maxRF)  
RF: Robinson-Foulds symmetric distance  
maxRF maximum Robinson-Foulds value for this comparison  
%src_br (percent source branch): frequency of edges in target tree found in the reference (1.00 = 100% of branches are 
found)  
%ref_br (percent reference branch): frequency of edges in the reference tree found in target (1.00 = 100% of branches 
are found) 
KF.dist (Kuhner-Felsenstein distance): branch score distance (Kuhner & Felsenstein 1994) [compute with Phargorn] 
 
The closer the normalized Robinson-Foulds (nRF) value is to 0, the better the match of the topology 
to the reference phylogeny. The results show that most of the trees are very different to the reference 
in terms of topology. Also, they seem to be consistently different from the reference phylogeny 
regardless of including the reference genome. 
The closest phylogenies are from Centre 1, Centre 3 and Centre 8. Centre 3 and 8 used the CSI-
phylogeny (CGE tools) and got better results. The phylogeny provided by Centre 1 is using a 
recombination detection software similar to the reference phylogeny explaining the similar results. 
The KF distance measures the difference in term of branch length. As we can see most of the trees 
have somewhat a similar branch length. The Centre 1 branch length in the newick file has been 
derived from the recombination software used to build the phylogeny, it is not based on the SNP 
explaining why the KF distance (difference in term of branch length) is really high compared to the 
others methods shown. 
Most of the partners have not used a specific tool or method to remove the recombination. Tables J.4 
and J.5 show the matrix of KF distances comparing results between each other. 
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Table J.4: KF distance between all centre phylogenies – reference genome included 
 1 4 5 6 7 8 10 
1 0.00       
4 25980.44 0.00      
5 25978.06 2.38 0.00     
6 25978.00 2.44 0.06 0.00    
7 25977.81 2.64 0.25 0.20 0.00   
8 25975.65 4.79 2.41 2.35 2.16 0.00  
10 25976.63 3.81 1.43 1.37 1.17 0.98 0.00 
 
Table J.5: KF distance between all centre phylogenies – reference genome not included 
 2 3 9 11 
2 0    
3 0.9487111 0.00   
9 3.2711648 4.16 0  
11 5.9792803 5.04 9.1041865 0 
 
These matrices pointed out that some of the phylogenies are more similar in term of branch length 
between each other than they are with the reference phylogenies. For example phylogenies 5 and 6 
seems highly similar. 
 
Conclusion 
The methods used to generate the SNP alignment by the different partners show similar results 
except for three (Centre 2, Centre 9 and Centre 4) where the comparisons of the distance matrix 
shows discrepancies between those isolates that are closely related. The distances matrices are 
informative to assess the relation between isolates and the phylogeny. 
The overall topology of the trees compared to the gold standard reference is respected with all the 
methods able to pool together the isolates related to the outbreak and detach the suspected source 
from the main cluster. The main discrepancy linked to the presence of a recombination appears on the 
branch length and on the topology inside the closely related cluster. 
The scores based on the topology demonstrate that most of the methods give different branch length 
and topology when a recombination occurs within the dataset, this could lead to biased distance 
matrices and an over-detection of SNPs. Removing the recombinant regions in this case shows 
strongest evidence of a cluster inside the dataset. 
During this benchmarking we have identified that a key point in building a phylogeny where a 
recombination can occur is to link distance matrices and the phylogeny. The subtle topology of a 
closely related cluster is highly correlated to the presence of a recombination. We can also confirm 
with this benchmarking that if the organism is likely to contain recombination and discrepancies 
occurs between phylogeny and epidemiology information it is recommended to carry out a detection 
of recombination. 
This benchmarking shows that partners have used “gold standard” methods both for SNP detection 
and tree building12. Filtering of SNPs has been properly carried out and most of the participants have 
used a maximum likelihood method to generate the phylogeny. It also demonstrated that despite 
knowing the good practise to derive a phylogeny from WGS, phylogeny need to be used with caution 
and can be only fully explained given support from other data, especially if in relation to outbreak 
investigations (i.e. for outbreak case definitions). 
                                                          
12 Gold standard methods here referred to the filtering apply to detect SNPs and build the phylogeny with a maximum likelihood 
method. 
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Table J.6: Genomes selected for the benchmarking (further info in Supplementary Table 6 in Annex F) 
Sequence name 
Reference: CP011015 
PHYLO_CAMPY_328787 
PHYLO_CAMPY_328789 
PHYLO_CAMPY_328811 
PHYLO_CAMPY_328815 
PHYLO_CAMPY_328828 
PHYLO_CAMPY_328839 
PHYLO_CAMPY_328847 
PHYLO_CAMPY_328863 
PHYLO_CAMPY_328876 
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Additional figures 
 
 
 
Scale represents the branch length stipulated into the newick file. 
 
Figure J.4: Reference phylogeny without reference genome and recombination removed 
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Scale represents the branch length stipulated into the newick file. 
 
Figure J.5: Reference phylogeny with reference genome and recombination removed 
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Scale represents the branch length stipulated into the newick file. 
 
Figure J.6: Phylogeny results Centre 1 
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Scale represents the branch length stipulated into the newick file. 
 
Figure J.7: Phylogeny results Centre 2 
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Scale represents the branch length stipulated into the newick file. 
 
Figure J.8: Phylogeny results Centre 3 
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Scale represents the branch length stipulated into the newick file. 
 
Figure J.9: Phylogeny results Centre 4 
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Scale represents the branch length stipulated into the newick file. 
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Scale represents the branch length stipulated into the newick file. 
 
Figure J.11: Phylogeny results Centre 6 
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Scale represents the branch length stipulated into the newick file. 
 
Figure J.12: Phylogeny results Centre 7 
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Scale represents the branch length stipulated into the newick file. 
 
Figure J.13: Phylogeny results Centre 8 
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Scale represents the branch length stipulated into the newick file. 
 
Figure J.14: Phylogeny results Centre 9 
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Scale represents the branch length stipulated into the newick file. 
 
Figure J.15: Phylogeny results Centre 10 
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Scale represents the branch length stipulated into the newick file. 
 
Figure J.16: Phylogeny results Centre 11 
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Appendix K – Proof of concept projects 
 
Appendix K.1   
Project title mcr-1-harbouring plasmids in Escherichia coli in Denmark and 
their phylogenetic relationship with mcr-1 plasmids from other 
geographical regions 
Consortium partner DTU 
Scientific lead Valeria Bortolaia, Jette Sejer Kjeldgaard, Ana Rita Rebelo, 
Pimlapas Leekitcharoenphon, Rene Hendriksen 
Other people involved Helle Bisgaard Korsgaard, Hanne Mordhorst, Frank Møller 
Aarestrup 
 
Purpose  
To assess possible pathways of dissemination of mcr-1 in E. coli 
 
Background  
Plasmid-mediated colistin resistance is an emergent public health threat since colistin is used as last 
resort drug to treat multidrug-resistant infections by E. coli in humans. 
Although detection of mcr-1 in Enterobacteriaceae has been extensively reported worldwide, few 
studies performed in depth characterization of the plasmids harbouring mcr-1. 
 
Objectives 
The objective of this study was to characterize mcr-1-harbouring plasmids in E. coli in Denmark. 
 
Project description 
Currently, the DANMAP collection at DTU holds 13667 E. coli isolates from poultry (n=6808), pig 
(n=4302) and calf (n=2557) collected between 2001 and 2016. Of those, 5447 strains are resistant to 
colistin with an MIC ≥ 4 mg/L while the remaining 8220 are susceptible isolates with MIC ≤ 2 mg/L. 
Our test collection consisted on two subsets extracted from this assortment and was selected based 
on MIC values and/or year of collection. A total of 115 isolates from food or animal origin were 
screened from which 50 were resistant to colistin with MIC ≥ 4 mg/L and 65 were susceptible with a 
MIC of 2 mg/L (Figure 1): 
 The subset of resistant strains corresponded to all isolates with MIC ≥ 4 mg/L collected for 
DANMAP between 2008 and 2013, composed by samples of poultry (n=45), swine (n=4) and 
calf (n=1). Six samples were from Denmark and 44 were of international origin;  
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 The subset of susceptible isolates corresponded to all E. coli strains with MIC of 2 mg/L 
collected since 2001, obtained from poultry (n=37), pig (n=14) or calf (n=14). 39 strains 
were of national origin and the remaining 26 were from imported products. 
 
 
Methods and Results 
PCR analysis revealed a total of 51 mcr-1-positive isolates. Of these, 41 corresponded to colistin 
resistant strains (MIC ≥ 4 mg/L) and 10 were colistin susceptible strains (MIC = 2 mg/L) (Figure 1). 
All isolates harboring mcr-1 were samples from poultry, from which 50 were of international origin and 
one was from Denmark. 
Whole genome sequencing was performed on the 51 mcr-1-positive isolates and on the remaining 9 
colistin resistant isolates (41 strains were sequenced under ENGAGE project), and the analysis was 
performed as follows: 
 mcr-1-positive isolates were screened for co-occurrence of mcr-2, mcr-3, mcr-4 and mcr-5. All 
isolates were negative for other mcr genes. 
 Colistin resistant but mcr-negative isolates were investigated in silico for other mechanisms of 
colistin resistance. One national swine isolate with a MIC of 8 mg/L presented a point 
mutation in pmrA/pmrB two component system (pmrB V161G). The lasting eight resistant 
isolates, with MIC between 4 mg/L and 8 mg/L, did not present any known mechanisms of 
resistance (Figure K.1). 
 Phylogeny of the E. coli harbouring the mcr-1 plasmids was inferred. Of the 60 isolates, 43 
were successfully characterized with both ST and serotype, nine were characterized with ST 
but not serotype, three were characterized with serotype but not ST and five were 
undetermined for both features. All strains were analyzed by cgMLST. The 60 strains belonged 
to 36 different STs, with eight remaining undetermined. The most prevalent ST was ST-10 
(n=6). Using SerotypeFinder we were able to characterize 46 isolates (14 were undetermined), 
which belonged to 40 different serotypes. cgMLST revealed 53 different core-genome 
sequence types and the construction of a phylogenetic tree based on these allowed for 
clustering of strains of the same STs and serotypes. Three strains were removed from the tree 
due to the low extent of allele attribution (353, 1666 and 331 undetermined alleles out of 
2513, respectively). All three corresponded to colistin resistant strains without known 
mechanisms of resistance.  
 All isolates presented varied profiles of antimicrobial resistance, virulence factors and plasmid 
content as determined by CGE batch upload pipeline. 
 The contigs harbouring mcr-1 were used to determine plasmid incompatibility type. 19 isolates 
have the gene integrated in IncX4 plasmids, one isolate has the gene integrated in the 
chromosome, and the remaining isolates possess the gene integrated either in type IncH, IncP 
or IncI (further analysis is necessary to determine incompatibly types). 
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Figure K.1: Isolate selection process and colistin resistance mechanisms. Highlighted the 
subsets of strains included in the studies 
 
Future work includes: 
 Determination of mcr-harbouring plasmid incompatibility type for the remaining isolates; 
 Annotation of mcr-1-positive contigs to examine the mcr-1 genetic context; 
 Single Nucleotide Variation-based phylogeny of the annotated mcr-1-positive contigs for each 
plasmid type detected; 
Comparison with the genetic context of mcr-1 harboured in plasmids of the same types described in 
other geographical locations. 
 
Additional notes 
Manuscript draft planned for June 2018 
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Appendix K.2  
Project title Phylogeny of Salmonella Paratyphi B variant Java (ST-28) 
harbouring mcr-1  
Consortium partner BfR 
Scientific lead Burkhard Malorny, Maria Borowiak 
Other people involved Rene Hendriksen, Pimlapas Leekitcharoenphon  
Purpose 
The study provides new insights into the evolution and spread of plasmid-mediated colistin resistance 
in S. enterica that can be useful for reduction strategies on resistance development in animals and 
humans. 
 
Background 
Liu and colleagues (2015) have recently described a mobilizable colistin resistance gene, mcr-1, 
located on a plasmid. The authors observed mcr-1 carriage in China in Escherichia coli isolates in 15% 
of 523 samples of raw meat, in 21% of 804 samples of animals and in 1% of 1322 samples from 
patients with infection during 2011 to 2014. Meanwhile, a number of publications reported also the 
occurrence of mcr-1 in European isolates from food, animals and humans, especially in E. coli and S. 
enterica. 
 
Objectives 
Objectives were to study the incidence and microevolution of mcr-1 in d-tartrate fermenting (dTa+) S. 
enterica subsp. enterica serovar Paratyphi B (variant Java) belonging to the sequence type (ST) 28 in 
terms of phylogeny of isolates carrying mcr-1 on plasmids and the horizontal spread of mcr-1 
throughout the food chain. 
 
Project description 
To achieve the objective of the study the following work plan and methodologies were applied: 
 Sequencing of the earliest identified mcr-1 positive S. Paratyphi B dTa+ ST28 isolate from 
Germany using PacBio technology for reference strain definition 
 Whole-genome sequencing using MiSeq technology of mcr-1 positive and selected mcr-1 
negative S. Paratyphi B dTa+ ST28 isolates from Germany (99 isolates) and Denmark (17 
isolates) received between 2008 to 2016 representing different multidrug-resistance patterns 
and covering sources from food-producing animals and food products thereof 
 Determination of the phylogeny and antimicrobial resistance determinants of isolates 
 Determination of the diversity of mcr-1 positive plasmids and comparison of plasmid 
sequences 
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Methods and results 
Approximately 400 S. Paratyphi B dTa+ isolates originating from food producing animals and food 
products, received from 2006 to 2016 in the German National Reference Laboratory for Salmonella 
were selected for PCR screening for the presence of the mcr-1 gene. Altogether 63 mcr-1 positive S. 
Paratyphi B dTa+ ST28 isolates were subjected to WGS. Sequencing data assembled and was 
analysed using the Bacterial Analysis Pipeline provided by the Center for Genomic Epidemiology 
(https://cge.cbs.dtu.dk/services/cge/) and SNP analysis was performed using BioNumerics 7.6 
(Applied Maths). Results showed that the mcr-1 gene was located on plasmids belonging to the 
IncHI2 or IncX4 replicon group. Strains isolated from 2008 to 2011 tend to carry the mcr-1 gene on 
large multidrug-resistant IncHI2 plasmids and build a cluster in the phylogenetic tree, whereas strains 
isolated after 2011 mainly carry mcr-1 on IncX4 plasmids and show a higher phylogenetic diversity. 
Some of the S. Paratyphi B dTA+ strains from Denmark were found to cluster together with German 
isolates. 
 
Additional notes 
The project will be finished within the year 2018, beyond the end of the ENGAGE period. Preliminary 
results have been presented on the ENGAGE workshop in 2016 (Warsaw, Poland) and the interim 
meeting in 2017 (Parma, Italy). Furthermore, a talk has been hold at the ECCMID 2017 conference in 
Vienna. 
A first publication appeared in ASM Genome Announcement describing the complete genome 
sequence of the earliest identified mcr-1 positive Salmonella Paratyphi B dTa+ strain in the collection 
of the National Reference Laboratory for Salmonella in Germany:  
Borowiak M, Hammerl JA, Fischer J, Szabo I, Malorny B. 2017. Complete genome sequence of 
Salmonella enterica subsp. enterica serovar Paratyphi B sequence type 28 harboring mcr-1. Genome 
Announc 5:e00991-17 
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Appendix K.3  
Project title Identification of a novel transposon-associated 
phosphoethanolamine transferase gene, mcr-5, conferring 
colistin resistance in d-tartrate fermenting Salmonella enterica 
subsp. enterica serovar Paratyphi B 
Consortium partner BfR 
Scientific lead Burkhard Malorny, Maria Borowiak 
Other people involved Rene Hendriksen 
 
Purpose 
The purpose of the study was to identify a novel colistin resistance meachanism in mcr-1, mcr-2, mcr-
3 and mcr-4 negative S. Paratyphi B dTa+ isolates with colistin MIC values > 2 mg/L which were 
received in the years from 2011 to 2016. 
 
Background 
Liu and colleagues (2015) have recently described a mobilizable colistin resistance gene, mcr-1, 
located on a plasmid. Among the reported mcr-1 positive Enterobacteriaceae isolates of d-tartrate 
fermenting Salmonella enterica subsp. enterica serovar Paratyphi B (S. Paratyphi B dTa+), formally 
called S. Paratyphi B variant Java, are described. In Germany, Belgium and the Netherlands a 
multidrug-resistant linage of S. Paratyphi B dTa+ belonging to the sequence type ST-28 persists in the 
poultry production since the 1990s. Between 2011 and 2016, 86 (21 %) of 414 tested S. Paraytphi B 
isolates from the strain collection of the German National Reference Laboratory for the Analysis and 
Testing of Zoonoses (NRL Salmonella) were determined to have a non-wild-type phenotype for colistin 
(MIC > 2 mg/L). PCR screening revealed, that 54 isolates carried the mcr-1 and none of them the 
mcr-2, mcr-3 and mcr-4 gene. Of the remaining 32 strains, twelve isolates showed non-wild-type 
phenotypes for ampicillin, ciprofloxacin, colistin, nalidixic acid, sulphamethoxazole, tetracycline, 
trimethoprim and in some cases tigecycline. This phenotypic pattern was unique to strains with 
unknown colistin resistance mechanism. 
 
Objectives 
Before this study, plasmid-mediated mobilised colistin resistance was known to be caused by 
phosphoethanolamine transferases termed MCR-1, MCR-2, MCR-3 and MCR-4. However, this study 
focussed on the dissection of a novel resistance mechanism in mcr-1, mcr-2, mcr-3 and mcr-4 
negative S. Paratyphi B dTa+ isolates with colistin MIC values > 2 mg/L. 
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Project description 
To achieve the objective of the study the following work plan and methodologies were applied: 
 Sequencing of a randomly selected isolate with non-wild-type phenotypes for ampicillin, 
ciprofloxacin, colistin, nalidixic acid, sulphamethoxazole, tetracycline and trimethoprim (this 
phenotypic pattern was unique to strains with unknown colistin resistance mechanism) using 
Illumina MiSeq technology 
 Bioinformatics analysis of obtained sequencing data including assembly and RASTtk 
annotation for identification of novel phosphoethanolamine transferase genes 
 PCR-screening of all 32 colistin resistant S. Paratyphi B dTa+ isolates with unknown colistin 
resistance mechanism for the presence of the newly identified gene 
 Functional characterisation of the novel gene 
 
Methods and results 
A selected isolate of mcr-1, mcr-2, mcr-3 and mcr-4 negative S. Paratyphi B dTa+ isolates with colistin 
MIC values > 2 mg/L from the strain collection of the German National Reference Laboratory for 
Salmonella was investigated by WGS and bioinformatics analysis (RASTtk annotation) as described in 
Borowiack et al., 2017 (see below). Analysis of sequence data lead to the discovery of a novel 
transposon-associated and plasmid-encoded phosphoethanolamine transferase involved in colistin 
resistance. The respective gene, further termed as mcr-5 (1644 bp), was part of a 7337 bp transposon 
of the Tn3-family and located on related multi-copy ColE-type plasmids. Subsequently PCR screening, 
S1-PFGE and DNA-DNA hybridisation were performed to analyse the prevalence and localisation of the 
mcr-5 gene. Altogether 14 isolates form poultry and food thereof collected between 2011 and 2013 
were found positive for mcr-5. Interestingly, in one isolate an additional subclone with a chromosomal 
location of the mcr-5 transposon was observed. All isolates harboured similar plasmids. Cloning and 
transformation experiments in Escherichia coli DH5α and S. Paratyphi B dTa+ control strains were 
carried out and the activity of MCR-5 was confirmed in vitro by MIC testing. 
 
Additional notes 
The project has been finished and is published:  
Borowiak M, Fischer J, Hammerl JA, Hendriksen RS, Szabo I, Malorny B: Identification of a novel 
transposon-associated phosphoethanolamine transferase gene, mcr-5, conferring colistin resistance in 
d-tartrate fermenting Salmonella enterica subsp. enterica serovar Paratyphi B. J Antimicrob 
Chemother. 2017 72(12):3317-3324 
 
 
   
ENGAGE 
 
 
 
www.efsa.europa.eu/publications 155 EFSA Supporting publication 2018:EN-1431 
The present document has been produced and adopted by the bodies identified above as author(s). In accordance with Article 36 of Regulation (EC) No 
178/2002, this task has been carried out exclusively by the author(s) in the context of a grant agreement between the European Food Safety Authority and 
the author(s). The present document is published complying with the transparency principle to which the Authority is subject. It cannot be considered as an 
output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the 
conclusions reached in the present document, without prejudice to the rights of the author(s). 
 
Appendix K.4  
Project title VIM-1 producing Salmonella Infantis isolated from swine and 
minced pork meat in Germany 
Consortium partner BfR 
Scientific lead Burkhard Malorny, Maria Borowiak 
Other people involved - 
 
Purpose 
The purpose of this study was the characterization of blaVIM-harbouring S. Infantis recovered from 
swine and minced pork meat in Germany in 2015 and 2016. 
 
Background 
Carbapenems are considered as last-line clinical antibiotics used to treat severe human infections 
caused by multidrug-resistant Gram-negative bacteria. In the last years, carbapenemase-producing 
Enterobacteriaceae (CPEs) leading to carbapenem resistance or carbapenem non-susceptibility spread 
in human settings worldwide and are associated with major public health concerns. First detections of 
VIM-1 carbapenemase-producing S. Infantis and E. coli isolates in livestock farms in Germany in 2011 
raised concern on their real prevalence in animals and their potential to be transferred to human 
settings. Indeed, Salmonella is a well-known zoonotic pathogen commonly transferred via 
contaminated food-products. Among them, S. Infantis is one of the leading causes of human 
salmonellosis in Europe.  
In the frame of the routine diagnostic, monitoring and control programs, the National Reference 
Laboratory for Salmonella in Germany received 145 S. Infantis isolates in 2015 (33.8% from primary 
production; 38.6% from food; 13.1% from feed; 14.5% from other sources). In the routine 
antimicrobial susceptibility testing one of these S. Infantis strains, isolated from minced pork meat 
produced in Germany (15-SA01028) showed a microbiological resistance (“non-wild-type” phenotype) 
against meropenem (MIC=0.5 mg/L), imipenem (MIC=4 mg/L) and ertapenem (MIC=0.12 mg/L) This 
isolate, together with another S. Infantis strain isolated in 2016 from a sick piglet (16-SA00749) which 
showed decreased susceptibility to meropenem (MIC=0.12 mg/L) were analysed by whole genome 
sequencing. 
 
Objectives 
The objective of this study was to characterize two VIM-1 positive S. Infantis strains isolated in 2015 
from minced pork meat produced in Germany (15-SA01028) and 2016 from a sick piglet (16-SA00749) 
by whole genome sequencing. 
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Project description 
To achieve the objective of the study the following work plan and methodologies have been applied: 
 Susceptibility testing in concordance with the European Commission Implementing Decision 
2013/652/EU) and following EUCAST epidemiological cut-off values (ECOFFs, 
http://www.eucast.org) 
 Comparison of newly detected VIM-1 positive isolates with previously identified isolates by S1 
nuclease pulsed-field gel electrophoresis (S1-PFGE) 
 Sequencing of newly detected VIM-1 positive isolates using Illumina MiSeq technology and 
bioinformatics analysis of obtained sequencing data 
 
Methods and results 
Two S. Infantis isolates with microbiological resistance (15-SA01028) or decreased susceptibility (16-
SA00749) to meropenem were investigated by WGS and bioinformatics analysis as described in 
Borowiak et al., 2017 and 2018 (see below). Both isolates were found to be positive for VIM-1 
carbapenemases. S1-PFGE and mapping of NGS data to already published resistance plasmid 
sequences revealed that the plasmid harboured by the food isolate (15-SA01028) is 100% similar to 
the previously published plasmid sequence of isolate R27 (pRH-R27) from 2011 whereas the isolate 
from swine (16-SA00749) harboured a plasmid with 96% similarity to pRH-R27. These findings hint 
towards a link between the isolates and to a transmission of this plasmid or these Salmonella isolates 
from the primary production into the food chain. The occurrence of carbapenemase-producing 
Enterobacteria (CPE) in food and food-producing animals might bear a risk of getting colonized with 
CPEs and raises major public health concerns. 
 
Additional notes 
The project has been finished and is published:  
Borowiak M, Szabo I, Baumann B, Junker E, Hammerl JA, Kaesbohrer A, Malorny B, Fischer J: VIM-1-
producing Salmonella Infantis isolated from swine and minced pork meat in Germany. J Antimicrob 
Chemother. 2017 Jul 1;72(7):2131-2133 
Borowiak M, Fischer J, Baumann B, Hammerl JA, Szabo I, Malorny B. 2018. Complete genome 
sequence of a VIM-1-producing Salmonella enterica subsp. enterica serovar Infantis isolate derived 
from minced pork meat. Genome Announc 6:e00327-18 
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Appendix K.5     
Project title 
Salmonella Infantis in Italy and EU: phylogeny and plasmid 
carrying virulence, fitness and antimicrobial resistance (AMR) 
genes 
Consortium partners IZSLT (lead), DTU 
Scientific lead Antonio Battisti, Rene Hendriksen 
Other people involved  
Alessia Franco, Patricia Alba, Pimlapas Leekitcharoenphon, 
Susanne Karlsmose Pedersen 
 
Purpose  
The purpose of the study was to provide molecular data based on WGS analysis in order to investigate 
similarities and differences within Salmonella enterica subsp. enterica serovar Infantis (S. Infantis) 
across Europe and across animal and food sources. This project was intended as a contribution to 
facilitating source attribution assessment of human cases arising in the European Union (EU), also 
when isolates investigated may not be outbreak-associated or whose epidemic nature has gone 
unrecognised. A collaborative EU study seemed to be the ideal approach for the purpose. 
 
Background  
Salmonella Infantis is emerging worldwide. It is the most frequently reported serovar in broilers 
(45.6%), the most prominent one in broiler meat (47.4%) and the fourth most prevalent one in non-
typhoidal Salmonella (NTS) human infections in Europe (EFSA EU Summary Report 2016). Over the 
last decade, MDR S. Infantis has increasingly been reported in Italy from food-animals and humans, 
and is also highly prevalent in the broiler meat industry, in several European countries (EFSA AMR EU 
Summary Report 2016). 
Additionally, according to the Italian antimicrobial resistance (AMR) monitoring data on isolates from 
the National Control Program (NCP) in broiler chicken flocks in 2012, 2013, and 2014, Extended-
Spectrum Cephalosporin (ESC)-resistance (R) rates in Salmonella spp., of which most were S. Infantis, 
have increased, from 15.6% (12/77, 95% CI 8.3–25.6%) in 2012 to 27.27% (18/66, 95% CI 17.03-
39.64%) in 2014, reaching in 2016 moderate level of resistance (12%).  
In cross-sectional studies performed in Italian broiler sector at slaughter in 2014 and 2016 (sampling 
frame: Commission Implementing Decision 2013/652/EU), S. Infantis accounted for 75% and 90% of 
all isolates detected, respectively, with an among flock prevalence of 9.6% (68/709) in 2014 and 8.7% 
(70/807) in 2016. An emerging clone harbouring a megaplasmid (around 300 kb) termed pESI, which 
carries virulence, fitness and MDR genes/traits, along with CTX-M-1 ESBL in an increasing proportion 
of isolates, was detected in these surveys (3/90 in 2014 and 16/77 in 2016 were MDR, ESBL-
producing S. Infantis, respectively) (EFSA AMR EU Summary Report 2016). 
 
Objectives 
Whole Genome Sequencing was the method of choice in this project to assess both population 
structure and phylogenetic relationships among isolates, and to investigate on genetic basis for 
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virulence, antimicrobial resistance, presence and characterisation of plasmids with the aim of 
comparing isolates from different stages of the food chain, in order to provide input data for 
epidemiology and risk assessment purposes. 
The objectives of the study were to characterize S. Infantis isolates from EU animal primary 
productions comprehensively by Whole Genome Sequencing, and to provide genomic insight to better 
elucidate transmission pathways along the food chain; from primary production systems (e. g. poultry, 
pigs), foodstuffs thereof (e. g. meats) to human cases arising in the community. 
 
Project description 
A collection of S. Infantis isolates from different primary productions and foodstuffs of animal origin, 
was investigated by Whole Genome Sequencing (WGS) and compared with isolates available from 
human cases. 
Selection criteria for isolates: Isolates from population-based studies (e.g. National Control 
Programmes, monitoring activities at farm or at retail level (food) were preferred. However, in order 
to account for as much of geographical origins as possible at EU level, isolates from convenience 
sampling activities in some Member States (MS) were also investigated. Human isolates were selected 
among those obtained by surveillance activities of cases occurring in the community. An outgroup of 
isolates, detected outside the EU, were included mainly on a convenience basis criteria, albeit 
accounting for different geographical origins. 
Sample size of isolates under study had taken into account prevalence/isolation rates from different 
sources, full susceptibility or resistance to selected antimicrobial classes (e.g. CIAs) and multidrug-
resistance (MDR) patterns and availability across EU. 
In order to gather as much variability as possible across EU for the purposes of the study, it was 
advisable to increase the minimum sample size provisionally set for the dominant Salmonella enterica 
serovars, as described within the ENGAGE scopes and agreement among the Consortium partners and 
EFSA. 
Since recent research studies (Franco et al., 2015) indicated that in Italy both ESC-S and ESC-R 
isolates are mainly transmitted by the broiler chicken poultry system to humans, with rare isolates of 
pig origin also described, these two sources, and any relevant/additional animal/food sources, were 
further investigated at EU level. 
A minimum samples size per EU Member State was set on each stage/origin (animal, food, human), 
with additional isolates requested to MS laboratories for selected sources or AMR patterns or 
accessory genome content, when necessary. 
Isolates selected: On the basis of the above-mentioned criteria, a total of N=229 S. Infantis isolated 
from humans (N=64), from animal (N=115) and food/environment (N=50) sources in the frame of 
National Control Programmes and monitoring activities were selected from 5 countries: 150 in Italy, 
20 in Ireland, 18 in Luxembourg, 26 in Netherlands and 15 in Poland. In addition, 34 sequenced 
genomes were provided by APHA (UK), 38 by BfR (Germany) and 80 by EURL-AR DTU-Food 
(Denmark). Additionally, seven pESI-like positive S. Infantis genomes from USA have been 
downloaded from ENA public repository (Tate et al., 2017). 
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Methods and Results 
All isolates were whole genome sequenced by the IZSLT or by other ENGAGE partners using Illumina 
technology. Raw reads were assembled using SPAdes v3.11.0 after a quality check performed with 
FastQC v0.11.5 and Trimmomatic v0.11.5.  
The obtained sequences were analysed by using different bioinformatic tools available at the Center 
for Genomic Epidemiology http://cge.cbs.dtu.dk/services/all.php or with Blast v2.2.31 using the CGE 
databases as reference, for the following purposes: 
- Detection of antimicrobial resistance genes (both horizontally acquired and known chromosomal 
point mutations), selected virulence genes, MLST, pMLST, and genetic environment of selected 
resistances (e.g. ESC-R, Plasmid-Mediated Quinolone-R (PMQR), Colistin resistance (COL-R) 
(whenever detected).  
- Construction of a SNP-based phylogeny for phylogenetic and phylogeographic insight into 
transmission patterns between animal primary productions and humans.  
- Identification and characterization of selected plasmids (e. g those carrying selected virulence genes 
or AMR pattern), also comparing them across productions and EU countries. 
At present, all the raw reads have been assembled and analysed for the presence of specific genetic 
markers associated with the pESI-like megaplasmid described in Italy in 2015 (Franco et al., 2015), 
the plasmid content and accessory antibiotic resistance genes. Remarkably, specific markers of the 
pESI-like megaplasmid, such as pESI backbone, fim and K88 genes have been found in isolates from 
all the countries participating in the study. Further in silico analysis to confirm the presence of S. 
Infantis isolates harbouring the pESI-like megaplasmid are still ongoing. 
WGS sequences obtained from isolates from Italy, Ireland, Luxembourg, Netherlands, Poland, UK and 
Denmark have been submitted to ResFinder 3.0 to investigate the presence of specific chromosomal 
point mutations related to fluoroquinolones resistance.  
The SNPs-based phylogenetic and phylogeographic analysis by using the CSI phylogeny is still 
ongoing. At present, a draft phylogeny tree with a subset (N= 265) of the sequenced isolates from 
different sources retrieved from Italy, Poland, Ireland, UK, Denmark, Finland and USA, has been 
constructed. Preliminary results suggest that no geographical links among the different S. Infantis 
clones have been detected so far. 
 
Additional notes 
- To date, the IZSLT, in collaboration with the DTU, are doing further analysis on accessory genome 
(especially pESI plasmid) harboured by the isolates in the collection. Most likely, a manuscript that 
includes part of the results of this proof of concept and with a working title of “Salmonella Infantis in 
Italy and EU: phylogeny and plasmid carrying virulence, fitness and AMR genes” will be ready to be 
submitted in a peer-reviewed scientific journal by the end of summer 2018. 
Preliminary results were presented in the following meetings and workshops: 
-Battisti A., Franco A. (NRL-AR Italy). Salmonella Infantis clones and emerging ESC-R in Italy: 
differences and similarities of strains and plasmids in Europe and USA. Scientific Network for Zoonoses 
Monitoring Data, 7th specific meeting on Antimicrobial Resistance data reporting, 08-09 November 
2017, Parma, Italy,  
https://www.efsa.europa.eu/en/events/event/171108; 
https://www.efsa.europa.eu/sites/default/files/event/171108-0-m.pdf 
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-Battisti A. (NRL-AR Italy). Spread of an emerging clone of MDR, ESBL-producing Salmonella Infantis 
harbouring a conjugative megaplasmid in Italy. 3rd joint meeting on AMR in Salmonella and 
Campylobacter, FWD-Network and EURL-AR Network. 6-7 April 2017, Copenhagen, Denmark 
https://ecdc.europa.eu/en/news-events/third-joint-workshop-amr-salmonella-and-campylobacter  
-Battisti A. (NRL-AR Italy). Spread of an emerging clone of MDR, ESBL-producing Salmonella Infantis 
harbouring a conjugative megaplasmid in Italy. Workshop EURL-AR 2016, Kgs. Lyngby April/2016 
https://www.eurl-ar.eu/CustomerData/Files/Folders/3-workshop-kgs-lyngby-april2016/10_spread-of-
an-emerging-clone-of-mdr-esbl-producing-salmonella-infantis-harbouring-a-conjug.pdf 
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Appendix K.6  
Project title 
Molecular epidemiology of mcr-encoded colistin resistance in 
Enterobacteriaceae in Italy  
Consortium partners IZSLT (lead) and DTU 
Scientific lead Antonio Battisti, Rene Hendriksen 
Other people involved  
Alessia Franco, Patricia Alba, Pimlapas Leekitcharoenphon, 
Valeria Bortolaia, Virginia Carfora 
 
Purpose 
The purpose of this study was to investigate the epidemiology of transferable colistin resistance 
mediated by mcr genes in food producing animals in Italy. 
 
Background  
Since the description of the mcr-1 gene on a transferable plasmid encoding resistance to colistin from 
E. coli in China in 2015 (Liu et al., 2016), at least 32 countries from the five continents have found 
mcr-1 in Enterobacteriaceae isolates from different sources including humans, animals and foodstuffs 
(Xavier et al., 2016). In the meanwhile, 11 mcr-1 variants have been described and four new mcr 
genes, namely mcr-2, mcr-3, mcr-4 and mcr-5 and its variants, have been found. 
In Europe, the presence of mcr-1 was first detected in E. coli from poultry meat and humans in 
Denmark (Hasman et al., 2015). Subsequently, this gene was detected in Enterobacteriaceae isolated 
from different sources in almost all European countries, including Italy (Battisti, 2016).  
The epidemiology of transferable mcr-mediated colistin resistance is evolving rapidly and in the next 
future may hamper effective antimicrobial therapeutic approach to invasive infections caused by 
multidrug-resistant Gram-negative bacteria at both hospital and community level. Thus, timely 
information on prevalence, trends and variants of mcr-positive isolates is needed to enhance 
surveillance, and implement prevention and control measures. 
 
Objectives 
The aim of this study was to determine the prevalence of colistin resistance, the molecular 
epidemiology of mcr-mediated colistin resistance genes and their genetic environment in commensal E. 
coli, Extended Spectrum Beta-Lactamase (ESBL)/AmpC-producing E. coli, and Salmonella spp. in 
different primary productions and foodstuffs of animal origin in Italy, over the last three-years (2014-
2016). 
 
Project description 
A collection of commensal E. coli, Extended Spectrum Beta-Lactamase (ESBL)/AmpC-producing E. coli, 
and Salmonella spp. isolates from Italian population-based studies (e. g. National Control Programmes, 
ENGAGE 
 
 
 
www.efsa.europa.eu/publications 162 EFSA Supporting publication 2018:EN-1431 
The present document has been produced and adopted by the bodies identified above as author(s). In accordance with Article 36 of Regulation (EC) No 
178/2002, this task has been carried out exclusively by the author(s) in the context of a grant agreement between the European Food Safety Authority and 
the author(s). The present document is published complying with the transparency principle to which the Authority is subject. It cannot be considered as an 
output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the 
conclusions reached in the present document, without prejudice to the rights of the author(s). 
 
monitoring activities at farm or at retail level (food)), conducted in a three-year period (2014-2016), 
was investigated by Whole Genome Sequencing (WGS). 
Isolates selected: A total of 55 E. coli and 14 Salmonella of different serotypes, phenotypically 
resistant to colistin (COL-R; MIC value ≥ 4 mg/L), with the majority of them being also MDR including 
Extended-Spectrum Cephalosporin-resistant (ESC-R), along with 6 fully susceptible E. coli isolates 
included as negative control, were selected. All isolates had been collected by the Italian National 
Reference Laboratory for Antimicrobial Resistance (NRL-AR) in the frame of National Control 
Programmes and monitoring activities (2014-2015-2016) from different primary productions (fattening 
turkey, broiler chicken, fattening pigs and calves). 
After the partial analysis of the results, additional three multidrug resistant (MDR) S. Infantis 
displaying a colistin MIC value ≥ 4 mg/L and mcr-1 positive by PCR, with two of them being also 
extended-spectrum cephalosporin-resistant (ESC-R), collected in the frame of National Control 
Programmes and monitoring activities (2016-2017) were sequenced after the end of the ENGAGE 
project (December 2017) and then included in this project. 
For a better interpretation of the results, the isolates were divided in sub-groups according to the 
species, the serotype and the source. At this regard, at least 2 subgroups were deeply investigated: 
- 42 commensal and ESBL/AmpC-producing E. coli and Salmonella spp. phenotypically resistant to 
colistin and mcr positive by PCR, isolated in the frame of the EU harmonised antimicrobial resistance 
(AMR) monitoring conducted in poultry (2014) and fattening pigs or calves (2015). Regarding their 
origin, 31 isolates were collected from turkeys (28 E. coli and 3 Salmonella enterica isolates), 5 E. coli 
originated from pig samples and 6 E. coli from bovine samples. 
- 4 multidrug resistant (MDR) S. Infantis from broilers (N=3) and broiler meat samples (N=1), 
displaying a colistin MIC value ≥ 4 mg/L and mcr-1 positive by PCR with two of them being also 
extended-spectrum cephalosporin-resistant (ESC-R), collected in the frame of National Control 
Programmes and monitoring activities (2016-2017). 
 
Methods and Results 
The sequences obtained from all isolates were analysed as follows:   
- Assembly of the raw reads using the pipeline of the Center for Genomic Epidemiology (CGE). In 
some particular circumstances, as in the case of the 4 MDR S. Infantis mcr-1 positive isolates, the 
sequences were analysed as reported in Appendix K.5. 
- Identification of serotypes, Sequence Types (STs), presence of virulence and accessory resistance 
genes by using suitable bioinformatic tools, as the CGE pipeline. 
- Determination of the presence of plasmids in the isolates, through detection of the different plasmid 
replicon types in the bioinformatic analysis output. 
- Description of the mcr variants harboured by the subset of the isolates sequenced, comparing them 
with the nucleotide archive of the NCBI using BLAST. 
- Description and characterization of the mcr gene molecular environment, obtained by the 
identification and annotation of the genes located upstream and downstream of mcr in the assembled 
sequences. 
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- When appropriated and based on previously collected epidemiological and molecular data, a SNPs 
based phylogeny of selected isolates compared with historical isolates from the italian NRL collection 
was built.  
The main findings derived from this study were: 
- The E. coli population harbouring colistin resistance mediated by mcr was highly heterogeneous, as 
proved by the diversity of STs found and by the variety of virulence and resistance genes detected. 
- The commensal and the ESBL/AmpC-producing colistin resistant E. coli populations harboured a high 
variability of mcr genes. In total, three different mcr genes were detected (mcr-1, mcr-2 and mcr-3) 
and six variants, including one variant not previously described (mcr-1.1, mcr-1.2, mcr-1.13, mcr-3.2, 
mcr-4.2, mcr-4.3). 
- The mcr gene was detected in different Salmonella serovars circulating in Italy, including S. 
Typhimurium, S. Newport, S. Blockley and S. Infantis, isolated from primary productions or food 
derived from animals. 
- The S. Infantis isolates contained both pESI-like megaplasmids and IncX4 plasmids harbouring mcr-
1.1 and also belonged to the emerging, pESI-like positive, ESBL-producing clone described in Italy in 
2015 (Franco et al., 2015). 
 
Additional notes 
-Part of this study has been included in a scientific paper: 
Alba P, Leekitcharoenphon P, Franco A, Feltrin F, Ianzano A, Caprioli A, Stravino F, Hendriksen R, 
Bortolaia V, Battisti A. Molecular epidemiology of mcr-encoded colistin resistance in 
Enterobacteriaceae from food-producing animals in Italy revealed through the EU harmonised 
antimicrobial resistance monitoring. Accepted for publication in the peer-reviewed scientific journal 
Frontiers in Microbiology (May 2018). doi: 10.3389/fmicb.2018.01217. 
-To date, the IZSLT in collaboration with the DTU are preparing a manuscript entitled “Colistin 
resistance mediated by mcr-1 in ESBL-producing, multidrug-resistant Salmonella Infantis in broiler 
chicken industry, Italy (2016-2017)” to be submitted in a peer-reviewed scientific journal, that 
includes part of the results of this proof of concept. 
 
Part of the results has been presented in the following international conferences: 
- Alba P, Feltrin F, Iurescia M, Amoruso R, Donati V, Caprioli A, Leekitcharoenphon P, Hendriksen RS, 
Battisti A, Franco A. Transferable colistin resistance mediated by the mcr- 1 gene is widespread 
among Escherichia coli and is emerging in Salmonella in the Italian fattening turkey industry. 26th 
European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2016). 9-12 April, 
Amsterdam, Netherlands. 
- Alba P., Feltrin F., Iurescia M., Amoruso R., Donati V., Caprioli A., Leekitcharoenphon P., Hendriksen 
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Appendix K.7  
Project title  Genomic diversity of Salmonella Derby in different European 
countries  
Consortium partner IZSVe 
Scientific lead  Antonia Ricci 
Other people involved  Eleonora Mastrorilli, Sara Petrin, Alessandra Longo, Carmen 
Losasso, Lisa Barco 
 
Purpose 
To characterise through WGS a collection of isolates of S. Derby from different sources, different steps 
of the food chain and representative of isolates circulating in the geographical area of competence of 
ENGAGE partners. 
 
Background 
S. Derby continues to represent an important serovar causing human infection in Europe (EU). In 
2016, according to the EFSA report on zoonoses, S. Derby was the fifth most common serovar notified 
from human domestic cases of salmonellosis in EU (EFSA and ECDC, 2017) confirming the situation of 
the previous years. 
S. Derby is generally associated to pig chain, and the strong association of the serovar with this 
source is evident for all the EU countries. However, with a lower frequency, S. Derby has been notified 
also from other sources, such as poultry and in particular turkeys. Few countries reported the isolation 
of S. Derby from sources different from pig during the last couple of years. In particular, UK and 
Ireland reported a notable number of S. Derby isolates from turkey flocks. Since the notification of 
this serovar is not mandatory (according to Reg. (EC) No 2160/2003 on the control of "Salmonella and 
other specified food-borne zoonotic agents" and subsequent implementing acts), it is not clear if the 
isolation of S. Derby from sources different form pigs is a local problem for some specific countries or 
if this finding is simply related to the different approaches followed by Member States in reporting 
Salmonella data to EFSA.   
Previous studies in UK have demonstrated that a pathogenicity island discovered in the genome of S. 
Derby (SPI-23) plays an important role in its adaptation to porcine jejunum over porcine colon. 
Moreover, through comparative genomic, it has been demonstrated that S. Derby isolates from pig 
and turkey chains belong to different clonal lineages (Hayward et al., 2016), confirming that different 
sources are associated to different clones of S. Derby. 
Looking at the persistence of S. Derby along the food chain there is the evidence that swine isolates 
are generally obtained from animals as well as from food sources. Conversely, considering isolates 
from other species, such as turkeys, the isolation is most frequent from animals than from foodstuffs. 
This statement is based on the data collected in Italy, but it has been confirmed also at EU level in the 
context of analysis of Salmonella serovars reported to EFSA for the 2015 and 2016 annual summary 
report on zoonoses (EFSA and ECDC, 2016, 2017).   
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Objectives 
The aim of this project was the characterisation of S. Derby isolates from different sources and 
lineages isolated from different countries, with the final goal of identifying the clones that circulate at 
the EU level. Moreover, we wanted to identify specific genetic features that could explain host 
adaptation and persistence of S. Derby isolates along the food chain in relation to specific sources, in 
order to ascertain if any differences occur among S. Derby isolated from different sources at different 
points of the food chain. Also human isolates were included in the investigation in order to infer the 
main sources of human infection associated to this serovar and the most virulent lineages. 
 
Project description  
Partners were asked to contribute to the project with 60-80 isolates from pigs, turkeys, humans and 
other species; isolates from both animals and foodstuffs were considered, but participants were asked 
to contribute also with human isolates.  
The project gained the favour of all the ENGAGE partners, who contributed with their own 
isolates/sequences. A total of 342 sequences of S. Derby were retrieved from 7 partners (IZSVe, BfR, 
DTU, NVRI, APHA, PHE and NIPH-NIH) whilst additional 87 strains were internally provided from PHE, 
for a grand total of 429 strains. This huge participation confirmed the interest toward the 
epidemiological issues related to this serovar.  
Methods and results 
Quality metrics checking, species identification, MLST based on the 7 housekeeping genes, MLST-
guided serotyping, prediction/serotyping from raw sequencing reads, AMR in-silico characterization, 
eBURST Group (eBG) assignation according to Achtman et al. and single nucleotide polymorphism 
(SNP) address assignation were performed using the internally developed PHE pipeline (including 
KmerID (https://github.com/phe-bioinformatics/kmerid), MOST (Tewolde et al. 2016, PeerJ - 
https://github.com/phe-bioinformatics/MOST), PHEnix (http://phenix.readthedocs.io/en/latest/) and 
SnapperDB (Dallman et al., 2018 Bioinformatics https://github.com/phe-bioinformatics/snapperdb)). 
Isolates belonging to different eBGS were further investigated by multiple alignment in order to 
ascertain their level of similarity in relation to sources, geographical area of origin and other distinctive 
features. A selection of isolates were subjected to in-silico Salmonella pathogenicity island (SPI) 
detection to characterize them and to ascertain the presence of SPI-23 to test the hypothesis of its 
role in characterizing host adaptability.  
With the end of the project both the sequencing of internal isolates and the collection of sequences by 
all the partners was finalized. A preliminary analysis of the collected sequences was carried out in the 
context of the twinning between IZSVe and PHE that took place in summer 2017. A subset of about 
200 isolates, available when the twinning took place, were analysed according to the standard PHE 
internal pipeline. The analysed isolates belonged to 9 different ST (39,40, 71, 682, 683, 1326, 3135, 
3857 and 3871), corresponding to three eBGs (57, 244 and 264). Two eBGs, containing more than 
one samples, were further investigated: all samples belonging to eBG_264 belonged to the same 50 
SNP difference cluster except one sample; samples sharing the highest degree of similarity were 
isolated in the same country (Italy of Germany); all samples belonging to eBG_57 belonged to two 
main clusters, depending on their ST (39 or 40). In-silico Salmonella pathogenicity island (SPI) 
detection confirmed the massive presence of a panel of different SPIs: SPI1, SPI9 and C63Pib; SPI5 
were found in all but one sample; SPI2, SPI4 were seen in more than 80 samples. 
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Additional notes 
The conclusion of the analyses is planned by 2018, beyond the end of the ENAGE project period.  
The analytical pipeline previously described will be extended to the entire collection of sequences. 
Moreover, the preliminary analyses carried out confirmed the need of getting a clearer picture of the 
genetic markers associated to Salmonella virulence. Thus, IZSVe decided to perform a systematic 
review aimed at identifying the genetic features which are involved in Salmonella virulence, with 
particular interest to genetic markers associated to S. Derby, in order to enlarge the targets of 
analyses for the entire panel of the sequences collected.   
This project has been a great opportunity of collaboration among ENGAGE partners in terms of 
sequences sharing as well as an opportunity for the proposing partner (IZSVe) to be trained by the 
PHE on the analytical approaches used on their routine.  
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Appendix K.8  
Project title Whole genome characterization of Salmonella Napoli isolates 
spanning 2005-2015: a national issue of international interest 
Consortium partner  IZSVe 
Scientific lead Antonia Ricci 
Other people involved Eleonora Mastrorilli, Sara Petrin, Alessandra Longo, Carmen 
Losasso, Lisa Barco 
 
Purpose 
To characterise through WGS a collection of S. Napoli isolates to increase the knowledge on the 
ecology of this serovar and the main risk factors for human infections. 
 
Background 
S. Napoli is among the top serovars causing human infections in Italy and accounted for 5.9% of 
salmonellosis cases reported in this country during the last two years (Sabatucci et al, 2018). The 
relevance of this serovar is demonstrated by the increasing number of cases notified each year: 
during 2000–2006, an increase of 140% of S. Napoli cases was reported in Europe, mostly (87%) 
related to Italy, France and Switzerland (Huedo et al., 2017; Sabatucci et al., 2018). 
This serovar is relatively uncommon in other European countries. Several outbreaks, caused by S. 
Napoli, have been documented during the last years (1982-2015) (Sabatucci et al., 2018). In these 
cases the sources of outbreaks were related to exported Italian food products, mostly vegetabes. 
S. Napoli are generally isolated from humans and environment, whereas strains from animals and 
food are quite rare. Several studies, using different approaches, tried to infer the sources of infection 
for this serovar; however the reservoirs and transmission pathways are still partly unknown (Fisher et 
al., 2009; Graziani et al., 2011; Graziani et al., 2015). Moreover, the interest toward this serovar is 
triggered also by epidemiological, clinical and molecular evidences revealing important similarities 
between S. Napoli and typhoidal serovars (Huedo et al., 2017). 
 
Objectives 
To clarify the epidemiology of S. Napoli, which differs substantially from the great majority of the 
other serovars and for which the environment is considered the main reservoir. The data collected will 
be valuable to identify putative vehicles of human infection in order to assess possible control 
measures.   
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Project description 
157 S. Napoli isolates from three partners (IZSVe, BfR and DTU) were collected and all S. Napoli 
sequence available on Enterobase (http://enterobase.warwick.ac.uk, 09/01/2018) were retrieved.  
Methods and Results 
Bioinformatic analysis included de-novo assembly (using SPAdes), automatic annotation (using Prokka) 
and core genome tree building (using Roary and Dendroscope for visualization). Samples were also 
characterized in terms of MLST, plasmid replicons, Salmonella Pathogenicity Islands (SPI), 
antimicrobial resistance genes (ARG), biocides and metal resistance genes (by BLAST), looking for 
features characterizing the clusters identified via phylogeny construction. 
Preliminary results confirmed high genetic variability of this serovar (only 3477 out of 10499 genes 
were assigned to core genome), although only a few samples showed plasmid replicons and/or 
acquired ARGs. Samples tended to cluster according primarily to ST-type and biocide and metal 
resistance genes profile. All STs were spread among isolation sources and years of isolation, 
highlighting the challenge this serovar poses to trace its epidemiology and evolution. 
 
Additional notes 
The conclusion of the analyses is planned beyond the end of the ENAGE project period.  
The project would be a valuable opportunity to collect important epidemiological evidences to clarify 
the epidemiology of an emergent serovar which is characterized by uncommon behaviour.   
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Appendix K.9 
 
Project title The ecological success of the monophasic variant of S. 
Typhimurium: a comparative genomic study 
Consortium partner IZSVe 
Scientific lead Antonia Ricci  
Other people involved Eleonora Mastrorilli, Sara Petrin, Alessandra Longo, Carmen 
Losasso, Lisa Barco 
 
Purpose 
The results of the study will contribute to clarify the success and diffusion of the S. 4,[5],12:i:- serovar 
and might provide valuable implications in terms of public health because of the recent emergence of 
this serovar. 
 
Background 
Over the past decades monophasic variant of Salmonella Typhimurium, S. 4,[5],12:i:- has been 
recognized as an emergent serovar worldwide for its rapid spread especially along the swine food 
chain. Since 2011 it has become the first serovar isolated both from human and veterinary sources in 
Italy and there has been an increasing interest toward the identification of the putative markers which 
could explain its epidemiological success. This was one of the main field of research of IZSVe during 
the last years and when ENGAGE started IZSVe had collected a panel of S. 4,[5],12:i:- strains to 
investigate through WGS to explore the epidemiological success of this relevant serovar. 
 
Objectives 
Although many studies have documented the ecological success of this serovar, few investigations 
have been conducted to explain this phenomenon from a genetic perspective. The aim of the study 
has been to identify the combination of different factors that could explain the eco-physiological role 
of this emergent serovar. 
 
Project description 
A comparative whole-genome analysis of 50 epidemiologically unrelated S. 4,[5],12:i:- isolates was 
performed. The isolates selected for the investigation were obtained from different sources (mainly 
cattle, pigs and poultry) over the last years (2010-2016) and characterized in terms of genetic 
elements potentially conferring resistance, tolerance and persistence characteristics.  
 
Methods and Results 
 
WGS was performed as described in Mastrorilli et al., 2018 (see below). The main genetic trait shared 
by the investigated strains was represented by heavy metals tolerance gene cassettes: most of the 
strains possess genes expected to confer resistance to copper and silver, whereas about half of the 
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isolates also contain the mercury tolerance gene merA. Functional studies were also performed to 
assess S. 4,[5],12:i:- capability to tolerate copper in the environment, in order to ascertain that the 
acquisition of heavy metal tolerance genes is useful for preventing the toxic effects of metals, thereby 
highlighting that this is a potential factor contributing to the success of this Salmonella serovar in 
farming environments. 
In addition, the analysis of the distribution of type II toxin-antitoxin families indicated that these 
elements are abundant in this serovar, suggesting that this is another factor that might favor its 
successful spread. Phylogenetic analyses indicated a distinction among the investigated isolates based 
on the above described genetic traits, suggesting the involvement of different polymorphisms that 
give rise to multiple independent clones of S. 4,5,12:i:-. 
 
Additional notes 
This project was entirely conducted by IZSVe and ENGAGE provided an important technical and 
financial support to finalize this research.  
All the activities planned were concluded. The results of the project have been described on a paper 
entitled Mastrorilli E, Pietrucci D, Barco L, Ammendola S, Petrin S, Longo A, Mantovani C, Battistoni A, 
Ricci A, Desideri A and Losasso C (2018) A Comparative Genomic Analysis Provides Novel Insights Into 
the Ecological Success of the Monophasic Salmonella Serovar 4,[5],12:i:-. Front. Microbiol. 9:715. doi: 
10.3389/fmicb.2018.00715  
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Appendix K.10   
Project title WGS of rare and unrecognised Salmonella serovars 
Consortium partners NVRI  
Scientific lead Magdalena Zając 
Other people involved  Dariusz Wasyl 
 
 
Purpose  
1) To characterise Salmonella isolates causing difficulties in serotyping: incomplete or ambiguous 
antigenic structure and rare serovars (i.e. antigenic formulas observed occasionally in routine 
laboratory diagnostics) and from uncommon isolation sources (i.e. sheep, hedgehogs). 2) To set up 
an in-house database of reference sequences of rare and uncommon Salmonella serovars. 
 
Background  
Traditional Salmonella serotyping, classical tool for epidemiological study, does not always give 
unequivocal results. Additionally, it is time consuming method and needs laboratory experience. There 
are many isolates with incomplete antigenic structure i.e. lacking somatic antigens, one or both 
flagellar antigens that makes impossible to identify Salmonella serovar. Those isolates are often 
isolated along the food production chain and remain unrecognised, although they belong to common 
serovars of public health relevance. Our previous studies have shown that based on PFGE profiling or 
microarray analysis on-typable and autoagglutinating Salmonella strains might be clustered with S. 
Enteritidis, S. Hadar or S. Infantis (Hoszowski et al., Medycyna Wet 2011, 67:194-197; Zając at al., 
Acta Vet Hung 61:425-431). Moreover, some of isolates show atypical biochemical features which 
cause difficulties with classification to proper Salmonella subspecies or have the same antigenic 
structure but different biochemical properties (i.e. S. Paratyphi B sensu stricto and its d-tartrate 
positive var. Java). The other group of problematic isolates are rare serotypes often found in exotic 
pets like reptiles or hedgehogs. Due to the occurrence of rare or entirely new antigenic structure 
these strains can also be difficult to recognize properly. Limited number of available reference strains 
needed for QC of diagnostic sera broaden the uncertainty of identification of field isolates.    
The next generation sequencing technology allows to look at isolates holistically and find information 
about the species, serovar, and subtype of bacteria in just one test. 
 
Objectives 
The project focused on the identification of problematic isolates where full antigen structure is 
unknown or small differences between serotypes do not allow to identify an isolate to Salmonella 
serovar and characterisation of rare serovars originated from exotic or uncommon sources (i.e. pet 
reptiles, sheep, hedgehogs). The research focused on developing of Salmonella identification methods 
and all aspects related with Salmonella characterisation. The project allowed to create a database of 
genomes which can be used as references and contribute to develop tools for rapid and reliable 
Salmonella identification. 
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Project description 
WGS was performed on the isolates complying to one of the four criteria: 
1. Serovar not identified due to missing antigens (O, H1 and/or H2) i.e.: 1,4,5:-:-; 4:d:-; 6,7:-:1,5; 
6,7:c:-; 6,8:-:-; 9:-:-; 9:l,v:-; (monophasic S. Typhimurium excluded), 
2. Serovar with ambiguous antigenic structure: S. Senftenberg (1,3,19:g,[s],t:-) and S. Dessau 
(1,3,15,19:g,s,t:-); S. Newport (6,8:e,h:1,2) and S. Bardo (8:e,h:1,2) (with particular emphasis on 
bolded serovars) 
3. Rare serovars belonging to species and subspecies other than Salmonella enterica subsp. enterica 
and/ or deriving from uncommon sources like reptiles (native and exotic), exotic pets, and sheep, 
4. Unknown antigenic structure and suspected of being new Salmonella serovar. 
 
Methods and results 
A total of 113 Salmonella strains were sequenced (Illumina MiSeq, HiSeq). WGS raw reads were 
processed with bbmerge v36.62, Trimmomatic v0.36, and SPAdes 3.9.0. Serovar presumptions were 
done with SeqSero 1.2, SISTR v1.0.1, SalmonellaTypeFinder 1.4. CGE tool MLST 1.8 was used for 
sequence type identification. In some occasions phylogenetic analysis based on the concatenated 
alignment of SNPs was performed to compare strains within specific serovars. 
1. WGS of 37 strains with incomplete antigenic structure make it possible to classify them to the most 
common and Salmonella control programme relevant serovars i.e. Salmonella 1,4,5:-:- recognised as 
Salmonella Typhimurium, Salmonella 9:-:- (S. Enteritidis), Salmonella 6,7:-:1,5, (S. Choleraesuis, S. 
Thompson), Salmonella 6,7:z10:- (S. Mbandaka), Salmonella 35:-:- (S. Monschaui). Sequence types 
of the strains allowed their allocation in the common clones i.e. S. Enteritidis ST 11, and S. Mbandaka 
ST 413 occurring in food chain in Poland. 
2. Twenty-six stains were sequenced. It has been confirmed that Salmonella Bardo should be actually 
included into Salmonella Newport. The isolates occurring occasionally in food chain in Poland are 
considerably diverse (SNP tree) and represent several sequence types (ST 31, ST 118, ST 166). 
Similar conclusions were drawn for Salmonella Dessau that should be included into S. Senftenberg 
(ST14, ST 210). 
3. Relevant gene identification confirmed serovar identification of 50 isolates of strange or uncommon 
origin i.e. European grass snake (Salmonella IIIb 28:z10:z, unknown ST; IIIb 38:r:z:[z57], ST 645; 
Salmonella Sunnycove, unknown ST), pet geko (Salmonella II 16:m,t:[z42], unknown ST). 
Noteworthy, few available sheep isolates were identified as Salmonella IIIb (diarizonae) 61:k:1,5 (ST 
432) – the serovar being considered sheep specific pathogen. As far as we are concerned this is the 
first report of Salmonella IIIb 61:k:1,5 (ST 432) in Poland. 
4. None of the sequenced sample revealed previously unknown antigenic formula. 
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Additional notes 
Conclusions were implemented in routine diagnostic activity of NRL Salmonella 
Zając M., Bomba A., Skarżyńska M., Giza A., Wasyl D. Whole genome sequencing of “non-existing” 
Salmonella serovars, International Symposium Salmonella and Salmonellosis, Saint Malo, France, 24-
26 Sept. 2018, submitted  
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Appendix K.11  
Project title Characterization of mcr-1 positive E. coli isolated from food-
producing animals in Poland 
Consortium partners NVRI, DTU 
Scientific lead Magdalena Zając 
Other people involved Dariusz Wasyl, Valeria Bortolaia, Pimlapas Leekitcharoenphon, 
Rene Hendriksen, Paweł Sztromwasser 
 
Purpose 
To assess prevalence and possible dissemination of mcr-1 positive E. coli among animals in Poland 
 
Background 
The emergence of transmissible plasmid-mediated colistin resistance (mcr-1) has posed a threat to 
effective use of polymyxins, which are considered the last line of defence against multidrug and 
carbapenem resistant Gram-negative bacteria. Little is known about the prevalence of colistin 
resistance and the mcr gene in livestock in Poland. 
 
Objectives 
The objective of this study was to characterize mcr-1-harbouring E. coli isolated from animals in 
Poland and determine the possible dissemination pathways of detected colistin-resistance mechanisms 
in tested isolates. 
 
Project description 
Analysis of MICs for colistin allowed for selection of 128 suspected colistin-resistant isolates. The 
presence of the mcr-1 gene was confirmed (PCR evaluation for isolates meeting the selection criteria 
of MIC≥2mg/L for E. coli isolated in 2014-2016 and MIC>2mg/L for isolates identified in 2011-2013) 
in 80 out of suspected strains. They were recovered from turkeys (n=64), broilers (n=12), laying hens 
(n=2), cattle (n=1) and pig (n=1).  
 
Methods and results 
mcr-1 positive strains were sequenced (Illumina MiSeq, HiSeq). The raw reads were processed using 
bbmerge v36.62 to merge overlapping reads and Trimmomatic v0.36 to trim adapters and low quality 
reads. Merged reads and trimmed not-merged pairs were used to generate assembly contigs using 
SPAdes 3.9.0. Sequences were analyzed for their content of resistance genes, plasmid replicons and 
virulence genes by using the CGE Web tools (https://cge.cbs.dtu.dk/services/) ResFinder 3.0, 
VirulenceFinder 1.5, PlasmidFinder 1.3 and pMLST v1.4 for typing of IncHI2 plasmids. MLST profiling 
was performed using MLST 1.8. Phylogenetic tree was constructed by complete linkage clustering 
using sequence-similarity distance matrix. The distance matrix was generated by global pairwise 
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MUMmer 3.23 alignments between samples’ contigs (automated by CONOCOCT 0.4.0 script 
dna_diff_distmatrix.py). I-Tol web-based tool was used to display the tree. The following analyses 
were performed:  
- generation of phylogenetic tree of mcr-1 positive E. coli; 
- determination of MLST of isolates; 
- identification of antimicrobial resistance genes; 
- detection of plasmids; 
- defining of virulence genes; 
- assessing possible location of the mcr-1 gene. 
 
All tested strains carried mcr-1 gene and no other mcr genes were found. The results showed an 
increase of colistin resistance with time and a sudden increase of E. coli harbouring mcr-1 in turkey 
flocks in 2016. Whole-genome sequencing showed high diversity of ST types, various plasmids (i.e. 
IncQ1, IncX4, IncHI2, IncFII, IncI1, IncFIB) and a complex resistance background. ESBL genes (i.e. 
blaCTX-M-1, blaCMY-2, blaSHV-12, blaTEM-52) and quinolone resistance genes (qnrS1, qnrB19) were present in 
a wide variety of E. coli STs. Chromosomal point mutations for fluoroquinolone resistance in gyrA 
(S83L, D87N) and parC (S80I) were the most frequently identified. All the above mentioned 
cephalosporin and quinolone resistance genes were previously detected in E. coli isolated from 
animals in Poland and tested with non-NGS methods. The mcr-1 genes were mostly found on the 
same contig as the IncX4 or incHI2 replicons, and mutations in pmrB were found along with the mcr-1 
gene. One isolate carried mcr-1 located on the chromosomal sequence and thus suggesting possible 
vertical spreading of the resistance. Current study is the first confirmed case of presence of the mcr-1 
gene in bacteria of animal origin in Poland. The simultaneous prevalence of mcr-1 and other genes 
conferring resistance to fluoroquinolones and cephalosporins in healthy food-producing animals draws 
attention to rational use of colistin in veterinary practice. As the abundance of resistant bacteria may 
be underestimated, rapid spread of mcr-1 among turkeys could forecast possible appearance of the 
gene in food chain in Poland. 
 
References 
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1. Introduction 
The main objective of this proficiency test (PT) is to facilitate the production of reliable laboratory 
results of consistently good quality within the area of whole genome sequencing (WGS).  
The PT evaluates the consistency and robustness of ENGAGE consortium members’ ability to perform 
deoxyribonucleic acid (DNA) extraction, library preparation, the WGS, and assembly following different 
laboratory protocols, software tools, and sequence platforms for the reliability of submitted sequence 
data to the public repositories. This ensures harmonization and standardization in WGS and data 
analysis, with the aim to produce comparable data for the ENGAGE initiative. To meet these objectives, 
the laboratory work and analyses performed for this PT should be performed using the methods 
routinely employed in the individual laboratories.  
The PT consists of a “Wet-lab” component targeting three common bacterial pathogens. The Wet-lab 
components assess the laboratories ability to perform DNA preparation, sequencing procedures and, if 
laboratories routinely do so, the analysis of epidemiological markers; Multi Locus Sequence Typing 
(MLST) and antimicrobial resistance (AMR) genes.  
The individual laboratory data are confidential and only known by the participating laboratory and the 
PT organizers (DTU Food).   
 Materials and Methods 
 Participants 
A pre-notification to announce the ENGAGE proficiency test was distributed on the 12th July 2016 by 
e-mail to the eight ENGAGE consortium partners. Seven of the eight partners signed up and 
participated in the PT. Only, the National Institute of Public Health – National Institute of Hygiene in 
Poland did not participate as they have not initiated in-house WGS. Some of the seven partners 
however, only took part in testing a subset of the target organisms after agreement with the PT 
organizers.  
 Strains 
Two strains of Campylobacter jejuni, Listeria monocytogenes, and Klebsiella pneumonia were selected 
for the wet-lab in 2016. In a GMI end-user analysis of what species to target, Campylobacter and 
Listeria have been indicated being of interest (Moran-Gilad et al., 2015). Campylobacter was selected 
for this PT due to its many repeats and rearrangements and Listeria due to it being part of many 
genomic pilot projects and it’s genetically heterogeneous with limited repeats and rearrangement. One 
of the Listeria strains belonged to a less virulent MLST – ST-121, whereas the other strain was of to a 
known virulent type, ST-2. We also included Klebsiella due to its many resistance genes for evaluating 
if the detection of these as can be used to indicate the quality level of the sequencing. 
Individual sets of the strains were lyophilized as KWIK STIKs by Microbiologics, St. Cloud, Minnesota, 
USA and the corresponding DNA were purified and pooled by DTU-Food prior to distribution in 
individual vials for each participant.  
To better be able to assess the differences in the sequences generated by the participants, each of 
the six strains in the Wet-lab component were sequenced on the PacBio to get a closed reference 
genome. This was done by creating 10kb template libraries using “10kb DNA Template Prep Kit 1.0” 
from Pacific Biosciences, which were then sequenced using C2 chemistry on single-molecule real-time 
(SMRT) cells with a 180min collection protocol. The data was then de novo assembled using the 
Hierarchical Genome Assembly Process (HGAP) within the Pacific Biosciences SMRTAnalysis software 
package. Polishing and finishing the genome were performed with custom python scripts, Quiver and 
Gepard, a dot plot tool to identify overlapping regions. 
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 Distribution 
On 24th October 2016, bacterial strains in agar stab cultures together with the corresponding purified 
and dried DNA and a welcome letter were dispatched in double pack containers (class UN 6.2) to the 
participating laboratories according to the International Air Transport Association (IATA) regulations 
as UN3373, biological substances Category B.  
 Procedure 
The protocol was made available on the website 
(http://www.globalmicrobialidentifier.org/Workgroups/About-the-GMI-Proficiency-Test-2016) allowing 
the PT participants access to all necessary information at any time. Additional relevant information 
was distributed by email directly to the participants. 
The protocol presented instructions as to the handling of the received bacterial cultures and DNA.  
Participants were requested to capture information in relation to the questions presented in the 
SurveyMonkey.  
Deadline for submission of results was initially set for 14th December 2016 but was extended to 13th 
January 2017.After this date, participants, #93 and #104 who had not yet submitted results according 
to the level of their sign-up, were approached to confirm if they were planning on submitting results. 
By the beginning of February 2017, all relevant data was captured and the data analysis was 
instigated. This report summarizes the results and allows for ensures full anonymity for the 
participants, as only the PT-organizers has access to the individual results.  
2.3.1. SurveyMonkey 
Apart from three questions relating to the contact information of the participant, 40 questions were 
asked focused on the storage of bacterial cultures and DNA prior to analysis, the cultivation and DNA 
extraction procedure, the quality assurance parameters applied, details related to the sequencing and 
analysis of the obtained sequencing data.  
2.3.2. Sequencing  
The participants uploaded raw sequence files in fastq format. The reads were de novo assembled 
applying the standard assembly pipeline used by the web-services from Center for Genomic 
Epidemiology (CGE) https://cge.cbs.dtu.dk//services/all.php, except for the reads which were not 
trimmed prior to the assembly.  
For the raw reads, the following QC metrics were calculated: 
• Number of reads that map to reference chromosome  
• Proportion of reads that map to reference chromosome out of all reads that map to total 
reference DNA  
• Coverage, total reference DNA. The number of reads mapping to the total reference DNA 
multiplied with the average length of the reads divided by the total size of the reference 
genome  
 
 
For the assemblies, the following QC parameters were calculated: 
• Size of assembled genome 
• Size of assembled genome per total size of DNA sequence 
• Total number of contigs  
• N50 (defined as the length of the shortest contig, in the set of largest contigs that represents 
at least 50% of the assembly)  
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In addition to the calculation of the above QC metrics and parameters, participants were requested to 
provide the identification of the strains corresponding MLST and AMR genes to support the 
assessment of the sequence quality. Participates identified the MLSTs and AMR genes using the 
software of their choice. To assess the proficiency of the participants, the PT organizers used a 
command line version of the CGE MLST-Finder v.1.7 Larsen et al., 2012) and ResFinder 2.1 (Zankari 
et al., 2012) (Threshold for %ID = 98% and HSP/Query length = 60%) including the CGE standard 
assembly pipeline on the participant’s raw reads to compare the results with those reported by the 
participants.  
 Results 
 Participation 
Seven laboratories responded to the pre-notification and were enrolled in the ENGAGE PT. When the 
deadline for submitting results was reached, all seven laboratories had uploaded data. Seven partners, 
#104, #114, #115, #77, #82, #93, and #95 submitted raw reads of both the culture and the DNA 
for both Campylobacter strains. Only four partners, #104, #115, #77, and #82 submitted raw reads 
of both the culture and the DNA for both Listeria strains and five partners, #104, #114, #77, #82, 
and #93 submitted raw reads of the Klebsiella cultures and the DNA.  
 Method description  
The bacterial cultures were stored at 4°C by 86% (n = 6) of the participants prior to the analysis. In 
addition, one participant, #104 (14%) stored the reference material at -20°C.  
Four participants (57%) stored the DNA in the time between reception and processing at room 
temperature (5 days by #115, 12 days by #77, 14 days by #82 and 41 days by #114) whereas the 
remaining three participants, #93, #95 and #104 stored the DNA at 4°C. 
All seven participants inoculated the bacterial cultures onto various types of blood agar. The Listeria 
and Klebsiella strains were incubated at 37°C between 16 to 24 hours in contrast to Campylobacter 
which were incubated at 42°C for 48 hours.  
By five partners, the Genomic DNA was extracted from the Gram negative and positive using a 
number of different commercially available kits including, Easy-DNA and PureLink Genomic DNA Mini 
Kit (Gram negative) from Invitrogen, Minikit (Gram negative) and QIAamp DNA Mini kit from Qiagen, 
Charge Switch gDNA Mini Bacteria Kit (Gram positive) and Genomic Mini from A & A Biotechnology. 
Two of the participants have modified the used Gram positive protocols by lysostaphin treatment prior 
to extraction. Two partners used a commercially available automatically DNA purification instrument/ 
robot, the MagNA Pure LC / MagNA Pure LC DNA Isolation Kit III (Bacteria, Fungi) from Roche and the 
QIAsymphony/ DSP DNA Mini Kit from Qiagen.  
DNA concentrations (ng/µl) of the bacterial cultures and DNA were determined prior to library 
preparation on a Qubit by four partners. In addition, one participant used the Nanodrop and another 
participant the GloMax® 96 Microplate Luminometer (QIAsymphony) and a third a quantifluor kit read 
on POLARstar Omega plate reader.  
For the Campylobacter cultures, the DNA concentration ranged from 0.26 to 80 ng/µl and from 0.22 
to 647.39 ng/µl for the provided DNA (Table L.1). For the Listeria culture, the DNA concentration 
ranged from 0.28 to 92.05 ng/µl and from 0.24 to 33.52 ng/µl for the DNA. The DNA concentration 
ranged from 0.18 to 34.3 ng/µl and from 0.24 to 58.3 ng/µl for the Klebsiella bacterial culture and 
DNA, respectively (Table L.1). 
For the Campylobacter culture, the total amount of DNA ranged from 0.001 to 4.8 µg and from 0.001 
to 3.12 µg for the provided DNA (Table L.2). For the Listeria culture the total amount of DNA ranged 
from 0.001 to 4.88 µg and from 0.001 to 3.11 µg for the total amount of DNA. The total amount of 
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DNA ranged from 0.001 to 1.43 µg and from 0.001 to 3.43 µg for the Klebsiella culture and DNA, 
respectively (Table L.2). Laboratory #77, consistently reported the concentrations of 0.001. 
All seven participants responded to the method applied to measure the DNA quality (e.g. RIN, 
260/280 ratio and/or 260/230 ratio) prior to library preparation for bacterial cultures and DNA 
received. For bacterial cultures, two (29%) of the laboratories used the Nanodrop, one used the Qubit, 
another one the BioPhotometer plus (Eppendorf), and a third one quantifluor kit read on POLARstar 
Omega plate reader. In addition, two (29%) did not measure the DNA quality. For the DNA received, 
the laboratories used the same method to measure the DNA concentration except for one of the 
participants that reported not measuring the DNA of the cultures, and which used the Nanodrop.  
Up to five of the laboratories depending on participation reported the measurement of the DNA quality 
(e.g. RIN or 260/280 ratio) for bacterial cultures and DNA received (Table L.3). Among the five 
laboratories providing data of the DNA quality for the cultures, the level ranged from about 1.47 to 
12.1 (Table L.3). 
Four participants reported the measurement of the DNA quality (260/230 ratio) for bacterial cultures 
and DNA received (Table L.4). For the cultures and received DNA, the DNA quality ranged from 0.2 to 
2.4 (Table L.4).  
Two out of the seven laboratories assessed the quality visually on an agarose gel. 
Of the seven participants, five used the Illumina Nextera XT DNA sample preparation kit FC-131-1024 
(n = 2) and FC-131-1096 (n = 2) and one indicated using the Illumina NEB Next Ultra DNA Library 
prep kit E6040L for the preparation of the sample library before sequencing. Two participants using 
the Illumina Nextera XT DNA kit FC-131-1024 or FC-131-1096, respectively indicated using this in 
combination with the Nextera XT Index kit FC-131-1001 or FC-121-1012. In addition, one participant 
did not indicate the cat no. but the lot no.  
The genomic DNA was prepared for pair-end sequencing by all seven (100%) participants. The 
libraries were sequenced by five participants (71%) using an Illumina MiSeq platform whereas two 
used the HiSeq 2000 or the HiSeq 2500 platforms, respectively. The read length of the sequences was 
set between 100 (n = 1), 250 (n = 1), 251 (n = 3) and up to 300 bp (n = 1). The reads were 
trimmed before upload by one, #115 out of the seven participants using trimmomatic 
(http://www.usadellab.org/cms/?page=trimmomatic). Five participants indicated that if assembled by 
themselves, three would have used SPAdes http://bioinf.spbau.ru/spades, one would have used the 
PATRIC provided tool (https://www.patricbrc.org) ; Assembly Strategy: FullSpades, output file 
"contigs.fa" and finally one have used Assembler 1.2: https://cge.cbs.dtu.dk/servicesAssembler 
available from CGE. 
 Sequencing, MLST, and antimicrobial resistance genes  
For Campylobacter GMI16-001 the expected MLST was ST7426 which was found by all laboratories 
except for Laboratory #114 that had mixed up the two strains GMI16-001-BACT and GMI16-002-BACT 
as well as GMI16-001-DNA and GMI16-002-DNA, explaining the incorrect MLSTs. Two laboratories, 
#95 and #114 did not report MLST data (own tool) but these were provided by PT-organizer (CGE 
tool) and found correct (Table L.5).  
The Campylobacter; GMI16-001 was pan-susceptible why no resistance genes were expected. 
Laboratory #114 reported however, resistance data matching the profile of GMI16-002 due to the mix 
up (Table L.6). 
The MLST ST6238 was expected in Campylobacter strain; GMI16-002. This was reported by all 
participants except for Laboratory #114 due to the above reported mistakes (Table L.5). 
A very high degree of concordance was observed between the reported resistance genes detected by 
own tools and the CGE reference tool and between culture and DNA samples. Only four participants 
reported what own tool being used to identify the resistance genes, #77, #82, and #93 used the CGE 
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ResFinder whereas #104 used Blastn.  Some of the resistance genes, were determined “like” which 
indicate that the homology to the reference genes were less than 100% which is often seen due to 
minute sequencing errors. The gene aph(2’’)-like was reported by a number of laboratories. In 
contrast, the CGE tool did not detect this specific gene which doesn’t mean that it is not present. It 
merely indicate that the commandline version of the CGE ResFinder tool did not pick up this gene 
most likely due to a higher threshold in homology than used by the laboratories. Laboratory #82 
reported chromosomal point mutations which are not yet included the commandline version of the 
CGE ResFinder tool why this very well could be true. Running the commandline version of the CGE 
ResFinder tool for the genome of Campylobacter strain; GMI16-002 submitted by laboratory #114 
showed resistance genes that do not match any of the expected profiles of the PT strains (Table L.6).  
Only four laboratories, #77, #82, #104, and #115 tested the two Listeria strains; GMI16-003 and 
GMI16-004. In all cases, the four laboratories managed to identify the correct and expected MLST ST-
2 and ST-121, respectively (Table L.5).  
The two Listeria strains were both pan-susceptible and no resistance genes were reported nor 
identified using the commandline version of the CGE ResFinder tool. 
Five laboratories, #77, #82, #93, #104, and #114 tested the Klebsiella strains, GMI16-005. The 
commandline version of the CGE MLSTFinder tool was used to test the submitted genome, GMI16-
005-DNA laboratory #114 which didn’t submit own data. In all cases, the laboratories managed to 
identify the correct and expected MLST ST-512 (Table L.5). 
The same laboratories were involved in testing the Klebsiella strains, GMI16-006. For this strain 
laboratories #114 didn’t submit own data. All MLST profiles were correct, ST-15 (Table L.5). 
Both of the Klebsiella strains were multidrug resistant harbouring a number of resistance genes 
(Tables L.7-L.8). Klebsiella strains, GMI16-005 were found to contain the following genes, aadA2, 
aac(6')-lb), blaTEM-1A, blaKPC-3, blaOXA-9, blaSHV-11, oqxA, oqxB, aac(6')lb-cr, fosA, mph(A), catA1, sul1, 
and dfrA12. Most of the genes were identified by both own and CGE tools indicated by a very high 
concordance. Several of the laboratories report the genes being with a lower homology than the 
reference gene indicated by being determined “like”. The mutation, aac(6')lb-cr was not identified by 
laboratory #82 using own tools for both the culture and DNA in contrast to the CGE tool. The 
laboratory however, identified the presence of the gene, aac(6')lb as all did. This indicate that the 
laboratory might have used another tool not able to identify this mutation in the aac(6')lb gene. 
Similarly, the CGE tool was not able to detect neither the aac(6')lb nor the mutation aac(6')lb-cr in 
GMI16-005-DNA for laboratory #104 indicating a potentially truncated gene. Almost all of the 
laboratories identified the gene, fosA in a “like” version. The commandline version of the CGE 
ResFinder tool did not pick up this gene most likely due to a higher threshold in homology than used 
by the laboratories (Table L.7). 
The Klebsiella strains, GMI16-006 contained the following genes, aadA1, aac(6')-Ib, aac(3)-Iid, 
aph(3')-Via, strA, strB, blaNDM-1, blaOXA-9, blaCTX-M-15, blaSHV-1/ blaSHV-28, blaTEM-1b/blaTEM-1a, qnrS1, oqxB, 
oqxA, aac(6')Ib-cr, sul2, tet(D), dfrA14, and fosA. The concordance was very high between the 
laboratories testing the strain GMI16-006. In two incidences, the commandline version of the CGE 
ResFinder tool identified blaTEM-1a whereas all “own” testing as well as the remaining testing by the 
CGE tool identified the gene, blaTEM-1b. The difference between the two genes is only a few SNPs why 
the error is often observed. Inconsistences in detection of the gene blaSHV gene were observed. Some 
laboratories couldn’t distinguish the type of blaSHV and reported blaSHV-28 or blaSHV-28, respectively.  
Consistency however, between “own” and CGE data was seen. The same explanation given for the 
blaTEM gene also accounts the blaSHV gene. Almost all of the laboratories identified the gene, fosA in a 
“like” version. The commandline version of the CGE ResFinder tool did not pick up this gene most 
likely due to a higher threshold in homology than used by the laboratories. Laboratory #93 reported 
the detection of the blaLEN-12-Like gene not reported by others (Table L.8). 
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 Sequencing, Quality markers 
All seven laboratories submitted sequencing data for the Campylobacter GMI16-001 and GMI16-002 
related to the quality metrics and parameters from both the received bacterial culture and 
corresponding DNA. For Listeria GMI16-003 and GMI16-004, four laboratories participated, #77, #82, 
#104, and #115 both the received bacterial culture and corresponding DNA except for laboratory #77 
which didn’t submit data for the corresponding DNA of GMI16-004. In testing the Klebsiella strains, 
GMI16-005 and GMI16-006, the following laboratories participated #77, #82, #93, #104, and #114 
submitting data for both the bacterial culture and corresponding.  
The quality metrics and parameters of GMI16-001-BACT, GMI16-002-BACT, GMI16-001-DNA, and 
GMI16-002-DNA from laboratory #114 were excluded the analysis due to mixing up the two strains. 
Initially, the quality markers were evaluated for potential contamination which revealed that all 
genomes were of only one species. 
The medians of the number of reads mapped to the reference DNA sequences was somehow 
consistent between the three species with a tendency of having higher medians for the DNA than the 
BACT samples (Figure L.1). The 25% upper and lower quartiles ranged largely for the Listeria and 
Klebsiella species compared to Campylobacter. In general, two laboratories, #93 and #115 were 
determined outliers with a high number of reads mapped to the reference DNA sequences for all 
species compared to the other laboratories (Figure L.1). This can be explained by the used sequencing 
platform e.g. Hiseq 2000 and Hiseq 2500 in contrast to Miseq being used by all other laboratories. In 
addition, these platforms often provide more reads and of shorter length e.g. 100bp as indicated by 
laboratory #93. The lowest observed values were of laboratory #104 and #114 (Figure L.1). 
The proportion of reads produced which map directly to the closed genome of the same strain should 
not exceed more than 100% indicating an error e.g. contaminations. The medians of the proportion of 
reads produced which map directly to the closed genome were almost 100% for both the DNA and 
the culture of the two Campylobacter genomes. A very little range of the 25% upper and lower 
quartiles were observed. This indicated that all laboratories performed equally well with the exception 
of laboratory #115. For GMI16-001-BACT, laboratory #115 only had 56.2% of reads mapped to the 
reference DNA sequence (Figure L.2). The median of the proportion of reads produced which map 
directly to the closed genome of the Listeria GMI16-003-BACT were as well almost 100% with a tight 
upper and lower quartile centered around. In contrast, for the GMI16-003-DNA, the upper and lower 
quartile were much larger but still close to 100% indicating that all reads produced map to the 
reference. Lower proportions of reads produced which map directly to the closed genome were 
observed for Listeria GMI16-004 with a median of close to 89% for BACT and 86% for DNA. The 
reason for this might be due to a high number of plamids.  The medians of the proportions of reads 
produced which map directly to the closed genome for Klebsiella GMI16-005 and GMI16-005 were 
about 95% or greater, especially for GMI16-005 which indicates a nice fit of the reads to the 
reference. In general, the proportions of reads produced which map directly to the closed genome 
were lower for the laboratories, #93, #104, and #115 than the others participating (Figure L.2). 
The total number of contigs assembled should ideally be less than 1000 indicating good quality – the 
lower the better. For Campylobacter GMI16-001 and Campylobacter GMI16-002, the medians are 
between 100 and 150 contigs with a tight 25% quartile fit except for GMI16-001-BACT and GMI16-
002-DNA where laboratory #104 produced 459 and 2.131 contigs, respectively and being considered 
an outlier. The 25% quartiles are much broader for Listeria GMI16-003 and GMI16-004 with an overall 
median less than 250 contigs indicating some unexpected difficulties sequencing Listeria. Similarly, the 
Klebsiella genomes of GMI16-005 and GMI16-006 revealed medians below the same number of 200 
contigs. For the DNA samples, the 25% quartiles are really tight compared to the BACT, indicating 
that the problems can be related to the DNA purification step of the bacteria. This seems to be a 
general observation (Figure L.3).  
ENGAGE 
 
 
 
www.efsa.europa.eu/publications 186 EFSA Supporting publication 2018:EN-1431 
The present document has been produced and adopted by the bodies identified above as author(s). In accordance with Article 36 of Regulation (EC) No 
178/2002, this task has been carried out exclusively by the author(s) in the context of a grant agreement between the European Food Safety Authority and 
the author(s). The present document is published complying with the transparency principle to which the Authority is subject. It cannot be considered as an 
output adopted by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the 
conclusions reached in the present document, without prejudice to the rights of the author(s). 
 
The size of the assembled genomes was observed to match the expected size of the species with 
Campylobacter being around 2mb, Listeria about 3mb, and Klebsiella of around 5mb. For the 
Campylobacter genomes, laboratory #104 was considered an outlier with a size of 2.077.671bp 
(107.92%) for GMI16-001-BACT and 3.260.167bp (171.72%) for GMI16-002-DNA (Figures L.4-L.5). 
For Listeria, the size the assembled genomes as well as the proportion of the size to the reference 
DNA sequences were much broader with larger 25% quartiles especially for the DNA samples. In 
contrast, the proportion of the size to the reference DNA sequences of Klebsiella GMI16-005 were in 
average 99.3% with an outlier of 111.67% (laboratory #104) (Table L.4). Larger 25% quartiles were 
observed for Klebsiella GMI16-006 but still close to the expected size of the species genome and with 
an almost 100% in proportion to the reference DNA sequence (Tables L.3-L.4). 
The N50 length is defined as the length for which the collection of all contigs of that length or longer 
contains at least half of the sum of the lengths of all contigs, and for which the collection of all contigs 
of that length or shorter also contains at least half of the sum of the lengths of all contigs. A N50 
more than 15000 normally indicate good quality and were obtained by all laboratories for all of the 
genomes. The lowest N50 value observed was 83.000 and by Laboratory #104 (Figure L.6). 
The depth (bp) of the coverage is calculated based on the number of bps sequenced divided by the 
total size (both chromosome and plasmids) of the closed genome (same strain). This number can be 
rounded to the nearest integer. In essence this number describes the number of times the sequenced 
bps covers the reference DNA and is often ended with an “x” (e.g. 30x) which also serve as a good 
average number in depth. All of the laboratories for all genomes were observed to have an overall 
depth of between 50X to 100X which is ideal (Figure L.7).   
 Discussion 
The majority of the submitted MLST data were correct and in line with the expected value. The results 
of MLST analysis revealed a systematic error for participant #114 when submitting the data causing a 
mix up of the test genomes for the MLST and resistance genes prediction. However, the MLST was 
correct for all PT strains when re-analysed using the CGE reference method.  
Most of the submitted AMR genes were in concordance with the expected results. Some deviations 
however were observed mostly due to the tools, own or CGE reference lower threshold setting 
ignoring genes with a lower homology.  
One of the objectives for the ENGAGE PT was to assess a range of quality markers to evaluate the 
performance by the consortium partners. Overall, the PT test show that all laboratories perform 
satisfactory with the exception of laboratory #104 which in general produced a low number of reads, 
a lower percentage of mapping reads to the references, a high number of contigs, a high size of the 
assembly, and a high proportion in the size of the assembly per reference sequence. A few other 
laboratories could benefit from an assessment of own sequencing quality including laboratory #114. It 
is noteworthy to mention that the lower quality of the sequeces produced by laboratory #104 did not 
affect the prediction of MLSTs nor resistance genes.  
Laboratory #104 have indicated that they tried to select standard parameters of sequencing (routinely 
used) with a depth oscillates of about 30x which can affect the results of laboratory #104. In addition, 
the laboratory submitted trimmed sequences as indicated in the protocol but failed to remove 
adapters which normally are removed by the platform itself. This might have affected the quality of 
the sequences as the PT organizers didn’t enhance any of the submitted data. The PT organizers 
offered the laboratory #104 to re-submit data with removed adapters but this was not possible due to 
the timeline and deliverable of this report.  
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 Conclusions  
The pilot PT was a useful exercise as it allowed ENGAGE consortium partners to assess the quality of 
own data as well as to identify critical points for improvement. In general, all data were satisfactory 
but the PT organizer encourage especially laboratory #104 to upload data which has removed 
adapters as well as ensuring the genomes being matched to the identical reference genome to avoid 
wrong prediction of the MLST and resistance genes.   
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Table L.1: The low and high range of DNA concentration (ng/µl) measured for both the bacterial cultures 
and DNA received  
  Low range (ng/µl) High range (ng/µl) 
GMI16-001-BACT (Campylobacter) 0.26 64.8 
GMI16-002-BACT (Campylobacter) 0.27 80 
GMI16-001-DNA (Campylobacter) 0.27 647.39 
GMI16-002-DNA (Campylobacter) 0.22 90.89 
GMI16-003-BACT (Listeria) 0.28 92.05 
GMI16-004-BACT (Listeria) 0.28 68.7 
GMI16-003-DNA (Listeria) 0.25 33.52 
GMI16-004-DNA (Listeria) 0.24 23.77 
GMI16-005-BACT (Klebsiella) 0.18 34.3 
GMI16-006-BACT (Klebsiella) 2.2 28.6 
GMI16-005-DNA (Klebsiella) 0.25 52.18 
GMI16-006-DNA (Klebsiella) 0.24 58.3 
 
 
Table L.2: The low and high range of total DNA amount (µg) measured for both the bacterial cultures and 
DNA received 
  Low range (µg) High range (µg) 
GMI16-001-BACT (Campylobacter) 0.001* 3.88 
GMI16-002-BACT (Campylobacter) 0.001* 4.8 
GMI16-001-DNA (Campylobacter) 0.001* 2.28 
GMI16-002-DNA (Campylobacter) 0.001* 3.12 
GMI16-003-BACT (Listeria) 0.001* 4.52 
GMI16-004-BACT (Listeria) 0.001* 4.88 
GMI16-003-DNA (Listeria) 0.001* 3.11 
GMI16-004-DNA (Listeria) 0.001* 1.79 
GMI16-005-BACT (Klebsiella) 0.001* 1 
GMI16-006-BACT (Klebsiella) 0.001* 1.43 
GMI16-005-DNA (Klebsiella) 0.001* 3.43 
GMI16-006-DNA (Klebsiella) 0.001* 2.45 
* All values from #77.  
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Table L.3: The low and high range of the measured DNA quality (e.g. RIN or 260/280 ratio) for both the 
bacterial cultures and DNA received 
  Low range High range 
GMI16-001-BACT (Campylobacter) 1.47 3.28 
GMI16-002-BACT (Campylobacter) 1.84 2.54 
GMI16-001-DNA (Campylobacter) 2 3.55 
GMI16-002-DNA (Campylobacter) 1.75 2.26 
GMI16-003-BACT (Listeria) 1.7 1.93 
GMI16-004-BACT (Listeria) 1.77 1.91 
GMI16-003-DNA (Listeria) 1.82 1.92 
GMI16-004-DNA (Listeria) 1.78 1.86 
GMI16-005-BACT (Klebsiella) 1.85 11.2 
GMI16-006-BACT (Klebsiella) 1.73 10.2 
GMI16-005-DNA (Klebsiella) 1.72 12.1 
GMI16-006-DNA (Klebsiella) 1.78 13 
 
Table L.4: The low and high range of the measured DNA quality (260/230 ratio) for both the bacterial 
cultures and DNA received  
  Low range  High range  
GMI16-001-BACT (Campylobacter) 0.79 2.4 
GMI16-002-BACT (Campylobacter) 1.71 2.24 
GMI16-001-DNA (Campylobacter) 0.54 2.3 
GMI16-002-DNA (Campylobacter) 0.21 1.62 
GMI16-003-BACT (Listeria) 1.31 1.73 
GMI16-004-BACT (Listeria) 1.35 1.95 
GMI16-003-DNA (Listeria) 0.32 1.75 
GMI16-004-DNA (Listeria) 0.2 1.83 
GMI16-005-BACT (Klebsiella) 1.36 1.92 
GMI16-006-BACT (Klebsiella) 1.22 1.76 
GMI16-005-DNA (Klebsiella) 0.24 1.76 
GMI16-006-DNA (Klebsiella) 0.32 1.6 
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Table L.5: Determined MLST for both the bacterial culture and DNA received  
 GMI16-001 GMI16-002 GMI16-003 GMI16-
004 
GMI16-005 GMI16-006 
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BACT #77 Own tool 
S
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7426 
S
T
-6
2
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6238 
S
T
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2 
S
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-1
2
1
 
121 
S
T
-5
1
2
 
512 
S
T
-1
5
 
15 
CGE tool 7426 6238 2 121 512 15 
#82 Own tool 7426 6238 2 121 512 15 
CGE tool 7426 6238 2 121 512 15 
#93 Own tool  6238   512 15 
CGE tool 7426 6238   512 15 
#95 Own tool       
CGE tool 7426 6238     
#104 Own tool 7426 6238 2 121 512 15 
CGE tool 7426 6238 2 121 512 15 
#114* Own tool       
CGE tool 6238 7426   512  
#115 Own tool 7426 6238 2 121   
CGE tool 7426 6238 2 121   
DNA #77 Own tool 
S
T
 7
4
2
6
 
7426 
S
T
-6
2
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6238 
S
T
-2
 
2 
S
T
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2
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121 
S
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1
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S
T
-1
5
 
15 
CGE tool 7426 6238 2 121 512 15 
#82 Own tool 7426 6238 2 121 512 15 
CGE tool 7426 6238 2 121 512 15 
#93 Own tool  6238   512 15 
CGE tool 7426 6238   512 15 
#95 Own tool       
CGE tool 7426 6238     
#104 Own tool 7426 6238 2 121 512  
CGE tool 7426 6238 2 121 512 15 
#114* Own tool       
CGE tool Unk Unk    15 
#115 Own tool 7426 6238 2 121   
CGE tool 7426 6238 2 121   
* Laboratory #114 mixed up the two strains GMI16-001-BACT and GMI16-002-BACT as well as GMI16-001-DNA and GMI16-002-DNA 
why the incorrect MLSTs. Some laboratories did not report MLST data (own tool) but these were provided by PT-organizer (CGE tool) 
marked in light gray. Deviating results indicated in bold. 
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Table L.6: Determined antimicrobial resistance genes in Campylobacter GMI16-002 for both the bacterial culture and DNA received 
 
* Laboratory #114 mixed up the two strains GMI16-001-BACT and GMI16-002-BACT why the incorrect AMR profile. The expected AMR profile for GMI16-
002-BACT was reported for the pan-susceptible GMI16-001-BACT. Similarly, the laboratory #114 mixed up the GMI16-001-DNA and GMI16-002-DNA why 
the incorrect AMR profile for GMI16-002-DNA. Some laboratories did not report AMR data (own tool) but these were provided by PT-organizer (CGE tool) 
marked in light gray. Deviating results indicated in bold. 
  
Participant
Own tool  aadE aph(3')-III  aph(2'')-like tet(O)-like
CGE tool aadE aph(3')-III tet(O)
Own tool aadE aph(3')-III aph(2'')-like tet(O)-like gyrA T86I (Quinolone) 23S A2075G (Macrolide)
CGE tool aadE aph(3')-III tet(O)
Own tool aadE aph(3')-III aph(2'')-like tet(O)-like
CGE tool aadE aph(3')-III tet(O)
Own tool
CGE tool aadE aph(3')-III tet(O)
Own tool aadE aph(3')-III  tet(O)-like
CGE tool aadE aph(3')-III tet(O)
Own tool
CGE tool
Own tool
CGE tool aadE aph(3')-III tet(O)
Own tool aadE aph(3')-III aph(2'') tet(O)
CGE tool aadE aph(3')-III tet(O)
Own tool aadE aph(3')-III aph(2'')-If-like tet(O)-like gyrA T86I (Quinolone) 23S A2075G (Macrolide)
CGE tool aadE aph(3')-III tet(O)
Own tool aadE aph(3')-III aph(2'')-like tet(O)-like
CGE tool aadE aph(3')-III tet(O)
Own tool
CGE tool aadE aph(3')-III tet(O)
Own tool aadE aph(3')-III tet(O)-like
CGE tool aadE aph(3')-III tet(O)
Own tool
CGE tool aac(6')-IIc blaSHV-12 blaCTX-M-15 blaTEM-1B dfrA18 strB strA ere(A) tet(A) tet(D) sul2 sul1 QnrB49 floR
Own tool
CGE tool aadE aph(3')-III tet(O)
#82
#93
#95
#82
#93
#95
#104
#114
#115
GMI16-002
BACT
#77
#104
#114*
#115
DNA
#77
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Table L.7: Determined antimicrobial resistance genes in Klebsiella GMI16-005 for both the bacterial culture and DNA received 
 
Data for the CGE tool were provided by PT-organizer and marked in light gray. Deviating results indicated in bold. 
  
Participant GMI16-005
Own tool aadA2 aac(6')-lb) blaTEM-1A blaKPC-3 blaOXA-9 blaSHV-11 oqxA oqxB aac(6')lb-cr fosA mph(A) catA1 sul1 dfrA12
CGE tool aadA2 aac(6')-Ib blaTEM-1A blaKPC-3 blaOXA-9 blaSHV-11 oqxA oqxB aac(6')Ib-cr mph(A) catA1 sul1 dfrA12
Own tool aadA2-like aac(6')-Ib blaTEM-1A-like blaKPC-3 blaOXA-9-like blaSHV-11 oqxA oqxB fosA-like mph(A) catA1-like sul1 dfrA12
CGE tool aadA2 aac(6')-Ib blaTEM-1A blaKPC-3 blaOXA-9 blaSHV-11 oqxA oqxB aac(6')Ib-cr mph(A) catA1 sul1 dfrA12
Own tool aadA2 aac(6')-Ib blaTEM-1A-like blaKPC-3 blaOXA-9-like blaSHV-11 oqxA oqxB aac(6')Ib-cr-like fosA-like mph(A) catA1-like sul1 dfrA12
CGE tool aadA2 aac(6')-Ib blaTEM-1A blaKPC-3 blaOXA-9 blaSHV-11 oqxA oqxB aac(6')Ib-cr mph(A) catA1 sul1 dfrA12
Own tool
CGE tool
Own tool aadA2-like aac(6')-Ib blaTEM-1A-like blaKPC-3 blaOXA-9-like blaSHV-11 oqxA oqxB aac(6')Ib-cr-like fosA-like mph(A) catA1-like sul1 dfrA12
CGE tool aadA2 aac(6')-Ib blaTEM-1A blaKPC-3 blaOXA-9 blaSHV-11 oqxA oqxB aac(6')Ib-cr mph(A) catA1 sul1 dfrA12
Own tool
CGE tool aadA2 aac(6')-Ib blaTEM-1A blaKPC-3 blaOXA-9 blaSHV-11 oqxA oqxB aac(6')Ib-cr mph(A) catA1 sul1 dfrA12
Own tool
CGE tool
Own tool aadA2 aac(6')-lb) blaTEM-1A blaKPC-3 blaOXA-9 blaSHV-11 oqxA oqxB aac(6')lb-cr fosA mph(A) catA1 sul1 dfrA12
CGE tool aadA2 aac(6')-Ib blaTEM-1A blaKPC-3 blaOXA-9 blaSHV-11 oqxA oqxB aac(6')Ib-cr mph(A) catA1 sul1 dfrA12
Own tool aadA2-like aac(6')-Ib blaTEM-1A-like blaKPC-3 blaOXA-9-like blaSHV-11 oqxA oqxB fosA-like mph(A) catA1-like sul1 dfrA12
CGE tool aadA2 aac(6')-Ib blaTEM-1A blaKPC-3 blaOXA-9 blaSHV-11 oqxA oqxB aac(6')Ib-cr mph(A) catA1 sul1 dfrA12
Own tool aadA2 aac(6')-Ib blaTEM-1A-like blaKPC-3 blaOXA-9-like blaSHV-11 oqxA oqxB aac(6')Ib-cr-like fosA-like mph(A) catA1-like sul1 dfrA12
CGE tool aadA2 aac(6')-Ib blaTEM-1A blaKPC-3 blaOXA-9 blaSHV-11 oqxA oqxB aac(6')Ib-cr mph(A) catA1 sul1 dfrA12
Own tool
CGE tool
Own tool aadA2-like aac(6')-Ib blaTEM-1A-like blaKPC-3 blaOXA-9-like blaSHV-11 oqxA oqxB aac(6')Ib-cr-like fosA-like mph(A) catA1-like sul1 dfrA12
CGE tool aadA2 blaTEM-1A blaKPC-3 blaOXA-9 blaSHV-11 oqxA oqxB mph(A) catA1 sul1 dfrA12
Own tool
CGE tool
Own tool
CGE tool
#82
#93
#95
#82
#93
#95
#104
#114
#115
BACT
#77
#104
#114
#115
DNA
#77
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Table L.8: Determined antimicrobial resistance genes in Klebsiella GMI16-006 for both the bacterial culture and DNA received 
 
 
Data for the CGE tool were provided by PT-organizer and marked in light gray. Deviating results indicated in bold. 
 
 
Participant
Own tool aadA1 aac(6')-Ib aac(3)-Iid aph(3')-Via strA strB blaNDM-1 blaOXA-9 blaCTX-M-15 blaTem-1b QnrS1 oqxB oqxA aac(6')Ib-cr sul2 tet(D) dfrA14 fosA blaSHV-1
CGE tool aadA1 aac(6')-Ib aac(3)-IId aph(3')-VIa strA strB blaNDM-1 blaOXA-9 blaCTX-M-15 blaTEM-1B QnrS1 oqxB oqxA aac(6')Ib-cr sul2 tet(D) dfrA14 blaSHV-1
Own tool aadA1 aac(6')-Ib aac(3)-IId-like aph(3')-VIa-like strA-like strB-like blaNDM-1 blaOXA-9 blaCTX-M-15 blaTEM-1B-like QnrS1 oqxA-like oqxB-like sul2 tet(D) dfrA14-like fosA-like blaSHV-28
CGE tool aadA1 aac(6')-Ib aac(3)-IId aph(3')-VIa strA strB blaNDM-1 blaOXA-9 blaCTX-M-15 blaTEM-1A QnrS1 oqxB oqxA aac(6')Ib-cr sul2 tet(D) dfrA14 blaSHV-28
Own tool aadA1 aac(6')-Ib aph(3')Vla-like strA-like strB-like blaNDM-1 blaOXA-9-like blaCTX-M-15 blaTEM-1B QnrS1 oqxA-like oqxB-like aac(6')Ib-cr-like sul2 tet(D) dfrA14-like fosA-like blaSHV-1
CGE tool aadA1 aac(6')-Ib aac(3)-IId aph(3')-VIa strA strB blaNDM-1 blaOXA-9 blaCTX-M-15 blaTEM-1B QnrS1 oqxB oqxA aac(6')Ib-cr sul2 tet(D) dfrA14
Own tool
CGE tool
Own tool aadA1 aac(6')-Ib aac(3)-IId-like aph(3')-VIa-like strA-like strB-like blaNDM-1 blaOXA-9-like blaCTX-M-15 blaTEM-1B QnrS1 oqxB-like oqxA-like aac(6')Ib-cr-like sul2 tet(D) dfrA14-like, fosA blaSHV-28
CGE tool aadA1 aac(6')-Ib aac(3)-IId aph(3')-VIa strA strB blaNDM-1 blaOXA-9 blaCTX-M-15 blaTEM-1A QnrS1 oqxB oqxA aac(6')Ib-cr sul2 tet(D) dfrA14
Own tool
CGE tool
Own tool
CGE tool
Own tool aadA1 aac(6')-Ib aac(3)-Iid aph(3')-Via strA strB blaNDM-1 blaOXA-9 blaCTX-M-15 blaTem-1b QnrS1 oqxB oqxA aac(6')Ib-cr sul2 tet(D) dfrA14 fosA blaSHV-1
CGE tool aadA1 aac(6')-Ib aac(3)-IId aph(3')-VIa strA strB blaNDM-1 blaOXA-9 blaCTX-M-15 blaTEM-1B QnrS1 oqxB oqxA aac(6')Ib-cr sul2 tet(D) dfrA14
Own tool aadA1 aac(6')-Ib aac(3)-IId-like aph(3')-VIa-like strA-like strB-like blaNDM-1 blaOXA-9 blaCTX-M-15 blaTEM-1B-like QnrS1 oqxA-like oqxB-like sul2 tet(D) dfrA14-like fosA-like blaSHV-28
CGE tool aadA1 aac(6')-Ib aac(3)-IId aph(3')-VIa strA strB blaNDM-1 blaOXA-9 blaCTX-M-15 blaTEM-1B QnrS1 oqxB oqxA aac(6')Ib-cr sul2 tet(D) dfrA14 blaSHV-28
Own tool aadA1 aac(6')-Ib aac(3)-IId-like aph(3')Vla-like strA-like strB-like blaNDM-1 blaOXA-9-like blaCTX-M-15 blaTEM-1B QnrS1 oqxA-like oqxB-like aac(6')Ib-cr-like sul2 tet(D) dfrA14-like fosA-like blaSHV-1 blaLEN12-like
CGE tool aadA1 aac(6')-Ib aac(3)-IId aph(3')-VIa strA strB blaNDM-1 blaOXA-9 blaCTX-M-15 blaTEM-1B QnrS1 oqxB oqxA aac(6')Ib-cr sul2 tet(D) dfrA14
Own tool
CGE tool
Own tool aadA1 aac(6')-Ib aac(3)-IId-like aph(3')-VIa-like strA-like strB-like blaNDM-1 blaOXA-9-like blaCTX-M-15 blaTEM-1B QnrS1 oqxB-like oqxA-like aac(6')Ib-cr-like sul2 tet(D) dfrA14-like, fosA blaSHV-28
CGE tool aadA1 aac(6')-Ib aac(3)-IId-like aph(3')-VIa-like strA-like strB-like blaNDM-1 blaOXA-9-like blaCTX-M-15 blaTEM-1B QnrS1 oqxB-like oqxA-like aac(6')Ib-cr-like sul2 tet(D) dfrA14-like, fosA blaSHV-28
Own tool
CGE tool aadA1 aac(6')-Ib aac(3)-IId aph(3')-VIa strA strB blaNDM-1 blaOXA-9 blaCTX-M-15 blaTEM-1B QnrS1 oqxB oqxA aac(6')Ib-cr sul2 tet(D) dfrA14
Own tool
CGE tool
BACT
#77
#82
#93
#95
#104
#114
#115
DNA
#77
#82
#93
#95
#104
#114
#115
GMI16-006
ENGAGE 
 
 
 
www.efsa.europa.eu/publications 194 EFSA Supporting publication 2018:EN-1431 
The present document has been produced and adopted by the bodies identified above as author(s). In accordance with Article 36 of Regulation (EC) No 178/2002, this task has been carried out exclusively by the author(s) in the context of a 
grant agreement between the European Food Safety Authority and the author(s). The present document is published complying with the transparency principle to which the Authority is subject. It cannot be considered as an output adopted 
by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). 
 
 
The black line inserted the box represent the median which indicates 50% of the data being greater than this value. The top and botton of the box indicate the upper and lower quartiles which 
is 25% of the data being greater or lower than this value. The end of the whiskers indicates the maximum (greatest value) or minimum (lowest value) excluding outliers. The red dots represent 
values considered outliers. 
Results for participant 2 omitted for both sample types of strain 1, 4, 5, and 6. The whiskers represent minimum and maximum values (range) and the box represent the Q1, Median, and Q3, 
respectively.  
 
Figure L.1: Number (No) of reads mapped to the reference sequence 
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The black line inserted the box represent the median which indicates 50% of the data being greater than this value. The top and botton of the box indicate the upper and lower quartiles which 
is 25% of the data being greater or lower than this value. The end of the whiskers indicates the maximum (greatest value) or minimum (lowest value) excluding outliers. The red dots represent 
values considered outliers. 
 
Figure L.2: Proportion (%) of reads mapped to the reference DNA sequence 
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The black line inserted the box represent the median which indicates 50% of the data being greater than this value. The top and botton of the box indicate the upper and lower quartiles which 
is 25% of the data being greater or lower than this value. The end of the whiskers indicates the maximum (greatest value) or minimum (lowest value) excluding outliers. The red dots represent 
values considered outliers. 
 
Figure L.3: Total number (No) of contigs  
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The black line inserted the box represent the median which indicates 50% of the data being greater than this value. The top and botton of the box indicate the upper and lower quartiles which 
is 25% of the data being greater or lower than this value. The end of the whiskers indicates the maximum (greatest value) or minimum (lowest value) excluding outliers. The red dots represent 
values considered outliers. 
 
Figure L.4: Size (bp) of the assembled genome 
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The black line inserted the box represent the median which indicates 50% of the data being greater than this value. The top and botton of the box indicate the upper and lower quartiles which 
is 25% of the data being greater or lower than this value. The end of the whiskers indicates the maximum (greatest value) or minimum (lowest value) excluding outliers. The red dots represent 
values considered outliers. 
 
Figure L.5: Proportion (%) of the assembled genome per reference DNA sequence 
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The black line inserted the box represent the median which indicates 50% of the data being greater than this value. The top and botton of the box indicate the upper and lower quartiles which 
is 25% of the data being greater or lower than this value. The end of the whiskers indicates the maximum (greatest value) or minimum (lowest value) excluding outliers. The red dots represent 
values considered outliers. 
 
Figure L.6: N50 - average length (bp) of sequences 
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The black line inserted the box represent the median which indicates 50% of the data being greater than this value. The top and botton of the box indicate the upper and lower quartiles which 
is 25% of the data being greater or lower than this value. The end of the whiskers indicates the maximum (greatest value) or minimum (lowest value) excluding outliers. The red dots represent 
values considered outliers. 
 
Figure L.7: Depth of coverage (X) of the sequences  
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1. Introduction 
The main objective of this proficiency test (PT) is to facilitate the production of reliable laboratory results of 
consistently good quality within the area of whole genome sequencing (WGS).  
The PT evaluates the consistency and robustness of ENGAGE consortium members’ ability to perform 
deoxyribonucleic acid (DNA) extraction, library preparation, the WGS, and assembly following different 
laboratory protocols, software tools, and sequence platforms for the reliability of submitted sequence data to 
the public repositories. This ensures harmonization and standardization in WGS and data analysis, with the 
aim to produce comparable data for the ENGAGE initiative. To meet these objectives, the laboratory work 
and analyses for this PT were performed using the methods routinely employed in the individual laboratories.  
The PT consists of a “wet-lab” component targeting three common bacterial pathogens. The wet-lab 
component assesses the laboratories’ ability to perform DNA preparation, sequencing procedures and, if 
laboratories routinely do so, the analysis of epidemiological markers, i.e. Multi Locus Sequence Typing (MLST) 
and antimicrobial resistance (AMR) genes.  
The individual laboratory data are confidential and only known by the participating laboratory and the PT 
organizers (DTU Food).  
 Materials and Methods 
 Participating laboratories 
A pre-notification to announce the ENGAGE proficiency test was distributed on the 8 May 2017 by e-mail to 
the eight ENGAGE consortium partners. Seven of the eight partners signed up and participated in the PT. 
The National Institute of Public Health - National Institute of Hygiene, Poland, did not participate as they 
have not initiated in-house WGS.  
 Strains 
In 2017, two strains each of Salmonella (GMI17-001, GMI17-002) Escherichia coli (E. coli) (GMI17-003, 
GMI17-004), and Staphylococcus aureus (S. aureus) (GMI17-005, GMI17-006) were selected for the wet-lab 
component. In a GMI end-user analysis of what species to target, Salmonella and E. coli were indicated to 
be of most interest to the end-users (Moran-Gilad et al., 2015). S. aureus, a public health relevant pathogen 
carrying a significant burden worldwide, was also indicated as important and therefore selected for this PT. 
All of the selected strains are resistant to critical important antimicrobials (CIAs) for human health. 
Salmonella, GMI17-001 belong to S. Bovismorbificans/S. Hindmarsh and confer resistance to colistin and 
harbor the mcr-1 gene whereas GMI17-002 is S. Westhampton and a carbapenemase producer containing 
both blaNDM-1 and blaCTX-M-15. The two E. coli strains, GMI17-003, GMI17-004 are also resistant to CIAs 
harboring the blaNDM-7 and mcr-1 genes, respectively. Finally, S. aureus GMI17-005 was included, and being 
a livestock associated (LA)-MRSA, spa type t034 of a novel sequence type (ST) which is a double-locus 
variant of ST130 belonging to Clonal Complex (CC) CC398 and additionally resistant to linezolid due to the 
presence of the cfr-gene. The second S. aureus GMI17-006 is a LA-MRSA spa type t843, ST130, belonging to 
CC130.  
Individual sets of the test strains were produced as agar stab cultures (nutrient) and the corresponding DNA 
was purified and pooled by DTU Food prior to distribution in individual vials for each participating laboratory.  
To better enable the assessment of the differences in the sequences generated by the laboratories, each of 
the six strains in the wet-lab component was sequenced on the PacBio by the Food and Drug Administration 
in the United States of America (US FDA) to obtain a closed reference genome. Initially, 10 kb template 
libraries were created using “10 kb DNA Template Prep Kit 1.0” from Pacific Biosciences. Subsequently, the 
libraries were sequenced using C2 chemistry on single-molecule real-time (SMRT) cells with a 180 min 
collection protocol. The data were de novo assembled using the Hierarchical Genome Assembly Process 
ENGAGE 
 
 
 
www.efsa.europa.eu/publications 205 EFSA Supporting publication 2018:EN-1431 
The present document has been produced and adopted by the bodies identified above as author(s). In accordance with Article 36 of Regulation (EC) No 178/2002, this 
task has been carried out exclusively by the author(s) in the context of a grant agreement between the European Food Safety Authority and the author(s). The present 
document is published complying with the transparency principle to which the Authority is subject. It cannot be considered as an output adopted by the Authority. The 
European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without 
prejudice to the rights of the author(s). 
 
(HGAP) within the Pacific Biosciences SMRTAnalysis software package. Polishing and finishing the genome 
were performed with custom python scripts, Quiver and Gepard, a dot plot tool to identify overlapping 
regions. The following reference genomes were generated for the PT, Salmonella (GMI17-001), Salmonella 
(GMI17-002), E. coli (GMI17-003), E. coli (GMI17-004), S. aureus (GMI17-005), and S. aureus (GMI17-006). 
 Distribution 
On 21 August 2017, bacterial strains in agar stab cultures together with the corresponding purified and dried 
DNA and a welcome letter were dispatched in double pack containers (class UN 6.2) to the participating 
laboratories according to the International Air Transport Association (IATA) regulations as UN3373, biological 
substances Category B. 
 Procedure 
The protocol was made available on the website allowing the PT laboratories access to all necessary 
information at any time (http://www.globalmicrobialidentifier.org/workgroups/about-the-gmi-proficiency-
test-2017). Additional relevant information was distributed by email directly to the laboratories. 
The protocol presented instructions as to the handling of the received bacterial cultures and DNA.  
Laboratories were requested to capture information in relation to the questions presented in the online 
survey.  
This report summarizes the results and allows for ensures full anonymity for the laboratories, as only the PT-
organizers has access to the individual results. 
 Sequencing protocols and quality metrics 
2.4.1. Online survey of the sequencing capabilities 
Apart from three questions relating to the contact information of the laboratory, 40 questions focused on the 
storage of bacterial cultures and DNA prior to analysis, the cultivation and DNA extraction procedure, the 
quality assurance parameters applied and also on the details related to the sequencing and analysis of the 
obtained sequencing data, were asked. 
The laboratories submitted raw sequence files in fastq format. As part of the analysis, the reads were de 
novo assembled using the SPAdes v 3.6.1 software. Reads were aligned to reference chromosomes and 
plasmids using Burrows-Wheeler Aligner (BWA)-MEM algorithm with default settings. Samtools was used 
to filter the reads that did not map. MLST genes and ST were predicted using MLST tool provided by 
Center for Genomic Epidemiology (CGE) (https://cge.cbs.dtu.dk/services/MLST/) Larsen et al., 2012). 
Antimicrobial resistance genes were predicted using ResFinder tool 
https://cge.cbs.dtu.dk//services/ResFinder/database.php (Zankari et al., 2012).  
For the raw reads, the following QC metrics were calculated: 
 Numbers of reads (for paired-end reads, the total numbers of reads is calculated as the sum of reads in 
the two files)  
 Numbers of reads after trimming  
 Numbers of unmapped reads  
 Number of reads that map to the total reference DNA (chromosome + any plasmids) using BWA 
 Number of reads that map to reference chromosome  
 Number of reads that map to the reference plasmid #1 - #4 
 Proportion (%) of reads that map to reference chromosome out of all sequence reads in the sample. 
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 Coverage of the reference chromosome (fraction of chromosome positions that were covered by at least 
one read pair). 
 Coverage of the reference plasmid #1 - #4 (number of plasmid positions that were covered by at least 
one read pair). 
 Depth of coverage of total DNA 
 Depth of coverage of the reference chromosome 
 Depth of coverage of the reference plasmid #1 - #4  
 Q-score R1 (Base calling accuracy, Phred quality score (Q score), is the most common metric used to 
assess the accuracy of a sequencing platform. It indicates the probability that a given base is called 
incorrectly by the sequencer). 
 Q-score R2 
For the assemblies, the following QC parameters were calculated: 
 Total size of assembly (bp) (all contigs)  
 Proportion (%) of size of assembly that map to the total size of DNA  
 Total number of contigs  
 Number of contigs with a length above 200 bp  
 N50 (defined as the length of the shortest contig, in the set of largest contigs that represents at least 
50% of the assembly)  
In addition to the calculation of the above QC metrics and parameters, laboratories were requested to 
provide the identification of the corresponding MLST and AMR genes of the strains to support the 
assessment of the sequence quality. Laboratories identified the MLSTs and AMR genes using the software of 
their choice. To assess the proficiency of the laboratories, the PT organizers used a command line version of 
the CGE MLST-Finder v.1.8 and ResFinder 3.0 (Threshold for %ID = 98% and HSP/Query length = 60%) 
including the CGE standard assembly pipeline on the laboratories raw reads to compare the results with 
those reported by the laboratories. Furthermore, strain-specific reference routed phylogenetic single 
nucleotide polymorphism (SNP) trees were created using the raw reads of both the culture and 
corresponding DNA submitted by each of the laboratories. This will support the assessment of the sequence 
quality of the laboratories.  
Phylogenetic SNP trees were created using the pipeline; CSI phylogeny v.1.4 available from CGE. The 
paired-end reads were mapped to the reference genomes; using BWA version 0.7.2. The depth at each 
mapped position was calculated using genomeCoverageBed, which is part of BEDTools version 2.16.2. SNPs 
were called using ‘mpileup’ module in SAMTools version 0.1.18. SNPs were filtered out if the depth at the 
SNP position was not at least 10X or at least 10% of the average depth for the particular genome mapping. 
Subsequently, SNPs were selected when meeting the following criteria: 1) a minimum distance of 10 bp 
between each SNP, 2) the mapping quality was more above 25, 3) the SNP quality was more than 30 and 4) 
all indels were excluded.  
The qualified SNPs from each genome were concatenated to a single alignment corresponding to position of 
the reference genome. The concatenated sequences were subjected to maximum likelihood tree using 
FastTree (Price et al., 2010).  
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 Results 
 Participation 
Seven laboratories responded to the pre-notification and were enrolled in the ENGAGE PT. When the 
deadline for submitting results was reached, all seven laboratories had uploaded data. All seven partners, 
#141, #146, #152, #156, #170, #182, and #185 submitted raw reads obtained from both the culture and 
the DNA for both strains of the three bacterial species with the exception of laboratory #152, which only 
participated in the E. coli and S. aureus trials.  
 Method description 
Three laboratories immediately initiated processing the cultures after receipt. The other four laboratories 
stored the cultures at 4ºC. Similarly, the DNA was stored at 4ºC by three laboratories whereas four 
laboratories stored the DNA samples at room temperature. Only one laboratory processed the DNA upon 
receipt of the samples. All the laboratories incubated the bacterial strains at 37˚C ranging from 16 h to 24 h.  
The laboratories also reported the DNA extraction procedures which indicated a high degree of variation 
among the kits being used.  
Among the seven laboratories, two laboratories used an automatic extraction based on the following 
instruments and kits, laboratory #182, QIAsymphony DSP DNA minikit added RNAse at 37ºC for 15 minutes 
and elution in water rather than buffer for Gram-negative bacteria and pre-lysis steps to include incubation 
in presence of lysozyme, lysostaphin, proteinase K for Gram positive bacteria and laboratory #185, King-
Fisher DUO Prime, MagMAX Core Nucleic Acid Purification kit with a sample volume of 270 µL. The other five 
laboratories followed a manual extraction protocol for the three bacterial species, Easy - DNA (#141), 
PureLink™ Genomic DNA Mini Kit included proteinase K digestion and lysostaphin for S. aureus (#146), 
QIAamp DNA Mini Kit (#152/ #156) and Genomic mini included lysostaphin digestion for the Gram-positive 
bacteria (#170). 
In addition, the laboratories also reported the DNA concentration (ng/µL) and DNA quality (e.g. RIN, 
260/280 ratio and/or 260/230 ratio) prior to library preparation. The DNA concentration (ng/µL) prior to 
library preparation was measured on Qubit by the five laboratories using a manual extraction procedure 
whereas laboratory #182 used the Quantifluor dsDNA system and laboratory #185 used GloMax® 96 
Microplate Luminometer, an automated plate reader using fluorescence. The DNA quality (e.g. RIN, 260/280 
ratio and/or 260/230 ratio) prior to library preparation was measured by three laboratories on Nanodrop 
(#146, #152, and #170) whereas the remaining four laboratories did not measure the quality. In addition, 
two laboratories, #146 and #170 performed quality check to verify the quality of the DNA on a gel. 
All of the laboratories used commercial kits for library preparation and all related to the used sequencing 
platform, Nextera XT DNA Library Preparation Kits. Modifications to the protocols were reported by 
laboratory #146 that used half the volume of the reagents and laboratory #152 which for manual 
normalization of purified libraries used TrisHCl 10 mM. 
The genomic DNA was prepared for pair-end sequencing by all seven laboratories. The libraries were 
sequenced using the following read length and platform, Illumina MiSeq by four laboratories (#146, #152, 
#156, (251 bp) and #170 (300 bp)), Illumina NextSeq by laboratory #141 (read length not known), Illumina 
HiSeq 2500 by laboratory #185 (200 bp), and Genome Sequencer Junior System (454) by laboratory #182 
(150 bp).  
Five laboratories indicated that if assembled by themselves, they would have used FoodQCPipeline (trimmed 
by bbduk2 (part of the suit bbtools version 36.49) and de novo assembly by SPAdes) (#141), Velvet 
Assembler 1.3 (#156), and SPAdes 3.9.0 (#146, #170, #185).  
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 Sequencing – quality markers 
All the seven laboratories participating in the PT trial submitted sequencing data for all the six test strains, 
except laboratory #152 which did not submit sequencing data for the Salmonella GMI17-001 and GMI17-002 
from both the bacterial culture and corresponding DNA.  
The sequencing quality of all submitted data was evaluated for potential contamination or a low performance 
by accessing the above quality parameters.  
3.2.1. Salmonella – genome size 
For the Salmonella genomes, GMI17-001-BACT and GMI17-001-DNA with an expected genome size of 
4,687,697 bp, none of the laboratories were considered outliers as for the obtained size (Figures M.1-M.2).  
For the second Salmonella genome, GMI17-002-BACT with a genome size of 5,119,002 bp, none of the 
laboratories were considered outliers (Figures M.1-M.2). Laboratory #71, however, provided the highest 
assembled genome size of the sample, GMI17-002-DNA with 5,219,504 bp compared with a genome size of 
5,119,002 bp (102 %) and was considered an outlier.  
3.2.2. Salmonella – Q-score 
All laboratories obtained a base calling accuracy, Phred quality score (Q score), between Q30 and Q40 for all 
Salmonella genomes and sample types indicating a 99.9 % base call accuracy with the probability of an 
incorrect base call in 1 out of 1,000 bp (Figures M.3-M.4). 
3.2.3. Salmonella – reads and coverage 
Regarding the number of reads produced, laboratory #141 was considered an outlier for both Salmonella 
genomes, GMI17-001-BACT, GMI17-002-BACT and GMI17-002-DNA, reaching 10,589,514 bp, 10,539,188 bp 
and 9,105,498 bp, respectively (Figure M.5). None of the laboratories reported high amounts of unmapped 
reads for the Salmonella genomes, GMI17-001 and GMI17-002-BACT and thus no outliers were identified 
(Figure M.10). Some consistency was observed in relation to underperformance when analyzing the reported 
number of reads mapping to the reference DNA, the reference chromosome, after trimming, and plasmid 1 
(Figures M.6-M.9, M.11). Laboratory #141 reported the highest number of reads mapping to the reference 
DNA sequence for both sample types and for both Salmonella genomes e.g. 9,180,225 bp for GMI17-001-
BACT and was considered as an outlier (Figure M.7). Interestingly, laboratory #185 obtained a very low 
proportion (64.9%) of reads mapping to the reference DNA sequence for GMI17-002-DNA and was identified 
as an outlier (Figure M.8). 
All laboratories obtained an almost 100% in the proportion of reads mapping to the reference DNA sequence 
and to plasmid 1 (Figures M.8, M.11).  
Laboratory #141 that was considered as an outlier for mapping reads to the reference DNA also sequenced 
the genomes including the chromosome and plasmid with a high sequencing depth of e.g. 229X for GMI17-
002-DNA and was considered an outlier compared to the other laboratories in relation to sequencing depth 
(Figure 15-17).  
The coverage of the reference chromosome and plasmid 1 for both sample types of the two Salmonella 
genomes were quite high with almost all laboratories close to having a coverage of 100% (Figures M.21-
M.22). 
The average insert sizes of the Salmonella genomes of both sample types seemed in many cases to be a bit 
greater than the read length except for laboratories #146 and #182 for which the insert sizes were 
approximately the double of the read length with #146 considered an outlier (Figure M.26).  
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3.2.4. Salmonella – contigs and N50 
The total number of contigs and number of contigs above 200 bp were estimated revealing no outliers 
(Figure M.27). Similarly to the contigs, also the N50 was estimated based on the submitted sequence data 
and revealed no outliers. The lowest observed N50 for Salmonella GMI17-001 was 177,550 bp and was 
obtained by laboratory #156 for the DNA sample (Figures M.29-M.30). Similarly, the same laboratory, #156 
obtained the lowest N50 value of 82,918 bp for the DNA sample of Salmonella GMI17-002 (Figure M.29).  
3.2.5. E. coli – genome size 
For the E. coli genome, GMI17-003 with a genome size of 4,923,235 bp, laboratory #156 was the only 
laboratory considered an outlier with a low assembled genome size of 2,397,310 bp (43.6 %) for the BACT 
sample (Figures M.1-M.2). No outliers were observed for the corresponding DNA sample. Regarding the 
proportion of reads mapped, laboratory #156 was considered an outlier with a slightly lower assembled 
genome size of 4,946,278 bp (99.6 %) compared to the expected genome size of 4,923,235 bp. In addition, 
laboratory #141 was also considered an outlier but with a slightly higher assembled genome size of 
4,989,924 bp (100.5 %) compared to the reference (Figures M.1-M.2). 
3.2.6. E. coli – Q-score 
All laboratories obtained a base calling accuracy, Phred quality score (Q score) ranging between Q28.9 
(laboratory #185, GMI17-003-BACT) and Q37.2 (laboratory #182, GMI17-004-DNA) for all E. coli genomes 
and sample types indicating an almost 99.9 % base call accuracy with the probability of an incorrect base 
call in 1 out of 1,000 bp for most laboratories (Figures M.3-M.4). 
3.2.7. E. coli – reads and coverage 
Laboratory #141 was considered outlier measuring the number of reads produced for both samples types of 
the E. coli genomes, GMI17-003 and GMI17-004 reaching 11,781,918 bp (GMI17-003-BACT), 11,261,596 bp 
(GMI17-003-DNA), 9,194,922 bp (GMI17-004-BACT), and 12,787,574 bp (GMI17-004-DNA), respectively 
(Figure M.5). The same laboratory, #141, revealed a high sequencing depth for both E. coli genomes 
including plasmid 1 to 4 and both sample types but considered an outlier for the DNA sample type e.g. 353X 
for GMI17-004-DNA when compared to the other laboratories (Figures M.15-M.20). The laboratory which 
reported the highest amount of unmapped reads for the E. coli genomes, GMI17-003-DNA and GMI17-004-
DNA was laboratory #185 with 1,142,545 bp and 1,079,169 bp, respectively, and was therefore considered 
an outlier (Figure M.10). Some consistency in the laboratory’s underperforming was observed for the 
reporting the number of reads mapping to the reference DNA sequence, the reference chromosome, and 
after trimming (Figures M.6-M.9, M.11-M.14). Laboratory #156 reported the lowest number and proportion 
of reads mapping to the reference chromosome for the GMI17-003-BACT with 44,333 bp (4.1%) and was 
therefore considered as an outlier (Figure M.9). Similarly, laboratory #185 reported low numbers and 
proportions of reads mapping to the reference chromosome of both E. coli genomes, GMI17-003 and GMI17-
004 and both samples types e.g. 1,421,916 bp (53.2%) for GMI17-003-BACT (Figure M.9). Laboratory #141 
reported the highest number and proportion of reads mapping to the reference chromosome and plasmid 1 
to 4 for both samples types of the E. coli of both genomes e.g. 11,832,263 bp (95.8%) for GMI17-004-DNA, 
and was therefore considered as an outlier (Figures M.9, M.11-M.14). In general, the proportion of reads 
mapping to the reference DNA sequence were lower than 100% for all of the laboratories (Figure M.8). The 
coverage to the reference chromosome and plasmid 1 to 4 for both sample types of both E. coli genomes 
were quite high with almost all laboratories presenting coverages of 100%, except for laboratory #156 
which obtained e.g. a coverage to the reference chromosome of 67.1% for GMI17-003-BACT (Figures M.21-
M.25).  
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The average insert sizes of the E. coli genomes of both sample types seemed to be similar to Salmonella 
with laboratory #146 exhibiting an insert size approximately the double of the read length and laboratory 
#146 was therefore considered an outlier (Figure M.26).  
3.2.8. E. coli – contigs and N50 
The total number of contigs and the number of contigs above 200 bp were estimated and a number of 
laboratories were considered outliers including laboratory #156 and #141 for the E. coli genomes, GMI17-
003-BACT and GMI17-004-BACT, respectively (Figures M.27-M.28). Laboratory #156 obtained an 
exceptionally high number of contigs above 200 bp of 3,397. Similarly to the contigs, also the N50 was 
estimated based on the submitted sequence data. Laboratory #156 was also considered an outlier related to 
the N50 for GMI17-003-BACT with 735 bp (Figure M.29).  
3.2.9. S. aureus – genome size 
For the S. aureus genomes, GMI17-005 and GMI17-006 with the genome sizes of 2,790,673 bp, and 
2,928,160 bp, respectively, laboratory #156 was the only laboratory considered an outlier with a too large 
size of the assembled genome of 3,017,011 bp (108.1%) and 3,283,558 bp (112.1%) for the BACT samples 
(Figures M.1-M.2). No outliers were observed for the corresponding DNA sample.  
3.2.10. S. aureus – Q-score 
All laboratories obtained a base calling accuracy, Phred quality score (Q score) ranging between Q31.3 
(laboratory #170, GMI17-005-BACT) and Q38.6 (laboratory #186, GMI17-005-DNA) for all S. aureus 
genomes and sample types indicating an almost 99.9 % base call accuracy with the probability of an 
incorrect base call in 1 out of 1,000 bp for most laboratories (Figures M.3-M.4). 
3.2.11. S. aureus – reads and coverage 
Laboratory #141 were considered an outlier related to the number of reads produced for both sample types 
of the S. aureus genomes, GMI17-005 and GMI17-006 reaching 11,198,996 bp (GMI17-005-DNA), and 
9,792,850 bp (GMI17-006-DNA), respectively (Figure M.5). The same laboratory, #141, revealed a high 
sequencing depth, 421.94X for the S. aureus genome, GMI17-006-DNA including plasmid 1 (2088.57X) and 
was considered an outlier when compared to the other laboratories (Figures M.15-M.17). The laboratory 
which reported the highest amount of unmapped reads for the S. aureus genome, GMI17-006-DNA, was 
also laboratory #141 with 938,292 bp and this laboratory was considered an outlier (Figure M.10). Some 
consistency to the above parameters was observed in relation to the reported number of reads mapping to 
the reference DNA sequence, the reference chromosome, and after trimming (Figures M.6-M.9, M.11). 
Laboratory #141 reported the highest number and proportion of reads mapping to the reference 
chromosome for both samples types of the S. aureus of both genomes e.g. 9,403,511 bp (94.0%) for 
GMI17-005-BACT and for plasmid 1 for genome GMI17-006 and was therefore considered as an outlier 
(Figure M.9). In general, the proportion of reads mapping to the reference DNA sequence was lower than 
100% for all of the laboratories (Figure M.8). The coverage to the reference chromosome and plasmid 1 for 
both samples types of the S. aureus of both genomes were quite high with almost all laboratories having 
coverage of 100% (Figures M.21-M.22).  
The average insert sizes of the S. aureus genomes of both sample types seemed to be similar as for 
Salmonella with laboratory #146 having an insert size approximately the double of the read length and 
laboratory #146 was considered an outlier (Figure M.26).  
3.2.12. S. aureus – contigs and N50 
The total number of contigs and the number of contigs above 200 bp were estimated and none of the 
laboratories were considered outliers (Figures M.27-M.28). Similarly to the contigs, also the N50 was 
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estimated based on the submitted sequence data and none of the laboratories were considered being 
outliers (Figure M.29). 
 Sequencing – MLST, and antimicrobial resistance genes  
For Salmonella GMI17-001, the expected MLST was ST142 which was identified by almost all of the 
laboratories except for laboratory #141 which identified the genome GMI17-001 of both sample types as 
ST377 (Table M.1). Laboratory #182 did not report MLST data for neither of the Salmonella, E. coli and S. 
aureus genomes (own tool) but these were provided by PT-organizer (CGE tool) and identified the correct 
MLST for GMI17-001, GMI17-003, GMI17-004 and GMI17-005 whereas it was incorrect for genome GMI17-
002 (which was also the case for all other laboratories) and for GMI17-006 (as expected).  
Salmonella spp. 
All laboratories, except for laboratory #158 which did not submit any Salmonella data, detected (own tools) 
and reported the following expected resistance genes, blaTEM-1, sul2, tetA, mcr-1, and drfA14 in both sample 
types from Salmonella; GMI17-001 (Table M.2). The genome also contained the genes, aph(6)-ld and 
aph(3")-lb which were not reported by the laboratories but only detected using the reference CGE tool, 
ResFinder. Thus, one laboratory (#185) was an exception correctly reporting the gene, aac(6')-ly but also 
incorrectly aph(6)-ld. In addition, all laboratories identified the genes strA and strB which according to the 
reference method were not present. The expected mcr-1 gene was not detectable in the reference GMI17-
001. The contig that contained the mcr-1 gene was 26,432 bp large which is part of plasmid. The reason 
was that the reference strain was sequenced by PacBio and PacBio only sequenced part of this plasmid and 
missed the mcr-1 gene. The reason was most likely that the plasmid was lost in culturing or DNA purification.  
The MLST ST14 was expected for the Salmonella genome; GMI17-002 which all laboratories 
reported correctly (Table M.1).  
All of the laboratories were able, using their own and the CGE tools to identify in the Salmonella genome, 
GMI17-002, the following expected genes: blaCTX-M-15, aac(6')-lb-cr, blaOXA-1, blaOXA-9, blaOXA-10, cmlA1, mph(A), 
catB4, arr3, and sul1 with the exception of laboratory #182 which did not report any genes and laboratory 
#158 detecting catB3 (Table M.3). In addition, all laboratories identified blaDHA-1 which was not one of the 
expected genes present in the reference genome. Moreover, all laboratories identified blaNDM-1 which appears 
not to have been captured by the PacBio sequencing of the reference. The expected blaNDM-1 gene was not 
detectable in the reference GMI17-002. The blaNDM-1 gene is located on a 4277 bp plasmid. The assembler 
form PacBio missed it. The reason was that the reference strain was sequenced by PacBio and PacBio has a 
limitation to sequence small plasmid. Thus the plasmid containing blaNDM-1 was not sequenced completely by 
PacBio and further analysis is ongoing. The Salmonella genome GMI17-002 was also expected to contain the 
gene blaTEM-1A which most laboratories were able to detect or the variant blaTEM-1B except for laboratory #185 
using own tools identifying the gene blaTEM-191. Similarly, the reference was expected to contain the gene 
aadA1 which were detected by both own and CGE tools by laboratory #146. The data submitted by 
laboratories, #141 and #156 reported the presence of the variant aadA24 (own tools used). The 
identification of the expected gene, aac(3)-lla caused issues but all laboratories were able to identify various 
variants of this gene. 
E. coli 
Almost all laboratories reported the correct MLST, ST448, for the E. coli genome GMI17-003 except for 
laboratory #156 using the reference tool, CGE tool, revealing an incorrect unknown ST (Table M.1). 
Four of the laboratories provided data using own and CGE tools whereas the laboratories, #152 (both 
samples types), #156 (DNA sample), and #182 for which only data from the CGE tools were generated 
(Table M.4). All laboratories were able to identify in E. coli genome GMI17-003 the expected antimicrobial 
resistance genes, aadA5, aac(3)-lld, aac(6')-lb-cr, blaTEM-1B, catA1, blaNDM-7, blaOXA-1, mph(A), catB3, and 
dfrA17 except for the GMI17-003-BACT sample of laboratory #156. Laboratory #156 only detected the 
blaTEM-1B and catA1 in the submitted genome of GMI17-003-BACT using the CGE tool. Furthermore, the sul1 
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gene was also expected in GMI17-003 and observed using the CGE tool by all laboratories except as 
mentioned in the BACT sample from laboratory #156. In addition, laboratories #170 and #185 did not 
report the sul1 gene using own tools whereas laboratory #185 also reported the presence of mdf(A) based 
on their own tool which contained this gene in the database of AMR genes excepted.  
In all cases, the laboratories managed to identify the correct and expected MLST ST10 (adk-10, fumc-11, 
gyrb-4, icd-8, mdh-8, pura-8, reca-2) of E. coli genome, GMI17-004 using the reference CGE tool (Table 
M.1). However, using their own tool, the MLST was misclassified by four laboratories, #141, #146, #170, 
and #185 which reported an allele difference compared to ST10 in icd-8 (#141), whereas the rest of the 
four laboratories reported a novel ST.  
Five of the laboratories provided data using own and CGE tools whereas the laboratories, #152 and #182 
(both samples types) for which only data from the CGE tools were generated (Table M.5). All laboratories 
were able to identify in E. coli genome GMI17-004 the expected antimicrobial resistance genes, blaTEM-1B, 
mcr-1, sul1, sul2, tet(A), strA, and drfA1 using own and CGE tools. Furthermore, the aadA1 gene was also 
expected in GMI17-004 and was observed using the CGE tool by all laboratories except for laboratory #185 
using own tool. In addition, also the two genes, aph(3")-lb and aph(6)-ld were expected in GMI17-004. 
These genes were only detected by using the CGE tool except for laboratory #185 which also reported the 
presence of these genes based on the use of their own tool. Laboratory #185 also reported mdf(A) using 
own tool. Interestingly, all laboratories reported the gene strB using own tools which was not expected in 
the reference genome. The strA gene was located on plasmid 2 and it might be that strB was not captured 
by the PacBio sequencing of the reference. 
S. aureus 
Almost all laboratories reported ‘unknown MLST’ as was also the expected result for the S. aureus genome 
GMI17-005 except for laboratories #141, #146, #170, and #185 using their own tool revealing an incorrect 
ST4307 (arcc-6, aroe-193, glpf-419, gmk-2, pta-7, tpi-58, yqil-52) or a novel ST (#146) (Table M.1). 
Four of the laboratories provided data using own and CGE tools whereas the laboratories, #152 (both 
samples types), #182 (both samples types), and #185 GMI17-005-DNA for which only data from the CGE 
tools were generated (Table M.6). The S. aureus genome GMI17-005 solely contained the antimicrobial 
resistance gene, mecC, which was detected by all laboratories using the CGE tool and only by laboratories 
#182 and #185 using own tool. The other laboratories reported the mecA gene using their own tool. 
The expected MLST S. aureus genome GMI17-006 was ST398 which was correctly reported by all 
laboratories using the CGE tool and their own tool with exception of laboratories #141 and #182 which 
reported ST4251 using own tool (both samples types) and ST2850 using CGE tool (BACT sample) (Table 
M.1). 
All laboratories were able to identify in S. aureus genome GMI17-006 the expected antimicrobial resistance 
genes, mecA, Isa(B), crf, Inu(B), fexA, tet(M), and drfG using own and CGE tools (Table M.7). Furthermore, 
a few discrepancies were observed among the laboratories detecting the following expected antimicrobial 
resistance genes, spc (laboratory #185, own tool), blaZ (laboratory #156, both sample types using own tool, 
#182, DNA using CGE tool), and tet(K) (laboratory #156, and #182 using CGE tool on the BACT sample). In 
addition, the following laboratories, #141, #146, #156 and #170, all detected the gene, norA, using own 
tools which was not expected in the reference genome. Similarly, laboratory #152 identified using the CGE 
tool the gene catA1 present in the BACT sample. Interestingly, all laboratories reported the str-gene using 
both tools but were not expected in the reference genome. 
 Sequencing – Single Nucleotide Polymorphism 
The raw reads of both the culture and corresponding DNA were mapped to the corresponding reference to 
identify SNP. No SNPs were observed in the genomes submitted by the laboratories with only one exception. 
One SNP was detected in relation to the GMI17-005-BACT sequence submitted from laboratory #170. This 
has been assessed as a spontaneous mutation and not due to a contamination. 
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 Discussion 
Laboratory #152 did not participate in the Salmonella trials. Laboratory #182 and #152 did not report any 
antimicrobial resistance genes for genome GMI17-001– GMI17-006 and GMI17-003–GMI17-006, respectively.  
The majority of the submitted MLST data were correct and in line with the expected results using the CGE 
reference method. A few laboratories, #141, #146, #170 and #185 reported variants or closely related 
MLST using own tools compared to the reference indicating that these laboratories might consider the tools 
used to predict MLSTs.  
Most of the submitted AMR genes were in concordance with the expected results. Some deviations, however, 
were observed especially related to laboratories reporting str genes using own tools and laboratories having 
problems to identify the following genes, aac(3)-lla in GMI17-002, aph(3")-lb and aph(6)-ld in GMI17-004, 
and mecA/norA in GMI17-005 using own tools. Interestingly, laboratory #156 identified a completely 
different number of antimicrobial resistance genes compared to those expected in GMI17-003-BACT raw 
reads from #156 laboratory using CGE tools. It was evident that laboratory #156 submitted and analysed 
the wrong genome as being an outlier when assessing the coverage compared to the reference chromosome 
and the plasmids. This also included a high number of contigs and low N50.   
One of the objectives for the ENGAGE PT was to assess a range of quality markers to evaluate the 
performance by the consortium partners. Overall, the 2017 PT showed that all laboratories performed 
satisfactorily, with minor exceptions. In general, laboratory #141 produced a high number of reads including 
a high percentage of mapping reads to the references, to plasmids and unmapped reads. This could 
potentially be explained by the laboratory running the test on a new large-scale NextSeq. In addition, also 
laboratory #185 revealed a high number of unmapped reads as well as a low percentage of reads mapping 
to the reference genome which also might be related to using a large-scale platform (HiSeq 2500). 
Laboratory #156 resulted an outlier for a few of the genomes in relation to the assembly conducted by the 
PT organizers, indicating a possible contamination of the genomes produced. It was not possible to identify 
the reason for the large assembly sizes but it apparently did not affect the results. It was also noteworthy 
that laboratory #170 obtained a Phred quality score (Q score) below Q30 (tentative QC threshold) for both S. 
aureus genomes indicating base call accuracy less than of 99.9 %, with the probability of an incorrect base 
call in more than 1 out of 1,000 bp. The laboratory has reported the use of an Illumina MiSeq platform 
which normally performs with a higher Q score.  
 Conclusions  
The PT was a useful exercise as it allowed the ENGAGE consortium partners to assess the quality of their 
own data as well as to identify critical points for improvement. In general, all data were satisfactory but the 
PT organizer especially encourages laboratory #141 to optimize the sequencing procedures for the new 
NextSeq to avoid too many reads including unmapped reads to be produced, laboratory #156 to investigate 
where in the process genome GMI17-003-BACT was switched and also why some of the assemblies made by 
the PT organizer were too large and laboratory #185 to investigate the reason behind the low percentages 
of reads mapping to the reference genomes. 
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Table M.1: Determined MLST for the bacterial culture and DNA received  
 
Reference strain MLST: GMI17-
001 
GMI17-
002 
GMI17-003 GMI17-
004 
GMI17-005 GMI17-
006 
ST-142 ST-14 ST-448 ST-10 Unknown ST ST-398 
BACT #141 Own tool ST-377 ST-14 ST-448 ST-10 ST-4307 ST-4251 
CGE tool ST-142 ST-14 ST-448 ST-10 Unknown ST-398 
DNA Own tool ST-377 ST-14 ST-448 ST-10 ST-4307 ST-4251 
CGE tool ST-142 ST-14 ST-448 ST-10 Unknown ST-398 
BACT #146 Own tool ST-142 ST-14 ST-448 Novel type ST-4307 ST-398 
CGE tool ST-142 ST-14 ST-448 ST-10 Unknown ST-398 
DNA Own tool ST-142 ST-14 ST-448 Novel type ST-4307 ST-398 
CGE tool ST-142 ST-14 ST-448 ST-10 Unknown ST-398 
BACT #152 Own tool - -  ST-10 Unknown ST ST-398 
CGE tool - - ST-448 ST-10 Unknown ST-398 
DNA Own tool - -  ST-10 Unknown ST ST-398 
CGE tool - - ST-448 ST-10 Unknown ST-398 
BACT #156 Own tool ST-142 ST-14 ST-448 ST-10 Unknown ST-398 
CGE tool ST-142 ST-14 Unknown ST ST-10 Unknown ST-398 
DNA Own tool ST-142 ST-14 ST-448 ST-10 Unknown ST-398 
CGE tool ST-142 ST-14 ST-448 ST-10 Unknown ST-398 
BACT #170 Own tool ST-142 ST-14 ST-448 Unknown ST-4307 ST-398 
CGE tool ST-142 ST-14 ST-448 ST-10 Unknown ST-398 
DNA Own tool ST-142 ST-14 ST-448 Unknown ST-4307 ST-398 
CGE tool ST-142 ST-14 ST-448 ST-10 Unknown ST-398 
BACT #182 Own tool - - - - - - 
CGE tool ST-142 ST-14 ST-448 ST-10 Unknown ST-2850 
DNA Own tool - - - - - - 
CGE tool ST-142 ST-14 ST-448 ST-10 Unknown ST-398 
BACT #185 Own tool ST-142 ST-14 ST-448 Novel ST ST-4307 ST-398 
CGE tool ST-142 ST-14 ST-448 ST-10 Unknown ST-398 
DNA Own tool ST-142 ST-14 ST-448 Novel ST ST-4307 ST-398 
CGE tool ST-142 ST-14 ST-448 ST-10 Unknown ST-398 
Data for the CGE tool were provided by PT-organizer and marked in light grey.
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Table M.2: Determined antimicrobial resistance genes for the bacterial culture and DNA received  
 
Reference antimicrobial resistance genes GMI17-001 
- - blaTEM-1B - sul2 tet(A) drfA14 - aph(6)-ld aph(3")-lb 
BACT #141 Own tool strA (partial) strB TEM-1B mcr-1 sul2 tet(A) drfA14    
CGE tool   blaTEM-1B mcr-1 sul2 tet(A) drfA14  aph(6)-ld aph(3")-lb 
DNA Own tool strA (partial) strB TEM-1B mcr-1 sul2 tet(A) drfA14    
CGE tool   blaTEM-1B mcr-1 sul2 tet(A) drfA14  aph(6)-ld aph(3")-lb 
BACT #146 Own tool strA strB blaTEM-1B mcr-1 sul2 tet(A) drfA14    
CGE tool   blaTEM-1B mcr-1 sul2 tet(A) drfA14  aph(6)-ld aph(3")-lb 
DNA Own tool strA strB blaTEM-1B mcr-1 sul2 tet(A) drfA14    
CGE tool   blaTEM-1B mcr-1 sul2 tet(A) drfA14  aph(6)-ld aph(3")-lb 
BACT #152 Own tool - - - - - - - - - - 
CGE tool - - - - - - - - - - 
DNA Own tool - - - - - - - - - - 
CGE tool - - - - - - - - - - 
BACT #156 Own tool strA strB blaTEM-1B mcr-1 sul2 tet(A) drfA14    
CGE tool   blaTEM-1B mcr-1 sul2 tet(A) drfA14  aph(6)-ld aph(3")-lb 
DNA Own tool strA strB blaTEM-1B mcr-1 sul2 tet(A) drfA14    
CGE tool   blaTEM-1B mcr-1 sul2 tet(A) drfA14  aph(6)-ld aph(3")-lb 
BACT #170 Own tool  strB blaTEM-1B mcr-1 sul2 tet(A) drfA14    
CGE tool   blaTEM-1B mcr-1 sul2 tet(A) drfA14  aph(6)-ld aph(3")-lb 
DNA Own tool  strB blaTEM-1B mcr-1 sul2 tet(A) drfA14    
CGE tool   blaTEM-1B mcr-1 sul2 tet(A) drfA14  aph(6)-ld aph(3")-lb 
BACT #182 Own tool - - - - - - - - - - 
CGE tool   blaTEM-1B mcr-1 sul2 tet(A) drfA14  aph(6)-ld aph(3")-lb 
DNA Own tool - - - - - - - - - - 
CGE tool   blaTEM-1B mcr-1 sul2 tet(A) drfA14  aph(6)-ld aph(3")-lb 
BACT #185 Own tool strA strB TEM-1 mcr-1 sul2 tet(A)-1 drfA14 aac(6')-ly aph(6)-ld  
CGE tool   blaTEM-1B mcr-1 sul2 tet(A) drfA14  aph(6)-ld aph(3")-lb 
DNA Own tool strA strB TEM-1 mcr-1 sul2 tet(A)-1 drfA14 aac(6')-ly aph(6)-ld  
CGE tool   blaTEM-1B mcr-1 sul2 tet(A) drfA14  aph(6)-ld aph(3")-lb 
Data for the CGE tool were provided by PT-organizer and marked in light grey. 
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Table M.3: Determined antimicrobial resistance genes for the bacterial culture and DNA received  
Reference antimicrobial 
resistance genes 
GMI17-002 
aadA1 - -  aac(3)-lla - - aac(6')-
lb-cr 
aac(6')-lb blaTEM-1A - - 
BACT #141 Own tool  aadA24 
(partial) 
  aac(3)-lla aac(6')Ib-
cr (partial) 
 aac(6')Ib-cr 
(partial) 
 blaTEM-1A   
CGE tool     aac(3)-lla aac(6')lb-cr  aac(6')lb-cr  blaTEM-1A   
DNA Own tool  aadA24 
(partial) 
   aac(6')Ib-
cr (partial) 
 aac(6')Ib-cr 
(partial) 
 blaTEM-1A   
CGE tool     aac(3)-lla aac(6')lb-cr  aac(6')lb-cr  blaTEM-1A   
BACT #146 Own tool aadA1  aac(3)-IId  aac(3)-lla aac(6')lb-cr  aac(6')lb-cr  blaTEM-1A blaTEM-1B  
CGE tool aadA1  aac(3)-IId  aac(3)-lla aac(6')lb-cr aac(6')-lb aac(6')lb-cr aac(6')-lb  blaTEM-1B  
DNA Own tool aadA1  aac(3)-IId  aac(3)-lla aac(6')lb-cr  aac(6')lb-cr  blaTEM-1A blaTEM-1B  
CGE tool aadA1  aac(3)-IId  aac(3)-lla aac(6')lb-cr aac(6')-lb aac(6')lb-cr aac(6')-lb  blaTEM-1B  
BACT #156 Own tool  aadA24 aac(3)-IId   aac(6')lb-cr  aac(6')lb-cr  blaTEM-1A   
CGE tool   aac(3)-IId  aac(3)-lla aac(6')lb-cr  aac(6')lb-cr  blaTEM-1A   
DNA Own tool  aadA24 aac(3)-IId   aac(6')lb-cr  aac(6')lb-cr  blaTEM-1A   
CGE tool      aac(6')lb-cr aac(6')-lb aac(6')lb-cr aac(6')-lb blaTEM-1A   
BACT #170 Own tool   aac(3)-IId   aac(6')-Ib-
cr 
 aac(6')lb-cr  blaTEM-1A   
CGE tool   aac(3)-IId  aac(3)-lla aac(6')lb-cr  aac(6')lb-cr  blaTEM-1A   
DNA Own tool   aac(3)-IId   aac(6')Ib-
cr-1 
 aac(6')Ib-
cr-1 
  blaTEM-1B  
CGE tool   aac(3)-IId  aac(3)-lla aac(6')lb-cr  aac(6')lb-cr   blaTEM-1B  
BACT #182 Own tool - - - - - - - - - - - - 
CGE tool   aac(3)-IId   aac(6')lb-cr  aac(6')lb-cr  blaTEM-1A   
DNA Own tool - - - - - - - - - - - - 
CGE tool   aac(3)-IId   aac(6')lb-cr  aac(6')lb-cr   blaTEM-1B  
BACT #185 Own tool    aac(6')-Iy aac(3)-lla aac(6')-Ib-
cr 
 aac(6')-Ib-
cr 
   TEM-191-p 
CGE tool   aac(3)-IId   aac(6')lb-cr  aac(6')lb-cr   blaTEM-1B  
DNA Own tool    aac(6')-Iy aac(3)-lla aac(6')-Ib-
cr 
 aac(6')-Ib-
cr 
   TEM-191-p 
CGE tool   aac(3)-IId   aac(6')lb-cr  aac(6')lb-cr   blaTEM-1B  
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Reference antimicrobial 
resistance genes 
GMI17-002, continued 
blaCTX-M-15 - blaOXA-1 blaOXA-9 blaOXA-10 mph(A) - catB4 cmlA1 ARR-3 sul1 - - - 
BACT #141 Own tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1 blaDHA-
1(partial) 
  
CGE tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1 blaDHA-1   
DNA Own tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1 blaDHA-
1(partial) 
  
CGE tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1 blaDHA-1   
BACT #146 Own tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1    
CGE tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1 blaDHA-1   
DNA Own tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1    
CGE tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1 blaDHA-1   
BACT #156 Own tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A) catB3  cmlA1 ARR-3 sul1 blaDHA-1   
CGE tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1 blaDHA-1   
DNA Own tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A) catB3  cmlA1 ARR-3 sul1 blaDHA-1   
CGE tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1 blaDHA-1   
BACT #170 Own tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1    
CGE tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1 blaDHA-1   
DNA Own tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1    
CGE tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1 blaDHA-1   
BACT #182 Own tool - - - - - - - - - - - - - - 
CGE tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1 blaDHA-1   
DNA Own tool - - - - - - - - - - - - - - 
CGE tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1 blaDHA-1   
BACT #185 Own tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)   cmlA1 ARR-3 sul1  gyrA_SET 
[83:S-Y;87:D-G] 
parC_SET 
[57:T-S;80:S-I] 
CGE tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1 blaDHA-1   
DNA Own tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)   cmlA1 ARR-3 sul1  gyrA_SET 
[83:S-Y;87:D-G] 
parC_SET 
[57:T-S;80:S-I] 
CGE tool blaCTX-M-15 blaNDM-1 blaOXA-1 blaOXA-9 blaOXA-10 mph(A)  catB4 cmlA1 ARR-3 sul1 blaDHA-1   
Data for the CGE tool were provided by PT-organizer and marked in light grey. 
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Table M.4: Determined antimicrobial resistance genes for the bacterial culture and DNA received 
 
Reference antimicrobial 
resistance genes 
GMI17-003 
aadA5 aac(3)-lld aac(6')lb-
cr 
blaTEM-1B blaNDM-7 blaOXA-1 - mph(A) catA1 catB3 sul1 dfrA17 - - 
BACT #141 Own tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
CGE tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
DNA Own tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
CGE tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
BACT #146 Own tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
CGE tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
DNA Own tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
CGE tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
BACT #152 Own tool - - - - - - - - - - - - - - 
CGE tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
DNA Own tool - - - - - - - - - - - - - - 
CGE tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
BACT #156 Own tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
CGE tool    blaTEM-1B     catA1      
DNA Own tool - - - - - - - - - - - - - - 
CGE tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
BACT #170 Own tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3  dfrA17   
CGE tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
DNA Own tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3  dfrA17   
CGE tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
BACT #182 Own tool - - - - - - - - - - - - - - 
CGE tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
DNA Own tool - - - - - - - - - - - - - - 
CGE tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
BACT #185 Own tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1 mdf(A) mph(A) catA1 catB3  dfrA17 gyrA_EC2[83:S-
L;87:D-N] 
parC_EC2[80:S-
I;84:E-G;88:L-Q] 
CGE tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
DNA Own tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1 mdf(A) mph(A) catA1 catB3  dfrA17 gyrA_EC2[83:S-
L;87:D-N] 
parC_EC2[80:S-
I;84:E-G;88:L-Q] 
CGE tool aadA5 aac(3)-IId aac(6')Ib-cr blaTEM-1B blaNDM-7 blaOXA-1  mph(A) catA1 catB3 sul1 dfrA17   
Data for the CGE tool were provided by PT-organizer and marked in light grey. 
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Table M.5: Determined antimicrobial resistance genes for the bacterial culture and DNA received  
 
  GMI17-004 
Reference antimicrobial resistance genes aadA1 strA - blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1 aph(3")-lb aph(6)-ld - 
BACT #141 Own tool aadA1 strA strB blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1    
CGE tool aadA1   blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1 aph(3")-lb aph(6)-ld  
DNA Own tool aadA1 strA strB blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1    
CGE tool aadA1   blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1 aph(3")-lb aph(6)-ld  
BACT #146 Own tool aadA1 strA strB blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1    
CGE tool aadA1   blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1 aph(3")-lb aph(6)-ld  
DNA Own tool aadA1 strA strB blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1    
CGE tool aadA1   blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1 aph(3")-lb aph(6)-ld  
BACT #152 Own tool - - - - - - - - - - - - 
CGE tool aadA1   blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1 aph(3")-lb aph(6)-ld  
DNA Own tool - - - - - - - - - - - - 
CGE tool aadA1   blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1 aph(3")-lb aph(6)-ld  
BACT #156 Own tool aadA1 strA strB blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1    
CGE tool aadA1   blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1 aph(3")-lb aph(6)-ld  
DNA Own tool aadA1 strA strB blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1    
CGE tool aadA1   blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1 aph(3")-lb aph(6)-ld  
BACT #170 Own tool aadA1 strA strB blaTEM-1B mcr-1_1 sul1 sul2 tet(A) drfA1    
CGE tool aadA1   blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1 aph(3")-lb aph(6)-ld  
DNA Own tool aadA1 strA strB blaTEM-1B mcr-1_1 sul1 sul2 tet(A) drfA1    
CGE tool aadA1   blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1 aph(3")-lb aph(6)-ld  
BACT #182 Own tool - - - - - - - - - - - - 
CGE tool aadA1   blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1 aph(3")-lb aph(6)-ld  
DNA Own tool - - - - - - - - - - - - 
CGE tool aadA1   blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1 aph(3")-lb aph(6)-ld  
BACT #185 Own tool  strA strB blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1  aph(6)-ld mdf(A) 
CGE tool aadA1   blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1 aph(3")-lb aph(6)-ld  
DNA Own tool  strA strB blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1  aph(6)-ld mdf(A) 
CGE tool aadA1   blaTEM-1B mcr-1 sul1 sul2 tet(A) drfA1 aph(3")-lb aph(6)-ld  
Data for the CGE tool were provided by PT-organizer and marked in light grey.
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Table M.6: Determined antimicrobial resistance genes for the bacterial culture and DNA received  
 
Reference antimicrobial resistance genes GMI17-005 
- mecC - 
BACT #141 Own tool mecA  norA 
CGE tool  mecC  
DNA Own tool mecA  norA 
CGE tool  mecC  
BACT #146 Own tool mecA  norA 
CGE tool  mecC  
DNA Own tool mecA  norA 
CGE tool  mecC  
BACT #152 Own tool - - - 
CGE tool  mecC  
DNA Own tool - - - 
CGE tool  mecC  
BACT #156 Own tool mecA  norA 
CGE tool  mecC  
DNA Own tool mecA  norA 
CGE tool  mecC  
BACT #170 Own tool mecA  norA 
CGE tool  mecC  
DNA Own tool mecA  norA 
CGE tool  mecC  
BACT #182 Own tool - - - 
CGE tool  mecC  
DNA Own tool - - - 
CGE tool  mecC  
BACT #185 Own tool  mecC  
CGE tool  mecC  
DNA Own tool  mecC  
CGE tool - - - 
 Data for the CGE tool were provided by PT-organizer and marked in light grey. 
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Table M.7: Determined antimicrobial resistance genes for the bacterial culture and DNA received  
Reference antimicrobial 
resistance genes 
GMI17-006 
 spc blaZ mecA - Isa(B) crf Inu(B) fexA tet(K) tet(M) drfG - 
BACT #141 Own tool str spc blaZ mecA norA Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
CGE tool str spc blaZ mecA  Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
DNA Own tool str spc blaZ mecA norA Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
CGE tool str spc blaZ mecA  Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
BACT #146 Own tool str spc blaZ mecA norA Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
CGE tool str spc blaZ mecA  Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
DNA Own tool str spc blaZ mecA norA Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
CGE tool str spc blaZ mecA  Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
BACT #152 Own tool - - - - - - - - - - - - - 
CGE tool str spc blaZ mecA  Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG catA1 
DNA Own tool - - - - - - - - - - - - - 
CGE tool str spc blaZ mecA  Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
BACT #156 Own tool str spc  mecA norA Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
CGE tool str spc blaZ mecA  Isa(B) cfr Inu(B) fexA  tet(M) dfrG  
DNA Own tool str spc  mecA norA Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
CGE tool str spc blaZ mecA  Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
BACT #170 Own tool str spc blaZ mecA norA Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
CGE tool str spc blaZ mecA  Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
DNA Own tool str spc blaZ mecA norA Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
CGE tool str spc blaZ mecA  Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
BACT #182 Own tool - - - - - - - - - - - - - 
CGE tool str spc  mecA  Isa(B) cfr Inu(B) fexA  tet(M) dfrG  
DNA Own tool - - - - - - - - - - - - - 
CGE tool str spc blaZ mecA  Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
BACT #185 Own tool str  blaZ mecA  Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
CGE tool str spc blaZ mecA  Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
DNA Own tool str  blaZ mecA  Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
CGE tool str spc blaZ mecA  Isa(B) cfr Inu(B) fexA tet(K) tet(M) dfrG  
Data for the CGE tool were provided by PT-organizer and marked in light grey.
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Legend to the following box plot figures (Figures M.1 to M.29): 
 
Plot A shows results for all the available samples (excluding the ones with wrong MLST sequence type). 
Red and blue lines indicate ± 2 and ± 3 standard deviations, respectively. 
 
Plot B is an extract from plot A and shows the interquartile ranges of the distribution from plot A. 
 
Boxplot points (red dots) indicate outlying values. 
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Figure M.1: Size of assembled genome 
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Figure M.2: Size of assembled genome per total size of DNA sequence 
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Figure M.3: Q-score, R1 
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Figure M.4: Q-score, R2 
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Figure M.5: Total number of reads 
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Figure M.6: Number of reads after trimming 
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Figure M.7: Number of reads mapped to reference DNA sequence 
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Figure M.8: Proportion of reads mapped to reference DNA sequence 
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Figure M.9: Number of reads mapped to reference chromosome 
 
ENGAGE 
 
 
 
www.efsa.europa.eu/publications 233 EFSA Supporting publication 2018:EN-1431 
The present document has been produced and adopted by the bodies identified above as author(s). In accordance with Article 36 of Regulation (EC) No 178/2002, this task has been carried out exclusively by the author(s) in the context of a 
grant agreement between the European Food Safety Authority and the author(s). The present document is published complying with the transparency principle to which the Authority is subject. It cannot be considered as an output adopted 
by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). 
 
 
Figure M.10: Number of unmapped reads 
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Figure M.11: Number of reads mapped to reference plasmid 1 
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Figure M.12: Number of reads mapped to reference plasmid 2 
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Figure M.13: Number of reads mapped to reference plasmid 3 
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Figure M.14: Number of reads mapped to reference plasmid 4 
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Figure M.15: Depth of coverage, total DNA sequence 
 
ENGAGE 
 
 
 
www.efsa.europa.eu/publications 239 EFSA Supporting publication 2018:EN-1431 
The present document has been produced and adopted by the bodies identified above as author(s). In accordance with Article 36 of Regulation (EC) No 178/2002, this task has been carried out exclusively by the author(s) in the context of a 
grant agreement between the European Food Safety Authority and the author(s). The present document is published complying with the transparency principle to which the Authority is subject. It cannot be considered as an output adopted 
by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). 
 
 
Figure M.16: Depth of coverage chromosome sequence 
 
ENGAGE 
 
 
 
www.efsa.europa.eu/publications 240 EFSA Supporting publication 2018:EN-1431 
The present document has been produced and adopted by the bodies identified above as author(s). In accordance with Article 36 of Regulation (EC) No 178/2002, this task has been carried out exclusively by the author(s) in the context of a 
grant agreement between the European Food Safety Authority and the author(s). The present document is published complying with the transparency principle to which the Authority is subject. It cannot be considered as an output adopted 
by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). 
 
 
Figure M.17: Depth of coverage, plasmid 1 sequence 
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Figure M.18: Depth of coverage, plasmid 2 sequence 
 
ENGAGE 
 
 
 
www.efsa.europa.eu/publications 242 EFSA Supporting publication 2018:EN-1431 
The present document has been produced and adopted by the bodies identified above as author(s). In accordance with Article 36 of Regulation (EC) No 178/2002, this task has been carried out exclusively by the author(s) in the context of a 
grant agreement between the European Food Safety Authority and the author(s). The present document is published complying with the transparency principle to which the Authority is subject. It cannot be considered as an output adopted 
by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). 
 
 
Figure M.19: Depth of coverage, plasmid 3 sequence 
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Figure M.20: Depth of coverage, plasmid 4 sequence 
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Figure M.21: Coverage of the reference chromosome 
 
ENGAGE 
 
 
 
www.efsa.europa.eu/publications 245 EFSA Supporting publication 2018:EN-1431 
The present document has been produced and adopted by the bodies identified above as author(s). In accordance with Article 36 of Regulation (EC) No 178/2002, this task has been carried out exclusively by the author(s) in the context of a 
grant agreement between the European Food Safety Authority and the author(s). The present document is published complying with the transparency principle to which the Authority is subject. It cannot be considered as an output adopted 
by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). 
 
 
Figure M.22: Coverage of reference plasmid 1 
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Figure M.23: Coverage of reference plasmid 2 
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Figure M.24: Coverage of reference plasmid 3 
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Figure M.25: Coverage of reference plasmid 4 
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Figure M.26: Average insert size 
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Figure M.27: Total number of contigs 
 
ENGAGE 
 
 
 
www.efsa.europa.eu/publications 251 EFSA Supporting publication 2018:EN-1431 
The present document has been produced and adopted by the bodies identified above as author(s). In accordance with Article 36 of Regulation (EC) No 178/2002, this task has been carried out exclusively by the author(s) in the context of a 
grant agreement between the European Food Safety Authority and the author(s). The present document is published complying with the transparency principle to which the Authority is subject. It cannot be considered as an output adopted 
by the Authority. The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the author(s). 
 
 
Figure M.28: Number of contigs > 200 bp 
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Figure M.29: N50 
 
 
